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Abstract 
 
This thesis explores the experiences and perceptions of people living with Leber 
hereditary optic neuropathy (LHON) and the healthcare professionals charged with 
diagnosing and treating the condition. LHON is the first disease linked to a 
mitochondrial mutation, characteristically resulting in bilateral sight loss over a 
period of 6‒12 weeks from the initial onset and predominantly (but not exclusively) 
affecting young men in their teens and early twenties. As with other mitochondrial 
conditions, there is currently no cure for LHON, and treatment options to slow the 
progress of the condition are limited. Qualitative research exploring the effect of 
LHON following a sudden and dramatic loss of sight has been absent from the 
literature. Addressing this gap, my study involves: (1) semi-structured interviews 
(N=41) with affected men and women, mothers who carry the condition, and genetic 
ophthalmologists; (2) participant observation over a period of nine months in two 
genetic ophthalmology clinics located in UK hospitals. Drawing upon key theoretical 
and empirical contributions from medical sociology and beyond, such as the work 
of Bury (1982) and Charmaz (1983), I explore the past, present and future lives of 
people with LHON by describing their chronic illness trajectory. Drawing 
predominantly on the interview data, I document their experience of the initial 
symptoms of sight loss, the challenges of receiving a formal diagnosis (as an 
uncertain, contested and often misdiagnosed condition), the aftermath of receiving 
a genetic diagnosis for participants and their wider family, and the disruption to 
everyday, mundane moments in people’s daily lives. Moreover, I unpack how people 
restore their former self-images (Charmaz 1987, 1991), gain control over their lives, 
and regain some sense of ‘normality’ (Davis 1995), whilst also reflecting on future 
aspirations with respect to treatment options and reproductive imaginaries. To 
conclude, I acknowledge how my thesis contributes to knowledge by uncovering the 
multi-faceted experience of people living with sudden bilateral sight loss—a group 
who have, thus far, been invisible in the sociological literature. 
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Chapter One: Introduction 
 
This thesis provides an account of the experiences and perceptions of a group of 
people living with Leber hereditary optic neuropathy (LHON) and the healthcare 
professionals charged with diagnosing and treating the condition. LHON is a 
neurodegenerative disease characteristically resulting in bilateral sight loss over a 
period of 6‒12 weeks from the initial onset, and predominantly (but not 
exclusively), affecting young males in their teens and early twenties. It is also one of 
the most common inherited optic neuropathies encountered in clinical practice 
(Abu-Amero 2011; Yu-Wai-Man et al. 2014).1  
LHON was originally suspected of being an X-linked2 disease until Erickson (1972) 
suggested that the inheritance of the condition was compatible with maternal 
inheritance, indicating that LHON was an underlying mutation of mitochondrial 
DNA (mtDNA) (Yen et al. 2006). In 1988, Wallace et al. confirmed for the first time 
the link between mtDNA mutations and human disease, with LHON caused by a 
point mutation—namely m.11778G>A—within the mitochondrial genome (Wallace 
1988). This was followed by the discovery in 1991 of the m.3460G>A mutation 
(Howell et al. 1991; Huoponen et al. 1991) and in 1992 the m.14484T>C mutation 
(Johns et al. 1992; Mackey and Howell 1992). Over 95 per cent of LHON cases have 
been identified as attributable to one of these pathogenic mutations and classed as 
a rare mitochondrial disease (i.e. affecting less than 5 in 10,000 of the general 
population Rare Disease UK 2016), with on average approximately 30 new cases a 
year across the UK (Moore and Burton 2008). However, this figure may be 
underestimated as the condition is often misdiagnosed in clinical practice (Moore 
                                                          
1 In England and Wales, inherited optic neuropathies affect at least 1 in 10,000 of the population 
(Newman and Biousse 2004) and are a significant cause of certifiable blindness (Yu-Wai-Man et al. 
2014,) accounting for approximately 20.2 of the Certificates of Visual Impairment (CVI) issued to 
adults (aged 16‒64) (Liew et al. 2014). 
2 Females have two copies of the X chromosome, one of which will almost certainly be normal and, 
thus, compensate for the faulty chromosome. Males have one X chromosome and one Y chromosome, 
and so do not have the ‘normal’ X chromosome to compensate. As such men can develop X-linked 
conditions, such as, Duchenne muscular dystrophy, haemophilia and fragile X syndrome. 
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and Burton 2008). As with other mitochondrial conditions, there is currently no cure 
and treatment options to slow the progress of LHON are limited.  
LHON displays a marked gender bias, and is characterised by incomplete 
penetrance, which means that not all carriers will lose their sight.  Approximately 
50 per cent of males and approximately 10 per cent of females who carry the 
mutation developing sight loss, typically between the ages of 15 and 35 (Newman 
and Biousse 2004; Yu-Wai-Man et al. 2014). Approximately 90 per cent of carriers 
will become symptomatic before the age of 50 (Spruit et al. 2006; Yu-Wai-Man and 
Chinnery 2011). However, there are reports of the condition occurring in children 
as young as two years old and in adults in their 70s and 80s (Chinnery et al. 2001; 
Newman and Biousse 2004; Yu-Wai-Man et al. 2011). 
LHON is a disease that targets the optic disc (also referred to as the optic nerve 
head—which connects the eye to the brain) and the retina (the light-sensitive tissue 
lining the back of the eye), both of which are contained within the posterior segment 
of the eye (Appendix 1). The disease is characterised by the selective loss of retinal 
ganglion cells (which transmit visual information from the retina to the brain), 
leading to optic atrophy (death of cells) and blindness. In the pre-symptomatic 
phase, people may become aware of problems with colour vision (dyschromatopsia) 
along the red‒green axis (Yu-Wai-Man et al. 2011). In the acute phase, people 
experience painless blurring of the central vision in one eye over a period of 6‒12 
weeks (Man et al. 2002; Hudson et al. 2007), with the fellow eye becoming affected, 
on average, within one year (Yu-Wai-Man et al. 2014). It is unusual for people with 
LHON to experience loss of vision in only one eye (Yu-Wai-Man and Chinnery 2011). 
The visual acuity (clarity of vision) at the point of maximum sight loss can range 
from only experiencing light perception, or only being able to see hand movements. 
In the majority of cases the sight loss is permanent, and people are registered as 
severely sight impaired (previously referred to as blind). 
The genes that cause LHON can be found in the DNA of cellular structures, 
mitochondria which are the minute structures present in the cytoplasm (the gel-like 
substance enclosed within the cell membrane) of the cells in the human body and 
are responsible for converting enzymes (sugars and fats) into the energy required 
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for the cells to function efficiently. They have been described as the ‘powerhouse’ or 
‘batteries’ of the cell (Nuffield Council on Bioethics 2012: 18). Mitochondrial disease 
is the umbrella term given to a diverse group of progressive and multisystem 
diseases which occur at any age (Haas 2007; Munnich et al. 1996). Women pass on 
mitochondrial DNA to their children via the mitochondria in their egg. Although men 
can inherit a mitochondrial disease, they cannot pass it onto their children. 
Mitochondrial diseases vary in severity, have the potential to cause chronic 
morbidity, and can prove fatal. Unpredictable in nature, the symptoms of 
mitochondrial diseases may vary between individuals, ranging from no apparent 
symptoms to life-threatening conditions. 
This thesis 
Only limited scholarship has considered the lived experience of people living with 
LHON, with the exception of three previous research studies, which adopted a 
psychological perspective, utilising quantitative (Kirkman et al. 2009b; Dator 2014) 
and qualitative research methods (Ferguson and de Abreu 2016). Kirkman et al.’s 
(2009b) research used questionnaires to assess the quality of life of LHON carriers 
from the UK, Netherlands and Germany. Dator’s (2014) PhD thesis used an on-line 
survey to assess psychological distress experienced by 65 unaffected mothers and 
52 unaffected siblings following the diagnosis of an affected relative. The third study, 
conducted by Fergusson and de Abreu (2016), used in-depth interviews to explore 
the lived experience of seven men following a LHON diagnosis. There are no 
sociological studies that have considered the impact of LHON. My thesis plugs this 
gap. 
The aim of this thesis is to adopt qualitative research methods to gather rich, 
informative, textured data to explore the impact of LHON on individuals and how 
relationships within the family are re-negotiated following a LHON diagnosis. Using 
participant observation undertaken over a period of nine months in two genetic 
ophthalmology clinics located in UK hospitals, and  in-depth interviews (N=41), I 
unpack the experience of children and young people living with sight loss as a result 
of LHON; adults who have experienced sight loss later in life; mothers who carry the 
LHON mutation and who have given birth to a child who subsequently loses their 
sight; and women who are considering their reproductive options knowing that, if 
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they conceive ‘naturally’, they will pass LHON on to their children. I also uncover the 
experiences of visually impaired mothers bringing up sighted children. 
This thesis is located within a long tradition of sociological scholarship including key 
theoretical and empirical contributions from medical sociology and beyond, such as 
the work of Bury (1982), Charmaz (1983, 1987) and Goffman (1959, 1968), which 
has explored individuals’ subjective experience of living with chronic illness. 
Grounded in key contributions of how chronic illness is an assault on the integrity 
of the body and the self (Frank 1995; Charmaz 1983, 1987), I explore participants’ 
narratives to highlight the impact of sudden sight loss on their sense of self and how 
this amounts to a ‘biographical disruption’, that is, a ‘disruption of taken-for-granted 
assumptions and behaviours’ followed by a ‘re-thinking of a person’s biography and 
self-concept’ (Bury 1982: 168). Adopting Bury’s conceptual framework I seek to 
understand the stories of individuals—as ‘wounded storytellers’ in body and voice 
(Frank 1996: xi) — and how they account to others for their sight loss. During in-
depth interviews I facilitate participants in uncovering their past, explicating their 
present and imagining their future. Illness narratives, identified by Frank (1995), 
resonate with participants in this study: (1) restitution (returning to the former 
self); (2) chaos (trying to make sense of the illness and not envisaging returning to 
normal health), and; (3) quest (striving to achieve a new self).  
Similar to Frank’s observations, participants in this study move through a number 
of stages commencing with the pre-diagnosis—where symptoms are first 
experienced, and the quest for a diagnosis begins. Often, the diagnosis is not 
forthcoming. LHON is frequently misdiagnosed by ophthalmologists who have not 
previously encountered the condition in clinical practice, relegating participants to 
the status of what Jeffrey (1979: 90) refers to as ‘normal rubbish’. Patients are 
judged by healthcare professionals, in such instances, to be time-wasters or 
attention seekers who fabricate their symptoms. Failure to attach a label or give a 
name to their symptom’s often means that they become ‘medical orphans’ 
(Aronowitz 2001: 803) and are often denied entry to the Parsonian (1951) ‘sick 
role’, thus being deprived of the opportunity to access welfare benefits, employment 
and educational support.  
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In the months which follow the diagnosis, participants strive to achieve a sense of 
equilibrium. Experiencing biographical disruption, they seek to make sense of their 
altered position, including questioning why this has happened to them. It is in this 
stage that they are no longer able to undertake taken-for-granted mundane tasks, 
such as making a cup of tea, reading a newspaper or using their mobile phone. 
However, with the passing of time, some participants move into the process of 
narrative reconstruction (Williams 1984) and, through biographical repair work, 
they commence the process of ‘reconstructing the self’. By adopting coping 
strategies to restore their former self-images (Charmaz 1987: 296), and become 
what Frank (1995: 62) refers to as ‘successfully ill’, participants see themselves 
arriving at the point of moving on with their lives. 
In the final stage of participants’ sight loss, the majority of them look to the future. 
Irrespective of age or gender, they claim that they have the same aspirations as 
others —such as having a successful career, being financially independent, buying 
their first home, getting married, and having children. However, not all participants 
reach this point. Some continue their quest to find answers for their sight loss and, 
by adopting narratives of hope, they invest emotionally and, in some cases, 
financially in finding new treatment options to cure their sight loss. I am not 
suggesting that participants move through the stages in a linear fashion; some move 
between the stages mirroring the wider sight loss literature. Indeed, over time they 
moved back and forth, experiencing what Charmaz (1991: 51) characterises as ‘good 
days’ and ‘bad days’.   
Based on the aims of this research, and a review of the sight loss and chronic illness 
literature, this thesis addresses the following broad research question: 
What are the subjective experiences and perceptions of people affected by 
LHON, and how are relationships within the family renegotiated following 
the diagnosis?  
 
The following subsidiary questions are addressed in the thesis: 
 
1. What are the challenges presented to genetic ophthalmologists in the 
diagnosis and treatment of LHON? 
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2. To what extent does LHON disrupt an individual’s biography and what are 
the implications for their identity and sense of self?  
3. How do people with LHON imagine their future? 
4 Are women influenced by their experiential knowledge of LHON when 
making reproductive decisions?  
 
 
Thesis structure 
This thesis comprises eight chapters. Having introduced my research in this opening 
chapter, in Chapter Two, I explore the previous sight loss literature which is 
primarily located within psychology and disability studies. LHON is a chronic 
condition as, although not terminal, it currently has no cure. Given the paucity of 
sociological scholarship exploring the experiences of living with sudden sight loss, I 
draw on the chronic illness literature, identifying key themes including uncertainty, 
biographical disruption (Bury 1982), loss of self (Charmaz 1983, 1987), and stigma 
(Goffman 1968), in order to ground my arguments.  
Chapter Three outlines the methodological approach I adopted in addressing the 
research questions. I outline the process of obtaining NHS ethical and R&D approval 
to undertake data collection in two UK hospitals. I detail the practical difficulties I 
encountered in accessing an unco-operative site, and the impact that this had on my 
original intention to undertake an ethnographic study.  
Chapter Four marks the beginning of the empirical chapters. I begin the chapter by 
describing how some participants initially ignored their symptoms. Medical 
attention was often sought only when participants were no longer able to undertake 
everyday mundane tasks. Drawing upon interview data and some participant 
observations, I unpack how a LHON diagnosis is accomplished in the eye clinic. Here, 
I recognise how LHON is the subject of diagnostic uncertainty and contestation as it 
is frequently misdiagnosed by ophthalmologists who have not yet encountered the 
condition in clinical practice.  
Chapter Five considers the initial reactions of participants to sudden sight loss. Here 
I draw upon Bury’s (1982, 1987, 1991) concept of biographical disruption to explore 
how following their diagnosis, participants cope with the emotional impact of 
experiencing sudden sight loss. A genetic diagnosis has repercussions for both the 
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immediate and extended family. I explore the complex moral dilemmas that arise 
when decisions are made to tell or withhold information from relatives who may 
also be at risk of developing LHON. Finally, I consider notions of guilt and self-blame 
(Arribas-Ayllon et al. 2008) experienced by mothers who were unaware of their 
carrier status when their children were conceived.  
Chapter Six explores the longer-term implications of living with LHON. Once again, 
I draw upon Bury’s conceptual framework of biographical disruption. Bury explicitly 
referred to biographical disruption as an event occurring at the onset of chronic 
illness, however, I suggest that his concept is relevant when exploring the longer-
term consequences of living with LHON as participants reported experiencing 
repeated incidents of disruption throughout the trajectory of the condition, 
irrespective of the age of onset.  
Chapter Seven looks to the future by considering participants’ narratives of hope 
associated with the development of new treatment options, which are currently the 
subject of clinical trials, to restore sight. Drawing predominantly on interview data 
and some observational data, I locate my discussion within the sociology of hope 
(Petersen and Wilkinson 2014; Brown et al. 2015; Petersen 2015). This chapter is 
presented in two parts. In the first, I introduce the concept of hope and explore how 
participants invest both emotionally and, in some cases, financially in a new drug 
designed to restore sight. In the second part, I explore narratives of hope associated 
with the use of mitochondrial replacement techniques (MRTs) to avoid the birth of 
a child with LHON.  
In Chapter Eight I conclude the thesis by further unpacking the findings of the 
empirical chapters. I reflect on the research questions posed in the introductory 
chapter and discuss to what extent I have answered them. I will discuss how my 
research addresses the gaps identified in previous LHON and wider sight loss 
studies. However, I will also discuss how my findings have highlighted the 
inadequacies of ophthalmology training, particularly in the diagnosis of LHON, 
which potentially have repercussions for the effectiveness of new treatment 
options. I will also refer to the variability in the provision of genetic counselling and 
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referrals to Local Authority Sensory Impairment Services in England and Wales. 
Finally, I briefly outline suggestions for future research. 
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Chapter Two: Literature Review 
 
Introduction   
In the previous chapter, I explained that the aim of this thesis is to use qualitative 
research to explore the subjective experiences and perceptions of people living with 
Leber hereditary optic neuropathy (LHON). In this chapter, I consider the previous 
sight loss literature to provide context for the four empirical chapters that follow. 
Recently, the scientific literature reviewing the pathogenesis of LHON has increased 
considerably. This renewed interest is, in part, attributable to the promise of new 
treatments currently the subject of clinical trials in the UK, Europe and North 
America. While I discuss the small number of psychological studies exploring 
individual experiences of LHON, there have been, as yet, no research looking at 
LHON from a sociological perspective. Therefore, this review will draw on the wider 
sight loss literature located within medical sociology, psychology and disability 
studies. By bringing together contributions from the three disciplines, I unpack the 
depth and breadth of the individual experience of sight loss.  
This chapter will be presented in three sections. In the first section, I consider the 
key findings from three research studies (located within psychology studies). The 
studies have adopted both quantitative (Kirkman et al. 2009b; Dator 2014) and 
qualitative (Ferguson and de Abreu 2016) research methods to explore the 
experiences of people affected by, or who are carriers of, the LHON mutation. In 
section two, I review the wider sight loss literature. LHON is characterised by 
sudden (bilateral) sight loss, presenting unique challenges to individuals. As such I 
therefore focus on research undertaken with people with acquired (as opposed to 
congenital) sight loss. Given the paucity of the current LHON sight loss literature, I 
include in this literature review, research exploring sudden traumatic sight loss 
experienced by ex-service personnel. In addition, I have taken the decision to 
include research that considers progressive eye conditions. My rationale for 
adopting this approach is that although the manner of the sight loss may vary, I 
would suggest that both groups ultimately face the same challenges in coping with 
their sight loss. Finally, drawing on Goffman’s (1968) work on stigma together with 
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other contributions, I explore how stigmatising attitudes towards the visually 
impaired shape their decisions to disclose or conceal their disability.  
It is evident from reviewing the sight loss literature, that the primary focus of this 
work has been on the ‘medical model of disability’, which depicts disability as ‘an 
individual failing and a personal tragedy’ (Barnes and Mercer 2010: 1). In focusing 
on the medical model, such research highlights symptoms, diagnosis and treatment, 
with scant regard given to the social model of disability which acknowledges that, 
by adopting disabling practices, it is society that marginalises those who are living 
with a disability (Thomas 2004, 2007; Scambler 2009; Barnes and Mercer 2010). In 
his research with visually impaired people living in New York, Ainlay (1989—cited 
in Green et al. 2002: 258) laments the ‘sighted world that has systematically avoided 
the world of blindness and segregated those who experience it from mainstream 
life’. 
 In opposition to the dominance of the medical model, there is an evolving body of 
sociological scholarship which considers the challenges encountered by the visually 
impaired in their everyday interactions with sighted persons (Hetherington 1999, 
2000; Schillmeier 2006, 2007a, 2007b, 2008; Måseide and Grøttland 2015). Måseide 
and Grøttland (2015: 594) note that, for the visually impaired, ‘sharing physical and 
social space with the sighted may imply special challenges for blind persons with 
regard to interaction order and social identities’. Similarly, in his ethnographic 
research with the visually impaired, Schillmeier (2007a: 195) observes how 
‘ordinary acts of everyday life make up the complex and contingent scenarios of 
disabilities and create enabling and disabling (dis/abling) practices’. 
This literature is situated alongside the chronic illness scholarship that explores the 
experience of individuals living with illness, disease and/or disability. The 
narratives of the participants in this thesis regarding the diagnosis and prognosis of 
LHON parallel key themes in the chronic illness scholarship including biographical 
disruption (Bury 1982), loss of self (Charmaz 1983), uncertainty (Fox 1957; 
Atkinson 1984, 1995), and stigmatisation (Goffman 1968). Over the next three 
sections I will draw upon these key theoretical and empirical contributions from 
sociology and the wider sight loss literature to explore the lived experience of 
individuals and their families following a LHON diagnosis. 
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Previous LHON research 
 
There is limited qualitative research in sociology which explores the lived 
experience of LHON. In this section, I refer to three studies, that explore the 
experiences of people who are affected by or are carriers of the LHON mutation. 
Kirkman and colleagues (2009b) undertook a large scale quantitative study to 
evaluate the quality of life of LHON carriers (196 affected with sight loss and 206 
unaffected carriers) from the UK, Netherlands and Germany. Telephone interviews 
were conducted using the visual function index (VF-14) questionnaire,3 with the 
findings concluding that LHON had a strong detrimental impact on the majority of 
the activities associated with daily living and quality of life. When compared with 
research undertaken with other inherited and acquired ophthalmic conditions, 
LHON was associated with the worst mean VF-14 score, attributable to the fact that 
the majority of the LHON participants had been issued with a certificate of visual 
impairment (CVI).4 The study also concluded that the VF-14 score did not worsen 
over time. The authors also refer to previous clinical research undertaken by Van 
Senus (1963) where he noted that of 352 participants diagnosed with LHON from 
27 large Dutch families, nearly half of his participants’ social and economic status 
dropped (resulting from loss of employment) following the onset of LHON.  
The second study—a PhD thesis using quantitative research methods (Dator 
2014)—examined the relationship between psychological well-being, social 
support and spirituality in unaffected carriers of LHON who have experience of 
living with an affected family member. The participants (65 mothers and 52 
siblings) were invited to complete a demographic questionnaire and four validated 
assessments (Outcome Questionnaire-45,5 via an internet survey. Dator’s findings 
suggest that both mothers and siblings experienced higher levels of psychological 
                                                          
3 The VF-14 Questionnaire measures the ability of individuals to perform 14 vision-dependent 
activities of daily living that are rated in terms of degree of difficulty, with a possible score of 5 for 
each question: 0 (unable to do), 1 (great deal of difficulty), 2 (moderate difficulty), 3 (little difficulty), 
and 4 (no difficulty) (Kirkman et al. 2009: 3113). 
4 A Certificate of Vision Impairment (CVI) is (usually) completed by a consultant ophthalmologist and 
certifies that the patient has a visual impairment. The CVI also acts as a referral to Social Services 
who instigate a care assessment (RNIB 2017). 
5The Outcome Questionnaire-45 (OQ-45) was developed by Lambert et al. (1996). The 45-item self-
report instrument requires patients to rate their functioning on a 5-point Likert scale. The OQ-45 was 
designed to access common symptoms across a wide range of adult mental disorders and syndromes, 
including stress-related illness.  
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stress than a normative sample, and siblings experienced significantly higher levels 
of interpersonal problems and social role dysfunction than a normative sample. The 
findings also indicated that mothers of affected children displayed significantly 
lower levels of psychological stress when perceiving that the levels of support from 
other family members had increased. Similarly, unaffected siblings with perceived 
higher levels of social support from other family members displayed significantly 
lower levels of psychological stress, interpersonal problems, and social role 
dysfunction.   
The two studies potentially allow the findings to be generalisable to the wider LHON 
population. However, the use of standard instruments to assess quality of life and 
psychological functioning using pre-determined responses is of limited value when 
the aim of the research—as in my thesis—is to unpack the complex emotional 
responses experienced by individuals affected by LHON and their family members 
who are also at risk of losing their sight.  
In contrast, a third (small) study on LHON (Ferguson and de Abreu 2016) used in- 
depth semi-structured interviews with seven affected men with an age range of 21‒
62 years. Focusing on their lived experience of LHON, the authors identified six key 
themes across the data, including the theme of ‘psycho-social losses’ (2016: 113), 
where the loss of vision is said to affect the individual’s ability to navigate in the 
world, resulting in irritation and decreased capabilities. Participants reported the 
loss of social/communication skills as they were unable to detect non-verbal 
communications, which led to feelings of frustration. The loss of independence and 
freedom featured strongly in the data, with participants again expressing their 
frustration when, for example, they boarded the wrong bus or train, and all of the 
participants expressing feelings of stress and frustration at their perceived loss of 
skill, ability, and independence.  
The second theme, ‘attitudes and coping strategies’ (2016: 114), documents how 
participants adopt a pragmatic approach to visual impairment by developing 
various coping strategies, such as telephoning in advance of meeting to ensure that 
the participant arrived at the right place. Theme three explores the ‘development of 
practical skills’ (2016: 115), with participants explaining how they acquired new 
skills which enabled them to use the latest assistive technologies or learnt to touch 
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type on a computer. The fourth theme explored ‘identity’ (2016: 115), where all 
participants registered as visually impaired (registration is voluntary)—
acknowledging their blind identity, and where participants who retain a good level 
of residual vision explained how this brought them into conflict with the public’s 
perception that blind people live in total darkness. The authors suggest that this 
perception results in LHON participants’ skills and abilities being overlooked when 
interacting with the sighted.   
The fifth theme that the authors discussed was ‘regaining independence’ (2016: 
116); participants adopted strategies dependent on the level of their residual vision 
to enable them to live and work independently. This included using large print on 
files to make them easier to locate at work, undertaking white cane training, learning 
new walking routes, and learning to use new assistive technologies. The final theme 
identified was that of ‘recurrent loss’ (2016: 117).  The participants acknowledged 
that there are always moments which evoke a feeling of loss for their sight. Whilst 
individuals adopted practical and emotional coping mechanisms to enable them to 
lead a fulfilling life, they also recognised that they have fewer options in life as a 
result of their sight loss, which at times leads to a feeling of loss and frustration 
reminiscent of their early period of adjustment. Ferguson and de Abreu (2016) 
suggest that one of the fundamental findings from the research is that the process of 
adjustment has no conclusion; from time to time, the challenges and restrictions of 
visual impairment overwhelmed the coping mechanisms their participants had 
developed. Despite the insight offered into the experience of living with LHON, 
Ferguson and de Abreu’s (2016: 120) study has a number of limitations. The authors 
acknowledge that their participants were active members of the LHON online 
community, the implication being that those who volunteered to be interviewed 
‘represent a sample of the population who have highly developed coping 
mechanisms allowing them to live a fulfilling life’. The study did not include affected 
women. I would suggest that including women in the research provides the 
opportunity to explore issues surrounding the inheritable nature of LHON and the 
factors that influence women’s reproductive choices. 
 
 
14 
 
Sight loss  
 
The majority of the current sight loss research is located in psychology and as such 
is mostly quantitative in nature, primarily using standard instruments to assess 
mood and social functioning (Boulton et al. 2006; Thurston 2010) and tends to focus 
on conditions that cause progressive sight loss, such as retinitis pigmentosa 
(Nemschick et al. 1986; Hayeems et al. 2005; Jangra et al. 2007; Bittner et al. 2010). 
More recently, some researchers acknowledging the inadequacy of quantitative 
research methods to explore the individual experience of visual impairment, have 
supplemented their data with in-depth semi-structured interviews (Stanford et al. 
2009; Thurston et al. 2013). 
Given the limited qualitative research exploring LHON, I unpack the literature 
exploring sudden traumatic sight loss experienced by ex-service personnel 
deployed in Iraq and Afghanistan (Stevelink et al. 2015a, 2015b; Stevelink and Fear 
2016) and research exploring progressive sight loss including glaucoma (Green et 
al. 2002), diabetic retinopathy (Devenney and O’Neill 2011) and retinitis 
pigmentosa (Hayeems et al. 2005; Fourie 2007), to identify commonalities across 
acquired sight loss conditions. According to this work (Hewson 1997; Thurston et 
al. 2010), when an individual loses their sight, they experience a number of 
responses, including: emotional responses (e.g. shock particularly when the loss is 
sudden and unexpected, sadness, anger and guilt); physical responses (e.g. 
emptiness, headaches and exhaustion); behavioural responses (e.g. isolation, 
insomnia and crying), and; cognitive responses (e.g.  denial and confusion).   
As explained in Chapter One, LHON is a condition that predominantly affects young 
people at a particularly vulnerable time in their lives, as they move from childhood 
through adolescence, ultimately arriving at adulthood. Evidence suggests that 
childhood visual impairment has the potential to adversely affect educational 
attainment (Corn et al. 2002) and the ability to participate in activities that involve 
an element of physicality, such as playing ball games (Khadka et al. 2012), leading 
to social disadvantages, including having fewer friends (Cochrane et al. 2008) and 
opportunities to socialise and develop interpersonal skills (Huurre and Aro 2000). 
Adolescents with sight loss are said to be particularly susceptible to feelings of 
worry, and to experiencing problems in forming romantic relationships, close 
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friendships and being accepted by peer groups (Pinquart and Pfeiffer 2014). Indeed, 
the process of adjusting to sight loss is said to negatively impact a child’s self-esteem. 
Research undertaken by Bowen (2010) with 60 children with visual impairment 
found that self-esteem plays a key role in determining life chances, academic success 
and mental and emotional health.  Drawing upon the work of Maslow (1968), Bowen 
(2010: 47) claims that nurturing of self-esteem is one of the top five needs in the 
hierarchy of human requirements:   
‘[…] the commodity termed self-esteem can be described as the 
procedure by which individuals set a value on themselves, appreciate 
their own worth and recognise their attributes as a person, so they can 
achieve a quiet sense of self respect in the process.’  
Research undertaken with visually impaired adults also suggests that acquired sight 
loss results in a loss of self-esteem (Lyons and Sullivan 1998) and independence 
(Horowitz 2003; Senra et al. 2011), affecting people’s capacity to fully participate in 
everyday life (Lamoureux et al. 2004; Vu et al. 2005; Senra et al. 2011). The visually 
impaired are said to feel as if they are ‘incompetent’ (Dodds 1989: 11), ‘useless’ 
(Devenney and O’Neill (2011: 712) or to have reverted to ‘child mode’ (Southwell 
2012: 111) when they attempt to undertake previously taken-for-granted tasks (for 
example, reading instructions, cooking a meal, applying makeup). This is because 
the tasks are impossible to accomplish without help from family, friends and the use 
of low vision aids (such as a white cane and magnifiers).  
Experiencing feelings of helplessness and incompetence have also been linked to an 
inability to accept sight loss (Dodds 1989). The loss of independent living skills, 
resulting in social isolation and lower self-confidence, have previously been 
reported in the Network 1000 study (Douglas et al. 2006) and is a recurring theme 
in the literature (Burmedi et al. 2002; Percival et al. 2005). In their research with 
900 adults in the UK with low vision, Bruce et al. (2007) explored perceptions of 
inclusion by family and friends in the context of social isolation. They concluded that 
the visually impaired are more likely than the population in general to feel a sense 
of exclusion as a result of a severe lack of social support. Participants in the study 
were more likely to be living alone, receive fewer visitors, have no hobbies, and go 
shopping less than once a month and on their own. Sight loss is said to negatively 
impact on emotional well-being (Thurston et al. 2013) and quality of life (Hassell et 
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al. 2006), resulting in increased emotional distress (Scott et al. 2001) anxiety, worry, 
suicidal thoughts (De Leo et al. 1999), and uncertainty about the future (Thurston 
et al. 2010; RNIB 2017a). 
There is an established link between sight loss and depression (Horowitz and 
Reinhardt 2000; Burmedi et al. 2002; Desrosiers et al. 2009; Renauld et al. 2010), 
loneliness and mental health problems (Leamon et al. 2014). Individuals with sight 
loss are said to experience consequential comorbidities, including a higher risk of 
falls (Leamon et al. 2014) and an increased risk of mortality (Vu et al. 2005). A 
recurring theme within the sight loss literature is that of experiencing loss not only 
of sight but also of future plans (including working abroad), independence (which 
impacts on self-esteem) and hobbies and pastimes (Baus 1999; Thurston et al. 2010; 
RNIB 2017). Charmaz (1983: 168) has also considered what she terms a ‘loss of self’ 
following the onset of chronic illness. Charmaz highlights the multifaceted 
experience of loss for her participants, as they experienced social isolation following 
the loss of friendships and the loss of independence when they were no longer able 
to drive. The themes identified by Charmaz are present in the sight loss literature 
but also have salience for participants in this thesis (discussed in Chapter Six). 
When people lose their sight, they are also aid to experience feelings of grief as they 
‘mourn the loss of the sighted self’ (De Leo et al. 1999: 339) resulting, in some cases, 
in attempted suicide. However, it is not only people with sight loss who experiences 
feelings of grief. Research suggests that the diagnosis of visual impairment can have 
an immediate and lasting impact on family members (Tuttle 1986; Bambara et al. 
2009). Grief is experienced by parents who mourn the loss of their child’s ability 
(Solinit and Stark 1961; Blacher 1984; Fortier and Wanlass 1984; Anderegg et al. 
1992; Hewson 1997) and the loss of the ‘idealised child’ (Hewson 1997: 1131). In 
his research with mothers of children diagnosed with Down’s syndrome, Thomas 
(2014: 287) explains how mothers spoke of their grief when learning of their child’s 
diagnosis, framing the diagnosis in terms of loss, ‘the child having disrupted 
preconstructed expectations of their child and the mother role’. Mirroring Thomas’s 
findings, mothers participating in this thesis also expressed feelings of grief 
following their child’s diagnosis (discussed in Chapter Five). 
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The feeling of grief experienced by individuals when they lose their sight is said to 
be similar to that experienced when a close family member dies (Kübler-Ross 1969; 
Hewson 1997; Baus 1999; De Leo et al. 1999; Fourie 2007; Murray et al. 2010; 
Thurston et al. 2010; Stevelink et al. 2015a; Ferguson and de Abreu 2016). Kübler-
Ross (1969) developed the five-stage theoretical grief model within the context of 
the emotional responses of terminally ill patients and their relatives to death and 
dying. The dying and the bereaved are thought to experience feelings of denial, 
anger, bargaining, depression and acceptance. Kübler-Ross’s grief model has been 
applied in diverse contexts including sight loss (Adams and Pearlman 1970; 
Giarratana-Oehler 1976; Schainholz 2000), chronic illness (Telford et al. 2006), and 
marriage breakdown (Somary and Emery 1991). Within the sight loss literature, 
denial is defined as a refusal to acknowledge the deterioration in sight, which 
manifests in a number of ways, including a refusal to participate in rehabilitation 
services (Bergeron and Wanet-Defalque 2012). Here, acceptance refers to 
recognising sight loss and adopting positive coping strategies (Bergeron and Wanet-
Defalque 2012; Stevelink et al. 2015a; Ferguson and de Abreu 2016).   
Kübler-Ross’s model has been critiqued as being unrealistic within the context of 
sight loss (Dodds 1989; Hewson 1997; Baus 1999; Murray et al. 2010; Stevelink et 
al. 2015a).  Murray et al. (2010: 79) argue that the assumption that people arrive at 
acceptance after they have ‘completed the linear and time-bound grief process’ is ill-
founded, as acceptance of sight loss is far more complex and nuanced than Kübler-
Ross’s model suggests. As a consequence, alternative models of adjustment to sight 
loss have been developed. Dodds (1989: 11) explores feelings of loss within the 
context of the development of rehabilitation services. He argues that the traditional 
grief model has had a ‘pervasive influence’ since it suggests that the process of 
adjustment to sight loss and rehabilitation are separate entities. He argues that the 
loss model tacitly suggests that rehabilitation cannot take place until grieving for the 
loss of sight is completed, with rehabilitation only beginning when the point of 
acceptance has been reached. Dodds outlines three grounds to support his 
contention: the grief model does not reflect what actually happens in practice; the 
model suggests that individuals experience strong emotions in a natural order; and 
the learning of new skills can only take place when the individual is ready.  
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Building on the work of Bandura (1977), Dodds (1989) developed the self-efficacy 
model of adjustment in which he proposes that it is possible for individuals to adjust 
positively to sight loss by having realistic expectations of their future competencies, 
and thus help them to regain their independence. In contrast to the grief model, the 
self-efficacy model advocates that early intervention is not only possible, but 
essential if the individual is not to descend into ‘learned helplessness syndrome’, 
which develops as a direct result of being unable to function effectively at the most 
basic level (1989: 15).                                                                    
Providing another alternative to the Kübler-Ross model of grief, Baus (1999)—in 
her work examining the physiological aspects of visual impairment— develops a 
grief model by adopting a four-phase approach. In phase one, there is an 
unwillingness to face the truth following diagnosis of sight loss, which leads to a 
state of paralysis and denial of the visual impairment. In the second phase, the 
paralysis gives way to anger, rage and fear—individuals are no longer able to hide 
their sight loss, resulting in limits being set by the outside world. In phase three, 
individuals experience depression and despair with the recognition that life will 
never be the same again; there is conformation of what one has lost, and at the same 
time, a search for what is still possible, leading to a process of withdrawal and 
isolation. Phase four marks a change in relationships between the individual and the 
world, with a new willingness to participate in activities of daily life and to adjust to 
life without sight. The individual once again becomes receptive to stimuli from 
outside and actively seeks contact with others, such as self-help groups. Baus (1999) 
acknowledged that the model represents the ideal case scenario; it is not watertight 
in practice, and the phases are not mutually dependent. In addition, Baus refuses to 
refer to phase four as ‘acceptance’ or ‘agreement’, as she considers that the ‘process 
of adjustment to disability will never quite be finished and we may at any time come 
into contact with our loss and our grief’ (1999: 43). 
Recognising the limitations of the traditional loss model, Thurston et al. (2010) posit 
a theoretical five-stage model, presenting the transition from sight to blindness as 
experienced by 18 blind and partially-sighted participants in their study. In stage 
one, participants are diagnosed with a serious eye condition, leading to blindness 
which evokes feelings of shock, panic and disbelief. In the second stage, participants 
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who display no outward signs of sight loss adopt strategies of concealment. 
Participants demonstrated an overwhelming desire to remain the same for as long 
as possible, evidenced by a resistance to participating in rehabilitation services. In 
the third stage, referred to as the point of impact, lifestyle becomes affected (for 
example, the withdrawal of a driving licence). In stage four, participants accepted 
rehabilitation services and adopted the use of low vision aids.   
These findings lend support to Dodds’ self-efficacy model in which it is appropriate 
for rehabilitation to take place before arriving at acceptance of sight loss. The 
authors further contend that in stage four, the outward manifestations of sight loss 
are said to be emotionally challenging, leading to changes in perceptions by others 
as well as perceptions of self. In her work as a sight loss counsellor, Southwell (2012: 
109) observed that many of her clients, following their sight loss (and similarly to 
the bereaved), refer to friends unexpectedly vanishing, which she suggests is a result 
of a ‘subconscious fear of contagion, embarrassment and helplessness’. In the fifth 
stage, participants arrive at the position of accepting their sight loss as they 
complete the process of ‘reconceptualization of self or of the condition’ (Thurston et 
al. 2010: 107). Again, Thurston et al. acknowledge the limitations of their theoretical 
model, in that it was developed from a limited sample and that individual lived 
experiences will differ. 
The reality that individuals may never really come to accept their sight loss has been 
echoed in research by Murray et al. (2010) who, using semi-structured interviews, 
explored grief and the needs of 10 adult participants (aged 26‒56 years old) who 
had experienced either sudden vision loss (retinal detachment; nerve damage) or 
progressive vision loss (macular degeneration and diabetic retinopathy). The 
participants were divided into two groups: those who had lost their vision for up to 
six years at the time the interviews were being conducted (short-term participants) 
and participants who had lost their sight more than six years ago (long-term 
participants). The study found that the long-term participants—who were acutely 
aware of the continuing daily challenges of living with sight loss and who 
experienced recurring grief even after a number of years—did not conform to the 
traditional grief model. Participants instead embraced what is referred to as chronic, 
recurrent but episodic grief. In this model, grief is considered to be recurrent and 
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cyclical. It is not, however, constant or unrelenting, but can exacerbate difficult times 
and situations throughout the lifetime of the visually impaired. In contrast, the 
short-term participants appeared to have accepted sight loss on an intellectual and 
emotional level, thus validating the assumption of a ‘linear, sequential and time-
bound resolvable grief process’ (Murray et al. 2010: 86). However, the authors argue 
that the short-term participants had not yet reached a point where they fully 
appreciated the long-term impact of sight loss.  
In Stevelink et al. (2015a) interviews with 30 ex-servicemen under 55 years old, 10 
of the participants had sustained traumatic irrevocable sight loss whilst deployed in 
Iraq and Afghanistan. Asked about their views on different aspects of visual 
impairment, the overarching theme identified by the authors for further discussion 
was: ‘coping with a visual impairment and impact on daily life’. Participants reported 
experiencing feelings of loss, (which included losing their job as a result of medical 
discharge), the breakdown of relationships and the loss of independence. Denial 
featured strongly in the data, with the ex-servicemen’s attempts at tasks they used 
to do resulting in feelings of frustration and irritation.  In adjusting to sight loss, the 
participants either adopted positive (adaptive) coping strategies, such as 
participating in rehabilitation, or negative (maladaptive) coping strategies, such as 
the use of illicit drugs and social withdrawal.  When positive coping strategies were 
adopted by the participants they were helped to adjust to sight loss and overcome 
future challenges. Coping was considered to be an ‘ongoing and dynamic process’ 
(2015a: 5) with participants experiencing good and bad days notwithstanding that 
several years had passed since losing their sight. Echoing Charmaz’s (1991) 
research with the chronically ill (discussed in Chapter Six), participants in my thesis 
also talk of experiencing good and bad days.  
Stevelink et al. (2015a: 5) concluded that in dealing with loss, their participants, in 
contrast to the Kübler-Ross model, experienced a far broader range of emotions and 
behaviours which were seen to be more ‘dynamic, highly interactive and a unique 
journey for every individual’. In some cases, the emotional responses occurred 
simultaneously as opposed to the linear process described by Kübler-Ross. For 
example, Kübler-Ross described acceptance as the final stage on the sight loss 
journey, but acceptance of sight loss may occur temporarily but interacts with new 
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periods of adjustment, and grief is characterised as a ‘chronic, recurrent but episodic 
process’ (Stevelink et al. 2015a: 6).  
Similarly, in line with Murray et al. (2010) and Stevelink et al. (2015a), Ferguson and 
de Abreu (2016), reject Kübler-Ross’s grief model favouring instead the Episodic 
Stress Response Model developed by Hewson (1997) in the context of loss of ability. 
Hewson’s model talks in terms of primary stress, (occurring after an unexpected 
diagnosis), and secondary stress, (associated with daily frustrations, and judged to 
be not as inherently challenging to everyday life or the future). Ferguson and de 
Abreu conclude that how the seven men participating in their study evaluate 
primary and secondary stress is dependent on the context and individual 
personality. Ultimately, the authors argue that using Hewson’s model helps to 
explain why feelings of loss and frustration are chronic and continue to be episodic 
throughout life.  
The overwhelming rejection of Kübler-Ross’s grief model in work exploring sight 
loss suggests that the process of adjustment to sight loss never reaches a conclusion 
as the visually impaired experience grief at intervals throughout their lives. 
Sight loss and stigma  
 
Stigmatisation is a recurring theme within the sight loss literature and is present in 
the narratives of participants in this thesis, and was reflected in their decision-
making, for example, not disclosing their disability on job application forms or 
refusing to eat in public for fear of spilling food on their clothing. In this section, I 
consider the stigma literature in terms of chronic illnesses, where stigma is 
frequently depicted as an inevitable consequence of chronic illness with the 
chronically ill reporting that the stigma associated with their condition is more 
difficult to cope with than the illness itself (Green and Sobo 2000; Green 2009). More 
recently, Green (2009: 1) has challenged traditional perceptions that those living 
with chronic illness experience stigma and are stigmatized, suggesting that: 
‘[T]he old order in which the sick and disabled are disempowered and 
marginalised is being replaced by a world characterised by their 
increasing confidence and a reassertion of their essential personhood.’ 
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There has been much scholarship devoted to the topic of stigma, resulting in an 
‘ever-widening circle’ (Prior et al. 2003: 2191) of research, particularly on chronic 
illness, including: HIV (Green 1995); epilepsy (Schneider and Conrad 1980; 
Scambler and Hopkins 1986; Scambler 1989); mental illness (Link and Phelan 2001; 
Tyler and Slater 2018), and; inflammatory bowel disease (Thompson 2013; 
Saunders 2014).  
However, social scientists have been criticised for studying stigma without 
demonstrating an understanding, or explicitly articulating, its ‘theoretical 
ingredients and boundaries’ (Livingston and Boyd 2010: 2150). This has prompted 
authors to suggest that stigma is constantly ‘under-defined and overused’ (Manzo 
2004: 401), with the plethora of studies that have added depth and breadth to the 
concept of stigma, also being criticised for lacking conceptual clarity (Livingston and 
Boyd 2010) and introducing ambiguities (Weiss et al. 2006). This prompted Prior et 
al. (2003) to suggest that stigma ‘is creaking under the burden of explaining a series 
of disparate, complex and unrelated processes to such an extent that the use of the 
term is in danger of obscuring as much as it enlightens’ (2003: 219). Link and Phelan 
(2001) suggest that this ambiguity is in part attributable to the fact that stigma has 
been described in a range of unique contexts which has encouraged multi-
disciplinary researchers (sociologists, psychologists, and anthropologists) to 
conceptualise stigma in diverse ways, a point also made by Green (2009), who 
agrees that there is an erroneous view that there is now a defined and shared 
understanding about the meaning of stigma.  
Conceding the point that there may not be a ‘universally accepted’ (Hersh 2013: 
246) definition of stigma in the literature, this thesis will draw on Erving Goffman’s 
(1968) seminal work, Stigma Notes on the Management of Spoiled identity. Goffman 
(1968:15) argues that society categorises individuals on the basis of normative 
expectations distinguishing the ‘normals’ from the ‘deviants’. Importantly, the 
relevance of Goffman’s conceptual framework for understanding health-related 
stigma in contemporary society has been the focus of intense debate (Link and 
Phelan 2001; Scambler 2004, 2006, 2009, 2018; Weiss et al. 2006; Green 2009; 
Livingston and Boyd 2010; Hersh 2013; Tyler and Slater 2018). Within the realm of 
health research and policy, Weiss and colleagues identified four significant failings 
23 
 
of Goffman’s conceptual framework of stigma: the use of what is now considered to 
be ‘antiquated’ language and concepts; the application of stigma to a vast array of 
circumstances outside the area of health and, significantly, the adoption of a 
conceptual framework based on notions of normalcy and deviance that is 
inadequate and inappropriate in the context of cross-cultural research; and policy-
making which is incompatible with multicultural or pluralistic societies with 
excessive generalisation and lack of attention to underlying structures. 
Similarly, Scambler (2009: 442), whilst conceding that Goffman’s work provides a 
‘paradigm and exemplar’ and that Goffman’s thoughts on stigma remain insightful, 
also suggests that we should now move beyond Goffman’s original telling 
contribution to ask and answer the questions which the original work overlooked 
(for example, ‘social structures and axes of power’ 2004: 29). Notwithstanding the 
criticism of Goffman’s work, I would argue that within the realm of sight loss, it is 
insightful and relevant to the current thesis. For one, in his typology of stigmatised 
groups, Goffman places the blind in the category of individuals who have what he 
refers to as an ‘abomination of the body’ (1968: 14). Drawing a distinction between 
‘virtual social identity’—the stereotyped imputations that occur in everyday life— 
and ‘actual social stigma’—the attributes that an individual actually possesses, for 
Goffman stigma is synonymous with possessing an ‘attribute that is deeply 
discrediting’ that arises from an ‘undesired differentness’ (1968: 13-14) which 
spoils one’s identity. Goffman argues that once a ‘discreditable’ difference becomes 
known, the person may be transformed from a ‘whole and usual’ person to a ‘tainted 
discounted one’ (1968: 12). Referring to the concept of possessing a spoiled identity, 
Scott (1969 118) suggests in his study of the visually impaired in America that: 
‘The social identity of a man [woman], indeed his [her] whole 
personality, is spoiled when he [she] is blinded. That he [she] is regarded 
as a different and lesser person than others is sharply brought home to 
him[her] whenever he [she] has dealings with the sighted. A major 
component in the experience of being a blind man[woman] is defending 
the self from imputations of moral psychological and social inferiority.’  
In his work, Goffman distinguishes between being ‘discreditable’—where the 
stigmatising characteristic is not ‘immediately perceived’ nor has it been 
disclosed—and being ‘discredited’—where the differentness is known about 
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already or is evident ‘on the spot’ (1968: 14). For some participants in this thesis 
this is a distinction that is particularly salient since LHON is an eye condition which 
presents a paradox with individuals being registered as severely sight impaired 
(blind) but still retaining sufficient residual peripheral vision not to require the use 
of low vision aids. In short, their eyes look ‘normal’ and their disability is ‘invisible’ 
to others (discreditable). In contrast, those who rely on a white cane or a guide dog 
may be said to be discredited as their sight loss is immediately apparent. In addition, 
I would suggest that for some of the participants in this thesis, Goffman’s 
dramaturgical work, The Presentation of Self in Everyday Life (1959), is of particular 
relevance. Goffman was interested in face-to-face interaction, focusing on the 
structure of interaction in everyday life and how the social order is maintained. 
Using terms borrowed from the theatre, Goffman suggests that individuals 
throughout their lives undertake a process of impression management. In effect, 
they play different roles (for example parent, spouse, and employee) in much the 
same way as actors on a stage. To quote Shakespeare: 
‘All the world’s a stage, and all the men merely players. They have their 
exits and their entrances. And one man in his time plays many parts’ 
(Shakespeare, As You Like It, Act 2, Scene 7).  
Goffman wrote of the ‘front’ [stage] where people undertake a performance; where 
in public spaces, when they perceived they are the subject of scrutiny, they conceal 
their stigmatising characteristic. In private spaces—Goffman’s ‘backstage’—they 
are able to relax, in those backstage moments they are true to themselves.  
At this point, it is worth remembering that Goffman’s work on stigma is not the 
product of original empirical research, but an account drawing upon several 
literatures. Goffman draws heavily on the work of the writer Hector Chevigny, My 
Eyes Have a Cold Nose (1947), whose work Goffman extensively quotes throughout 
his book. Chevigny, who at the age of 37 experienced bilateral sight loss following 
retinal detachment, wrote about his experience of sight loss and his refusal to be 
viewed by society as an object of pity relying on charitable handouts:  
‘Towards the blind the world presents a face it turns to no other group 
on earth. Everyone else must struggle for his existence, must fight for 
survival. The blind, however, need not want. Society, profoundly 
convinced of the utter helplessness of a man[woman] who has lost his 
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sight, stands ever ready to help him [her], whether this be a small thing 
as crossing the street or the larger one of food and shelter for the rest of 
his[her] days’ (1947: 81). 
Drawing upon Goffman’s work, Scott (1969) in his study also refers to societal 
attitudes toward visual impairment:  
‘Blindness is a stigma carrying with it a series of moral imputations about 
character and personality. The stereotypical beliefs […] lead normal 
people to feel that the blind are different; the fact that blindness is a 
stigma leads them to regard blind men[women] as their physical, 
psychological, moral, and emotional inferiors. Blindness is therefore a 
trait that discredits a man[woman] by spoiling both his identity and 
respectability’ (1969: 24). 
Scott further notes that when the stigmatised associate with ‘others’, barriers are 
created between them. The barriers result in the ‘normals’ shunning the stigmatised 
by adopting avoidance strategies which Scott believes are grounded in fear that 
‘direct contact with a blind person may be contaminating, or that the stigmatised 
person will somehow inflict physical or psychic damage’ (1969: 24). Davis (1961) 
comments on the presence of the embarrassment factor in face-to-face interaction 
between ‘normal’ people and the visibly impaired. He argues that normal people are 
apt to make ‘faux pas, slips of the tongue, revealing gestures and inadvertent 
remarks’ (1961: 121‒122) that betray their discomfort in dealing with other people 
who have a disability. Whilst the visually impaired may try to lead a normal life―and 
indeed consider themselves to be normal―they are forced to face the reality that, in 
their everyday encounters, others do not see them in the same way and are 
unwilling to deal with them on an ‘equal footing’ (Scott 1969: 24).  
Covering and passing 
Those living with a visible disability adopt strategies of ‘concealment of the impaired 
self’ (Lingsom 2008: 2), allowing them to be perceived by others as normal. Goffman 
(1968) describes two such strategies: covering (a process of tension management) 
and passing (a process of information management). By covering a stigmatising 
attribute, an individual adjusts their behaviour to ensure that their disability is kept 
as inconspicuous as possible. By doing so, tension or embarrassment for others 
(who are aware of the disability) is avoided during social interaction. Goffman 
(1968: 126) illustrates the point by referring to the reluctance of the partially 
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sighted to read a book in public. Although the sight loss is known about, it would 
necessitate holding the book extremely close to the eyes, thus ‘express too glaringly 
the qualities of blindness’. Individuals can go to great lengths to ensure that a 
stigmatising attribute remains hidden from the gaze of others. 
Those who possess a discrediting characteristic seek to conceal their differentness 
by adopting strategies of passing and so appear to ‘others’ as ‘normal’. One of the 
primary motivations for passing is a fear of ‘devaluation, exclusion or 
marginalisation’ (Lingsom 2008: 5). Fourie acknowledges this point by noting that 
one motivation for passing is that individuals feel threatened by the ‘perceived loss 
of normality in a society that seems to highly value the “normal”’ (2007: 224). This 
point is also alluded to by Southwell who argues that passing stems from a ‘deep-
rooted need to appear “normal”’ (2012: 108). In the context of sight loss, passing 
entails a reluctance to associate with other visually impaired people (Southwell 
2012). Similarly, Wright’s (1960) psychological perspective of disability observes 
that concealing disability does not make it disappear; it still remains in the eyes of 
the disabled person as a barrier to acceptance by the non-disabled group. Wright 
also argues that by not accepting their disability, the disabled have to pay the 
consequences of being in the ambiguous position of the marginalised who do not 
belong fully to any group: 
‘like a man [woman] without a country he [she] will wander in the search 
for acceptance that cannot be until he [she] accepts himself [herself]’ 
(1960: 40).  
 
There is also refusal by the visually impaired to utilise assistive technologies, as 
Hersh (2015) found in her research with 93 individuals with adult onset visual 
impairment. Her participants expressed a number of barriers to using the white 
cane, including corns about the reaction of others who had known them before sight 
loss. This prompted feelings of shame and embarrassment. Other factors 
discouraging the use of the white cane included negative self-image as a 
consequence of negative public opinion; retaining a self-perception as sighted; 
allowing relatives to be over protective, and beliefs that the white cane is only for 
blind people. This popular misconception that blindness means living in total 
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darkness, whereas in reality only a very small proportion of visually impaired 
people experience no light perception.  
Hersh’s (2015) and Stevelink et al.’s (2015a) participants both report experiences 
of being verbally and/or physically abused when using the white cane. Participants 
claimed people jumped over or kicked the cane away. Such behaviour, resulting in a 
reluctance to use the white cane and feelings of vulnerability and fear of being 
assaulted as others may perceive them as weak and helpless. Page (1984) discusses 
covering and passing in the context of blind acceptors—those who try to ensure that 
they behave in ways that would be regarded as normal by the sighted (this would 
include looking directly at people when engaging in conversation). Blind rejecters, 
Page argues, ignore the sensitivities of the sighted and will adopt behaviours that 
are most practical for any given situation, for example using their fingers to eat 
rather than using cutlery.  
Goffman (1968: 95) posits that, given the advantages of appearing normal, ‘almost 
all persons who are in a position to pass will do on some occasion by intent’. 
However, passing comes at a price as normative expectations of behaviour (for 
example, not bumping into inanimate objects or spilling food and drink) are 
required, forcing the visually impaired to participate in ‘self-censorship’ and ‘self-
surveillance’ and in so doing silence the ‘blind-self’ (Lingsom 2008: 14).  
The sociological literature on stigma has predominantly focused on those who, 
because of their perceived differentness, experience stigma. Goffman argues that 
stigmatisation is not confined to those with a stigmatising attribute, but also affects 
those who are closely associated with them; ‘the problems faced by the stigmatised 
persons spread out in waves’ (1968: 43). Goffman refers to this phenomenon as 
courtesy stigma. In his research with the parents of children diagnosed with high 
functioning autism, Gray (2002: 735) refers to the ‘stigma of affiliation that applies 
to people who associate with stigmatised groups rather than through any quality of 
their own’. The accounts given by the parents referred to experiencing both felt and 
engaged stigma (discussed in detail later). However, as with participants in this 
thesis, experiences of felt and enacted stigma blended together. Visually impaired 
parents in this thesis, to avoid their children being stigmatised, avoided using 
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‘stigma symbols’ (Goffman 1968: 124), for example they would not use a white cane 
when taking their children to school or to the park.  
Goffman suggests that stigmatised individuals reach a point where they no longer 
feel the need to indulge in passing and undertake a process of voluntary disclosure: 
‘after laboriously learning to conceal, the individual may go on to unlearn his 
concealment’ (1963: 125). This is the stage that Kübler-Ross (1969) calls acceptance 
and also relates to the alternative grief models developed by Murray et al. (2010) 
and Thurston et al. (2010), in which the visually impaired finally come to terms with 
the blind self and take part in rehabilitation services. Hayeems et al. (2005: 618), in 
their research with 43 participants with retinitis pigmentosa, refer to this process 
of voluntary disclosure as the ‘action stage’ where the visually impaired, in 
undertaking mobility training (for example, using the white cane), ‘out’ themselves.   
Enacted and felt stigma 
A significant contribution to Goffman’s conceptualisation of stigma is provided by 
Scambler and Hopkins (1986) in their study of people diagnosed with epilepsy. The 
authors (1986: 33) developed the ‘hidden distress model’ of epilepsy, drawing a 
distinction between what they refer to as ‘enacted’ and ‘felt’ stigma. The former 
refers to overt acts of discrimination, whilst the latter encompasses feelings of 
shame and fear of being confronted with enacted stigma (Scambler and Hopkins 
1986; Scambler 1989, 2004, 2009). Scambler (2009: 445) explains that the hidden 
distress model may be articulated by three propositions.  Firstly, when faced with a 
medical diagnosis (in this case epilepsy), ‘state-sanctioned, culturally authoritative 
and carrying legal weight, individuals develop a “special view of the world”’. This 
view is characterised by a powerful feeling of felt stigma, which results in acts of 
concealment of the disability. Secondly, by successfully managing their condition 
(with medication), others do not become aware of the illness. Finally, felt stigma was 
found to cause the most anxiety and was more disruptive to an individual’s life than 
enacted stigma. Scambler and Hopkins (1986: 33) also draw a distinction between 
the concepts of stigma and deviance. Scambler (2006: 293) suggests that individuals 
are ‘imperfect beings’ with characteristics often beyond their control and, thus, 
stigma denotes an ‘ontological deficit’. In contrast, deviance denotes a ‘moral deficit’ 
that is associated with conditions such as HIV/AIDS. 
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Scambler (2004, 2009), critiques the hidden distress model, suggesting that there is 
a risk that the concept, (1) potentially reinforces medical authority, by accepting the 
biomedical perspective, (2) reinforces the perception that disease is a personal 
tragedy, and (3) can imply that the sick are victims, who passively accept their fate. 
Scambler has called for the reframing of stigma within medical sociology, advocating 
a more ambitious sociology of illness-related stigma, one that moves away from the 
medical model of disability which depicts disability as personal tragedy. For 
Scambler, influenced by the work of disability activists, stigma is a social concept 
that is reproduced and sustained through social inequalities. More recently, 
Scambler (2018: 768) has argued that what is missing from Goffman’s original work 
is ‘the causal role of social structures like class, command, gender, and ethnicity’. In 
a similar vein, Tyler and Slater (2018) extending the conceptual framework 
espoused by Parker and Aggleton (2003), critically examine the anti-stigma mental 
health campaign (Heads Together). Focusing on the limitations of existing 
conceptual understandings of stigma, the authors suggest that to fully grasp the role 
and function of stigma in contemporary society, it is necessary to develop a more 
nuanced understanding of stigma as a cultural and political economy. 
Summary 
This chapter has presented an overview of the literature which provides the 
foundation for the empirical chapters that follow. I have highlighted that LHON is 
receiving considerable attention within the scientific community as a consequence 
of the promise of new treatment options to cure the condition. Yet this clamour is 
not reflected in social scientific contributions regarding the everyday lived realities 
of people with LHON. The paucity of sociological literature exploring LHON and sight 
loss more generally underpins my decision to align my thesis with key themes 
developed within sociology, including biographical disruption (Bury 1982); loss of 
self (Charmaz 1983); and stigma (Goffman 1968; Scambler and Hopkins 1986; 
Scambler 1989, 2004, 2006, 2009, 2018). I have also discussed psychology models 
of adjustment to sight loss (Dodds 1989; Baus 1999; Murray et al. 2010) and 
disability studies that advocate adopting a social model of disability (Oliver 1990; 
Thomas 2004, 2007; Barnes and Mercer 2013).  
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Evident from the literature is that the visually impaired, similar to the bereaved, 
experience a number of emotional responses to their sight loss, including denial and 
anger. However, the notion that people arrive at acceptance having moved through 
the stages of grief in a linear way is contested. Similarly, Murray et al.’s (2010) 
research is a point of departure for participants in this thesis who, irrespective of 
how long they have experienced sight loss, claim that they will never accept it 
(discussed in Chapter Six). 
The literature also suggests that for the visually impaired there is an overwhelming 
desire to be perceived as ‘normal’ and avoid the stigmatising gaze of ‘others’. People 
living with visual impairment face the dilemma of whether to conceal their sight loss 
or disclose information. However, disclosure is not a straightforward process as 
decisions must be made as to when to disclose information, and how much 
information to disclose (discussed in Chapter Six).  
In the next chapter, I describe the methods employed to achieve the aims outlined 
in this thesis and to answer the research questions. This will be followed by four 
empirical chapters which describe the key findings from the research.  
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Chapter Three: A Methodological Discussion 
 
Introduction 
 
In this chapter, I outline the methodology I adopted in undertaking my research in 
the ophthalmic genetic clinic—a site that has not previously been the focus of 
sociological interest. The clinic provides the opportunity, firstly, to explore the work 
of an elite group of professionals—the genetic ophthalmologists (comprising 
clinician scientists and neuro-ophthalmologists) instrumental in diagnosing, 
treating and developing new treatment options to cure Leber hereditary optic 
neuropathy (LHON). Secondly, it facilitates interviews with participants diagnosed 
with LHON to explore their experiences and perceptions of living with a rare 
mitochondrial condition.  
I take this opportunity to reflect on the challenges I encountered when I made the 
decision to undertake qualitative research in two genetic ophthalmology clinics 
located in NHS hospitals in two UK countries. Starting from a perhaps too-naïve 
position, I thought that once I had secured ethical approval from the Research Ethics 
Committee (REC), obtaining R&D permissions to access the two NHS sites would be 
a relatively straightforward process. In reality, obtaining NHS ethical approval and 
R&D permissions was the start of a long and complex journey in which I became 
embroiled in the National Institute of Health Research (NIHR) Clinical Research 
Network (CRN) portfolio adoption requirements and NHS governance training, both 
of which were mandatory requirements to access my chosen research sites. I 
provide an account of the practical difficulties I encountered when accessing an 
unco-operative site. I had originally intended to undertake an ethnographic study of 
the genetic eye clinic, however, ultimately, I was not able to resolve the access issues 
I encountered. Therefore, this thesis utilises in-depth qualitative semi-structured 
interviews supplemented with some observational data. I will explain how I 
analysed my data and developed the themes that emerged across the data set. 
Finally, I reflect upon my role as a researcher investigating a sensitive topic, 
highlighting the ethical issues I encountered during the data collection process.  
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Adopting a qualitative approach  
  
One of the aims of this thesis is to understand the lived experience of sudden sight 
loss—a highly individual experience which is not easily quantifiable. Adopting 
qualitative research methods enables the collection of rich and informative data, 
thus bringing a greater depth of understanding of the impact of sudden sight loss on 
individuals and their families. Undertaking semi-structured interviews not only 
enabled me to be sensitive to the particular needs of my research participants, but 
also facilitated my participants’ ‘deliberations without restricting their responses to 
a narrow set of predefined areas’ (Dovey-Pearce et al. 2007: 78) and, thus allowed 
me to capture their individualised in-depth thoughts, emotions and reactions to 
their sudden sight loss.  
Qualitative research is the ‘method of choice’ (Ebrahim and Sullivan 1995: 196) 
within healthcare research, and this is particularly evident when the primary aim is 
to gain an understanding of the ‘processes, events and relationships in the context 
of social and cultural situations’. Notwithstanding the undoubted continued 
popularity of qualitative research, it is not without its critics (Anderson 2010).  Mays 
and Pope (1995: 109) identify the main areas of concern associated with qualitative 
research. Firstly, it is subject to bias as findings are based on anecdotal evidence, 
personal impressions and idiosyncrasies of the researcher and, as such, research 
findings lack ‘scientific rigour.’ Secondly, qualitative research is criticised for lacking 
generalisability with qualitative methods generating voluminous amounts of 
detailed information about a small number of people.  
My research design builds in multiple sources and types of data, which means that 
understandings and experiences can be compared across policy, clinical and patient 
populations (Latimer 2008). Each of these accounts provides a different 
representation of LHON. Whilst the accounts may be qualitatively different, it is 
possible to build rigour into the analysis in the form of checks and balances. For 
example, fieldnotes are checked against interview transcripts, thus providing the 
opportunity to uncover how reality is constructed via multiple voices and positions 
across time and space (Latimer 2008). All these accounts are laid alongside each 
other to make comparisons, capture patterns, highlight similarities and identify any 
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deviations (Silverman 1993) to upset original interpretations or provide further 
explanations (Latimer 2008).  
 
Preparing the ground—pre-fieldwork 
In this section, I will discuss the preparatory work undertaken before accessing my 
research sites. I also provide an overview of the process of applying for NHS ethical 
approval and R&D permissions. 
Locating a gatekeeper 
Before applying for the necessary NHS ethical approval and R&D permissions, I 
became aware that there was a very small group of experts in the UK with an interest 
in the diagnosis and treatment of LHON. One leading expert, Dr Morgan, is an 
Honorary Consultant Ophthalmologist at St Tristan’s Hospital in the UK. I 
approached Dr Morgan to act as gatekeeper and facilitate my research within the 
NHS. Involving a clinician at an early stage ensured that my research protocol was 
accurate in terms of the information I had outlined (for example, the inheritance, 
diagnosis and treatment options for LHON). It also ensured that potential access to 
research participants was accurate. Pope (2005) also argues that securing a 
gatekeeper located within the host organisation can legitimise the research and 
smooth the way for the researcher to access the site and be accepted by clinical and 
administrative support staff. My thesis provides an example of where Pope’s claims 
do not always hold true (discussed later). Dr Morgan agreed to my request and 
explained that there were approximately 20 LHON patients, with on average 1–2 
new referrals a year. One of the aims of my research was to observe how a LHON 
diagnosis was accomplished in the clinic—and how clinicians communicate complex 
genetic information in respect of inheritance to their patients. I realised that the 
opportunities to observe appointments with patients who had not received their 
diagnoses were going to be limited, mainly owing to the small number of referrals 
per year.  
Dr Morgan made two suggestions, the first of which was that I observe appointments 
both in her Retina and Optic Nerve Screening Clinic and in her Ophthalmic Genetics 
Clinic. The Ophthalmic Genetics Clinic receives not only new patients referred from 
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other consultants within St Tristan’s Hospital, but also referrals from other hospitals 
in the area. Attending these clinics provided the opportunity to observe the work of 
the ophthalmic genetics clinic and to understand how a genetic diagnosis is 
constructed for diverse eye conditions.6 Although the pattern of inheritance may 
differ (autosomal dominant, autosomal recessive, and, X-linked), the diagnostic 
procedures are similar to those used in identifying LHON (visual field test; optical 
coherence tomography (OCT); electroretinogram (ERG); and blood test). Dr Morgan 
explained that patients of interest would be identified and invited to participate in 
this study. 
In consultation with my supervisors at the time, I made the decision that I would 
follow Dr Morgan’ suggestion and amend my research protocol to enable me to 
undertake participant observation in the two clinics with adult participants and 
children aged 13–15 years, who had been referred with a suspected genetic eye 
condition. I decided that I would not conduct interviews with this group of 
participants as their deterioration in visual acuity was likely to be a gradual process, 
whereas my interest is the participant’s reaction to sudden sight loss. The second 
suggestion made by Dr Morgan was that I contact Dr Penvenen, one of the other 
leading experts in LHON, and an Honorary Consultant Neuro-ophthalmologist at The 
Royal Albion Hospital. Dr Morgan agreed to contact Dr Penvenen on my behalf, and 
Dr Penvenen agreed to participate and indicated that his Optic Nerve Genetics Clinic 
located at The Royal Albion Hospital took place one afternoon a month, receiving 
referrals from hospitals in the UK. A major objective of his work is taking research 
from the laboratory into clinical practice. Dr Penvenen is a clinician scientist 
utilising next-generation sequencing technologies to identify the underlying genetic 
causes of eye conditions for families who do not have a confirmed diagnosis. During 
2013‒14, in excess of 20 LHON patients had been referred to Dr Penvenen.  
To further maximise data collection, I also contacted stakeholders in the third sector 
who confirmed they would support my research by helping me to recruit 
participants. To maximise recruitment to my study, I attended two Patient Days 
organised by Dr Morgan and Dr Penvenen. Prior to submitting my research protocol, 
                                                          
6  For example, Retinitis Pigmentosa, Stargardt’s Disease, and Cone-Rod Dystrophy. 
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I attended the genetic eye clinic at St Tristan’s Hospital in order to orient myself and 
gain an understanding of the everyday, mundane processes and practices of the 
clinic. Attending the eye clinic was a useful exercise as it not only helped me develop 
my research protocol, but also gave me confidence in answering questions when I 
appeared before the REC. 
Applying for NHS ethical approval and R&D permissions  
The process of obtaining NHS ethical approval has been described as ‘lengthy and 
bureaucratic’ (Pope 2005: 1182), the system originally having been developed for 
the governance of clinical and biomedical research (Murphy and Dingwall 2007). 
This became apparent to me when I was asked questions on the application forms 
that were clearly not relevant to conducting qualitative research. Other researchers 
have made similar observations (Bosk and De Vries 2004; Israel and Hay 2006; 
Boden et al. 2009). Indeed, some scholars have suggested that social science 
research should not be the subject of ethical review (Schrag 2011), with arguments 
in part founded on the belief that the REC has a propensity to adopt an overly 
paternalistic attitude towards research participants (Edwards et al. 2004) and that 
competent participants should be allowed to make their own judgments about 
possible harm. More generally, the requirement to apply for ethical approval to 
undertake social science research in the NHS has been the subject of much debate 
(Dingwall 2006; Reed 2007; Hedgecoe 2008b, 2012; Nicholls et al. 2012).  
I found the process of obtaining the necessary approvals both time-consuming and 
frustrating. In drafting the mandatory forms, I avoided the use of overly technical 
language, but instead included information that I hoped would reassure the NHS 
REC that I was competent to conduct the research. Having completed the forms, I 
booked my appointment via the Central Booking System and submitted the 
application via the Integrated Research Application System (IRAS).  I attended a 
meeting with the NHS REC in October 2015. I was asked to undertake minor 
amendments to my invitation letters and information and consent forms. Within 
two weeks of making the necessary amendments, I received ethical approval.  
Notwithstanding the criticisms of ethics committees, my experience was extremely 
positive. This is in stark contrast to my experience of applying for NHS R&D 
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permissions to access the two sites in two different countries. The R&D offices at St 
Tristan’s Hospital and The Royal Albion Hospital advised me that I would not be 
given access to the sites unless my study was adopted by the NIHR CRN Portfolio of 
Studies in the UK. This began a time-consuming process of finding two experts to 
review my research protocol. The peer reviewers were required to be independent 
(in that the reviewers were external to Cardiff University) and not involved in the 
study in any way. They had to be experts in their field and be able to demonstrate 
knowledge of the relevant discipline in order to consider the clinical and/or service-
based aspects of the protocol. The NIHR CRN suggested that the peer reviewers 
should include a sociologist and an ophthalmologist with experience of ophthalmic 
genetics, and particularly LHON, to review the project. Following favourable peer 
reviews, my study was adopted on to the CRN. In January 2016, I was issued with 
Letter of Access to undertake data collection at St Tristan’s Hospital. The Royal 
Albion Hospital declined access to the site until I had undertaken online governance 
training (designed for clinicians) and passed an online test. I was eventually issued 
with an Honorary Contract to commence data collection at The Royal Albion 
Hospital at the end of March 2016; this delay was in part due to a change of 
personnel in the Human Resources department which resulted in paperwork being 
mislaid. The process of portfolio adoption and the requirement to undertake 
governance training caused a substantial delay in accessing The Royal Albion 
Hospital which, in turn, had repercussions for my data collection as I only had a 
narrow window of opportunity to undertake participant observation in Dr 
Penvenen’s clinic (discussed later).  
The research sites 
As outlined, my fieldwork was undertaken in two sites: St Tristan’s Hospital and The 
Royal Albion Hospital. Having explained the challenges I faced in gaining access, I 
will now take this opportunity to introduce the research sites. 
St Tristan’s Hospital 
St Tristan’s Hospital is an NHS teaching hospital located in an urban setting in the 
UK. The eye clinic is one of the busiest outpatient departments in the hospital. On 
entering the eye clinic waiting area, patients are requested to take a numbered ticket 
from a machine located to the side of the reception desk, sit down and wait for their 
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number to be called. The irony was not lost on me that this information is given to 
patients via a notice on the wall; patients who are visually impaired and do not have 
a relative or friend with them invariably do not see the notice and stand by the 
reception desk waiting to be booked in. Depending on how busy the appointment 
clerk is will influence whether the patient is booked in or told to take a ticket and sit 
down. 
Once patients are booked in, they wait in the large waiting area for a specialist 
ophthalmic nurse, or Health Care Support Worker (HCSW), to call them into the 
vision testing room, where they confirm their personal details and have their visual 
acuity tested. Once the patient’s pupils are dilated, they are either directed to have 
retinal imaging of their eyes or they are sent to the appropriate waiting area for the 
clinician to see them. The clinical assessment rooms are coloured coded: Orange 1–
3; Purple 1–3; Black 1–3, and so on. To assist patients in finding their waiting area, 
corresponding coloured tram lines are marked out on the floor. Again, this is only of 
use if the patient is accompanied or has a sufficient level of visual acuity to 
distinguish the colours.  
There are approximately 10 consultants working in the eye clinic engaged in a 
number of sub-specialties including oculoplastics; glaucoma; medical retina and 
uveitis. The majority of the consultants are assisted by specialist registrars (SpR). 
Dr Morgan is unusual in not routinely having a SpR working within the clinic. 
Patients are called in for their appointment by the clinician. On entering the clinical 
assessment rooms, it is immediately apparent that they are not rooms in the 
conventional sense of the word. They are actually semi-open plan work spaces, with 
walls replaced by partitions which are solid up to approximately 4–5ft high, and 
then glass to the ceiling. At the back of this area is another solid partition, again 4–
5ft high, with a shelf on the top where patients’ files are placed by the HCSW to 
indicate to the clinician which patients are ready for their examination.  At the back 
of the work space is a narrow walkway used by clinical staff and, occasionally, by 
patients entering and exiting the assessment spaces. When sitting in the assessment 
space, it is possible to see into the spaces on either side and across the walkway. It 
is also possible to hear the consultation that is being conducted in the other spaces. 
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All the spaces have the same standard equipment,7 and a light switch which makes 
it possible for the clinician to dim the lights during the ophthalmic examination. 
The Royal Albion Hospital 
The Royal Albion is a large NHS teaching hospital located in a large metropolitan city 
in the UK. The hospital was built in the mid-19th century and currently has over 70 
ophthalmologists working at the site and across its sister hospitals. The building is 
no longer fit for purpose and extensive refurbishment is ongoing. The Royal Albion 
Hospital is celebrated as a world-class centre of excellence for ophthalmic education 
and research. The NHS-funded eye clinic receives patients with a range of complex 
eye conditions from both the surrounding area and across the UK. 
The eye clinic where Dr Penvenen examined LHON participants is located on the 
lower ground floor to which access is gained by using the stairs or a lift. On entering 
the clinic, visitors are confronted with a maze of corridors, some with uneven floors 
that slope down into the waiting areas which can make it difficult for the visually 
impaired to navigate. The ceilings are lower than one would expect, giving the 
impression of having descended into the bowels of the building. The clinical 
assessment rooms are accessed via the multiple waiting areas. There is no natural 
light in the eye clinic and the layout of the clinical assessment areas is similar to the 
spaces in St Tristan’s Hospital. However, in contrast to St Tristan’s, the clinical 
assessment rooms were cramped and felt claustrophobic. This may be attributed to 
the sheer number of clinicians and patients moving in and out of the assessment 
areas.  
Data collection 
Participant demographics  
Previous qualitative research undertaken with LHON participants in the UK has 
focused on the lived experience of male participants (Ferguson and de Abreu 2016). 
I was keen to recruit both male and female affected participants to my study, as I 
wanted to explore to what extent (if any) gender impacted on how participants 
                                                          
7 A desk slit lamp, large ophthalmology examination chair, sink, one chair for relatives which is fixed 
to the floor, an illuminated Snellen visual acuity test chart displayed overhead, a cabinet containing 
eye drops, prescription forms, consent forms and leaflets for various procedures including 
fluorescence angiogram. 
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adjust to sudden sight loss. I was also keen to recruit participants who had been 
diagnosed later in life to obtain diverse experiences of living with sudden sight loss. 
During my data collection phase, I observed 49 appointments in the eye clinics 
(seven with LHON patients). I complemented my participant observation with 41 
semi-structured interviews which commenced in April 2016 and continued until 
July 2017. The reason for the extended period of interviewing was because I was 
continuing to receive emails from prospective participants who had become aware 
of my study. I also presented my early findings at a patient conference which 
resulted in further potential research participants contacting me. I interviewed 16 
affected males and 11 affected females. I also interviewed six mothers who carried 
one of the three primary mutations and had given birth to child who had developed 
sight loss, as well as one female carrier who was a sibling of one of the affected males 
and, at the time of the interview, was considering her reproductive options. The 
youngest participant was 14 at the date of the interview and, the oldest 71. The most 
recent diagnosis was 18 months prior to the interview and, the longest was 27 years. 
Finally, I interviewed seven professionals, including clinician scientists, 
ophthalmologists with a sub-specialty in neuro-ophthalmology, an Eye Clinic 
Liaison Officer (ECLO), and a Trustee from a sight loss charity. I also interviewed a 
representative of the pharmaceutical company manufacturing the drug Idebenone 
which is currently involved in the Santhera Pharmaceutical LEROS8 clinical trial 
evaluating its effectiveness. I adopted a purposive sampling strategy, to ensure that 
I was able to answer the research questions. I selected participants, both men and 
women, of varying ages who had been diagnosed (affected or carriers) with LHON. 
The participants were recruited in the two eye clinics and from third sector 
charities. Ophthalmologists were recruited through the UK Eye Genetics Group (UK 
EGGS).  
Invitations to participate 
At St Tristan’s hospital, the LHON participants were identified by Dr Morgan from a 
list that had prepared for an annual NHS clinical audit. Invitation letters were sent 
                                                          
8 LEROS is an open-label interventional Phase IV study designed to further assess the efficacy and 
safety of Raxone® (Idebenone) in the long-term treatment of LHON patients. The study is being 
undertaken in centres across the UK and internationally. Recruitment for the study commenced in 
May 2006 and is scheduled to end in April 2020.  
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out to the adult participants (Appendix 2) and invitations were sent to the parents 
of the child participants (Appendix 3). I was given the dates when these participants 
would be attending the clinic and I ensured that I was in clinic on those days. In 
respect of participants listed in the clinic with other inherited eye conditions, Dr 
Morgan’ secretary viewed the list of patients two weeks in advance of their 
appointments and sent out invitation letters.  
Where possible, emails were sent to research participants. Electronic 
communication is now the preferred method of communication for the blind and 
visually impaired since the development of software packages for computers, 
iPhones and android devices. The purpose of the invitation letters was to ensure, 
firstly, that participants were fully informed about the purpose and nature of the 
research and, secondly, that participants (if they decided to participate) understood 
the reason for, and the process of, taking their informed consent.  
In The Royal Albion Hospital, the Clinical Research Fellow working with Dr 
Penvenen contacted LHON participants in the first instance. In the early stages, this 
worked very well. However, when the Clinical Research Fellow had finished her 
work with Dr Penvenen, no one was willing to take on the responsibility of accessing 
the information from the database. Eventually, a clerical assistant was allocated the 
task. However, The Royal Albion Hospital has a high turnover of support staff and 
she left very soon afterwards: I was back to square one. I sent numerous emails to 
try and resolve the situation, unfortunately without success. Murphy and Dingwall 
(2007) observe that ethnographers are extremely dependent upon the willingness 
and continued co-operation of the host organisation—without such co-operation, 
research can be obstructed or terminated. My experience at The Royal Albion 
Hospital impacted on my ability to undertake participant observation at the site; this 
meant that I was no longer able to undertake an ethnographic study and effectively 
brought this method of data collection to a premature end.  
Families that had been identified by RNIB as having one or more members with 
LHON were sent the invitation letter by the Children and Family Support Manager. 
Those who wished to participate in my study were then invited to contact me 
directly by telephone or email. The Trustees of the LHON Society circulated details 
of my research to their members via their Facebook page. Again, anyone interested 
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in participating in the research was invited to contact me. Having sent out the 
invitation letters, I started to receive telephone calls and emails from prospective 
participants. After explaining my research, the participants were given the choice of 
having the information and consent form sent to them by post/email or me 
providing these at the clinic. I could go through the documents with them on the 
telephone or could wait until they attended the clinic if they felt more comfortable 
with this. The majority of my participants indicated they would prefer to wait to 
receive the documents in the clinic. Those who did want the forms sent ahead of the 
appointment were given the opportunity to discuss the consent form over the 
telephone before they signed or, again, were invited to wait until the clinic for 
further explanation before they signed.  
Informed consent/assent  
I drafted information and consent forms for my adult participants (Appendix 4) with 
information which varied according to where the participant was recruited. In 
addition, for the child participants (aged 13‒15), I drafted parental information and 
consent forms (Appendix 5). As children do not legally have capacity to consent, I 
also prepared an assent form (Appendix 6) for the child to sign which contained 
simplified information in respect of my study. All the forms were drafted with 
reference to guidance issued by the National Research Ethics Service (2011) which 
recommends having two separate documents for the information sheet and consent 
or assent form. However, I had decided to produce one document containing both 
parts. This decision was taken on the basis that it would be more convenient for 
visually impaired research participants to have all information in one document as 
opposed to dealing with two separate documents. 
I ensured that I read through the information sheet with the participant, either in 
person or on the telephone, to confirm that they had a grasp of the research and 
what would be expected of them should they consent to participation. I encouraged 
participants to ask questions. Participants were strongly encouraged to contact me 
if they had further questions at a later date. The invitation letters and 
consent/assent forms were also drafted in accordance with the ‘See it Right’ Clear 
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Print Guidelines (2006) produced by RNIB,9 to ensure the documents were 
accessible to the participants. Research participants who were severely visually 
impaired or blind were given the option of receiving the information in Braille, or 
alternatively, the relevant information could be recorded on a CD. In any event, none 
of my participants requested Braille or a CD. 
Interviews  
In undertaking interviews, I prepared interview schedules which were designed to 
elicit in-depth narratives of the research participants’ initial experiences of sight 
loss, the challenges encountered in receiving a diagnosis, and the information they 
received at the time of diagnosis (for example, prognosis, genetic information). I also 
wanted to explore how participants adapted to sight loss in the longer-term. I 
wanted to avoid a ‘question and answer’ type scenario, instead aimed to achieve 
what Wolfson (1976: 189) refers to as a ‘conversational narrative’, which I hoped 
would encourage participants to feel at ease and more likely to discuss their feelings 
and experiences. To achieve this, participants were asked an opening narrative style 
question in which they were invited to talk about their experience of LHON, starting 
with when they first realised they had a problem with their sight. This worked very 
well for the majority of the participants, some of whom initially spoke for in excess 
of 40 minutes without interruption. Adopting this style of interviewing ensured that 
topics that were considered important to the participants were not overlooked. 
However, where necessary, I did use the interview schedule (Appendix 7) when 
participants ran out of steam or if participants were finding it difficult to talk. 
Developing the interview schedules was an iterative process informed by my 
observations in the ophthalmology clinic, reading the literature, and modifying the 
questions as a result of transcribing the early interviews. Not all questions were put 
to every participant; questions were tailored to the personal circumstances of the 
individual.  During interviews, I made notes that enabled me to return to any points 
my participants had made on which I wished them to elaborate.  
                                                          
9 The RNIB suggest that all documentation should be drafted in large print (Arial bold, font size 14) 
with a maximum of 70 characters per line, double line spacing, and justified to the left margin (but 
not the right margin). 
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My interviews were conducted either face-to-face in the two clinics, or over the 
telephone (due to the geographical location of the participants). I acknowledge the 
point made by Barlow et al. (2007) that telephone interviews may potentially 
impact on developing a rapport with participants. Similarly, it has been suggested 
(Chapple 1999; Novick 2008) that the absence of visual or nonverbal cues in 
telephone interviews could possibly result in the loss of contextual and nonverbal 
data, and compromise the researcher’s ability to effectively probe and interpret 
participant accounts. All interviews were audio-recorded using a digital voice 
recorder with the consent of my participants. In St Tristan’s Hospital, I was provided 
with a room located at the far end of the eye clinic to undertake interviews. This 
worked very well, and I was not interrupted by the clinical staff. The interviews in 
St Tristan’s Hospital varied in duration from 55 minutes to 80 minutes.  The first 
interviews I conducted at the hospital were with two young males (aged 20 and 14) 
who, I discovered later, had agreed to be interviewed because their mothers thought 
it would be good for them to have the opportunity to talk about living with LHON.  
The two interviews were not a great success. The older participant attempted to 
avoid answering my questions by drinking from a plastic bottle of water; every time 
I asked him to discuss his emotions, he would crunch the bottle, so I could not 
understand what he was saying. A couple of times I gently reminded him that the 
digital recorder would not be able to pick up what he was saying, at which point he 
apologised and put the bottle down. The second interview with the 14 year old was 
equally challenging and was of shorter duration. He mostly answered “yes”, “no” or 
“don’t know” to the questions. At the end of the interview, he explained: “I don’t like 
talking about stuff. I don’t like talking about personal things even with family or 
friends”. My experience of interviewing males was in sharp contrast to my female 
participants (particularly mothers) whose interviews lasted from 1 hour 45 minutes 
to 2 hours 45 minutes. Many of the mothers indicated they had enjoyed the 
experience. This resonates with the research undertaken by Brannen (1993) who 
interviewed mothers returning to work after maternity leave. However, unlike 
Brannen where a number of her participants were critical of the length of time the 
interviews took (2 hours 30 minutes), none of my participants complained about 
this. Indeed, at times I struggled to bring the interviews to a conclusion. At the 
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conclusion of the interview, if the participants indicated that they had more to say, I 
arranged a follow-up interview to take place. During interviews, the mothers often 
claimed that it was the first time anyone had asked them how they were feeling 
following their child’s diagnosis and that they found the interview process cathartic. 
This resonated with the research undertaken with parents of children newly 
diagnosed with diabetes (Lowes and Paul 2006). 
My experience with the two males is not unique; there is a considerable body of 
literature that has investigated the issue of gender in undertaking qualitative 
research, albeit focusing on female researchers interviewing female participants 
(Oakley 1981; Finch 1984). Brown (2001), a female researcher, investigated the 
issue of gender in two research studies. In the first study, 17 men were interviewed 
in general terms about their health and health needs. In the second study, 24 men 
who had had a heart attack were interviewed.  Brown observed that in the first study 
she struggled to get the men to talk; some of the interviewees gave abrupt answers 
and refused to expand on their answers or provide personal information. In 
contrast, those in the second group, having been asked to tell the story of their heart 
attack, were much more willing to open up and talk about their experiences. Brown 
(2001: 190) concludes that, generally, men are not used to talking about health as it 
is not part of their ‘day to day discourse’. What she believed distinguished the 
response of her two groups was not the gender of the interviewer, but the nature of 
the subject matter. The men in the first study did not want to be perceived as 
vulnerable; however, those in the second group deemed it acceptable because they 
had been affected by a significant health event. Participants in my thesis have been 
exposed to a serious life event, albeit not life-threatening. I am not convinced that 
Brown’s argument holds true for my participants. I suspect that my participants’ 
reticence to talk is more complex and likely to be linked to a number of factors 
including their age, maturity, when they were diagnosed, if they were still in a 
process of adjustment and the fact they do not want to appear to be vulnerable or 
different.   
The interviews with affected children and adults focused on a number of issues, 
including: their experience of being diagnosed with LHON, focusing on their feelings 
at the time of diagnosis; to what extent they understood the information they were 
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given in respect of their genetic status; and their thoughts on undertaking genetic 
testing. The participants were asked to reflect on the coping strategies they adopted 
to deal with the uncertainty surrounding the diagnosis and treatment of the 
condition. Participants were also asked about their life before their sight loss and 
how they perceived the impact of their visual impairment on aspects of their 
everyday life, including independence, self-esteem, education, social experiences, 
well-being and identity. They were also asked to indicate the level of support they 
had received following sight loss from their Local Authority Sensory Care Team and 
other agencies. As LHON is a condition that is passed on maternally, participants 
were asked to discuss how their diagnosis had affected their relationship with their 
mother. In addition, female participants were asked to consider (where 
appropriate) whether they were aware of mitochondrial replacement techniques 
(MRTs) and, if so, whether they would consider using new technologies to avoid 
passing the condition on to their children. Finally, participants were asked to discuss 
their aspirations for the future. 
I considered it appropriate to interview mothers as they may be said to have a dual 
role in the clinic, firstly, by acting as ‘gatekeeper to the patient’s body’ (Dimond 
2014: 4), and secondly, following the diagnosis of LHON, they are transformed into 
patients in their own right. There is a dearth of literature that explores the 
experience of sighted mothers who are raising visually impaired children (Kelly 
2005), and the experience of visually impaired mothers (Conley-Jung and Olkin 
2001; Molden 2014; Fredrick 2015, 2017a, 2017b) raising sighted or visually 
impaired children. Mothers who carry the LHON mutation may or may not display 
any symptoms, and so mothers were asked to what extent they were aware of any 
members of the wider family who have sight loss and whether they knew that LHON 
was in the family. Mothers were asked to discuss, inter alia, their feelings when their 
child was diagnosed, and to what extent (if any) the diagnosis had altered their 
relationship with that child; their thoughts in respect of communicating their 
genetic test results to their other children and the wider family; and also, whether 
their carrier status would affect their future reproductive decision-making.  
I conducted interviews with genetic ophthalmologists located in hospitals across the 
UK. The interviews were conducted over the telephone (participants’ choice) and 
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were of 30–45 minutes’ duration. The interviews were arranged towards the end of 
my data collection; my rationale for adopting this approach was that I wanted to use 
my fieldnotes to construct an interview schedule and identify salient issues. 
Interviewing this group later in the study proved to be a good strategy. Firstly, I had 
a better understanding of the work of the genetic eye clinic. Secondly, my 
participants had identified a number of issues including the lengthy delay in being 
diagnosed: a number of participants were told they were making up their symptoms 
or had being misdiagnosed. Thirdly, participants gave the impression that LHON is 
a condition that can be difficult to identify for ophthalmologists who have not 
previously encountered the condition in clinical practice.  
Genetic ophthalmologists were asked to comment on a range of issues, including 
(where relevant) the research they are currently undertaking in the laboratory, the 
potential effectiveness of new treatments, and the likely availability of new genetic 
reproductive technologies for mothers who carry the LHON mutation. They were 
also asked to consider whether there is a delay in referring patients to specialist 
genetic services and, if so, to what extent this affects patient outcomes; to what 
extent misdiagnosis by ophthalmologists who have no experience of the condition 
is prevalent; and how the referral process to specialist genetic ophthalmology clinics 
can be improved. They were also asked to recount the strategies they employed in 
explaining complex genetic information to children, young adults and their families, 
how they explain to patients the uncertainty associated with LHON, and whether 
they provided any genetic counselling.  
Initially, it was not my intention to interview representatives from the third sector 
or the pharmaceutical industry. However, during the early stages of interviewing 
participants, there were a number of issues raised around the delay in diagnosing 
LHON which would potentially impact on the effectiveness of new treatment 
options. I interviewed a representative from sight loss charity and asked him to 
comment on a number of issues including why he thought delays in diagnosis 
occurred and how the charity was addressing this issue. I interviewed a 
representative from the pharmaceutical company manufacturing a drug that claims 
to stabilise sight loss, but also potentially restores sight.  
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Interviewing participants at The Royal Albion Hospital was more challenging as 
space in the CRU was at a premium.  My participants were attending the hospital to 
take part in a clinical trial which required them to undertake six assessments during 
the day. The assessments were scheduled to take place either consecutively or with 
small gaps of approximately 20–30 minutes in between. The rooms I used were 
examination rooms with slit-lamps and other equipment used to undertake 
diagnostic testing, and it was not possible to book a room for the day. During my 
interviews, I was mindful of the time to ensure I did not over-run as I was anxious 
to ensure that my participants were not late for their next assessment.  
One of the problems I encountered in the CRU was that my interviews were 
constantly interrupted by clinical research staff who were either looking for pieces 
of equipment or who were trying to eject me from the room because they had not 
booked a room. On one occasion, the Clinical Research Fellow interrupted the 
interview as she had forgotten to dilate my participant’s pupils for the next test. We 
had to stop the interview until she had finished. Interviewing at the CRU was not 
ideal as I shuttled between participants and rooms. This resulted in the interviews, 
when transcribed, occasionally appearing disjointed as my participants lost their 
train of thought. Due to the time constraints at The Royal Albion Hospital, a number 
of the interviews were concluded over the telephone. Notwithstanding the problems 
I have highlighted, I still believe it was an appropriate idea to undertake the 
interviews at the CRU as it provided me with the opportunity to meet my 
participants, to establish a rapport, and to speak to them in an environment where 
they could be reminded of the matter at hand (i.e. their LHON diagnosis). 
Participant observation  
I commenced participant observation in St Tristan’s Hospital in January 2016 and 
The Royal Albion Hospital in April 2016, with the intention of immersing myself in 
the clinic. I was interested in observing at first-hand the mundane and routine 
practices of the clinic (Latimer 2008), and how the medical staff interacted with each 
other and patients. As Silverman (2014) comments, there is no guarantee that what 
people say they do in a given situation is what they actually do in reality. I also 
wanted to observe how the genetic ophthalmologists accomplish a diagnosis using 
48 
 
their clinical judgment and advances in technology. All participants consented to me 
being present during their clinical consultations. My attendances at The Royal 
Albion Hospital were scheduled to coincide with the appointments arranged by Dr 
Penvenen’s Clinical Research Fellow who was collecting data for their research 
study. I was able to observe Dr Penvenen’s examination of two recently affected 
males who had been referred to the clinic from their local hospitals. However, I was 
not able to observe appointments conducted by the Clinical Research Fellow. During 
one of my early attendances at The Royal Albion Hospital, I asked the Fellow if I 
could observe the appointments of the participants who had signed a consent form. 
The Fellow indicated that she would rather I was not present in the assessment 
room whilst the tests were being undertaken. My experience resonates with 
Atkinson’s (1995) experience of working with the haematologists. Whilst having 
secured access to the site and being sponsored by a senior clinician, Atkinson 
encountered initial hostility from junior doctors, who believed he was there to 
evaluate their competence. Atkinson resolved the problem by writing a personal 
note to each of the Haematologists in which he explained he was not there to criticise 
or evaluate their work. I was not able to resolve the issue with the Clinical Research 
Fellow as, shortly after I commenced data collection, the Fellow completed work on 
her project and left the Hospital. 
Fieldnotes 
Whilst observing appointments in the clinic, I used my digital voice recorder which 
was placed unobtrusively on the desk to capture the verbal exchanges between the 
clinician and the participants. I was initially concerned that the recorder might 
prove to be distraction for my participants. However, my impression was that 
participants forgot that the recorder was being used, as it became invisible sitting 
next to all the other equipment on the desk. I also supplemented the observations 
with fieldnotes which I wrote down in a series of notebooks. As I sat in the eye clinic, 
I made a conscientious effort to take contemporaneous fieldnotes. At times, the 
clinic moved at such a fast pace that it was impossible to do this. During the 
ophthalmic examinations the overhead lights are often dimmed, making it difficult 
to take notes as I was sat in semi-darkness. On those occasions, I endeavoured to 
ensure that the notes were written up after I left the clinic, relying on my memory 
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to accurately record what I had found unusual or interesting during the 
appointments. In the early stages of data collection, I tried to keep my writing legible 
as I knew I was going to be referring back to my fieldnotes, possibly 12 months later 
when I commenced writing up. However, as time went by and my handwriting 
deteriorated, I resorted to my own form of shorthand. Similar to the experience of 
Pope (2005: 1182), my fieldnotes are ‘embarrassingly scruffy’. When I transcribed 
the digital recordings from the clinical appointments, I was able to read through my 
fieldnotes to add in the descriptive accounts of individuals, their dialogue, non-
verbal communications and my reactions and reflections to events as they unfolded. 
I also included my detailed observations of the organisation of the eye clinics and 
the ‘inanimate artefacts’ (Latimer 2008: 9): the Snellen eye chart, slit-lamp, and 
other technologies used in accomplishing a diagnosis. 
Data analysis 
Early in my data analysis I made the decision that I would transcribe my participant 
observations and interview transcripts in full. I did not start coding my data until 
after the participant observations and interviews had been concluded. I had 
previously received training at Cardiff University in using computer assisted 
qualitative data analysis software (CAQDAS) which included both ATLAS.ti and 
NVivo 11. After I had transcribed my data, I started to use NVivo 11 (which I 
acknowledge is a good tool for organising data) but, of course, the decision on what 
parts of the transcripts to code and allocate to the themes or nodes rests with the 
researcher. I decided that, given the size of my study, manual coding would be more 
appropriate as it provided me with the opportunity not only to work in depth with 
the data to generate themes but, as Saldaña (2016: 22) has commented, it allowed 
me to demonstrate ‘control and ownership’ of the research. I also read through my 
fieldnotes. As Atkinson et al. (2001: 3) note, when fieldnotes are written, they do not 
become ‘closed, completed final text: rather, they are indeterminate, subject to 
reading, rereading, coding, recording, interpreting, reinterpreting’. Reading the 
fieldnotes alongside the transcripts of the participant observations acted as an aide 
memoire.   
I printed the transcripts and repeatedly read through them to identify themes which 
were coded using a variety of coloured highlighter pens. I analysed the data using 
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thematic analysis, primarily adopting the six-phase approach advocated by Braun 
and Clarke (2006).10 Adopting this approach enabled me to identify the main themes 
present in the data. In addition to identifying, analysing and reporting themes in my 
data, thematic analysis also facilitates ‘searching across a data set—be that a number 
of interviews or focus groups, or a range of texts—to find repeated patterns of 
meaning’ (Braun and Clarke 2006: 86, original emphasis). The popularity of 
thematic analysis may in part be attributable to the view that, as an analytical 
method, it is not tied to any particular discipline and is considered compatible with 
a number of diverse epistemological positions and research questions (Braun and 
Clarke 2006; Ritchie and Lewis 2014).  
Thematic analysis has been criticised for the lack of guidance on how actually to 
identify a theme and, once identified, how the theme should be coded (Braun and 
Clarke 2006; Aronson 1995). Ryan and Bernard (2003: 780) account for this lack of 
clarity on the basis that themes are ‘abstract and often fuzzy constructs’. I chose 
thematic analysis for three reasons. Firstly, I had previous experience of using 
thematic analysis in earlier projects. Secondly, thematic analysis has been selected 
as it is equally suitable for use with both large datasets (De Brun et al. 2013) and 
with small data sets (Fielden et al. 2011), which is the case with my study. Finally, 
thematic analysis is considered to be particularly useful when investigating an 
under-researched area, such as LHON or where the research participants’ views are 
not known (Braun and Clark 2006). There is a dearth of literature exploring the 
impact of LHON, and therefore, I did not have any preconceived ideas before I 
commenced my analysis. Themes were developed inductively, with codes developed 
based on repeated reading of the raw data itself, ensuring that the codes and themes 
were strongly linked to the data (Braun and Clarke 2006). I also adopted an iterative 
approach, in that when I identified new points of interest, I was able to include this 
in my analysis.  
                                                          
10 Braun and Clarke (2006) refer to the six phase approach as: Phase 1: familiarising yourself with 
your data; Phase 2: generating initial codes; Phase 3: searching for themes; Phase 4: reviewing 
themes; Phase 5: defining and naming themes, and Phase 6: producing the report.  
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Ethical considerations and researcher reflexivity 
Having outlined my methods for collecting data, I will now explore the ethical issues 
I encountered during the conduct of my research and reflect on my role as a 
researcher investigating a sensitive topic. In doing so, I pause to consider not only 
the emotional impact on my participants of taking part in my research, but also how 
I was affected by listening to my participants’ narratives. During data collection, 
there were times when I called into question my role as a researcher as I became 
acutely aware of what Guillemin and Gillam (2004: 261) refer to as the dichotomy 
between ‘procedural ethics’—obtaining ethical approval from the NHS REC, and 
‘ethics in practice’—the everyday ethical issues that arise during the conduct of the 
research study. 
One of the first ‘ethics in practice’ problems I encountered was with the process of 
obtaining informed consent from my participants. It became apparent at a very early 
stage that the National Research Ethics Service (NRES) guidance for producing the 
consent forms are not designed for the visually impaired. The level of visual acuity 
of some of my participants meant that, even with font 14 and the use of computer 
software, they were unable to initial the boxes on the form or see where they needed 
to sign. I received a number of forms in the post or by email where the signature was 
in the wrong place, the date was missing, and/or the boxes had not been initialled. 
Some participants in the clinic asked me to initial the boxes for them. When it came 
to sign the consent forms, I used my finger to assist the participant in placing the 
pen at the right place on the form and guided them in placing their signature in the 
right place on the form. It has been suggested that the requirement for the visually 
impaired to sign the consent form should be updated to allow them, instead, to 
provide ‘recorded audio consent’ (Saleh 2004: 310). 
Dr Morgan indicated that currently children (aged 13 and 14) with LHON were being 
treated in the clinic. The decision to involve children in this research project was not 
taken lightly. There has, in recent times, been a move away from adopting a 
paternalist attitude to children’s involvement in research, with a growing 
recognition that children have the right to be involved in making decisions about 
their welfare (Piercy and Hargate 2004). Article 12 of the United Nations Convention 
on the Rights of the Child (1989) confirms that all children and young people who 
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are capable of forming their own views have a right to express those views freely in 
all matters affecting them. Previous research exploring children’s expectations and 
experiences of attending the eye clinic is missing from the literature. I would suggest 
that involving children in this research adds another dimension to the research 
findings.   
Children who are aged between 16‒18 years old, are presumed in law to be 
competent to give consent. Notwithstanding this, it is considered to be good practice 
to encourage competent children to involve their families in the decision-making 
process (DH 2001). This was the approach I adopted. In respect of children under 
the age of 16, the position is more complex. The decision to assent or consent 
children was taken by me on a case-by-case basis and it would have been 
inappropriate for me to assume that children under 16 were not competent to 
consent. I obtained guidance on this subject from a number of sources. Medical 
research involving children is regulated by The Medicines for Human Use (Clinical 
Trials) Regulations 2004. Research that falls outside the regulations is subject to 
common law principles developed by the courts and to other statutory provisions 
including the Family Law Reform Act 1969. In addition, a number of research 
councils and professional bodies have provided guidance on when it is appropriate 
to consent or assent children in non-medical research.11  
Further guidance is provided by the judgment of Lord Fraser in the case of Gillick v 
West Norfolk and Wisbech AHA [1984] QB 581. Lord Fraser confirmed that in making 
the decision to obtain consent from children under 16; “It is not sufficient that the 
child understands the nature of the advice which is being given, the child must also 
have a sufficient maturity to understand what is involved”. Children under 16 who 
are considered not competent to give consent should be asked to assent to the 
research after their parent or guardian has given consent. The National Children’s 
                                                          
11The Medical Research Council (2004) suggest that where children have sufficient understanding 
and intelligence to understand what is proposed, it is their consent and not that of the parents that is 
required by law. The Department of Health (DH) (2001) states that for a child’s consent to be valid 
the child must: (1) be capable of taking that particular decision, in other words must demonstrate 
that they are competent; (2) be acting voluntarily and not coerced into giving consent; (3) be given 
sufficient information to enable them to make the decision.  
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Bureau (NCB) (2011) guidelines suggest that, ideally, informed consent should be 
obtained directly from the child by the researcher, thus enabling the researcher to 
satisfy themselves that informed consent has been given voluntarily. Given that I 
would not have had any previous contact with the child, the NCB confirms that it is 
appropriate for the parent/guardian or healthcare professional to provide the child 
with information in respect of the research and to make the decision whether the 
child is competent to consent. This was the approach I adopted, and the 
parent/guardian was asked to confirm whether their child was competent to 
consent.  
Respecting the right to confidentiality of the research participants has also proved 
to be challenging as they are drawn from a small pool of individuals diagnosed with 
a rare condition. In anonymising data, the major concern has been to ensure that 
participants are not identified by family or friends. In my research, I have 
interviewed mothers, children and, on one occasion, siblings—and it is inevitable 
that participants with a familial connection may identify each other. Many of my 
participants have joined the LHON (national and international) on-line community, 
where they have developed friendships. They have placed in the public domain 
details of their condition and other personal information. A number of my 
participants attend lay and professional conferences. To overcome the potential for 
participants to be identified, I have allocated pseudonyms and changed the names 
of the two hospitals where I collected data. I have also changed some minor details 
in respect of the clinics and the participants.  However, as a researcher it is not 
possible to legislate for every eventuality. Whilst I was presenting at a Patient Day, 
one of my participants ‘outed’ himself by disclosing to the audience that I had 
interviewed him: in that moment, any sense of anonymity and confidentiality 
disappeared. 
Moreover, interviews involved asking participants to confront sensitive issues 
which they might find very emotionally challenging. For example, I interviewed a 
young male who became extremely angry and was shouting at me as he recounted 
how his parents were aware of his mother’s carrier status but chose to have a child 
notwithstanding the risks. On occasions my participants, particularly mothers, 
became tearful when they talked about learning of their carrier status, and the 
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enormous guilt they felt when given their child’s diagnosis. The affected participants 
explained the anxiety they felt that their visual acuity may deteriorate, or that they 
may never find a girlfriend/boyfriend, or one day have children of their own. 
Whenever I felt that participants were struggling with my questions, I offered them 
the opportunity to stop the interview and continue another time or to withdraw. 
None of the participants chose the latter option. Both Dr Morgan and Dr Penvenen 
agreed that participants could be referred to them for further advice. I also 
contacted a senior clinical geneticist at St Tristan’s Hospital who confirmed that 
participants could be referred to his service for advice. In addition, I provided 
information in respect of sight loss charities that could give further support.   
As qualitative researchers, we are anxious to provide a safe and comfortable space 
that empowers our participants to take part in the interviews and encourages them 
to open up and share with us their stories (Dickson-Swift et al. 2007). It is these 
disclosures that contribute to enhancing our knowledge and which help us to gain a 
deeper understanding of how individuals come to terms with living with chronic 
illness. At times, I was surprised at the level of information disclosed, given that I 
had never met the participant before. In some instances, participants informed me 
that having the opportunity to revisit their past and reflect on what had been a 
distressing and emotionally draining time for them was a cathartic experience. Birch 
and Miller (2000) comment that in the qualitative interview, the researcher 
becomes a catalyst for participants to reflect on and give voice to very private and, 
on occasions, deeply upsetting past events. The authors go on to suggest that this 
calls into question the judgment of the researcher in evaluating a good or successful 
interview. In my research, a number of my participants claimed that I had asked 
questions that no one else had asked before. Similarly, they said that they had 
disclosed to me information that they had not previously discussed with family or 
close friends because they wanted to ‘protect’ them. This is particularly the case with 
participants who had contemplated suicide or had been self-medicating on illicit 
drugs. Ultimately, the researcher is asking participants to relive traumatic events 
and has no way of knowing the long-term harm such disclosure will have on the 
participant. 
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The qualitative interview has the potential to provide a space in which the boundary 
between research and counselling, particularly when discussing sensitive topics, 
may become blurred (Dickson-Swift et al. 2006). This point is also made by Gale 
(1992) who claims that participants may view qualitative interviews as having more 
therapeutic value than a therapy interview. This is not surprising, considering that 
qualitative researchers utilise comparable skills to those adopted by therapists and 
counsellors when conducting therapeutic interviews, including the ability to listen 
to what is being said while also demonstrating empathy (Kvale 1996). However, if 
researchers are not mindful, they may inadvertently open the door to transforming 
the qualitative interview into an impromptu therapeutic session (Dickson-Swift et 
al. 2006)—one in which the qualitative researcher is ill-equipped to participate 
(Kvale 1996).  
On occasions, interviews were considered by participants as an opportunity to 
canvass my view on recent advances in research on potential treatment options, 
particularly relating to mitochondrial replacement techniques, the use of Idebenone 
and gene therapy. In her research with the bereaved, Sque (2000: 27) claimed that 
participants seek information from the researcher which, if imparted, can itself have 
‘beneficial effects in eliminating latent misunderstanding and securing pertinent 
knowledge’. In qualitative research, Daly (1992: 5) advocates the concept of ‘fair 
exchange’ or reciprocity—where researcher and participant share information 
(Ackler et al. 1991). In sharing information, the researcher is seen to be giving 
something back to the participant and, as a result, this increases both the ‘depth and 
quality’ of the data (Dickson-Swift et al. 2007: 334).  I found these moments difficult 
to negotiate, as I did not want to be perceived by my participants as someone who 
held themselves out as having expert knowledge. I in response, suggested that the 
participants may like to discuss their questions with their ophthalmologist the next 
time they visited the clinic.  
I also experienced the problem of the ‘reluctant respondent’ (Becker and Geer 1957; 
Adler and Adler 2003; Scott et al. 2012) where a participant, having agreed to take 
part in the interview, then fails to disclose information is well recognised. There may 
be a number of reasons for a participant’s reluctance to speak: shyness, inability to 
articulate emotions, not wanting to answer questions, or not understanding the 
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questions (Becker and Geer 1957). Establishing a rapport enables the researcher to 
build a relationship with the participant and encourages them to impart their story 
(Dickson-Swift et al. 2007; Goodwin et al. 2003). Acknowledging the importance of 
developing a rapport with research participants, Scott et al. (2012) consider that 
this can be achieved by sharing information, finding common ground and on 
occasions using humour to break the ice. However, as Dickson-Swift and colleagues 
(2007) observe, the level of disclosure has been viewed as problematic by a number 
of feminist authors (Oakley 1981; Finch 1984), with concerns raised that 
participants may be ‘seduced into disclosing information that they later regret’ 
(Kvale 1996: 116). As Kvale explains, the interview is not produced as a result of a 
collaboration of two equal parties. There is a distinct asymmetry of power when the 
researcher decides on the topics to be discussed. 
I acknowledge that I failed to build a rapport with the two young men discussed 
earlier. On reflection, I realise that my lack of confidence as a first-time researcher 
meant I over-compensated by trying to appear professional and this gave the 
impression of my being a little reserved. Having said that, I am not sure whether if I 
had been more experienced the males would have ‘opened up’ to me, it could have 
been that their level of maturity inhibited them, that they felt uncomfortable talking 
to me because I was a female or, irrespective of my gender or their age, that they just 
did not like talking about their emotions.  
During the interviews, I heard some very positive and upbeat accounts of how 
participants on a daily basis overcome the challenges they face living in a sighted 
world. At times I marvelled at their resilience and fortitude in overcoming adversity. 
However, at other times I was privy to harrowing and disturbing accounts. One 
participant gave me a very detailed description of how he had been going to end his 
life; he had decided on the method and acquired the means to do so. He would have 
ended his life had it not been for the intervention of a school friend who happened 
to come across him and was able to talk him out of it. When undertaking research 
dealing with emotive topics, Lowes and Paul (2006) suggest that researchers should 
not under-estimate the potential impact such disclosures may have on their own 
emotional well-being. There has been little empirical research focusing directly on 
the experiences of researchers who may be affected by the stories they have been 
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told. Dickson-Swift et al. (2007) highlight the need for researchers investigating 
sensitive topics to be given appropriate training to deal with the emotional impact 
of their research and also to be provided with contact details for sources of 
professional advice and support. Similar to Atkinson (1997), I found my research 
was a source of mixed emotions.  It gave me a great sense of personal satisfaction in 
highlighting an under-researched rare condition, but at the same time, there were 
occasions when I felt anxious and out of my depth.  
Study limitations  
 
LHON is a rare condition and this was reflected in the small sample (N=41). It would 
not be possible given the size of the sample to suggest that the findings are 
generalisable to the wider LHON community.  Secondly, a number of the participants 
were recruited through a sight loss charity, and received regular newsletters 
updating them on recent developments in the treatment of LHON. Many of the 
participants also attend expert conferences and patient days, and It may be argued 
that this group are highly motivated and not representative of the wider LHON 
community. My intention to interview women who were considering their 
reproductive choice was limited as only two women were currently considering 
having children. As I explained in Chapter Three, I encountered a number of 
problems in gaining access to The Royal Albion Hospital which limited my 
opportunities to be present when participants attended the clinic to be receive their 
diagnosis. I have therefore relied on the retrospective account of participants. 
Whilst some participants had a vivid recollection of the events others were vague.  
Summary 
In this chapter, I have outlined the methodological challenges I encountered during 
my research. I have explained the problems I faced in gaining access to the two 
research sites, and how delays in securing the necessary R&D permissions in The 
Royal Albion Hospital had a significant impact on my data collection. 
Notwithstanding issues with accessing the two sites, I believe that the data I 
collected provides a valuable insight into the diagnosis and treatment of LHON. I 
have acknowledged the ethical issues that arise when discussing a sensitive topic 
and how I adopted strategies to minimise harm to participants. I have also referred 
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to the issues surrounding anonymity when interviewing participants drawn from a 
small pool of people who have been diagnosed with a rare condition.  
I have explained my rationale for adopting qualitative research methods to explore 
the highly individual experience of sudden sight loss for people affected with LHON 
and their families. I have also described the processes of transcribing and analysing 
my data, justifying my decision to manually code my data.  
Over the following four empirical chapters, I explore participants’ chronic illness 
trajectory, highlighting the key findings from my research. 
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Chapter Four: “The Doctor Didn’t Believe Me”: Negotiating 
Diagnostic Uncertainty 
  
Introduction 
 
Over the following four empirical chapters, I outline a number of the key findings 
from my study. In this chapter, drawing upon interview and observational data, I 
explore participants’ accounts of receiving a diagnosis of Leber hereditary optic 
neuropathy (LHON). The unexpected loss of sight is the beginning of what is often, 
a tortuous process for participants, requiring multiple hospital appointments, 
undertaking numerous (often deleterious) diagnostic tests, and, on occasions, being 
subjected to the indignity of having their symptoms dismissed as attention-seeking 
behaviour. I commence the discussion by describing participants’ accounts of their 
initial reactions to experiencing problems with their eye sight and how symptoms 
were often ignored until they reached a critical point and medical attention was 
sought. Diagnosis is a key stage in participants’ illness trajectory and, as Jutel (2009: 
278) has observed, ‘is integral to the system of medicine and the way it creates social 
order’. Diagnosis is also said to identify treatment options, predict outcomes and 
provide explanatory frameworks (Jutel 2009). I explore the boundaries of diagnosis 
and how assigning a label to symptoms legitimises participants’ claims to enter the 
‘sick role’ (Parsons 1951). From here, I will unpack the narratives of participants 
regarding their experience of receiving the diagnosis of LHON. For many 
participants, receiving a diagnosis is the start of their quest for information with 
respect to the aetiology, prognosis, treatment and inheritance of LHON. In the final 
part of the chapter, I discuss the uncertainty surrounding LHON and why 
ophthalmologists fail to identify the condition in clinical practice. I will also describe 
their own interpretations of interacting with ophthalmologists who dismiss their 
symptoms as the product of an over-active imagination, thereby resulting in a 
contested diagnosis.  
Experiencing symptoms of LHON 
Reflecting the chronic illness literature (Bury 1982; Robinson 1988; Scambler 1989; 
Kelly 1992), Corbin and Strauss (1988: 22) suggest that when symptoms of illness 
appear, whilst some people in this thesis immediately sought medical attention, 
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others waited until the symptoms become ‘undeniable, so visible or alarming that 
they can no longer be ignored’. I begin the discussion by unpacking the multiple 
interpretations participants attributed to experiencing initial symptoms of sight loss 
and how, through a process of deferral, some participants downgraded their 
symptoms until they reach a critical juncture, such as not able to see road signs when 
driving or read documents at work. It was at this point, when symptoms could be 
ignored no longer, that medical attention was sought. Mirroring research 
undertaken by Green and colleagues (2002) with people diagnosed with glaucoma, 
participants in this thesis, reflecting on their initial symptoms, referred to a range of 
problems with their eyes. However, only in retrospect (i.e. after their diagnosis) did 
they realise the significance of the symptoms. John started experiencing symptoms 
when he was 42 years old: ‘I was looking at an email at work and the middle of the 
word was missing. I thought that’s “strange”, then I couldn’t see the computer screen 
properly any more’. At the time, John had been experiencing stress and drinking 
heavily, which is how he accounted for his symptoms. Sandra, who was diagnosed 
in 2015 aged 69, recalled an odd episode when her right pupil dilated: ‘Looking back, 
it became apparent that something funny was happening with the right eye which was 
typified by text being broken up, by colours being distorted and by a lack of acuity’.  
Sandra had recently been diagnosed with glaucoma and had undergone surgery to 
reduce the pressure in her eyes, which is how she accounted for the problem she 
was experiencing.  
Problems with sight were often pushed to the margins of participants’ lives and 
overlooked; this was particularly true of the younger participants as they 
constructed innocent explanations to account for their symptoms. David, who was 
diagnosed with LHON in 2011 aged 23, explained that he had been playing football 
prior to first noticing symptoms:  
‘It was quite a sunny day, so I thought I had damaged my eyes from the 
sun because I noticed, I think in my right eye, I kind of had that after 
image you get after looking at a bright light sometimes.’ 
 Andy noticed that the road signs were blurred whilst he was on a long journey and 
thought his symptoms were due to tiredness. He was subsequently diagnosed when 
he was 20 in 2008: ‘I was on a four-hour car journey, the [road] signs looked a bit 
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blurry, I put it down to tiredness, but it was due to me having started to lose my sight, 
but I wasn’t aware of that then’. Unaware of the seriousness of his symptoms, Andy 
went back-packing for six weeks, during which time his sight rapidly deteriorated. 
Two women, Beth and Tina initially ignored their symptoms, notwithstanding that 
both shared the experience of living with a brother who had been diagnosed with 
LHON. Beth, who was diagnosed when she was aged 51 in 2015, explained that she 
had been wearing glasses for many years: ‘I had noticed for a few weeks previously I 
was having difficulty reading. I couldn’t really read, I just thought I needed to check 
my [glasses] prescription’. Tina had for a number of years been experiencing 
recurring migraines and initially did not give any importance to her blurred vision: 
‘I had a massive migraine the day before. I was driving along, and I thought that the 
road sign isn’t as crisp as it should be. I didn’t initially think that there was a problem’. 
Tina was subsequently diagnosed with LHON aged 30 in 2013.  
Beth and Tina did not appreciate that women could be affected by LHON and, so, 
accounted for their symptoms as a consequence of ageing (Beth) or ongoing health 
issues (Tina). Irrespective of how they first experienced symptoms, all of the 
participants recounted feelings of devastation when they were given what was an 
unexpected diagnosis (discussed in Chapter Five). Having taken the decision to seek 
medical attention, participants in the first instance were referred to the eye casualty 
department. This heralded the start of what for many was a lengthy process to find 
a diagnosis.  
Before dissecting the challenges which participants encountered when attending an 
eye clinic, I consider how a diagnosis has the power to legitimise illness by ‘putting 
a name’ to symptoms, providing entry to the sick role and providing an explanation 
for what would otherwise be inexplicable symptoms of sight loss (Jutel 2011: 1). 
  
Defining the boundaries of diagnosis 
The quest for a diagnosis has been recognised as one of the most pressing issues 
identified by patients suffering with symptoms of illness (Jutel 2011) and, 
unsurprisingly, this was evident from the interviews with participants in this thesis. 
In a world where uncertainty is ‘omnipresent in life’ (Corrigan 2012: 27), receiving 
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a diagnosis has the potential to deliver much sought after certainty for both the 
patient and the doctor, receiving a diagnosis is ‘like being handed a road map in the 
middle of a forest’ (Jutel 2011: 1). Without the road map, the doctor is left ‘casting 
around in the dark’ unable to articulate a plan of action (Pinder 1992: 8). Diagnosis 
is said to incorporate two distinct but interrelated characteristics, it is both a 
category (a label), specifying the pathological nature of the condition, and a process 
(an activity), utilised by the medical profession to assign the label (Blaxter 1978; 
Jutel 2009; Jutel and Nettleton 2011; Locock et al. 2016). As Blaxter (1978: 9) puts 
it, diagnosis as a process is dependent on diagnosis as a category, in that the process 
of describing is reliant on the descriptions ‘acceptable or available in the relevant 
universe of knowledge’. In turn Jutel and Nettleton suggest that diagnosis has a third 
component—it is a consequence, arguing that the way in which diagnosis is 
organised, structured and delivered has consequences for patients as it has the 
potential to ‘vindicate and blame; legitimise or stigmatise illness’ (Jutel and 
Nettleton 2011: 797). Receiving a diagnosis gives individuals permission to be ill 
(Jutel and Nettleton 2011), with Nettleton (2013: 27) noting: 
‘a diagnosis: validates what counts as disease, offers explanations and 
coheres patients’ symptoms, legitimises illness enabling patients to 
access the sick role, provides a means to access resources and facilitates 
their allocation, and forms the foundation of medical authority.’  
In a more detailed sense, Parsons’s (1951) conceptualisation of the sick role is 
founded on the premise that the social system is dependent on individuals being 
healthy and carrying out expected social roles (for example, being employed). Illness 
is a form of deviance and disrupts the ability to perform social roles, thus posing a 
threat to normative standards. People who are ill have temporary access to the sick 
role which is a form of ‘sanctioned social deviance’ (Barnes and Mercer 2010: 44). 
By entering the sick role, people obtain a ‘claim for exemption’ from undertaking 
‘normal social obligations’ and responsibilities (Parsons 1951: 455). However, they 
must also adhere to the obligations placed upon them, such as acknowledging being 
ill, seeking appropriate medical intervention, and demonstrating the desire to get 
better.  
Parsons’s (1951) conceptualisation of the sick role has been criticised for providing 
an ideal-typical account of acute illness rather than taking account of chronic 
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illnesses, where recovery is unlikely. Those with a chronic illness, such as LHON, 
may be said to have a legitimate claim to the sick role and all its benefits. However, 
if individuals fail to follow medical advice to adjust their lifestyle to avoid further 
deterioration of their eye sight, one may wonder whether they are still entitled to 
the benefits that the sick role bestows upon them.  
In the following extract from my observation at Dr Morgan’s clinic in St Tristan’s 
Hospital, John attends the clinic for his annual review, having experienced vision 
loss at the age of 42. At the time of his diagnosis, he was drinking and smoking 
heavily. Unaware of a previous family history of LHON, he was initially diagnosed 
with toxic amblyopia,12 but was subsequently diagnosed with LHON. During the 
appointment, John raises concerns that his right eye is deteriorating, and it is 
evident that John has not been following medical advice regarding his smoking and 
alcohol consumption: 
John: The only problem I have is in the past my right eye has always been 
the best eye. That’s why I usually see the top letter [on the Snellen 
eye chart]. I couldn’t see the top letter today. It might just be a 
temporary glitch, I don’t know.  My right eye seems to have gone 
a bit worse. My left eye is the same. 
 
Dr: You are right, if you look back through the readings when you 
come (flicking through the file). In fact, looking at your notes you 
do not always see the top letter with the right eye. You obviously 
do feel that the right eye is the best eye. In general terms, the issue 
around protecting yourself is maintaining as healthy a lifestyle as 
you can. 
 
John: I eat well, and I go to the gym, I occasionally drink too much at the 
rugby.  I mean the problem I have is I try not to drink because if I 
drink, I smoke as well for some reason. I know I shouldn’t. 
 
Dr:  Smoking is probably worse than the drinking. If there is any way 
that you can try to not smoke? 
  
John: I know that. I am not a heavy smoker. 
 
Dr:  You are not really smoking regularly so the nicotine patches 
wouldn’t help you. You don’t need them daily. 
                                                          
12Toxic amblyopia presents as a painless bilateral loss of vision. Almost all patients complain of a 
blurring of vision and difficulty in reading small print.  Patients may also complain of difficulty in 
differentiating red from green. The disease usually evolves over a period of several weeks to several 
months (Prakash et al. 2011). 
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John:  No, that’s true. Are the vapes [e-cigarettes] bad for you? 
 
Dr: Nobody knows… nobody knows that they are good for you.  
 
John:  You can’t really say? 
 
Dr:  Ingesting or taking in or breathing in any form of drug or chemical 
can’t be neutral, it must have some effect. There are chemicals in 
them that are going into … it’s going to be absorbed. People will 
not know if it’s dangerous and may not know for 5, 10, 15 or 20 
years. I doubt if it’s neutral, I doubt if it’s got no effect. I don’t 
necessarily think it is a good thing.  
In his appointment, John articulates his concern that his eyesight may be 
deteriorating. When asked about his lifestyle, particularly his smoking, he becomes 
slightly irritated and is keen to present himself as adopting a healthy lifestyle, 
clarifying that he eats well and exercises on a regular basis. However, it is apparent 
that John’s real concern is his level of smoking and drinking, and the impact this is 
having on his right eye. John is aware that alcohol consumption, and smoking are 
associated with an increased risk of sight loss for people with LHON (Yu-Wai-Man 
et al. 2014; Kirkman et al. 2009a). Dr Morgan subtly suggests that using e-cigarettes 
may not be a solution for him and that he should give up smoking altogether. I 
interviewed John after his appointment with Dr Morgan where he continued to be 
preoccupied with the perceived deterioration in his right eye and reflected on his 
lifestyle both before and since his sight loss: 
How long had you been drinking heavily before you noticed the symptoms?      
It was a couple of months. […] I was living with a friend who died; he was 
an alcoholic. It’s hard to say [how much], a couple of bottles of wine a day, 
maybe 2–3 bottles of wine a day at the time, I eventually went on to… 
sometimes it could be a bottle of vodka. […] [drinking spirits] was only a 
temporary thing and then I stopped. Not on top of the wine. It would be 
wine or vodka or something. He was drinking as well, you see. He was a 
bad influence. I was living with him because I was going through a 
divorce. He died, and he was my best friend. It was a build-up of things. 
Then I got depressed about my eyesight. It wasn’t a particularly good year 
for me (laughs). […] I suppose with any eye condition …even if you have 
good eyesight, it’s a no, no because smoking can cause sight problems […] 
I would like to stop drinking, but whether I will or not is another question. 
I will stop smoking.  Friends keep trying to get me out on Friday and they 
pour me large vodkas and things, you know. I have told them I shouldn’t 
be drinking. They are happy carrying on; they are not really thinking 
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about me. They say, “Have another drink”. […]  I am a social creature, a 
party animal-type thing. I have tried to change as much as I can. I don’t go 
out as frequently as I used to, drinking I mean. I don’t drink in the week 
at all. At the weekends, if I go out, I drink more than I should (laughs). 
(John, diagnosed aged 42 in 2009) 
John is aware of the precarious position he is putting himself in by continuing to 
smoke and drink. However, he seeks to abrogate responsibility, firstly, by attributing 
the conduct to a friend who he was living with at the time of his sight loss and, more 
recently, his circle of friends, with John believing it was his drinking and smoking 
that triggered LHON. One of the other participants, David, also reflected on his 
lifestyle prior to his sight loss. David smoked and drank alcohol before his sight loss, 
suggesting that this may have triggered LHON: 
‘I was drinking quite a lot at the time (laughs). I was drinking after work, 
drinking to catch up with my friends and stuff, and then going into work 
hung-over quite a few times and things…  and I would go to kind of… 
there were a couple of times when I went to all day parties and stuff, 
especially during the summer and things. And, yeah, like it was just a lot 
of binge drinking and stuff and drinking everything and anything.’ 
During his interview, David placed considerable emphasis on his previous drinking 
habits with respect to a diagnosis of LHON. Later in the interview, he told me that 
whilst he knows that smoking and drinking are not good for him and after initially 
giving up alcohol following his diagnosis, he has since started drinking again: 
‘I stopped drinking and smoking stuff for, like, six months or something 
and then it was after that I kind of thought to myself, you know, I quite 
enjoy drinking at least.  If I am perfectly honest, (laughs) I do enjoy 
smoking cigarettes as well, but I know that’s definitely bad for you; I 
would love to smoke if it had health benefits or wasn’t bad for you 
(laughs). I enjoy drinking and my friends enjoy drinking and stuff and so 
I kind of felt I don’t want LHON to stop me from living my life and 
enjoying the things I used to enjoy beforehand as well, and so, you know, 
that’s why I am still drinking and stuff. I still do go a bit too wild 
sometimes, but before I lost my eyesight, there were times when, you 
know, I got through the stages when I thought I am drinking a bit too 
much, maybe I should quit for a few months and then start up again. So, 
you know, I would kind of stop and start.’ 
(David, diagnosed aged 23 in 2011) 
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John and David continue to undertake activities that they know may exacerbate 
their residual vision. Petersen (2006: 33), suggests that being unable to achieve or 
restore optimum health is often perceived as a ‘weakness of the person and a failure 
to fulfil one’s obligation as a citizen’. John and David, at times, are unable to follow 
medical advice—and thus continue to participate in ‘deviant’ (Parsons 1951: 453) 
behaviour, placing in jeopardy their legitimate claim to the sick role. There is of 
course no certainty that John’s and David’s sight loss can be attributed to their 
lifestyle choices. One of the abiding mysteries of LHON is that there are affected 
individuals who have never smoked, consumed alcohol or been exposed to toxins 
(Newman 2009). Ollie, who is a good example of this phenomenon, experienced 
sight loss when he was 18. He explained: ‘I wasn’t smoking; I led a very healthy life 
really. I had just done a charity cycle, I played football to a high level, I played cricket 
to a high level’. As far as Ollie is aware, there is no family history of LHON and he 
remains puzzled as to why he was affected. 
After their diagnosis other participants also scrutinised their previous behaviour. 
Gerry had recently retired from his job when his eyesight started to fail. He had a 
vague recollection of an aunt on his mother’s side of the family who had an issue 
with her sight, but no one in her family was aware of what had caused her sight loss. 
Gerry pondered on the possible reasons for his sight loss, indicating that he had 
given up smoking many years ago. Gerry speculated that his previous employment 
may be the cause: ‘I was working in a University research lab, I was working with 
chemicals, but I wasn’t in day to day contact with them… whether there was anything 
there that triggered it.’ Declan, who experienced symptoms when he was 12 years 
old explained, that during a school rugby match, he was injured:  
‘I did play rugby for a local team, and it was when I was playing rugby for 
the school when my head was stamped on. They think that’s what could 
have triggered it because it was around about the same week I can 
remember sort of noticing things.’ 
(Declan, diagnosed aged 12 in 2006) 
Other people, when they received the diagnosis, researched their family tree to find 
relatives who had experienced sight loss. Tim was 22 years old when he experienced 
symptoms of LHON. He explained that after his diagnosis: ‘We went back and looked 
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at the family tree because going back to the early 1900s, you would know if anyone 
had been registered blind; there isn’t anyone’. Tim’s experience is fairly common: the 
majority of participants in this thesis were unaware of a family history of LHON.13 
In the following section, I discuss the challenges which participants encountered in 
being diagnosed with LHON (with particular focus on the eye clinic), and how the 
diagnosis was the start of a quest to understand the aetiology and prognosis of their 
condition.  
The clinical encounter  
 
Medical sociologists have found the work of the clinic to be a fertile ground in which 
to undertake research—particularly in the field of genetic diseases. Studies have 
considered diverse topics including the use of pre-implantation diagnosis (Franklin 
and Roberts 2006), amniocentesis (Rapp 2000), genetic counselling (Bosk 1992), 
and dysmorphology (Shaw et al. 2003; Featherstone et al. 2005; Latimer et al. 2006; 
Latimer 2013).  Previous research with families at risk of developing Huntington’s 
disease (Konrad 2005) has highlighted the significant impact which knowledge 
gained from genetic testing can have on an individual’s life and their relationships 
within the family. Konrad’s study has resonance for this research in that it highlights 
the ethical dilemmas faced by women who are asymptomatic. In the case of LHON, 
this includes mothers who may not have experienced symptoms and who were 
unaware of their carrier status until their child was diagnosed. The identification of 
a genetic eye condition can have far-reaching consequences, not only for affected 
individuals, but also for other family members, including mothers and siblings 
(discussed in Chapter Five).   
The clinic has been identified as an important site for the discovery of modern 
medical knowledge (Latimer et al. 2006). It is in the clinic that medical knowledge 
is produced and reproduced—where medical conditions are ‘created’ rather than 
simply being ‘discovered’ (Featherstone and Atkinson 2012: 25). It is through the 
‘spectacular display and representation of bodies, organs and pathologies’ 
                                                          
13Evidence suggests that up to 40% of individuals do not have a family history of LHON (Harding et 
al. 1995). However, it is suspected that these families most likely represent cases where family 
history is difficult to trace given that de novo mutations are rare in LHON (Biousse et al. 1997; Man 
et al. 2003).  
68 
 
(Featherstone et al. 2005: 552) that disease is identified. Foucault (1973: 108) talks 
of the clinic as the place where the ‘clinical gaze’ is utilised to look into the patient’s 
body and identify signs of disease. Similarly, Featherstone and Atkinson (2012: 17) 
refer to the clinic as a place for transforming patients and families into ‘clinical 
entities’. In her ethnographic study of the dysmorphology clinic, Latimer (2013: 28) 
suggests that the clinic is also the place where new classifications begin to emerge 
for ‘organising patients, medical knowledge and authority’. The process of 
categorisation is not undertaken by simply fitting individuals into existing 
diagnostic categories. As Featherstone and Atkinson (2012: 25) note, the categories 
are constantly evolving by a process of ‘description, definition and classification’. 
Bowker and Star (1999: 86‒87) expressed the view that classification systems may 
be said to ‘provide a stabilising force between the natural and the social 
worlds…they hold in place sets of arrangements that allow us to read the natural as 
stable and objective and the social as tightly linked to it’. The act of naming 
symptoms is a ‘prestige-enhancing’ (Pinder 1992: 2) achievement for clinicians, 
setting them apart from the lay person and other medical professionals, confirming 
greater knowledge and status as well as medical authority (Jutel 2010: 1084; 
Friedson 1970). Until the medical profession acknowledges and classifies a 
condition as abnormal, it arguably does not officially exist (Blaxter 1978; Jutel 2009; 
Jutel and Nettleton 2011).  
LHON is a condition traditionally diagnosed in the eye clinic by ophthalmologists 
who, utilising their clinical experience, identify the presence of classic symptoms 
(discussed in Chapter One). The ophthalmic genetics clinic is a domain that is 
increasing being reconfigured by the introduction of genetic technologies. The rapid 
expansion of next generation sequencing (NGS), and the advent of whole exome 
sequencing, has brought with it increased opportunities for molecular confirmation 
of a clinical diagnosis (McKibben et al. 2014; Ganne et al. 2015). Newman argues 
that NGS is becoming the ‘new’ standard for mitochondrial DNA (mtDNA) genome 
sequencing (Newman 2017: 56). Whilst testing for the three primary LHON 
mutations continues to be the norm, it is now possible to identify the rarer LHON 
mutations by undertaking complete mtDNA genome sequencing, which is no longer 
a ‘difficult or exceptional process’ (Newman 2017: 56). Featherstone and Atkinson 
(2012: 10) posit that advances in genetic technologies have not usurped the 
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practical and interpretive work of the clinician—who still retains the power to fix 
classifications. The authors suggest that ‘diagnosis is not wholly dependent on the 
use of laboratory technologies and the clinician’s perception is not reduced to 
laboratory findings’ Indeed. Hedgecoe (2008a) suggests that clinicians, relying on 
their acquired knowledge and experience, adopt genetic testing into their clinical 
practice only when they are persuaded of the clinical usefulness of such tests.  The 
following extract illustrates that, in the identification of LHON it is the 
ophthalmologist’s judgement that is central to the diagnostic process.  Sarah, whose 
son developed symptoms of LHON when he was 22 years old, attended the eye 
casualty department. During the day her son participated in numerous tests—which 
failed to identify the problem. As the day was drawing to a close, the eye casualty 
specialist registrar (SpR) referred Sarah’s son to a neuro-ophthalmologist who was 
working in the clinic on that day: 
‘We went to A&E and they did a few basic tests and they were stumped 
by what was going on. After he had the basic initial examination, they 
said: “He hasn’t got a detached retina, he hasn’t got any bleeding in the 
eye, and he hasn’t got pressure behind the eye. We had better put him in 
to see Dr [neuro-ophthalmologist]”. He said straight away, “this is what I 
think it is”. He couldn’t guarantee what it was without doing the genetic 
test, but he knew straight away what it was. He said, “I hope it’s not, but 
this is what I think it is”.’ 
 
The neuro-ophthalmologist immediately identified the characteristic signs of LHON 
and arranged for a blood sample to be sent to the gene panel for confirmation. 
Sarah’s experience is an exception, as the majority of participants do not receive a 
diagnosis so (relatively) straightforwardly. Sally experienced symptoms in the mid-
1970s prior to the discovery of the three LHON mutations:  
‘It [symptoms] started when I was seven. I was passed from pillar to post. 
A lot of it is really clear because it was one of the most traumatic times in 
my life. I think they thought at some point that I had had a bang to the 
head. I seemed to be at the hospital every other day. It would either be to 
the eye bit or to the neurologist because I think they were looking for 
tumours and goodness knows what. I was admitted at one point for two 
weeks and I was on an elderly ward; again it was not very pleasant. I 
remember a lady dying. It was my first experience of death and it was 
really upsetting. They [doctors] even joked with me and said I would 
have my eye taken out and bounced up and down in the corridor to see 
what was wrong with it. It was ridiculous. For years, I never actually got 
a diagnosis’.  
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(Sally, experienced symptoms aged seven, diagnosed aged 29 in 1998) 
The clinicians treating Sally trivialised her symptoms by joking that they would 
bounce her eye up and down the corridor and downgraded her care by discharging 
her from the eye clinic. Unaware that she had LHON, Sally gave birth to her sons. It 
was only in her late twenties after her youngest son also experienced sight loss that 
she was given her diagnosis. The lack of diagnosis has had a devastating impact on 
Sally and her family. 
 I asked Dr Morgan (consultant ophthalmologist and clinician scientist with a 
specialist interest in LHON) to explain the diagnostic process for patients attending 
the clinic with sudden unexplained sight loss: 
‘Immediately you would do a dilated examination, you would do an OCT 
[Optical Coherence Tomography] and [retinal] imaging, you would 
request visual field tests―they would have to have that on their next visit 
anyway, you probably wouldn’t be able to do them that day. Then you 
would take the blood samples for just checking whether or not it could be 
any other inflammatory markers, anything else, causing it [sight loss]. 
Then you would consider doing electrophysiology and a brain scan. You 
would not do the gene test first visit―definitely not―but you would 
probably at least get them back once they have had their brain scan, 
which would be relatively urgent then do the genetic test. The genetic test 
would theoretically come at the end.’        
 
(Dr Morgan, Ophthalmologist and Clinician Scientist)    
I asked Dr Morgan why the ophthalmic diagnostic tests are not undertaken at the 
same time. Dr Morgan suggested: ‘We should be doing them at the same time. One of 
the problems with British medicine is that we do things in order. So, people come back 
for a year going from one test to another; that’s nonsense, you need to do all of these 
things at once’. In the above extract, Dr Morgan describes the process of categorising 
patients, using both traditional diagnostic tests (such as slit-lamp examination, and 
OCT) and molecular testing. Dr Morgan, using clinical expertise, inspects the scans 
and photographs to detect subtle changes and abnormalities in the optic nerve that 
provide clues to the cause of the sight loss. Atkinson (1995: 196) describes 
accomplishing a diagnosis as akin to the work of a detective participating in ‘a kind 
of puzzle-solving activity’. Only after the eye has been subjected to a rigorous 
examination, and the clinician is highly suspicious that LHON may be responsible, is 
a blood sample sent to the laboratory. Drawing upon research in the dysmorphology 
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clinic Latimer et al. (2006) describe how patient categorisation is accomplished 
between the clinic and laboratory, and the decision to ask for a molecular test is a 
negotiated process, used alongside more traditional means of diagnosis. However, 
in the case of LHON, the blood test (on occasions) is inconclusive. Ginny was 
originally tested for LHON when she was 18. The test was negative, as she explains: 
 
‘He [consultant] had a suspicion that it was LHON, but he didn’t do any 
more tests after it [blood test] came back negative. After that, he then said 
to my parents “I don’t know what’s wrong with her, she clearly can’t see. 
I am just going to register [certificate of severe visual impairment] her.”’  
 
Ginny was referred twelve months later to another consultant who sent another 
blood sample to the gene panel for testing: 
 
‘The first thing she said was she wanted to resend it [blood] because that 
was her... she was heavily suspicious that it was LHON and she was right. 
At the time of my first test, they had found the first two [mutations], then 
they found the third one.’ 
 (Ginny, diagnosed aged 18 in 1999) 
Tina recalls that when her blood sample was sent for genetic testing in 2013, the 
gene panel did not identify any of the three primary LHON mutations. Tina sent a 
second sample of blood for full DNA sequencing. On this occasion, Tina was 
diagnosed with one of the rarer LHON mutations.  
For many participants, receiving a diagnosis was described as a pivotal moment and 
one that changed their lives forever. It was also described as the worst moment of 
their lives, as the manner in which the diagnosis was delivered to them was as 
traumatic as the diagnosis itself. The way in which diagnosis is communicated by 
healthcare professionals to patients has been identified as a key area of sociological 
interest (McLaughlin 2005). Previous studies have explored the trauma experienced 
by parents when told that their child has a life-limiting condition (Kerr et al. 1998; 
Williams et al. 2002). In her research with parents whose child has learning 
disabilities, Cunningham (1994), identifies three areas of particular concern to 
parents. Firstly, the diagnosis was delivered in an unsympathetic and insensitive 
manner. Secondly, inadequate information was given in respect of the diagnosis and 
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possible treatment options. Finally, there was a lack of signposting to access help 
and resources.  
The views expressed by participants in this thesis mirror Cunningham’s arguments. 
Some participants felt that the way they were given their diagnosis caused them 
unnecessary distress. This was particularly the case when an ophthalmologist told 
them that there were no treatment options or cure and they would be registered as 
severely sight impaired and discharged from the eye clinic. Many participants 
expressed the view that the prognosis could have been dealt with more sensitively. 
This was particularly the case when the inheritance of LHON was discussed. In the 
following extract, Marion, who attended the appointment with her affected son 
David, and her daughter, Naomi, a carrier, explained how the diagnosis was given: 
‘He (ophthalmologist) turned to us and he said, “there is no other way to 
break bad news”, looking at me, “you are a carrier, you will pass it on to 
all your children” and then pointed to my daughter and said, “you will 
pass it on to all of your children; all of your children will be born carrying 
the disease”. He said to my son “you will go blind”. Bye, bye, thanks very 
much.’ 
Marion described the consultant’s manner as abrupt; her daughter Naomi also 
alluded to this:  
‘I remember that moment of it [diagnosis] being a really horrible 
moment. He [consultant] was very blunt… said pointing at me “you carry 
it and all of your children will be affected”. Doctors have always got a 
hard job delivering bad news, but it felt quite brutal. I remember that 
feeling of like hot tears that I couldn’t control.’  
Other participants gave similar accounts of the moment they received their 
diagnosis. Ginny, who was 18 when she was diagnosed, has a vivid recollection of 
the ophthalmologist giving her the LHON diagnosis: ‘you are not going to die from it 
sort of thing and I thought he was an arrogant “what’s it” (laughs)’. Jake was 
diagnosed when he was 15 years old and remembers attending the appointment 
with his parents:  
‘The consultant basically said I am going to be certifying you blind now. 
I will never forget—there are certain things you will always remember. 
Bearing in mind my age at the time—I was looking forward to having a 
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moped and driving in the next year or so—he said, “you can get a third 
off your rail travel” and I just thought that’s not really great.’  
(Jake, diagnosed aged 15 in 2005) 
Participants also referred to the lack of information or specialist referrals to genetic 
counselling or sight loss agencies. Ollie (discussed earlier) sums up the experience 
of many of the participants:  
‘The post-diagnosis care was, quite frankly, shambolic, in terms of the     
inability of some of the most sophisticated eyesight hospitals in the 
world to signpost you on to your local sensory team is quite frankly 
disgraceful. I had to basically feel my way to [name of local authority]. I 
turned up with a scrap of paper [Certificate of Visual Impairment], at 
which point they put me on to the sensory impairment team. If I hadn’t 
demonstrated that drive and determination to get there, I don’t think I 
would have been signposted to that place to this day. It is incredibly 
important for there to be a successful transition from a diagnosis on the 
medical side to a rehabilitative stage, which is really a partnership 
between the local council’s sensory impairment team and local charities.’ 
(Ollie, diagnosed aged 18 in 2009) 
 
All participants raised concerns that when they received their diagnosis, they were 
given very little information before being discharged from the eye clinic. When 
participants were given the opportunity to see a genetic ophthalmologist, they 
ensured that they obtained as much information as possible. To illustrate this point, 
I now draw upon fieldnotes taken from an observation at in Dr Penvenen’s specialist 
LHON clinic in The Royal Albion Hospital. I arranged to be present in the clinic as 
Garyn was attending his first appointment with Dr Penvenen. Garyn experienced bi-
lateral sight loss in 2015 when he was aged 21. Initially diagnosed with optic neuritis 
[inflammation of the optic nerve], the ophthalmologist in Garyn’s local hospital, 
suspicious that he may have LHON, sent a blood sample to the gene panel which 
confirmed the LHON m.14484T>C mutation.  
Prior to the appointment, I spoke privately with Garyn, his mother, Lowri and his 
father. The account they gave of the delays in receiving a diagnosis are echoed in the 
narratives given by other participants. The family also expressed concerns that, 
following the diagnosis, they were given little information on the prognosis of LHON 
or risk to other family members of developing sight loss. In his study of the 
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interaction of clinicians and parents in a paediatric clinic, Strong (1979) suggests 
that the clinical appointment is conducted within a bureaucratic role format. 
Doctors and parents are subject to specific rules of engagement in which they adopt 
complementary roles to produce a ceremonial order of the clinic. Parents within the 
clinical hierarchy are relegated to being seen and only heard at the invitation of the 
clinician. It is clinicians who exercise their authority in determining what will be 
discussed.  
The appointment between Dr Penvenen and Garyn began with a discussion of the 
family tree:  
Dr: Looking at a very unusual family tree I have here [talking to 
Lowri], you are one of five siblings and you have an older brother 
who is 29 and the youngest is your sister, she is 20. There is a 
suggestion here of a distant cousin.  
Lowri: A cousin of mine, she was diagnosed with MS going back about 30 
years ago. She lost her vision. She is totally blind. They told her 
the MS had caused her to lose vision. She accepted that, but she 
saw a new consultant and he suggested that she had Leber's and 
they did the test and it came as the... 
Dr:  (turning to Garyn) when did you start having problems with your 
vision? 
Garyn: Middle of July last year [2015]. It started in both eyes at the same 
time. 
Lowri: (interrupting Garyn) we detected it in July on the night of his 
Graduation. We went out for a meal and I noticed he was 
squinting slightly at the menu. I suggested he went to have his 
eyes tested. It was just a bit of a squint and the following week 
everything had gone blurred. 
In the early stages of the appointment, Lowri answers questions on Garyn’s 
behalf, before he has the opportunity to answer the questions. At this point, Dr 
Penvenen examines Garyn’s eyes and relays his observations:  
Dr: There has been some visual recovery (reading the notes). Of the 
three mutations 14484 has the best visual prognosis and the best 
chance of spontaneous recovery. If you are going to recover any 
vision, and that normally happens within the first year, but it can 
happen up to five years. 
Lowri:  Excellent. 
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Dr Penvenen takes the opportunity to discuss the inheritance of LHON: 
The important thing to say is that, in terms of the genetics, it goes 
down the maternal line because the mutation’s spelling mistake 
is in your mitochondrial DNA. These mitochondria are like little 
batteries in your cells and they are the ones that produce enough 
energy. It is very straightforward—if the mitochondria in your 
cells are not working properly, you do not produce enough energy 
and, therefore, the cells at the back of the eye which form the optic 
nerve stop working properly. It is a very simple system: the eye is 
a camera, the brain is a computer, and in between the optic nerve 
is a high speed broadband cable. In Leber’s optic neuropathy it is 
the cable which gets damaged. The eye is always fine, the brain 
we hope is okay (everyone laughs).  
At this point, Lowri reaches into her handbag and produces a piece of paper on 
which she has written a list of questions and systematically reads through the list:  
Lowri: Does age help in recovery? Because I have read up to the age of 
20 or I heard it on YouTube. 
Dr:  Normally it is less than the age of 12. I think at the age of 21 you 
fit the adult criteria. I don’t think that would apply in your case. 
Unfortunately, there are a lot of unanswered questions. I think in 
your case… because if it all goes well, and you recover some more 
vision… the important thing is to try and maintain a reasonably 
healthy lifestyle. 
Once again checking her list, Lowri asks about the availably of new treatments: 
Dr:  There is the gene therapy. We are doing gene therapy at the 
moment but only for patients with the 11778 mutation and who 
have had the condition for less than one year. We are not doing 
gene therapy for your mutation, only the 11778 mutation. 
Lowri: Is there an option to pay privately for the gene therapy? 
Dr: No, there is none because this is entirely under research. The 
other thing that might happen as a result, if you are happy, I will 
keep you on my research database. There might be other clinical 
trials coming around the corner. Things are moving in the right 
direction, but things are pretty much limited at this point.  
Lowri becomes tearful that Garyn is not eligible for the current gene therapy trial 
and continues to try and persuade Dr Penvenen to allow Garyn to take part in the 
trial.  It is at this point that Dr Penvenen, reiterates that it would not be ethical for 
Garyn to participate in the gene therapy trial, nor is there the option to pay privately 
to be included. However, Dr Penvenen is able to placate Lowri by indicating he will 
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include Garyn’s details on a database for future clinical trials.  Lowri, now reassured 
that Garyn may be eligible to participate in future clinical trial, turns the focus of 
attention towards her concerns for her own eyesight. Here, it is worth remembering 
that when Garyn was diagnosed, Lowri also became a patient, as she is a carrier of 
the LHON mutation. Whilst Lowri is currently asymptomatic, she is at risk of 
developing problems with her eyesight. Lowri has entered the menopause and asks 
Dr Penvenen whether she should take hormone replacement therapy (HRT)14: 
Dr: There are two mysteries with this condition. One is if you have the 
mutation, it does not mean you are going to lose vision. But purely 
from a statistical point of view, the risk is about 50 per cent if you 
are a man and 10 per cent if you are a woman. But there are 
known risk factors; if you smoke, then your risk is much higher. 
The second mystery is why does it tend to affect men in 
preference to women? We don’t know why this is the case. There 
must be other genetic risk factors which influence whether or not 
you lose vision. What these other genetic risk factors are we don’t 
know. As to whether a woman has an increased risk around the 
perimenopausal period is quite a contentious issue. What I 
normally say is that you should not be taking HRT just because of 
the Leber’s problem. You should only be taking HRT if there are 
other reasons for taking it… so having very bad menopausal 
symptoms. 
Throughout the appointment, Lowri was acting as a gatekeeper and transmitter of 
genetic knowledge by actively asking questions on behalf of the family. Arribas-
Ayllon et al. (2008: 1522) suggest that the ‘new genetics’ still relies on the ‘old 
structures of kinship’, where responsibility for the family’s health falls 
disproportionately on women. Garyn only spoke when asked a direct question, often 
deferring to his mother who repeatedly answered questions on his behalf. Garyn’s 
father sat as a passive observer to the events that unfolded in front of him. 
Throughout the appointment, Lowri takes the lead and plays the role of the 
informed patient. Starke and Möller (2002: 245) argue that parents, in reacting to 
their child’s diagnosis of a chronic illness, seek information and gain knowledge 
about the diagnosis as a way to ‘restore order in a chaotic existence’. One of the first 
                                                          
14 Research (laboratory tests) have suggested that the female hormone oestrogen may protect cells 
from the effects of LHON (Giordano et al. 2010). However, there are also reports of cases where low 
oestrogen levels might have triggered LHON in females (Badura-Stronka et al. 2013). 
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places families seek information is from the internet, prompting Nettleton (2004) to 
suggest that formal medical knowledge has escaped (or ‘e-scaped’ to be more 
precise) and is no longer hidden within medical institutions but instead is available 
in books and through internet search engines. In a similar vein, Dew and Jutel (2014: 
70) note that the availability of medical knowledge has reduced the authority of the 
doctor, creating the ‘informed consumer rather than the acquiescent patient’, with 
Petersen (2006) suggesting that patients and their families are in a unique position 
to provide valuable information to their doctor. Although to what extent it may be 
said that this acquired knowledge elevates them to the position of an expert is 
contentious. Whilst acknowledging that patients possess extensive knowledge of 
their own lives and their medical conditions, Prior (2003: 45) suggests this does not 
make them experts as they lack the necessary skills to gather medical facts and 
undertake the ‘business of medicine’. Nonetheless, a number of participants in this 
thesis do consider that they know more about their condition than their 
ophthalmologist. Adrian, following his son’s diagnosis, was instrumental in 
establishing a sight loss charity to support families with LHON and has acquired 
considerable expertise:  
‘I have become a mini expert in this [LHON]. The last few times that we 
saw the consultant ophthalmologist in [name of hospital], he actually 
said to my son “I don’t know why you bother coming to see me, your 
father knows far more than I do about this”. Without any question I do. 
On the other hand, I am not an ophthalmologist. […] I can look at several 
photographs of the optic nerve and they all look the bloody same to me; 
it takes a trained eye. It takes the sort of years of knowledge and 
experience that I don’t even begin to pretend to have. So, if I say I am an 
expert, I know just how much it is I don’t know. I am trying to educate 
myself about the whole genetic side of things, as in the specific mutations 
et cetera, but I must admit I struggle; it doesn’t come easy for me.’ 
Reinforcing the comments made by Prior, although considering himself an expert, 
Adrian acknowledges his limitations; he does not have the technical skill to look at 
the retinal imaging scans and identify LHON. Adrian has continued to acquire 
knowledge by attending both national and international patient conferences and is 
extremely proactive in working with other stakeholders to raise awareness of LHON 
(discussed in Chapter Seven). 
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Earlier in this chapter, I referred to Jutel’s analogy of the roadmap used by the doctor 
to arrive at the right destination—in this case a diagnosis. However, 
ophthalmologists (when diagnosing LHON) frequently struggle to read the road 
map. In the following two sections, I consider the consequences of the failure by 
ophthalmologists to identify symptoms of LHON, resulting in diagnostic uncertainty 
and contested diagnoses.  
Diagnostic uncertainty 
 It is apparent from the foregoing discussion that the art of diagnosis is a complex 
process. On occasions, it is also pervaded with uncertainty; this is particularly 
evident in the diagnosis of rare diseases (Rare Disease UK 2016). LHON is a 
condition that is shrouded in uncertainty in respect of its aetiology, treatment 
options and prognosis. The participants in this thesis present to the eye clinic with 
diverse symptoms; whilst some retain very poor residual vision, others maintain a 
good level of both central and peripheral vision. Conrad (1987) suggests that there 
are several types of uncertainty which, I would argue resonate with the experience 
of participants in this thesis. Firstly, the uncertainty felt by participants when they 
notice subtle changes in their eyes and seek medical attention. Secondly, medical 
uncertainty is experienced by clinicians who attempt to provide a diagnosis, often 
misdiagnosing LHON, and is also experienced by participants who are subjected to 
numerous tests including MRI scans, and imagine they have a life-threatening 
condition, such as a brain tumour. Thirdly, there is the uncertainty following the 
diagnosis when questions are asked such as ‘will I be able to carry on working? Or 
will other people treat me differently?’ Finally, there is what Conrad refers to as 
‘trajectory uncertainty’ (1987: 8). LHON is a condition that is unpredictable, as some 
participants experience spontaneous recovery, whilst others become anxious that 
their sight will continue to deteriorate. There is also uncertainty as to whether other 
family members will become affected.  
Atkinson (1995: 110) has argued that uncertainty is one of the most ‘pervasive’ and 
overworked themes in medical sociology, with an over-reliance on the concept in 
discussions around the boundaries of medical knowledge, medical education and 
the relationship between doctors and patients in the clinical consultation (Atkinson 
1995). There is a considerable volume of literature within medical sociology that 
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has considered the concept of uncertainty within medical settings (Parsons 1951; 
Fox 1957, 1980; Davis 1960, 1963; Freidson 1970; Atkinson 1984, 1995). Much of 
the current scholarship has been developed with reference to the study ‘Training for 
uncertainty’ by Renée Fox (1957). In her work, Fox explored the education and 
socialisation of medical students and, in so doing, highlighted how in their early 
medical training, and later during their early professional development, they were 
able to identify the various dimensions of uncertainty in their own knowledge and 
the limits of medical knowledge, more generally. Fox argues that, in Western society, 
the doctor is regarded as an expert equipped with skills to cure all illnesses. 
However, this ‘utopian view’ (1957: 208) of the doctor is not consistent with reality. 
The knowledge and skills possessed by the doctor are not always adequate to 
identify disease or prescribe a cure, notwithstanding advances in medical science. 
The doctor’s life, therefore, is full of uncertainty.  
Fox (1957: 208) articulated two origins of uncertainty in diagnoses and medicine. 
Firstly, there are limitations of individual knowledge: ‘no one can have at his [her] 
command all skills and all knowledge’. Secondly, the limitation of current medical 
knowledge means that it is not possible for medical students to have all the answers. 
As Groopman suggests (2007: 7), ‘medicine is, at its core, an uncertain science’. 
Participants during interview with me, explained that when they attended eye 
casualty they were examined by a specialist registrar (SpR) who triages the patient 
and makes the decision to either refer into the eye clinic—to be examined by a 
consultant—or alternatively discharges them. For a number of participants, the SpR 
failed to include LHON in the differential diagnosis and they were subsequently 
discharged from the eye clinic and told to return if the symptoms persisted. This was 
the experience of Andy, who having been referred to eye clinic, was examined by a 
specialist registrar: 
‘He [registrar] did loads of different tests and things and said he thought 
that it was an eye virus and so, “People,” he said “can get eye viruses. 
They are not totally uncommon but what it is with them is that the sight 
will come back in 10 weeks”. He advised waiting 10 weeks to get my sight 
back. When I asked what might cause it, he said it could be stress.’ 
Andy was given a diagnosis of an eye virus. Other participants after undergoing 
numerous diagnostic tests were initially discharged from the eye clinic with a 
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diagnosis of optic neuritis. Timmermans and Buchbinder (2010: 410) suggest that 
prolonged diagnostic uncertainty is uncomfortable for patients and clinicians who, 
they suggest, ‘will exert pressure to fold an incomplete characterization back into 
more conventional categories’. Andy’s eyesight continued to deteriorate, and on 
returning to the hospital, he had further diagnostic tests before being diagnosed 
with the LHON m.11778G>A mutation: 
‘I went back to the hospital to see the ophthalmologist and they were 
quite concerned because they said it’s affected the other eye so it’s 
basically not the virus. I had various tests and I can’t remember all of 
them, to be honest with you, brain scans, et cetera to see about MS 
[multiple sclerosis] and different blood tests and different things like 
that. They thought that there are three options. In effect, it’s either LHON, 
or MS, or it’s a brain tumour.’  
Andy received his diagnosis five months after initially experiencing symptoms. One 
of the other male participants, Ollie, was 18 years old when he experienced 
symptoms of sight loss and, like Andy, also experienced delays in receiving his 
diagnosis:  
‘At the hospital, LHON is not a condition that they come across frequently 
at all. There was a huge amount of ambiguity and confusion into what I 
was suffering from. I was obviously suffering quite severe symptoms in 
terms of visual acuity and my visual field decreasing rapidly in my left 
eye. Within two months of suffering those problems, I think that problem 
had transferred to my right eye. I undertook a lumbar puncture, CT scan, 
MRI scans just to check whether there were any physiological issues, 
neuron-degradation in my head, to see whether it [could] be any other 
condition, including MS [multiple sclerosis]. But those tests came back 
negative. In terms of doctors spotting that, ironically, it wasn’t anywhere 
which deals very specifically and strongly with VI. It was actually at 
[hospital] where a second year F2 medic, who was incredibly junior, 
spotted it and recognised it from his rare diseases module and said it 
could be Leber’s. I had genetic tests which took another six weeks to turn 
around. It was seen that there was a point mutation on the 11778 gene 
on my mitochondrial DNA, which is effectively a positive diagnosis for 
LHON.’  
Andy and Ollie’s experience of being subjected to numerous diagnostic tests is 
typical of the experiences described by other participants. What is unusual in Ollie’s 
case is that it was a medical student who had recently studied the rare disease 
module during his training. Given the delays which participants encountered in 
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obtaining their diagnosis, I asked Dr Penvenen to explain the challenges presented 
to ophthalmologists in diagnosing LHON:  
‘This is a grey area, it can be from the no brainer where you have 
someone who is presenting with bi-lateral visual loss in a family known 
to have the disease.  You may have someone, a young man who presents 
with a bi-lateral optic neuropathy and the original scans are normal with 
nothing but optic neuritis. Of course, LHON is going to be part of the 
differential diagnosis right from the start. So, if someone presenting [in 
the clinic], it can be very few things that are going to result in such a rapid 
bi-literal loss of vision. It is a medical emergency; as you can expect, 
everyone is freaking out by the time you have excluded inflammation, a 
tumour or something else in the brain. You have to think about LHON, 
that’s what I always drill into people’s brains.’  
The experience of participants in this thesis suggest that LHON is not routinely 
considered. I asked Dr Penvenen if in reality LHON is always included in the 
differential diagnosis by the juniors: 
  ‘I think probably, for the juniors, they would probably not think about 
this straightaway. In all fairness, if someone is presenting in eye casualty 
with bi-lateral visual loss, they should be really thinking about the more 
common causes because it [LHON] is still quite rare. I think it is a balance 
really. I think the juniors have this thing, looking at the common things—
inflammation, optic neuritis, tumours and all the rest. I think by the time 
someone will present acutely and that they will be having initial 
investigations and get referred to a clinic for their re-assessment, I think 
in the bigger teaching hospitals, most of the patients will get referred to 
a neuro-ophthalmologist. I think the difficulty is when someone presents 
in a district general hospital or they move from eye casualty to a general 
clinic and then people still do not think about LHON because it is still 
quite rare, that’s where there are major delays.’ 
As highlighted in Chapter One, LHON has historically been characterised as a 
condition which predominantly affects young males in their late teens and early 
twenties (Yu-Wai-Man et al. 2014). However, a number of participants in this study 
(men and women) experienced symptoms in later life. The preoccupation with 
exclusively young males has contributed to misdiagnosis of the condition for a 
number of participants. Sandra was in her late sixties when she was eventually 
diagnosed with LHON. She had previously undergone surgery for glaucoma and 
realised that her sight was not improving. When asked if she was given any 
indication that they thought it might be LHON, she answered: ‘all that was said… the 
registrar had said to me at quite an early stage “oh it can’t be LHON, you are far too 
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old”. He said it in quite a jokey way (laughs)’. Gerry, who was diagnosed with LHON 
when he was 62, had a similar experience: 
‘I saw one of the junior members of the team and was talking to me about 
it and he was looking and thought he saw some form of cataract. I then 
saw a different consultant and she couldn’t see any sign of a cataract but 
thought it was PVD [posterior vitreous detachment]. So it’s the sack 
around the eye that holds the fluid in. When you get to a certain age, it 
starts to crack up and you get lots of floaty bits and distorted vision. She 
did a lot of prodding and poking; she was convinced that was it and told 
me not to worry, that it would be problematic at the moment, but it 
would eventually get better and my vision would return to normal. It 
[LHON] was missed because they automatically assumed that I was too 
old to have it because they saw it as a young person’s problem; they 
dismissed the diagnosis as far as I was concerned because I was of the 
wrong age, it didn’t fit his pre-determined concept. The three consultants 
at [hospital] missed it and were unaware of it.’ 
Whilst Gerry was initially examined by one of the juniors who failed to diagnose 
LHON, he was also examined by three consultants in his local hospital, who again 
failed to diagnose the condition. Sandra and Gerry’s experience is consistent with 
Latimer’s (1997, 1999, 2000) research in an acute medicine unit. Latimer (2000) 
observed that older patients’ symptoms (breathlessness and chest pains) are 
reconfigured as social rather than medical problems. Latimer further suggests that 
‘older people have been targeted as inappropriate users, and even as “misusers” and 
“abusers” of acute health services’ (Latimer 2000: 387).  
The experiences of participants suggest that LHON is a condition that experienced 
ophthalmologists do not always consider when dealing with bi-lateral sight loss. 
When there is a known family history of the condition, LHON may still be overlooked 
in the differential diagnosis when a woman presents with vision loss. This is 
illustrated by the experience of Beth, whose brother had been diagnosed with LHON 
25 years before. Beth first became aware of problems when she could no longer read 
a magazine. Having been referred to the eye clinic, several months passed before 
Beth’s blood sample was sent to the gene panel:  
‘One week, I went five times [to hospital]. I had a VFT [visual fields test] 
and then I went for an MRI scan. All these tests they were doing, they 
were all coming back normal. First of all, we were hoping there would be 
a blocked blood vessel behind my eye which they could do something 
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about. I was even hoping it might be a tumour there. Anyway, he 
[consultant] eventually referred me.  He said “There may be a chance you 
might have Leber’s”. He referred me to [consultant neuro-
ophthalmologist]. He did various tests and all these tests were coming 
back normal. And I knew it was only going to point to Leber’s. So anyway, 
I decided to have the blood test.  I paid for it myself.’ 
To speed up the diagnostic process, Beth paid privately for her blood sample to be 
sent to the gene panel. The delays in receiving genetic test results was another issue 
identified by participants, some of whom explained that they had waited up to eight 
weeks for confirmation of their LHON diagnosis. I asked Dr Penvenen whether it was 
usual for there to be delays in receiving the genetic test results: 
‘I think the major issue is the fact that now, even in major centres, the 
turnaround time for tests for LHON is still eight weeks. It’s four months 
at [hospital] at the moment. There is also a problem with the delay in 
getting genetic results back.’ 
Dr Penvenen suggest that delays occur for a number of reasons. Firstly, hospitals do 
not always send samples to the gene panel straightaway. Financial constraints 
within the eye clinics result in samples being held back, particularly toward the end 
of the financial year. Secondly,  in an age of austerity, cuts to the  NHS budget has 
impacted on recruitment of specialist clinicians to undertake the testing.  
In contrast to the older participants, very young participants were also considered 
to be unlikely to have LHON.  Declan experienced symptoms when he was 11 years 
old and was subsequently diagnosed when he was 12 years old. His mother, 
Gwyneth, explained why LHON was initially dismissed: 
‘He [consultant] didn’t think it was Leber’s because of him [son] being so 
young. He said it didn’t really affect boys until their late teens. That’s why 
it took such a long time for the diagnosis and making the connection 
because he was only 12.’ 
Four of the female participants in this thesis experienced an added dimension to the 
uncertainty surrounding their diagnosis as, in addition to being affected by sight 
loss, they also presented either simultaneously or at a later date with multiple 
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sclerosis-like (MS)15 symptoms (referred to as Harding’s disease).16 Laura’s account 
of being diagnosed is typical of the other three women in this study:   
‘There were doubts about it [diagnosis] and we played a lot of ping pong 
because no one was singing on the same hymn sheet. It [diagnostic 
process] did go on for quite a long time; it took a long time for them all 
to say yes, it is Harding’s disease. Then some consultants have said “what 
is Harding’s disease?” […] It’s very confusing because some consultants 
say I have MS and I also have Leber’s?’ 
(Laura, diagnosed aged 48 in 2012) 
The terminology to describe the symptoms of sight loss with the MS-like symptoms 
is contested as I discovered when I attended Dr Morgan’s clinic in St Tristan’s 
Hospital.  Two sisters attended the clinic who had been diagnosed with LHON, but 
also experienced the MS-like symptoms which they also referred to as Harding’s 
disease. When I also used the terminology in conversation, Dr Morgan, quickly 
corrected me: ‘Don’t call it that, if you walked around the eye clinic and asked any of 
the consultants what Harding’s disease is, they wouldn’t know what you were talking 
about’. Here, it is clear that some general ophthalmologists are not familiar with 
LHON since it is so rare. It is only when an experienced genetic ophthalmologist 
examines the patient that the symptoms are observed. Reflecting on whether there 
is adequate training for ophthalmologists in identifying rare inherited eye 
conditions, Dr McDaid, a neuro-ophthalmologist with extensive experience of 
diagnosing and treating LHON patients, suggested that: 
‘The problem is… of course, it is very easy to say they [juniors] should 
know more but the reality is that there are lots of things they should 
know more about and, you know, there is only a limited amount of time 
and there is only a limited amount of memory and brain power in any of 
us to cope with all the information.’ 
This view resonates with the work of Becker (1961) and his colleagues who 
observed that medical students are introduced to a vast body of knowledge which it 
                                                          
15 MS is a condition that can affect the brain and/or the spinal cord causing a wide range of symptoms 
including sight loss. MS is not directly inherited; however, research has suggested that people who 
are related to someone with MS are more likely to develop it (NHS Choices 2018). 
16 LHON has also been associated with multiple sclerosis-like (MS) symptoms in females who carry 
the m.11778G>A mutation. Harding et al. (1992) first described the symptoms following their 
research with eight females who presented with bilateral, sequential sight loss. Six of the females 
later developed a neurological syndrome indistinguishable from MS.   
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is impossible to master. Fox also identifies a third source of uncertainty consisting 
of difficulty in distinguishing between ‘personal ignorance or ineptitude and the 
limitations of present medical knowledge’ (Fox 1957: 208). Later in the same 
interview, Dr McDaid suggests that:   
‘They [juniors] over-investigate because there are all sorts of ideas in 
their head and they don’t have enough experience to be able to pin it 
down to just one or two and very quickly get to the answer with some 
clinical tests, instead they just order loads of tests. I have just done a 
ward round this morning at one of the hospitals I work at and, you know, 
the juniors there over the Christmas period have ordered all sorts of 
scans and blood tests which were total unnecessary and that does reflect 
that they are more junior. They are more anxious about missing 
something, they are less trusting of their own clinical skills to interpret 
the signs and so they do a lot of ‘just in case’ kind of investigations.’ 
Fox suggests that medical students are often expected to ‘see before they know how 
to look or what to look for’ (1957: 214).  LHON is a rare condition that is not often 
encountered in the clinic.  Dr Morgan was also asked whether there was adequate 
ophthalmology training for the rarer eye conditions: 
‘I think as trainee ophthalmologists, I know that all of them are 
completely aware of Leber’s. I mean we were all aware of it even though 
we had never seen a patient. Everyone knows if you set them an exam 
question, they would all be able to write about it. But that’s not the point. 
They need to be able to spot somebody that’s suspicious. The point in a 
way is that it’s not that they don’t know about it, of course they know 
about it. You set any of them an exam question about it, and of course 
they will be able to parrot what it says in the text books. But there is a 
very big difference between knowing about the condition and being able 
to spot it.’ 
Ultimately, Fox concludes that training for uncertainty is an essential component of 
the medical curriculum as it prepares medical students to deal with the challenges 
they are confronted with in their medical training and clinical practice. Managing 
uncertainty is therefore considered to be an important aspect of professional 
socialisation. Fox’s work has been critiqued, most notably by Atkinson (1984, 1995) 
who is critical of the treatment of uncertainty within the sociology of medicine. He 
delineates it as ‘inadequate and incoherent’ (1984: 949) and considers that it has 
lacked sufficient theoretical analysis. Atkinson proffers an alternative approach to 
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uncertainty by suggesting that whilst medical students are required to assimilate a 
considerable body of knowledge and grapple with over-burdened curricula, this 
does not necessarily result in uncertainty. On the contrary, he contends that medical 
students adopt a ‘pragmatic approach to the accumulation and construction of a 
stock of knowledge’ (1984: 952), which they call upon to navigate their way through 
medical training and clinical practice. For Atkinson, it is ‘certainty’ that reigns 
supreme. Atkinson goes on to argue that whilst ‘medical knowledge and practice are 
inherently “uncertain” […] the certainty of dogmatism and personal judgement are 
responses to that on the part of the clinician’ (1984: 954). 
Other sources of uncertainty within the clinical encounter have been considered by 
Olsen and Abeysinghe (2014), who focus on patients’ presentation of information to 
the doctor. Patients may not disclose key symptoms because they fail to appreciate 
their significance, resulting in uncertainty in the mind of their doctor. Whilst 
acknowledging that patients do provide reliable accounts of their illness and family 
history, Gardner (2014: 152) suggests that, equally, patients can be emotional and 
allow irrational fears to hamper their ability to act as ‘reliable observers of their 
condition’. In his study of paralytic poliomyelitis [polio], Davis (1960, 1963) 
identified several dimensions of uncertainty arising in the doctor–patient 
encounter. Davis (1963: 67) suggests that, on occasions, doctors “feign” uncertainty 
with the purpose of breaking bad news in a controlled way, allowing patients to 
come to terms with the diagnosis: 
‘Uncertainty is to some extent feigned by the doctor for the purpose of 
gradually—to use Goffman’s […] analogy— “cooling the mark out,”—i.e., 
getting the patient ultimately to accept and put up with a state-of -being 
that is intolerable to him.’ 
In his research with people diagnosed with epilepsy, Scambler (1989: 25) found that 
his participants often used real or feigned uncertainty as ‘tools of negotiation’ in an 
attempt to avoid being labelled as an epileptic. Davis (1960) also describes how 
doctors, when dealing with an uncertain diagnosis or prognosis, will either disclose 
their uncertainty (admission of uncertainty) or adopt a process of dissimulation in 
which they fail to communicate the uncertainty, but instead adopt delaying tactics 
or provide (possibly ineffective) treatment. Davis suggests that dissimulation is 
particularly prevalent when the doctor perceives that an admission would damage 
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their professional reputation. Dr McDaid was asked why he thought that general 
ophthalmologists were slow to refer cases onto specialists:   
‘What is needed is for my colleagues who are not experts in this area, to 
have a lower threshold to refer onwards to specialist centres as quickly 
as possible. What I think should be improved is not the training of doctors 
but their willingness to say “I don’t know what this is and I better send it 
quickly on to a place where they see a lot of rare things and they can 
probably get to the bottom of it quicker than I can.” I think patients 
languish for a long time in non-specialist secondary care. Then it can be 
almost grudging. They are sort of “I don’t know, I am fed up with this 
patient coming every six months or every year and we still don’t know, 
let’s send it on”.  Then you see the patient and, when you do get the 
diagnosis, you think “I wish I had met you two years ago”, we could have 
got to the whole thing a bit quicker. […] I think what we need is for there 
to be a greater urgency and willingness for non-specialist 
ophthalmologists to say, “I don’t recognise this, I don’t know what it is” 
and rather than wasting a lot of time doing tests that are expensive to the 
NHS and which are on the wrong track, it would be better to send it to a 
specialist clinic’. 
The majority of participants experienced uncertainty whilst waiting to be diagnosed 
with LHON and, as Dr McDaid notes, the process of receiving the diagnosis could be 
more effective if ophthalmologists were prepared to refer cases to specialist centres. 
However, receiving the diagnosis does not bring an end to experiences of 
uncertainty for some participants, who report experiencing further occurrences of 
uncertainty in relation to the prognosis of their condition and whether other family 
members will develop sight loss (discussed in Chapter Seven).  
The medical merry-go-round—the challenge of unexplained symptoms 
 
Building on the previous discussion of diagnostic categories and uncertainty 
prevalent in the diagnostic process, I now turn to consider the conflict that arises 
between the medical profession and patients when uncertainty in the diagnostic 
process results in medically unexplained symptoms (MUS) or contested illnesses—
in Dumit’s terms, ‘illnesses you have to fight to get’ (2006: 578). Diagnoses are said 
to be contested when patients identify their symptoms with a specific clinical entity, 
where the very existence of the entity is disputed within mainstream medicine 
(Atkinson and Gregory 2008; Trundle et al. 2014).  Contested illnesses are those for 
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which the medical profession has failed to find a pathological basis (Nettleton 2006).  
As Trundle et al. (2014: 165) note, conflict arises when ‘illnesses refuse to yield the 
level of proof that epidemiology, clinical medicine and toxicology require’. The 
authors go on to elaborate by suggesting that diagnosis is a contested process when 
a patient explains their symptoms to the doctor who, unable to observe any ‘organic 
disruption or pathology’ (2014: 166), makes a diagnosis based on the symptoms 
described by the patient. 
The lack of a diagnosis relegates patients to the status of ‘medical orphans’ 
(Aronowitz 2001: 803). There are conditions that are extremely difficult to 
diagnose. For example, Lyme disease displays classic symptoms including (but not 
always) a distinctive circular rash [erythema migrans] which can appear with or 
without flu-like symptoms (Rebman et al. 2017). The disease is often diagnosed on 
the presence of the rash. However, if the diagnostic test is undertaken too soon or 
there is a delay in the rash developing, the disease can be dismissed as a virus (Olsen 
and Abeysinghe 2014). Similarly, LHON is a condition that has proved challenging 
to diagnose for ophthalmologists who have not encountered the condition in clinical 
practice. As with Lyme disease, the timing of the initial ophthalmic examination can 
be crucial, as Dr Morgan explains in the following extract:  
‘They [patients] don’t necessarily always have a swollen disc when you 
see them… that might have subsided by the time you get to see them.  The 
reasons why a general ophthalmologist might miss this is that if they are 
referred a patient by a GP, it’s not picked up as being urgent. By the time 
they [A&E] see the patient, they no longer have the classic signs. If you 
are sitting in casualty as a casualty doctor, you wouldn’t know that it’s 
Leber’s. It could be five or six or seven different things. You would be 
trying to exclude any cause of vision loss. The point is, if that person is 
sitting in front of you and they have virtually lost no vision yet, that can 
be very difficult.  It’s completely dependent on at what stage you meet 
this person. The paleness of the optic nerve can take months to develop 
so the swelling can subside, and you will have a phase when maybe the 
disc is still slightly swollen, but it is a bit iffy. They are certainly not seeing 
normally, their colour vision is down, their field [of vision] is down, their 
acuity is down but they haven’t developed the optic atrophy yet. That can 
take months and, actually, what’s happening is that they are gradually 
losing more and more vision… it’s quite a difficult stage. Maybe that’s the 
kind of in-between stage that patients fall into.’ 
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Dr Morgan identifies a number of issues associated with the timing of the 
ophthalmic examination. Firstly, delays in the referral process occur, either because 
patients delay acting upon symptoms, or secondly, patients make an appointment 
with their GP, who does not realise the significance of the symptoms and fail to make 
an urgent referral. Some participants indicated that when they presented in the eye 
clinic, the scans of their eyes appeared to be normal and, as such, they were thought 
to be making up or exaggerating their symptoms. Within the context of his research 
with patients experiencing symptoms of chronic fatigue syndrome (CFS) and 
multiple chemical sensitivity (MCS), Dumit (2006) identified a number of cultural, 
political and structural characteristics associated with contested diagnosis. Firstly, 
they frequently present as chronic conditions which fail to fit into mainstream 
understanding of disease. Secondly, they are of indeterminate aetiology and labelled 
‘biomental’, reflecting the dispute as to whether they are primarily mental, 
psychiatric or biological. Thirdly, treatment strategies include both conventional 
and alternative medicine. Fourthly, they have fuzzy boundaries and are linked to 
comorbid conditions, other illnesses with similar symptoms, or are misdiagnosed. 
Finally, they are considered to be ‘legally explosive,’ in that patients who are denied 
disability status and welfare benefits resort to litigation to achieve recognition of 
their condition and challenge existing diagnostic categories (Dumit 2006: 578). 
The lack of a diagnosis challenges medicine’s ‘modus operandi’ which is to identify 
and treat symptoms. Trundle et al. (2014: 165) observe that when presented with a 
contested diagnosis, the medical profession is faced with managing two competing 
goals: ‘the need to explain illness within the boundaries of scientific certainty and 
the desire to provide a successful outcome for the patient by returning them to good 
health’. Becker (1993), who together with colleagues described the socialisation of 
medical students in the USA, observed that patients who described multiple 
complaints, but no visible physical pathology, were considered to be ‘crocks’ (1993: 
29). The patients were considered to no longer have the potential to add to the 
acquisition of medical knowledge. As the patients were not considered to be sick, it 
was impossible for the medical students to cure them. This, in turn, resulted in the 
patients becoming devalued in the eyes of the medical students (and discharged as 
a result) since they failed to provide the stuff that medical miracles are made of.  
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In his study of three Accident and Emergency (A&E) Departments in the UK, Jeffrey 
(1979) laid bare the process of labelling and categorisation of patients by the 
medical staff and, in doing so, illustrated how judgements are made about the moral 
worth of patients based not exclusively on their symptoms but also on their social 
identity. Patients who were perceived as ‘good’ were described by the medical staff 
in terms of their medical symptoms, such as head injuries or cardiac arrests—they 
were not considered to be the authors of their own misfortune. The ‘bad’ patients 
were identified as “normal rubbish” (for example, drunks, overdoses, tramps and 
timewasters) (1979: 94). Classification processes have been identified in more 
recent work too, where certain patients (for example the elderly and the chronically 
sick) are seen to belong—or not—in the clinical space (e.g. Latimer 1997, 1999, 
2000; White et al. 2012; Hillman 2014). Gerry, discussed above, talked of his 
experience in the eye clinic, explaining that it had been a particularly difficult time 
for him as the consultant was unable to detect a problem with Gerry’s eyes, and 
failed to identify the symptoms as pathological:  
 ‘He was absolutely clueless. He was looking at my retina and calling me 
back a couple of weeks later and doing the same thing.  It was as though 
I was talking about the loss of sight and the fact that it was getting worse, 
but he couldn’t see anything physical that could be accounting for that 
and it was as though he wasn’t accepting what I was saying about the 
sight loss because he couldn’t see any physical manifestation to back up 
what I was saying. We got into an argument with him at one time because 
I asked isn’t there anything else he could do. I recounted this to my GP. I 
hadn’t made the connection… it was my GP who looked at me and said 
maybe he just thinks you are lying… the fact he can’t see anything and 
what you’re telling him isn’t matching up with what he is seeing.’   
Other participants reported that ophthalmologists, who initially failed to identify 
symptoms of sight loss, suggested they were making up their symptoms or indulging 
in attention seeking behaviour and, as such, were wasting the ophthalmologists 
time. This was particularly evident when younger participants presented in the eye 
casualty department. Amy experienced symptoms in her left eye when she was 18. 
She was initially examined in eye casualty, but then referred into the eye clinic: 
‘They kept referring me to each individual doctor in the hospital, like the 
next higher one. It was a nightmare. They were doing different tests on 
my eyes, but they kept finding nothing wrong with them. I saw a 
consultant and, again, nothing. And he just started scratching his head 
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and he was like “I don’t know what to do”. I saw a children’s specialist 
[paediatric ophthalmologist]. She [consultant] did loads of tests on my 
eyes and Mum was in the room with me. She [consultant] said “I am just 
going to have a word with your Mum. Do you want to walk out?” I was 
18. Mum came out of the room and she looked really tearful and quite 
upset. I was like “What has she just said?” She [consultant] said I needed 
a psychiatric report because she thought I was going crazy. I could see 
some bits but not others. I could see bits because obviously my 
peripheral vision was still there. It was going but I had bits of sight. I just 
couldn’t believe it and at that time ...I am a very strong person and I don’t 
cry very often… but, that time, I broke down in tears because the whole 
time I was losing it [eyesight].’  
 (Amy, diagnosed aged 18 in 2011) 
Amy’s experience is mirrored in research by Nettleton and colleagues (2014) who 
explored patient narratives within a neurology outpatients’ clinic in the UK. The 
research uncovered that a number of patients who were experiencing profound 
symptoms of illness failed to receive a clinical diagnosis. The authors highlighted 
recurring themes within the patient narratives which included talk about the illness 
being ‘imagined’ or ‘fake’ (2004: 47). Describing a similar experience to Amy, Jason, 
who at the age of 13 was unable to read the blackboard in his French class, spoke of 
his experience in the eye clinic: 
‘I went to see Dr [name of consultant] and he did a series of different tests 
and looking at coloured dots [Ishihara test], looking in the eye, 
photographing the retina and the one where you put your chin on the 
thing [Slit-Lamp] and they look right up close, all sorts of pressure tests. 
He decided he knew what was wrong. He said to my Dad “Does he stress 
about things? Does he worry about things?” Dad said “No, not really”. 
“What about his school work, is he competitive, is he stressed about 
that?” My Dad gave quite an honest answer, said “No, because he doesn’t 
do very well at that. He fails at most things. He barely passes so why 
would he be stressed?” Because the guy was leading up to a diagnosis 
that it was psychosomatic. That was the diagnosis I walked away from 
him with. He said, “It will get better itself”. [That] was all I knew or 
understood. 
Did your sight initially improve? 
No. By then, I presumed that I had some kind of mental illness because of 
what I was told. It was me making it up or physically manifesting some 
kind of mental problem. In the midst of that, I think my Dad said “He is a 
lot of things but he is not nuts”. I then went through a series of other 
hospitals. 
How many hospitals did you visit? 
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It was eight or nine, over probably 12–14 months. Fourteen months later 
I still believed that I am mentally ill.’  
(Jason, diagnosed aged 13 in 1990) 
Other participants reported that when the ophthalmologists identified out— of —
the —ordinary symptoms and acknowledged that they were observing a condition 
they had not encountered before in clinical practice, participants were suddenly 
transformed into objects of medical interest (Becker 1993). Sally experienced sight 
loss when she was seven years old and was discharged from the eye clinic with a 
misdiagnosis of Neuromyelitis optica (extremely rare neurological condition). She 
has a vivid recollection of attending appointments with the consultant, who would 
then call in all the medical students in the eye clinic to examine her: 
‘I remember there was always lots of [medical] students called in. I 
remember once there were lots of student’s visiting from Japan. I was 
laid in this chair like a dentist chair. I remember all these students 
looking at me; I just recall it as being really traumatic.’ 
The problem encountered by many participants is that their ophthalmologist did not 
recognise the characteristic symptoms of the condition, and several months passed 
before they received a diagnosis, or were discharged without a diagnosis.  Whilst 
previously there were no treatment options for LHON, the landscape for the 
diagnosis and treatment of LHON is changing rapidly. New treatments are currently 
the subject of clinical trials to restore sight (discussed in Chapter Seven). However, 
delays in diagnosis have the potential to impact on the effectiveness of these new 
treatments. As Dr Penvenen outlined: 
‘I think it [diagnosis] is really going to be a major issue. If, for example, 
the gene therapy trial is seen to work for patients with 0‒6 months’ 
disease duration, but not from 6‒12 months this will mean you have a 
very narrow critical window of opportunity. If and when there is a 
treatment that works, if the treatment only works in a very narrow 
window, then the pressure will be on [to diagnose LHON quickly].’ 
For patients with a rare condition, obtaining a diagnosis may be particularly 
troubling. In 2016, Rare Diseases UK published their report, The Rare Reality, in 
which they identified a number of key findings. Firstly, patients and families were 
frequently given limited information about their condition by health professionals. 
Secondly, patients face significant delays in securing a diagnosis, with the majority 
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receiving at least one incorrect diagnosis. Thirdly, patients experience difficulty in 
persuading health professionals to believe their symptoms and their condition and 
are initially written off as ‘psychological’ and, in some cases, ‘neurotic’. Finally, not 
receiving a diagnosis is a significant barrier to accessing coordinated care and 
appropriate treatment. The lack of an effective treatment can exacerbate the 
challenges patients face on a daily basis. The themes identified in The Rare Reality 
report echo the narratives of participants in this research, who reflected back on 
their experience of receiving their diagnosis as one of the most traumatic times in 
their life, in part due to the fact that they were not believed by healthcare 
professionals, at the same time as they were losing their sight.  
Summary 
The quest to find a diagnosis is a thread which runs through this chapter. However, 
rather than a linear process, diagnosis, is on occasions pervaded with uncertainty 
and contestation. There are two main reasons for this. Firstly, LHON is a condition 
which relies upon the ‘clinical gaze’ (Foucault 1973: 108).  There appears to be a 
lack of training for ophthalmologists in identifying rare conditions and, therefore, 
they fail to identify the characteristic symptoms of LHON in clinical practice. 
Secondly, participants who delay seeking medical advice may no longer display the 
textbook symptoms of LHON when they arrive in the clinic. As a result, LHON is 
overlooked in the differential diagnosis; participants report being discharged from 
the clinic with a diagnosis of optic neuritis, or they are discharged without a 
diagnosis as the ophthalmologist (failing to spot the symptoms) believes they are 
timewasters (Jeffrey 1979: 94) and are either inventing or exaggerating their sight 
loss.   
My findings suggest that the discovery of the three primary LHON mutations, and 
the introduction of next-generation sequencing, has revolutionised the diagnosis of 
LHON. However, participants report experiencing significant delays in receiving 
their genetic test results (up to four months) in some hospitals. Whilst previously 
delays in diagnosis did not impact on the treatment of LHON, as there were no 
treatments available, LHON is now a condition that is located within a rapidly 
changing landscape, with new treatment options being developed. The clinical 
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evidence (Newman 2017) suggests that there is a narrow window of opportunity in 
which to start treatments to maximise their effectiveness.   
Participants refer to the lack of information they receive at the time of their 
diagnosis. Referrals to genetic counselling services and sight loss are variable across 
the UK. Receiving a genetic diagnosis, whilst providing some certainty, also 
introduces an element of uncertainty for asymptomatic familial carriers as to 
whether they will also experience loss of vision in their lifetime or whether their 
children will experience sight loss (Yu-Wai-Man et al. 2014). The lack of information 
at the time of diagnosis provided the motivation for many participants to research 
LHON using the internet, and subsequently, they become lay experts in or at least 
extremely knowledgeable about, the condition. 
In the next chapter, I will consider participants’ initial reactions to their sight loss, 
and how they struggle to cope with bi-lateral sight loss in the weeks and months 
following their diagnosis, including dealing with notions of blame, shame, and 
responsibility.  
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Chapter Five: “I Don’t Blame My Mother”: Reactions to the 
Diagnosis 
 
Introduction 
In the previous chapter, I highlighted the contested nature and uncertainty 
surrounding the diagnosis and treatment of Leber’s hereditary optic neuropathy 
(LHON). In this chapter, I consider how people with LHON negotiate the aftermath 
(the early weeks and months) of their diagnosis. The point of diagnosis has been 
characterised as ‘biographically shattering, providing a symbolic marker in patients’ 
lives from which there is no return’ (Pinder 1992: 2). This is certainly true for many 
of the participants in my research who claimed that the diagnosis marked a pivotal 
point, with the realisation that life would never be the same again. They were 
confronted with an uncertain future, one over which an ‘ominous shadow’ was cast 
(Pinder 1992: 13). Although not terminal, LHON is a long-term condition that 
currently has no cure, and limited treatment options, and presents a ‘threat to self 
and identity’ (Conrad 1987: 11). Bury (1982: 171) has theorised that chronic illness 
is a major disruptive experience to everyday life—a ‘biographical disruption’ which 
alters an individual’s life course, forcing a ‘biographical shift from a perceived 
normal trajectory through relatively predictable chronological steps, to one 
fundamentally abnormal and inwardly damaging’. Focusing on the destructive effect 
on identity following the onset of chronic illness, Charmaz (1983: 168) refers to the 
‘loss of self’ which she defines as ‘the crumbling away of former self-images without 
simultaneous development of equally valued new ones’. Participants in this thesis 
refer to their body letting them down, impacting on their self-esteem as they 
struggle to undertake simple tasks. Clarke and James (2003: 1387) suggest that the 
‘sine qua non of the self is the body’, and when the body is no longer able to function 
as it once did, this has repercussions for the self.  
In this chapter, I use the work of Bury (1982, 1987, 1991, 2001) as a foundation to 
explore the emotional impact of sudden sight loss on participants’ biographies. 
Bury’s work has been extremely influential in shaping the research into a wide range 
of chronic conditions, including osteoporosis (Sanders et al. 2002), multiple 
sclerosis (Green et al. 2007) and motor neurone disease (Locock et al. 2009). 
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However, there is limited research utilising this theory within the context of sight 
loss, although two notable exceptions are provided by Green and colleagues’ (2002) 
research with people diagnosed with glaucoma and Larsson and Grassman’s (2012) 
research with visually impaired people living with diverse chronic illnesses. Bury’s 
work is particularly relevant to LHON as he developed his explanatory model from 
his research with relatively young participants—the majority were aged between 
25 and 54—who had recently been diagnosed with rheumatoid arthritis, a condition 
traditionally associated with older people. Sight loss is often perceived in a similar 
way since it is expected to emerge in older age with the onset of conditions including 
Cataracts or Age Related Macular Degeneration (AMD). Yet, as highlighted in 
Chapter One, LHON affects individuals at any age, but predominantly young men in 
their teens and twenties. 
Having considered the emotional effect of LHON, I will discuss the implications of a 
genetic diagnosis for the family. With some exceptions (notably Huoponen et al. 
2002), little research has investigated how individuals diagnosed with LHON 
understand the inheritance of their condition, and to what extent their (lack of) 
knowledge influences their decision to share genetic information with family 
members. Disclosing genetic information raises complex social and ethical issues 
(Hallowell et al. 2003; Clarke et al. 2005; Keenan et al. 2005; Arribas-Ayllion et al. 
2008). Drawing on data from my research, and previous research undertaken with 
diverse inherited conditions, I discuss how participants make the decision to 
disclose LHON to their family members. I also unpack discourses of guilt and self-
blame expressed by mothers, and the extent to which their children blame them for 
their loss of sight.  
Sight loss as biographical disruption 
There has been considerable sociological interest in the subjective experiences of 
individuals diagnosed with chronic illness, which has produced a plethora of classic 
texts (Bury 1982, 1991; Charmaz 1983, 1991; Williams 1984; Conrad 1987; Corbin 
and Strauss 1987).  Focusing on the onset of chronic illness and drawing on 
interview data with 30 people recently diagnosed with rheumatoid arthritis, Bury 
(1982: 167) highlights ‘the problems of recognition and changes in life situation and 
relationships occasioned by the development of the illness’. Unusually for the 
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condition, the majority of Bury’s participants were aged between 25 and 54. Bury 
observed that the distress experienced by his participants was, in part, underpinned 
by the cultural belief that arthritis is a condition that is the preserve of older people 
which, when experienced by the relatively young, suggests they are prematurely 
aging. George, who experienced symptoms of LHON when he was 16 years old, sums 
up the feelings of many younger participants: 
‘I don’t want to sound selfish, but you expect people who are 80 and 90, 
their eyes to get worse as you get older, it’s just life. But not when you 
are 16 and 17-years-old.’  
Adopting Giddens’s concept of ‘critical situation’ (1979), Bury posits that chronic 
illness may be viewed as a ‘major kind of disruptive experience […] where the 
structures of everyday life and forms of knowledge which underpin them are 
disrupted’ (1982: 169). The onset of chronic illnesses, Bury suggests, is ‘insidious’ 
in nature as they ‘creep-up’ (1982: 170) on individuals. Bury’s participants did not 
recognise their symptoms as the first signs of rheumatoid arthritis. Similarly, as 
discussed in Chapter Four, participants in this thesis initially dismissed symptoms 
of LHON as innocuous until their loss of sight reached a critical situation where they 
struggled to perform daily tasks. 
When people try to make sense of the onset of their illness, Bury argues that they 
locate it within the wider context of their past lives. In this sense, chronic illness can 
be understood as biographical disruption in that it disturbs not only the physical 
body, but the trajectory of one’s whole life. He further suggests that chronic illness 
‘involves a recognition of pain and suffering, possibly even of death, which are 
normally only seen as distant possibilities or the plight of others’ (1982: 169), 
articulating three mutually-dependent aspects of disruption. Firstly, there is the 
‘disruption of taken-for-granted assumptions and behaviours: the breaching of 
common-sense boundaries’ (1982: 169). In this initial stage, individuals ask ‘what is 
going on here?’ which Bury (1982: 169) suggests entails paying ‘attention to bodily 
states not usually brought into consciousness’, and decisions about seeking help. 
Secondly, there are disruptions in the explanatory frameworks normally adopted by 
individuals, necessitating a ‘fundamental re-thinking of the person’s biography and 
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self-concept’ (1982: 169). Thirdly, individuals respond to the disruption by the 
‘mobilisation of resources, in facing an altered situation’ (1982: 170).  
The onset of LHON for participants was sudden, unexpected and characterised by 
some participants as a ‘bolt from the blue’. They referred to varying levels of 
disruption being present in their lives in the weeks and months following the 
diagnosis. Some reflected on their past life which had been extremely active and 
contrasted this with the life they were now living. This echoes the work of Charmaz 
(1995: 662) who suggests that at the onset of chronic illness, ‘people compare their 
present body with their past body; they assess the differences between then and 
now, and they measure the costs and risks of ordinary activities’. In the following 
extract, George reflects on his previous life, one in which his identity was defined by 
his sporting achievements: 
‘I was one of the popular kids in school… and then all of a sudden… I felt 
there was me who felt helpless in a way. I couldn’t even bloody write my 
own notes down or read from my own book. It was quite hard, well, really 
hard—just mixed emotions. It was a horrific feeling. It’s just like... I am 
not going to say I wanted to take my own life, but did I ever contemplate 
it, did it ever enter my mind?  Yes, of course it did.  Like I was always like 
top of the sports team, like I used to represent the school at athletics and 
things like that. I loved my sport, any sport.  Obviously, I couldn’t do it no 
more.’  
 (George, diagnosed aged 16 in 2004) 
Similar comments are articulated by other participants, underlining the theme of 
biographical disruption which emerged strongly in the data irrespective of age or 
gender. For two of the affected women, the disruption was particularly acute. 
Although they were aware of the family history of the condition, they were given the 
impression by other family members that only men would lose their sight. This is 
illustrated in the following extracts, firstly by Kate whose two brothers had been 
diagnosed with LHON:  
‘I was always told by my relatives that it only affects the boys, but you 
know, I think there is a bit of… umm ...in the family, there is a bit of... they 
won’t find any information out, they have got their heads stuck in the 
sand about it. I remember my Grandma, she lost her sight when she was 
50. My relatives and the doctors, they didn’t tell me that females could be 
affected. But, you know, my relatives could have [told me] because my 
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Grandma was affected. When I asked my aunties, they are like “oh, we are 
not quite sure”.’ 
 
(Kate, diagnosed aged 48 in 2012)  
There are many reasons why Kate’s family may not have discussed the family history 
with her, including their own lack of knowledge, a desire to avoid causing her 
distress, or a wish not to allow LHON to influence the way she lived her life. The 
various factors influencing disclosure of a genetic diagnosis within the family will be 
discussed in greater detail later in this chapter. Similarly, Beth, whose younger 
brother was diagnosed when he was in his early 20s, explained that the family were 
fully aware of her carrier status, but had not recognised that women could be 
affected: 
‘It never really occurred to me that it would be Leber’s because it’s 
normally… predominantly in the males. I have never worried for myself… 
never really worried about it.’  
(Beth, diagnosed aged 51 in 2015) 
In Pinder’s (1992) research with people diagnosed with Parkinson’s disease, she 
highlights that, after receiving the diagnosis, individuals experience a complexity of 
emotions and turmoil as one emotion is overtaken by another. This was mirrored in 
my interviews as participants expressed feelings of embarrassment, anger, 
frustration, denial and shock. For many of the participants, the diagnosis marked the 
start of a period of grieving for the loss of their sight. In the following extract, Ollie—
in articulating his feelings—also sums up the thoughts expressed by other 
participants: 
‘I was quite conscious of the fact that it was a grieving process. I probably 
did feel pretty sorry for myself, which I think is very important too. You 
have got to understand that you have reached a certain low, it would be 
really ignorant of someone to go through sight loss and not realise it is a 
huge blow to someone’s self-esteem and confidence. I had gone to 
University. All of a sudden, I didn’t have anything. I felt pretty sorry for 
myself.’  
(Ollie, diagnosed aged 18 in 2009) 
Ollie, after his diagnosis, talks of experiencing low self-esteem and a lack of self-
confidence. Echoing Stevelink and colleagues’ (2015a) research with young ex-
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service personnel who experienced sudden sight loss, Ollie’s feelings are 
exacerbated because he was no longer able to continue with his education. 
Participants also refer to experiencing a range of other emotions, including anger, 
an emotion that for a number of participants was, on occasions, inextricably linked 
to feelings of denial. Stevelink et al. (2015a) observed that their participants, who 
were in denial after sudden sight loss, continued to try and perform tasks they had 
previously undertaken with ease, resulting in feelings of frustration and irritation. 
In the following extract, Adam, who lost his sight when he was 14 years old in 2004, 
explains that he tried to carry on his life much as it had been before his sight loss:  
‘I was in denial by continuing to play football, continuing to try and be 
something that I wasn’t in terms of “I am fully sighted”. I still tried to 
continue to use a phone that didn’t talk or didn’t have any sort of 
magnification on it for a while. What was the point? I continued to try and 
do what I was doing as best I could.  I was so angry. I was angry because 
this whole thing had disrupted my life. It’s like in life in general you get 
yourself into a bit of a groove in life and that’s where I had just got myself. 
The eyesight starts to deteriorate, it all kicks in and then you are out of 
that groove, you have to start again.’ 
In attempting to carry on with his life, Adam, is striving to retain a sense of normality 
(Davis 1995), discussed in more detail in Chapter Six. Jake was diagnosed with 
LHON when he was 16 years old and as with Adam, tried to hold on to his former life 
by continuing with his education and working part-time: 
‘I would say I was in denial and remember at the time I was in year 11.  I 
was doing my GCSEs, I couldn’t really stop. The school said I didn’t have 
to do them if I didn’t want to. I just thought I need normality, so I carried 
on going to school. I carried on trying to do my part-time job at the 
weekend for a long time. But I suppose when I talk about denial, I never 
tell new people [about sight loss] and I still struggle today. I am better 
now but I used to lie a lot or do anything to try and cover up. So, I would 
just pretend to look at my phone if I was lost. It sounds stupid.’ 
  (Jake, diagnosed aged 16 in 2005) 
Jake retains a good level of residual vision which gives him the opportunity to ‘pass’ 
(Goffman 1968: 92) as fully sighted and, so, avoids telling people that he is visually 
impaired. He also refers to ‘covering’ (Goffman 1968: 125) by pretending to look at 
his phone. Why Jake and other participants are motivated to avoid disclosing their 
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sight loss will be discussed in Chapter Six. Participants also referred to experiencing 
suicidal thoughts in the weeks and months following their diagnosis. In his 
interview, Ollie referred to having “dark days” when he experienced suicidal 
thoughts: 
‘It is incredibly difficult to articulate what was going through my head, 
but I know that there were huge amounts of thoughts about suicide. I feel 
like it was a natural reflex of the brain to think about that. All you could 
think about was suicidal thoughts. I know that there are many people 
that have potentially committed suicide as a result [of LHON].’ 
Ollie’s comments are consistent with the sight loss literature (De Leo et al. 1999) 
and are typical of both the younger and older participants. At the heart of these 
emotions is the nature of sight loss as a ‘life changing experience’ (Horowitz 2004; 
Nyman et al. 2010; Pinquart and Pfeiffer 2011; Stevelink et al. 2015a), something 
observed by several of the participants, and highlighted by the following extract: 
‘As soon as I knew this was permanent, and this would now be a way of 
life, suddenly everything became much more of a struggle. Literally two 
days after, I remember making a cup of tea and I was thinking “God, 22 
years or however many years of making a cup of tea, you don’t even think 
about it, you get the milk out, you put the tea bag in, and you literally 
don’t even think about it”. Then all of a sudden, it’s a massive struggle. I 
just remember feeling really, really tired all the time because any menial 
little task took so much concentration. So yeah, everything was a struggle 
whatever the task was.’ 
(Tim, diagnosed aged 23 in 2013) 
Ollie also articulates a range of emotions to explain his feelings at the time of the 
diagnosis: 
‘I think the emotions at first are just utter disbelief, unhappiness, 
devastation. The way it affects people and the age it affects people. You 
are incredibly self-conscious about yourself, let alone having a disability. 
It’s a huge amount of shock, a huge amount of horror, and you initially 
think of “Why me?”  You can’t really digest what’s just happened, let 
alone what’s going to happen in the future. The thought of having limited 
to no sight for the rest of your life is a pretty scary thought when you are 
18. You just want to shut the world out and every time you wake up, you 
just want to believe it’s not happening.’ 
Ollie seeks an explanation for his sight loss—a ‘quest for meaning’ (Carricaburu and 
Pierret 1995; Pierret 2003)—and asks, ‘why me?’ Conrad (1987) suggests that when 
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given a diagnosis, people are faced with uncertainties which prompt them to 
question their identity—for example: who are they? How will they be perceived by 
others? How will the diagnosis impact on their life? What will the future hold for 
them?  Conrad’s comments are echoed by Stuart, who had left school at 16 without 
taking any exams. He was offered what he termed his “dream job” of working on the 
fishing boats. There was no possibility that he would be able to continue with his 
chosen occupation after his diagnosis. Stuart recounted his thoughts at the time of 
diagnosis and how his life would change:  
‘I was a fisherman, I was quite an independent person and I did a lot of 
things on my own. I lived on my own… well, not on my own… I lived on 
the boat with a group of lads so realising that I was going to lose all of 
that terrified me. I was processing it all and thinking “What’s going to 
happen?  What am I going to have to do? How is my life going to change?” 
I used to go out a lot with my friends socialising and I stopped that for a 
long time, about three months. I spent a lot of time at home, didn’t do the 
things I was doing before, didn’t play any sport, stopped going to the gym, 
yes, all sorts of things. But once I had processed it and realised the thing 
to do was to man up, find out what they [doctors] are going to do, what 
they can do, can’t do, what I need to do to move on.’ 
(Stuart, diagnosed aged 23 in 2013) 
Stuart’s level of residual vision gave him no choice but to give up a job he loved, and 
he struggles to understand why he has lost his sight. ‘I wondered what I have done to 
deserve this.  All I have done ever since leaving school was I wanted to work hard and 
be happy and then this happens’. Stuart’s identity was embedded in his life as a 
fisherman. He lived on the boat with the other fishermen who were not only his 
work colleagues but also his friends. When he lost his sight, his life changed forever; 
he could not contemplate a future where he is not working as fisherman. Flurey et 
al. (2018: 115), in their research exploring the impact of rheumatoid arthritis on 22 
men, argue that current scholarship has overlooked the impact of chronic illness on 
masculine identity. The authors suggest that ‘retaining hegemonic ideals of 
masculinity’ appeared to be important to many of the men, who tried to hold on to 
activities and roles valued by hegemonic masculinity (for example, sporting 
activities and paid employment) that they took part in before being diagnosed with 
the condition. The authors’ findings resonate with the view expressed by Stuart, and 
other men in this thesis, who also struggled to adapt to their new identity. Other 
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participants also struggled to make sense of why they had lost their sight and spoke 
of their sense of injustice as they reflected on their life before sight loss, and their 
feelings that they were somehow being punished for some previous misdemeanour 
of which they were unaware.  
Some of the younger participants expressed the view that their body, or to be precise 
their eyes, had unexpectedly let them down. Ollie sums this up when he says: ‘I don’t 
think you ever associate sight loss with younger people.’ Nettleton (2013: 65) claims 
that biophysical changes in the body have significant social consequences; ‘if we 
cannot rely on our bodies to function “normally”, then our interaction with the social 
world becomes perilous […] and our sense of self may be challenged’. In her 
reflections on the body in the context of health and illness, Corbin (2003: 258) 
suggests that the body is not just an object to be adorned and enhanced, nor is it 
simply a ‘physiological organism’ performing according to a ‘prescribed genetic 
code’. Rather than being just a container of the self or simply a mediator between 
the self and the world, it is the ‘embodiment of who we are’. Corbin and Strauss 
(1987) observe that when chronic illness enters an individual’s life, it separates the 
person of the present from the person of the past and shatters any images of self 
that had been held for the future.  This is particularly the case when the illness is 
severe or debilitating. When chronic illness strikes, the body is perceived as failing 
in some way (Corbin and Strauss 1987). Disruption occurs because tasks that could 
be completed previously become difficult or impossible to accomplish following the 
onset of illness. This results in the person of the past and the person they aspired to 
be in the future, in whole or in part, being rendered discontinuous with the person 
of the present.  
The comments strike a chord with many of my participants who, in their narratives, 
reminisced about their past achievements which were now just a distant memory. 
Similarly, the aspirations they held for the future were now considered unrealistic. 
A number of the younger participants focused on the activities they could no longer 
undertake. Jake was aged 15 when he first experienced symptoms of LHON. He 
recounts how he was no longer capable of undertaking simple activities, such as 
using a mobile phone or computer: 
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‘It was heart-breaking to be honest. It was a massive blow. Obviously, I 
just put on a brave face but inside it tore me apart really. I just don’t 
know… it was horrible. It was just weird, really different, and I felt 
different. […] I just didn’t feel able anymore. I know it sounds stupid, but 
you constantly think about the things you can’t do. I couldn’t play football 
with my mates anymore. I couldn’t... the other thing is they tell you that 
you can’t drink, you can’t smoke, you can’t do all these types of things. 
Everything was an issue really. Reading I used to love, mobile phone that 
was a big thing as well. For ages I was trying to find a phone I could use. 
Obviously, when you are a teenager, it is a big thing. I couldn’t use a 
computer properly. I couldn’t watch football on the television. It was just 
everything, it was just heart-breaking.’ 
Jake summarises all of the activities, including football, he can no longer participate 
in because of his physical limitation. His inability to function, as he once did, 
impacted on his sense of self. When a chronic condition is unexpected, as is often the 
case with LHON, greater work in undertaking identity reconstruction may be 
required to come to terms with the disruption (Bury 1982; Whitehead 2006). Jake 
also highlights the health advice he was given to avoid smoking and drinking. For 
Jake, going out and drinking with his friends was a big part of his social life. Petersen 
(2006: 36) suggests that being diagnosed with a genetic condition poses a 
substantial threat to the individual’s sense of self, when individuals are advised to 
avoid ‘risky’ activities which can lead to social exclusion. 
When changes in bodily function take place, the self becomes ‘unsettled and 
uncertain’ (Clarke and James 2003: 1388). Corbin (2003) suggests that, over time, 
individuals learn to live with an altered body and, once again, take the body for 
granted and build their self-concepts and identity around what they can do rather 
than what they cannot do. To what extent this is true in the longer term for my 
participants will be discussed in Chapter Six. However, in the short term, it was clear 
that participants struggled to adapt to their altered situation. The disruption Beth 
experienced was particularly acute in the early weeks and months because she also 
developed Charles Bonnet Syndrome17 and experienced visual hallucinations, which 
                                                          
17 Charles Bonnet Syndrome (CBS) is named after a Swiss philosopher who wrote about his 
grandfather, who following sight loss, experienced ‘visions’; he could see patterns, people, birds and 
buildings, which were not really there. The main cause of CBS is loss of vision and how the brain 
reacts to this loss. Exactly how sight loss leads to hallucinations is the subject of continued debate.  
Current research suggests that when we are seeing real things around us, the information received 
from our eyes stops the brain from creating its own pictures. When a loss of sight occurs, however, 
the brain is not receiving as much information from the eyes as it used to. The brain can sometimes 
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have become less frequent as time has passed. Beth explained that the hallucinations 
were extremely frightening as she was unable to distinguish what was real from 
what was not:  
‘Because of this condition, I thought I was going daft, I started suffering 
hallucinations. I can see people. I didn’t know who was real and who 
wasn’t. I actually see people in the bedroom sometimes; I am frightened 
to go to bed. In fact, the other week, it got to a stage I didn’t know what I 
was going to wake up to. My bedroom wasn’t my bedroom. One day―you 
might laugh―I had five naked men in the bedroom. My bedroom has been 
an operating theatre, it’s been a hotel room and I haven’t been able to get 
out of there. The bedroom is completely different, not my bedroom and 
one night, I couldn’t get out of there. I was all panicky, I didn’t know 
where I was. The other week I phoned my dad at quarter to six in the 
morning. He came around because I couldn’t find the bedroom door.  I 
couldn’t get out of my room. The lady across the road came over one day 
to see how I was. She had three girls with her. I thought they were real I 
said “who are these girls you have got with you?” and she said, “I haven’t 
got anybody with me, I am on my own”.’ 
Beth can no longer trust what her eyes are telling her. Corbin (2003) highlights how 
people learn to trust their bodies and the sensations that it sends. Using the example 
of placing a foot on the ground, Corbin suggests that the body sends a message that 
the pavement is even or uneven. As result of the message sent, the necessary 
adjustment is made. We, as individuals, know that certain experiences are ‘real’ 
(2003: 258) because we have learned to trust the messages our bodies send. Beth 
was no longer able to rely on what her senses were telling her. She could not trust 
the signals being sent to her brain and has had to adapt her perception of the world 
accordingly.  
Bury (1991) notes that the loss of confidence in the body’s ability to function as it 
once did leads to a loss of confidence in social interaction. Coming to terms with 
limited sight proved to be overwhelming for many of the participants who felt that 
it was easier to shut the world out by participating in what can be described as self-
imposed exile, often locking themselves away in their bedroom and keeping friends 
and family at a distance. Charmaz (1983) has identified that following the onset of 
                                                          
fill in these gaps by releasing new fantasy pictures, patterns or old pictures that it has stored. When 
this occurs, the images stored in the brain are experienced as hallucinations. CBS tends to begin in 
the weeks and months following a deterioration in eyesight (RNIB 2018). 
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chronic illness, individuals recognise that they can no longer undertake the activities 
they once enjoyed in the past. This leads to a restricted life as they choose to 
withdraw rather than allow friends and family to see them in their altered state.  This 
was certainly true for many of my participants. David was diagnosed when he was 
23, and at the time, was in the final year of his degree. He explained that his reaction 
to his sight loss, not untypical of other participants, was that he felt he needed time 
to himself:  
‘I needed some time to come to terms with this [sight loss]. I thought I 
am going to need some time to myself.  I did kind of end up having that 
bit of time to myself. I kind of pushed them [family] and the world away 
a little bit for a while.’ 
Eventually, after having time to himself, David returned to University to complete his 
degree. Tim, who was diagnosed when he was 23 in 2013, also talks of avoiding his 
friends:  
‘I certainly pushed my friends away because you know what 23-year-old 
guys can be like. No one knows how to deal with those emotions and 
fears. The only way you deal with it is by taking the mick out of each other 
and, at the time, I hadn’t really accepted it and I couldn’t be dealing with 
that.’  
Ollie, who experienced suicidal thoughts during the early months following his sight 
loss (as highlighted earlier in this thesis), also withdrew from the outside world: 
‘When I left [name of university], it was three months of not really 
leaving the house. You just don’t want to let anyone know what you have 
become. You’re very embarrassed about your condition. You’re very 
insecure and the people that know you very well will see how much it 
affects you, how much you have changed.’ 
Ollie’s perception is that he feels his identity has changed following his sight loss and 
that his friends will see him in a different light. The onset of chronic illness has been 
described by Little et al. (2003) as an ‘extreme experience’ and one that challenges 
the individual’s sense of identity in all its elements because it ‘leaves no aspect of 
identity untouched’ (2003: 76). Similarly, Bury (1991) claims that chronic illness 
represents an assault not only on the person’s physical self, but also on their sense 
of identity. In the following extract, Adam explains how he felt different after he lost 
his sight and refers to the reaction of his friends: 
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‘I was 14, I was free spirited. I used to have a credit phone, £20 would 
last me six months because people wanted to ring me, they wanted to 
text me, they wanted to come around. That all died very quickly:  
“You are not the same, are you? No, so we don’t really want to be 
around you.  
I wouldn’t be different if you didn’t treat me differently”.  
I quickly realised that you can’t ask 14-year-old kids to understand. They 
have a spot on the end of their nose and it’s like the end of the world. 
Having a friend who has just lost 95 per cent of his sight overnight… I had 
friends who didn’t understand it. A lot of people do get lucky, I have 
spoken to a couple of my [visually impaired] friends and their friends 
stuck by them and were a bit more understanding. Mine just went “You 
are not what you were, go and stuff yourself”. They didn’t want to know.’ 
Being perceived as different by friends following sight loss was also present in the 
narratives of other participants who indicated that friends disappeared following 
sight loss. Beth was both upset and angry that one of her oldest friends now avoids 
her: ‘one of my friends, I had known her for 30 years and, you know, I saw her twice 
last year.  I was so upset by it; I don’t think she could cope with it (sight loss). She 
avoided me, she never rang’. Amy, who was 18 years old at the time of her sight loss, 
also talks of losing friends: ‘I lost a lot of my friends because they can’t seem to accept 
that I have got something wrong with me. ...like I am registered blind, or I have got an 
eye condition. They are like “we can’t speak to you now”’. Ollie, whilst acknowledging 
that he also lost friends after his sight loss, also has a good group of friends who have 
continued to support him:  
‘You lose friends. You really do understand who your friends are. A lot 
of people just don’t know how to react [to sight loss], so the best thing 
you can do when you don’t know how to react is not react at all. My 
friends dropped out of my life. I had two or three really good friends 
and very quickly… they haven’t spoken to me since. On the converse, 
you have friends who will stick with you through thick and thin. They 
were absolutely brilliant; it is six of one and half a dozen of the other 
really.’  
 
Beth, Ollie and Amy, consistent with the sight loss literature (Davis 1961; Scott 
1969), believe their friends did not know how to react to sight loss and, so, chose to 
avoid them. A number of the younger participants also referred to their initial early 
fear that their sight loss would stop them from finding a girlfriend or boyfriend. The 
fear of rejection prompted George, who retains a good level of residual vision, not to 
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tell his girlfriend that he was visually impaired. ‘I didn’t tell her for a year. She was 
living in [city] and I would go up on weekends and I was literally living my life on edge 
because I was trying to do everything without even showing her that I had bad sight. 
In the end, I had to tell her’. When the relationship ended, George, resolved that he 
would tell his next girlfriend straight away that he is visually impaired.  George is 
now married with two children. Not all participants have been fortunate in finding 
a partner. Declan, who was aged 12 when he was diagnosed with LHON, is now in 
his early twenties and believes his sight loss has prevented him from finding a 
girlfriend: ‘I have never had a relationship because of it [sight loss]. I feel like no one 
wants to be with me’. Unsurprisingly, the majority of the participants spoke of their 
initial reaction to sight loss in very negative terms. However, for a few participants, 
receiving the diagnosis was viewed as having a positive effect on their lives. David, 
diagnosed when he was 23 years old, described himself as lacking in confidence 
before his sight loss, but now feels that sight loss has helped him gain in confidence: 
‘I feel losing my eyesight helped me gain in confidence, I think it pushes you, it’s either 
sink or swim’. I also interviewed David’s mother, Marion, who whilst acknowledging 
that David’s sight loss was a steep learning curve for the family, also highlighted 
positive aspects: ‘My son has certainly ...it sounds clichéd but… gained a vision through 
losing his vision. Before he lost his vision, we used to say when is he going to grow up 
and realise there is a world out there that he has got to contribute to’. For one of the 
other younger participants, Jason, who was initially disbelieved by the 
ophthalmologist, who thought he was making-up his symptoms, receiving a 
diagnosis after 14 months had a positive effect upon him:   
‘It had a profoundly positive effect, I started to try a bit harder. Alongside 
all the medical stuff, you then kick into the educational system and 
assessing your needs. By now you are a special needs kid. They are 
testing you. I think the difference for me was I started to get my head into 
stuff. I remember sitting in a room for basically most of the afternoon. My 
mum was present whilst they tested me on English and they tested my 
maths and everything else and they started doing IQ testing. I think that’s 
when they started to click that I wasn’t thick, I was lazy (laughs) because, 
as I say, during this period, I had started to read more and work.’  
(Jason, diagnosed aged 13 in 1990) 
Jason, reflecting on his previous identity, described himself as lazy and 
underachieving: ‘I was a very different child in terms of personality to the person I 
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grew into after it (LHON).  At school, I was a fad kid so after a month, I would then get 
bored and stop trying’. Jason’s comments mirror the view expressed by Frank (1993: 
42) using the analogy of the ‘phoenix’ rising from the ashes. Notwithstanding being 
catapulted into a critical situation, individuals in talking about their chronic illness 
present their experience as a life changing event. Charmaz (1987: 296) also talks of 
people, in coming to terms with chronic illness, constructing a new identity—a 
‘supernormal self’, which will be discussed in more detail in Chapter Six.  
Re-conceptualising biographical disruption 
 
Bury’s conceptual framework has been omnipresent in the medical sociological 
literature for over 30 years, having been both adopted and extended (Carricaburu 
and Pierret 1995; Locock et al. 2009; Larson and Grassman 2012; Saunders 2014). 
However, it has also been critiqued. Williams (2000: 51) suggests that biographical 
disruption is grounded, for the most part on the adult experience of illness—thus 
neglecting congenital and childhood conditions which he argues are ‘integral to an 
individual’s biographically embodied sense of self’. In their study exploring 
responses to the onset and impact of stroke in older age. Pound et al. (1998: 490) 
consider that studies which have adopted Bury’s model are based on the ‘unspoken 
assumption that illness enters lives which have—until then—been untouched by 
crisis or struggle’. For these authors, biographical disruption is not an inevitable 
consequence of chronic illness when experienced in later life; once individuals have 
survived into their 70s and beyond, their life experience equips them to deal with 
crises and adapt to their new situation, accepting chronic illness as an inevitable 
consequence in old age. Williams, (2000), suggests that when chronic illness is 
viewed against a background of general hardship and adversity, it may be perceived 
as ‘biographically anticipated rather than a disruptive (i.e. unanticipated) event’ 
(2000: 51, original emphasis). This view was subsequently endorsed by Faircloth et 
al. (2004: 245) who also argue that the onset of sudden illness such as stroke is not 
always perceived as a disruptive event, but instead may be viewed in terms of a 
‘biographical flow’: once mitigating factors, including age and previous illness 
experience, are factored into the equation illness, ‘melds into an enduring chronic 
illness narrative, part and parcel of biography’. Two of the participants who were 
the oldest at the time of their LHON diagnosis articulate very different experiences 
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following their sight loss. Firstly, Sandra had previous experience of being 
diagnosed with glaucoma, a condition her father had also experienced:  
‘[I] feel almost cheated because if you say “Okay I have been doing all the 
right things with my glaucoma” … I had lived with the fear of anything to 
do with sight for a long time you know. Everyone has a fear. Lots of 
people have a fear of cancer or whatever it is. This had been my big one 
[fear of sight loss]. I have been doing all the right things, I have been 
doing exercise, eating healthily, absolutely compliant with the 
medication down to almost the exact minute of the day. I know there are 
plenty of people who forget medication, but I never do and then 
something else comes in from left field and, you know, completely 
unexpected. It is that feeling of being cheated.’ 
(Sandra, diagnosed age 69 in 2015) 
Sandra’s history of glaucoma did not prepare her for experiencing further sight loss. 
As with Stuart (discussed above), who felt he worked hard and did not deserve to 
lose his sight, Sandra also talks about living a healthy life, and feels cheated that she 
has lost her sight. Charmaz (1995: 66) posits that when ‘wholly unanticipated, even 
middle-aged people may view their bodily changes with a sense of betrayal’. In 
contrast to Sandra, Gerry, who was diagnosed aged 62 and who had previously 
enjoyed good health with no history of sight problems, explained:  
‘I am very pragmatic about things. Once I had got the diagnosis… my 
view on things is that a lot of people go around with the attitude “why 
did it happen to me?” On the other hand you can say “why shouldn’t it 
happen to me?” Once it’s happened, you might as well accept it and get 
on with it and try and make the best of it.’ 
Gerry talks of accepting his sight loss and moving on. In displaying a stoic attitude 
towards his sight loss, he may be said to be adopting the ‘tough-men stereotype’ 
(Garcia-Calvente et al. 2012: 920) by hiding his true feelings because he may feel 
that to do otherwise would display vulnerability. Charmaz (1995: 268) has also 
noted that ‘illness can reduce a man’s status in masculine hierarchies, shift his power 
relations with women and raise his self-doubts about masculinity’. As the interview 
with Gerry progressed, he also referred to experiencing suicidal thoughts in the 
early stages of his sight loss:  
‘I was feeling low, I did go through a phase where... I don’t think 
particularly seriously… where I was thinking I might as well kill myself, 
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what’s the point of living if I can’t do these things, I can’t get out, I have 
lost all my independence, I feel like a prisoner. What can I do? What’s the 
value in my life…?’  
(Gerry, diagnosed aged 62 in 2014) 
Gerry focuses on his feelings of loss including the loss of independence, explaining 
that he has to rely on his wife to help him with everyday tasks. Just after his sight 
loss, Gerry did not have the confidence to go out on his own so again he was 
dependent on his wife to accompany him. However, if she was busy, he would have 
to stay home, and, thus, he described how he felt like a prisoner. Corbin and Strauss 
(1987) take the view that for some people, chronic illness becomes the focus of their 
life (Sandra). Yet others, like Gerry, are able to integrate their illness into their life 
as it ‘remains as part of the texture of a biography—something to be managed and 
taken into consideration but certainly not the only aspect of life (1987: 251).  
Telling the family: disclosing genetic test results  
Having considered the emotional impact of the LHON diagnosis on affected 
participants, I now consider the complex moral dilemmas negotiated within families 
when deciding to communicate genetic information to members of the wider family 
who may also be at risk of developing the condition. Mothers have to make difficult 
decisions regarding whether to tell the siblings of an affected child that they may 
also lose their sight. Previous research (McAllister et al. 2007) suggests that being 
diagnosed with a genetic condition is viewed as doubly emotionally burdensome by 
the proband [initial person to be diagnosed], who is faced with the challenge of 
coming to terms with the diagnosis, and also with the dilemma of whether to deliver 
‘bad news’ (d’Agincourt-Canning 2001: 240) to other family members that they may 
have inherited a genetic condition. Scholars have suggested that genetic information 
belongs not only to the proband, but also to other members of the biological kinship 
as the information may have implications not only for their long-term health, but 
also be relevant in reproductive decision-making (d’Agincourt-Canning 2001; 
Forrest et al. 2003). 
In their research with patients at risk of hereditary breast and ovarian cancer and 
Huntington’s disease, Forrest and colleagues (2003) argue that there is a moral duty 
to disclose test results; failing to disclose such information to relatives potentially 
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deprives them of the opportunity to make autonomous health decisions. Providing 
wider family members with genetic information may encourage carriers to engage 
in health surveillance and possibly avoid exposure to triggering mechanisms. This 
is particularly salient for my participants, both affected and carriers, who are 
encouraged to avoid smoking, limit alcohol consumption, avoid contact sports, and 
exposure to toxins (Yu-Wai-Man et al.  2014).  
Disclosing genetic information raises complex social, ethical and legal issues 
regarding not only whether there is a duty to disclose genetic information, but also 
whether family members have a right not to know (Hallowell et al. 2003; Adorno 
2004; Arribas-Ayllon et al. 2008). When making the decision to inform other family 
members, questions arise as to whether to disclose the information, how much 
information to disclose, the potential impact of the information, deciding when the 
best time would be to disclose, and which family members need to be told (Forrest 
et al. 2003; Hamilton et al. 2005). Gaff et al. (2007) suggest that where the proband 
does not immediately communicate genetic information to their relatives, they are 
likely to be undergoing a period of deliberation in which they balance a feeling of 
obligation to pass on information against not wanting to cause alarm or distress. 
Forrest et al. (2003) suggest that disclosing genetic information may be viewed as a 
process as opposed to an act. The authors identify two broad categories of disclosure 
which they define as ‘pragmatism’ and ‘prevarication’. The pragmatists are 
perceived as being pro-active in a practical way in disclosing information to other 
family members.  
In contrast, the prevaricators described waiting for appropriate opportunities to 
bring up the subject but, as the authors highlight, it could take months or years to 
find the ‘right moment’ (Forrest et al. 2003: 321). In my study, at the time of 
diagnosis, several of the affected participants were children or young adults, and the 
decision to tell other family members was entrusted to their mothers. This finding 
is not unexpected given the previous research which highlights that in the Global 
North, women are traditionally considered to be the ‘gatekeepers’ and ‘transmitters’ 
of health information (Richards 1996; d’Agincourt-Canning 2001; Arribas-Ayllon et 
al. 2008).  
113 
 
The participants in my thesis displayed both pragmatism and prevarication. The 
adult women participants (carriers and affected) displayed pragmatism; as soon as 
they were aware of the diagnosis, they decided to contact immediate family 
members. When those family members also had children, this was considered to be 
imperative. It was not apparent from the interviews whether they had considered 
the impact the information would have on other family members. There was little, if 
any, thought given to whether those relatives would want to know or, indeed, the 
psychological impact of receiving the information. For a number of the participants, 
disclosing the information was prompted by a sense of duty, mirroring d’Agincourt-
Canning’s (2001) findings that her participants felt a moral responsibility to 
safeguard and inform other family members irrespective of the impact the 
information would have or whether the relatives would wish to know. When Sarah’s 
son was diagnosed, she adopted a proactive approach, disclosing the diagnosis to 
her sister who has two young sons and also arranging for her and her sister to attend 
genetic counselling: 
 ‘As soon as we knew it was a mitochondrial disease, we realised what the 
implications were. They did tell us at one point “you would have passed 
it on to your son”. I said “how can I have passed it on to my son, because 
my mum never had anything”. They said it doesn’t always come out. I 
then had to tell my sister that she and her boys are involved in it. She was 
like “no, no”. We went for genetic counselling, me and my sister. We had 
a blood test taken and they said it won’t be worth testing my daughter or 
my sister’s boys because they have got the gene and all it would do is 
hinder them if they ever needed to get any insurance by getting it put on 
their record that’s what they have got. Obviously, if I and my sister have 
got it, then the children have got it, there is no doubt about it. They don’t 
need it actually put in writing, it is not going to help anybody.’ 
In contrast, Sandra waited several months trying to find the right time to tell her two 
daughters who are of child-bearing age:  
‘Inevitably, I had been putting it off and putting it off. One lives in [city] 
and the other in [city]. I wanted to do it at a time when they were both 
together and also a time when their partners were there to support them. 
There hadn’t been many opportunities. I was going to do it in the 
November, but there wasn’t a space or time in which we could all talk 
and so it wasn’t until my birthday party (December 2015). They were 
much more grown up about it than I was. I suspect that they had 
probably worked out that it was something of this sort’. 
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One of the affected adult males, John, has delayed discussing his condition with other 
family members: 
‘My mother had two sisters, I have four female cousins, so they haven’t 
passed it on to their children at the moment. So, my mother has a brother, 
but I don’t see the brother due to a family dispute. The two sisters, one 
has passed away now, but both had two daughters each. So potentially it 
is still progressing through their side. So, you know, possibly they should 
be made aware of it.  I could certainly contact them and make them aware 
that this goes through female genetics and so potentially because my 
mother must have got it from her mother, their mother is probably 
carrying the gene. I don’t know what triggers the gene, you see. With me, 
they thought because I was drinking a lot that it could have triggered the 
Leber's, you see. It might have stayed dormant. Unfortunately, it didn’t. I 
might not have been aware I had it myself (laughs)’. 
(John, diagnosed aged 42 in 2008) 
 
John displays signs of prevarication and, although diagnosed in 2008, he has not had 
a conversation with his female relatives. In part, this is due to his belief that it was 
his alcohol consumption which triggered the condition. He considers it unlikely, 
therefore, that his relatives will be affected. John also refers to a rift in the family 
which has precluded him from disclosing his condition to his uncle. Previous 
research (Forrest et al. 2003; Hamilton et al. 2005) suggests that the decision to 
disclose genetic information is influenced by pre-existing relationships within the 
family, cultural factors, and the perceived vulnerability and receptiveness of the 
individual receiving the information. This was apparent in my research with 
mothers who were reluctant to inform unaffected siblings that they could develop 
sight loss because they were uncertain of their reaction. The following extract 
illustrates a typical response from Gwyneth, a mother, whose elder son was affected 
aged 12. Her younger son is now aged 14, and she has not discussed (and does not 
intend to discuss) the possibility of developing LHON with him: 
I have spoken to his school and explained to them that he could develop 
it [LHON]. They are really good and said they wouldn’t say anything, but 
they would keep an eye on him. 
Why have you decided not to tell him?  
  He seems for a young boy to be quite sensitive. I think he would dwell on 
it and think about it a lot. I wouldn’t really want to worry him for 
something that might not happen. 
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Did you communicate the results to other family members? 
 Yes. I told my niece because she has got boys. She said she would rather 
not know. She said if they have got it, they have got it. She would rather 
not think about it. 
Gwyneth faces a dilemma which was articulated by other mothers in my thesis that 
there is a great deal of uncertainty surrounding which family members will 
potentially develop sight loss. Gwyneth does not want to affect the way her younger 
son lives his life by telling him that he may lose his sight—an event that may not 
happen. In her research with families affected by Huntington’s Disease, Skirton 
(1998: 107) suggests that in disclosing genetic inheritance, there may be a critical 
age at which this should be undertaken as the ‘disadvantage of delay may outweigh 
any benefit’. Adam, explained that his mother was aware that she carried the LHON 
mutation, having been tested as her three uncles had lost their sight. Adam’s parents 
decided not to tell him that he was a carrier as they did not want to affect how he 
lived his life. When Adam was aged 14, he developed problems with his sight. During 
an appointment with an optometrist, the family history started to emerge.  
I knew I had uncles in America [who were blind] …but it was never really 
mentioned. It all came to a head when I had my optician’s appointment. 
My Mum and Dad knew that I could have an eye condition. They [uncles] 
all knew about it. My Mum had a test to determine whether I was a boy 
or a girl. Apparently, it was the “done thing” then. If you have a boy, you 
terminate the pregnancy because he could go blind.  
Did your mum know how LHON is inherited? 
Yes, she was fully aware. So was my dad before he married my mum and 
had me. They kept it to themselves because they didn’t want to affect 
how I lived my life: “I don’t want to do this just in case I lose my eyesight”. 
The dream was to play for [professional football team] in goal. My mum 
said that when she was 16, her and her sister had a test because they 
thought they could be affected.  
At the time, that Adam started to experience sight loss, he was being evaluated by a 
football scout on behalf of a professional football team. On the day the football coach 
was watching, Adam conceded five goals—which was unusual and was the first 
indication Adam had that there was a problem with his sight. I asked Adam if he 
understood the significance of his diagnosis: 
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I was fully aware. You have got your Mum and Dad saying to you “We had 
you because we wanted a kid”. I want my frigging eyesight back, but it 
isn’t going to happen. I can’t read a newspaper; I have to get magnifiers 
for everything. I don’t bump into things as much now but at the start, I 
was a bumping into everything, hitting my head on things. It was 
horrible, really horrible, and it was like “what’s the point?” I am not going 
to save the world. I am not going to do anything magnificent, so what was 
the point in having me for this?  
What were your feelings towards your parents after your diagnosis?  
I resented my parents something shocking because it was, like, they 
knew about it. Other people who I have spoken to with this eye condition, 
their parents didn’t know. I had two parents looking me straight in the 
face saying “We knew about this, we love you.” I can’t see because of you 
two. I have had my eyesight taken away from me and you did it because 
you knew about it?”  
Adam’s relationship with his parents remains difficult, firstly, because he believes 
they were selfish when they decided to have him, knowing that he could lose his 
sight. Secondly, he believes they should have told him that sight loss was possibility, 
so that he would have had time to prepare himself. In research undertaken into 
diverse genetic conditions, McAllister and colleagues (2007) note that individuals, 
when confronted with a genetic diagnosis, may express anger towards the person 
who provides them with the information, but also towards someone for not 
disclosing the family history.  
Previous research suggests that the decision to tell children that they may be 
affected by a genetic condition is considered to be the responsibility of the parents 
(Forrest et al. 2003; Keenan et al. 2005).  However, when the parents make the 
decision not to disclose genetic information to their children—in some cases, even 
when they are adults—that has the potential to engender intense emotional 
reactions from relatives who feel they cannot tell their cousins, nieces and nephews 
about their genetic status (Green et al. 1997; d’Agincourt-Canning 2001; Gaff et al. 
2005). This was apparent in my thesis with Beth, who expressed her frustration that 
her aunts did not want their children to know about the inheritance of LHON: 
‘My Mum and Dad were devastated but it has split the family up a bit 
really. My Mum's youngest sister has two sons, the eldest one is in his 
30s and the younger one is in his 20s.  She has never told them about this 
condition, probably because she has wanted to protect them. Some 
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people have said maybe it’s a good thing, she has done the right thing, 
but other people have said she should have told them.’  
Beth expressed her own view that her aunt should have told both of her sons. She 
then recounted an incident when the younger son, although not experiencing 
symptoms, believed he was losing his sight and experienced a problem with his 
mental health. Beth went on to say: ‘we believe she still hasn’t told the two sons. They 
don’t know anything about my sight going and she has gone to great lengths [to hide 
this] … she has put a bar on the telephones, so I can’t ring the house’.  I asked Beth why 
she thought her aunt had not disclosed the diagnosis:  
‘She is frightened of it happening to her, isn’t she? I think she is in denial. 
One day I said to her “You haven’t told him [younger son], have you?” She 
said “No, I haven’t”. I said “Why, would it tip him over the edge?” and she 
said “Yes”. So now he is sort of back on track, she doesn’t want anything 
to disrupt that. I won’t be there to support her if anything happens 
because I have had no support off her at all.’   
Having discussed the factors that influence the disclosure of genetic test results to 
the wider family, I now consider the reaction of mothers on learning of their child’s 
diagnosis, and how they negotiate feelings of guilt. 
Reactions of mothers to the diagnosis 
All mothers, on receiving the news, of their child’s diagnosis, described experiencing 
feelings of devastation and sadness. The mothers mourned the loss of their child’s 
future expectations, believing that following the diagnosis, their child’s life would be 
over and that they would become dependent on their parents for the rest of their 
lives. Sarah, whose son Tim was diagnosed when he was 22 years old and living at 
home, captures this view: 
 ‘As far as we were concerned, that’s it. Tim’s life was over, our lives were 
over. We would be his carers; he is going to be completely blind, he is 
going to have a white stick, a guide dog. We were like this is how it is 
going to be.’  
Sarah’s comments resonate with the research of Locock et al. (2009) exploring 
biographical disruption within the context of the terminal illness, Motor Neurone 
Disease (MND). The authors suggest that, on receiving the diagnosis, participants 
believed they had been given a ‘death sentence’ (2009: 1043) and that that their life 
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was over. Sarah feels that not only was her son’s life over, but that her and her 
husband’s lives were also over, as they perceived a future where they would look 
after their dependent son. Expressing similar sentiments, Jacqui, whose son Stuart 
was diagnosed in 2013 aged 23, explained that, fearing he would never live 
independently, they built an annex for him: 
 ‘At the back of the house we had a shed and a toilet area. We converted 
that into an en-suite for him. He has got his own space. It’s outside the 
house so he has got his own separate building. He has got his bedroom in 
there.’ 
Both Tim and Stuart are now in relationships and have left home. Gloria’s daughter 
Amy lost her sight when she was 18 and, at the time, did not have a boyfriend. Amy 
became what Gloria describes as ‘clingy’ and did not like being left at home when 
her parents went out. Gloria, reflecting on the early months following the diagnosis, 
recounted her thoughts:  
‘I was thinking how is she ever going to meet anyone and coming out 
with me and my husband. How are we going to find somebody for her, 
who is going to have her now she has lost her sight? All these sorts of 
things were running through your mind.’ 
 Amy is now in a relationship, and although still living at home, has become less 
dependent on her mother. When I interviewed Amy, she described how, on being 
introduced to Amy’s boyfriend, her mother had been over-protective: ‘It took her a 
very long time for her to accept someone else looking after me. Not looking after me, 
but someone else to sort of look out for me. Bless her’. A number of the other affected 
participants also referred to their mothers becoming very protective of them which, 
at times, they found difficult to cope with. This may in part be attributed to the guilt 
that the mothers experience when being told they have transmitted the condition to 
their children. Joyce, whose son was affected when he was 13 years old, spoke of her 
guilt and how, on occasions, she ‘fusses over him’ which causes arguments between 
them as her son gets irritated:  
‘It’s just the guilt doesn’t go away and it’s probably more difficult because 
when I try to make sure he is alright he gets really annoyed with me. He 
doesn’t like it when I fuss because he says he is fine.’  
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Joyce is one of the few mothers who was offered genetic counselling and, although 
she attended appointments for three months, and did not know of her carrier status, 
continues to feel guilty. Despite having been unaware that they were carrying the 
LHON mutation before their children were born, mothers with affected children 
articulated feelings of guilt, and self-blame when given the diagnosis. This is 
consistent with previous studies that have explored parental self-blame and guilt 
when children are identified as carriers or are affected by a genetic condition 
(Chapple et al. 1995; Arribas-Ayllon et al. 2008). The mode of inheritance has also 
been reported to have a major impact on feelings of guilt and self-blame experienced 
by female carriers of sex-linked conditions in contrast to autosomal disorders 
(where both parents have a copy of the mutant gene) (James et al. 2006; Clarke 
2016). There is a scarcity of research into mothers’ emotional responses to 
transmitting mitochondrial conditions to their children. In their research into 
genetic counselling strategies for maternally inherited mitochondrial disorders, 
Poulton et al. (2017) claim that the uncertainty surrounding the diagnosis and 
prognosis of mitochondrial conditions results in feelings of psychological distress, 
including feelings of blame and guilt. The following three extracts are typical of the 
responses of mothers in my research when discussing transmitting LHON to their 
children. Catrin says: 
‘I felt pretty shit to be honest with you (laughs). You know throughout 
[son]’s life, we had always encouraged him to try and do well at school 
and get a good job and everything else. To be honest with you, that all 
came crashing down. He wanted to travel the world, he wanted to have a 
nice car and everything and then, all of a sudden, all those opportunities 
seem to have been taken away from him. To be honest with you, I tried 
to take every day as it came and support him, and to a degree, keep my 
feelings to one side because he was the most important person. I do have 
the odd moment where I think “this is my fault”’. 
In this extract, Catrin expresses her feelings of self-blame by focusing on the 
opportunities her elder son will now miss out on and the life he would have had. 
Catrin also has a younger son and is acutely aware he may also lose his sight: ‘I now 
have [younger son] coming up to GCSEs and, you know, I can’t let my guard down really 
because if he thinks that I am worried about him, he might not try as hard at school.’ 
Catrin’s guilt is exacerbated because she has not told her younger son that he may 
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also lose his sight. Catrin referred to walking on eggshells as she did not want her 
anxiety to be visible to her younger son in case it had an impact on his upcoming 
exams. In the following extract, Sarah talks about her feelings of guilt and how she 
has struggled to come to terms with her son’s sight loss and blames herself for it: 
 ‘If [son] hadn’t have had me for a mother, he wouldn’t be blind, but then 
he wouldn’t be here (laughs). Realistically, you think I am talking 
nonsense, but it is still a nagging feeling at the back of your mind. If he 
had got anything else that wasn’t related to something I had given him… 
if he had picked up an illness, he had lost his sight through contamination 
of dirty water or something, it would be nothing to do with me. He would 
still be my son that has lost his sight and I would still have to be dealing 
with it and I would still be there for him. But it wouldn’t have been 
through something I have done to him. I know there are lots of hereditary 
things and some of them can be a lot worse than this.  But it [the thought] 
is still there, unfortunately.’ 
Gwyneth also explains her sadness that she has transmitted LHON to her son and 
explains that her son holds her responsible for his sight loss, directing his anger 
towards her:  
‘I did feel sad that this had happened. I did feel guilty, really all the stress 
of it all as well. I had a lot going on with [son] at the school and then…he 
became very…he was becoming a teenager as well. He became very angry 
and bitter and nasty towards me. He would say “it’s your fault, you and 
your family”. He became very nasty, quite aggressive and hostile. He was 
saying “you should never have had me”. I did feel guilty and things. It was 
very hard; he even still blames me now. He will bring up things like “you 
didn’t understand what sort of childhood I had, I was bullied”. Obviously, 
I think some children would make comments about his sight and things. 
They would call him a blind whatever. He still brings up every now and 
again “you never wanted me, you don’t realise what a hard life I have 
had”.’  
Gwyneth has to deal with her own sadness and guilt which she refers as 
overwhelming at times, particularly when her son blames her for his sight loss. 
Other participants have also spoken of their anger, and how on occasions this has 
been directed towards their mother. Amy, discussed above, in addition to inheriting 
LHON from her mother has also inherited other conditions 18for which she will have 
to take medication for the rest of her life: 
                                                          
18Although LHON is a condition predominantly associated with sight loss, a small group of people 
also experience what has been referred to as “LHON plus” (Yu-Wai-Man et al. 2011) including 
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‘Sometimes I still blame her [mother], which sounds horrible. I don’t 
blame her, but when we sometimes have an argument, I will say “it’s your 
fault”. She hasn’t just given me the sight problem. It’s the other [health] 
problems as well. Then I make her cry and that’s awful. It’s not her fault. 
She didn’t mean it to happen.’ 
(Amy, diagnosed aged 18 in 2011) 
Similarly, Beth also described how, at times, she also blames her mother: ‘sometimes 
I am so angry with her [mother], I say it’s her fault and... I will say it more so when I 
have had a drink.’ Later in the interview, Beth acknowledges that she knows that her 
mother would not have realised she was a carrier: ‘It is something they didn’t know 
about. She couldn’t have known, but I think she feels... she would go to the ends of the 
earth to try and get my sight back.’ Jake sums up the view of many of the participants 
when he says: ‘It’s not at all my mother’s fault. It’s no one’s fault really. It’s just one of 
those things. My mum didn’t know.’ With one notable exception, Adam, whose mother 
was aware of her carrier status, the other participants realise that their mothers did 
not know they would transmit LHON when they decided to have children. In Chapter 
Seven, I will discuss how females who are aware of their genetic status negotiate 
reproductive decision- making.  
Summary 
This chapter began by reiterating that LHON is a chronic condition —it is of long-
term duration and currently has no cure. In exploring participants’ initial reactions 
to their unexpected diagnosis, I used Bury’s (1982) conceptual framework of 
biographical disruption. As explained, although LHON can affect people at any age, 
it predominantly affects young men who, prior to their diagnosis, were fit and 
healthy, which made it more difficult for them to understand why they had lost their 
sight. Unsurprisingly, and consistent with the sight loss literature (Kübler-Ross 
1969), participants spoke of grieving for the loss of sight as they experienced a 
complexity of emotions including denial, anger and depression, which led to suicidal 
thoughts. A number of the participants felt that their body, or more precisely their 
eyes, had let them down as they struggled to undertake simple tasks, including using 
                                                          
symptoms of cardiac conduction defects [heart’s normal rhythm is disturbed] and neurological 
abnormalities (including ataxia).  
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a mobile phone or making a drink.  It was in these moments of frustration that 
participants experienced a loss of self-esteem and asked themselves ‘Why me? What 
have I done to deserve this?’ The loss of self-esteem has repercussions for their 
identity work as participants come to terms with who they now are and how they 
will be perceived by others. As Green et al. (2002: 259) suggest, ‘[a]t the level of self-
identity, vision loss potentially disrupts a secure sense of self in the world, with a 
new identity having to be incorporated into biography’. 
This chapter has also discussed the dilemmas that individuals face when making 
decisions to disclose genetic test results to other family members who may be at risk 
of sight loss. Given the ages of the majority of participants when they were 
diagnosed, responsibility for communication of genetic test results to the wider 
family was left to the mothers. However, one of the most challenging decisions 
negotiated by mothers was whether to tell unaffected siblings, that they were at risk 
of losing their sight. Decisions not to disclose information was grounded in the belief 
firstly, that the sibling would not be able to cope with the information.  Secondly, 
given the uncertainty surrounding the inheritance of LHON there is a possibility that 
the siblings will not become affected. Finally, mothers were concerned that the 
information would affect how they lived their life. In the final part of this chapter, I 
explored notions of guilt and blame. Notwithstanding that they were unaware of 
their carrier status when they decided to have children, all the mothers interviewed 
expressed feelings of guilt. Similarly, their children also conceded that they do not 
blame their mothers as they were unaware of their carrier status, although they did 
admit that, in moments of frustration and anger, they had expressed the view to 
their mothers that they were to blame.  
In the following chapter, I consider the longer-term implications of sight loss for 
participants and how, over time, they adjust to this.   
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Chapter Six: “I Just Want My Life Back”: Living with Leber 
Hereditary Optic Neuropathy 
 
Introduction 
In previous chapters, I have described participants’ chronic illness trajectory from 
experiencing symptoms of sight loss, through to the challenges encountered in 
receiving a diagnosis and their first reactions to the irrevocable loss of sight. In this 
chapter, I explore the longer-term disruption for participants and their families of 
living with Leber hereditary optic neuropathy (LHON). The chapter will be 
presented in three sections. In the first section, I build on the previous discussion 
around the physical limitations imposed by sight loss to consider the mundane 
everyday reality of living with LHON, highlighting the changing nature of 
relationships within the family following sight loss. While family members are the 
primary source of practical help by providing care and emotional support following 
sight loss, at times, the transformation of those relations causes friction between 
family members as they adjust to the changing dynamics of their relationships. A 
number of participants referred to no longer being able read documents, watch 
television, go shopping or cook a meal. They rely on others (parents, partners, and 
friends) to assist them in such tasks. These changes influence how individuals view 
themselves and how they think others perceive them, shaping their social 
relationships and their identity (Charmaz 1983; Nettleton 2013).  
In exploring the on-going daily challenges of living with LHON, I again draw upon 
Bury’s (1982) conceptual framework of biographical disruption. Taking Bury’s 
explicit reference to biographical disruption as an event occurring at the onset of 
chronic illness, as a point of departure suggesting that his conceptual framework is 
equally relevant in exploring the longer-term implications of living with LHON; 
participants reported experiencing repeated incidents of disruption throughout the 
trajectory of the condition, irrespective of the age of onset. My positioning is not 
unique; Larsson and Grassman (2012) adopted Bury’s conceptual framework when 
exploring, over a 30-year period, the narratives of chronically ill people who had 
lived with sight loss from childhood, adolescence and early adulthood. Mirroring 
findings in this thesis, rather than experiencing a single event of disruption at the 
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onset of symptoms Larson and Grassman’s participants experienced repeated 
disruptions which shaped their lives.  
In the second section, I consider whether the passage of time has changed my 
participants’ attitudes towards their sight loss. At the time of interview, participants 
had experienced sight loss for at least 12 months, but some were ‘seasoned 
professionals’ (Williams 1984: 176) having been diagnosed over 20 years earlier. I 
explore how (un)successful participants have been in regaining a sense of 
ordinariness (McLaughlin and Coleman-Fountain 2018) and a sense of normality 
(Davis 1995; Buse and Twigg 2018) by undertaking biographical repair work 
(Locock et al. 2009), and in so doing, have ‘become whole again’ (Corbin and Strauss 
1987: 264) by ‘restoring their former self-images’ (Charmaz 1987: 283).  
In the final section, I consider the complex inter-relationship of sight loss, disability 
and stigma, by exploring the dichotomy between the medical and social models of 
disability. Whilst the disability movement has pushed forward the agenda that 
promotes a more inclusive social model of disability, it is also evident that the 
visually impaired are still subjected to discrimination, marginalisation and 
stigmatisation. This is not limited to micro-level social interactions, but also occurs 
at the macro level in the built environment where public spaces are designed in such 
a way as to potentially exclude those who have a disability. Throughout this chapter, 
it is evident that participants have an overwhelming desire to undertake ordinary 
everyday tasks and regain a sense of what they perceive as “normality”. 
The everyday reality of living with sight loss 
 
Sight loss is a life changing, unique, and variable individual experience.  The majority 
of the participants were fit and healthy before and after their diagnosis. However, 
four women (Laura, Moira, Mary and Sian) in addition to their sight loss also 
experience multiple sclerosis-like symptoms (MS).19 For these four participants, 
their embodied experience of sight loss differs from that of other participants, as 
they overcome the challenges of sight loss but also cope with debilitating illness 
                                                          
19 LHON has been associated with multiple sclerosis-like (MS) symptoms in females who carry the 
m.11778G>A mutation (Harding et al. 1992).  
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(including prolonged bouts of pain, muscle weakness and sensations of tingling and 
numbness). 
 In this thesis I draw on participant interviews, highlighting not only commonalities 
but also the variations in subjective experiences between individuals and also the 
‘fluctuations that occur within the individual’s experience’ (Warren and Ayton 2018: 
142, original emphasis) of living with LHON. Focusing on everyday mundane 
activities—by which I mean the ‘mundane, familiar and unremarkable stuff of 
everyday worlds that is the routine, repetitive, and rhythmic reproduction of social 
life’ (Thomas and Sakellariou 2018: 6, original emphasis)—allows the identification 
of recurring themes within the data including frustration, loss of independence and 
social isolation confirming the findings of the wider sight loss literature (Lamoureux 
et al. 2004; Vu et al. 2005; Senra et al. 2011; Stevelink et al. 2015a). Here, I am 
referring to the taken-for-granted activities that are reproduced at the same time in 
the same places every day (Scott 2009). It is only by observing the minutiae of the 
everyday that we see how social life is produced and reproduced in the context of 
living with a disability. These every day activities include going to work, continuing 
with education, going to the gym, or having a drink with friends. By exploring the 
micro-encounters of the visually impaired, I highlight the changing nature of the 
relationships between partners, children, friends and work colleagues.  
I commence an exploration of the everyday by drawing on the interviews of the 
younger participants, many of whom, at the time of sight loss, were either in their 
early teens preparing to go to university or in their twenties and had already 
commenced studying for their degree. Ollie, a keen sportsman, was diagnosed with 
LHON when he was 18. Prior to his diagnosis, he had devoted considerable time and 
effort gaining the necessary examination grades and undertaking extracurricular 
activities to secure a place at a prestigious university. Within a few months of 
commencing his degree, Ollie’s sight deteriorated, and he was faced with the reality 
of no longer being able to continue with his studies. Ollie explains his frustration 
when he realised his dream was no longer a possibility:  
‘I asked the doctor what that [diagnosis] really meant and he said “Well it’s 
going to have huge ramifications on your life style” and those words stuck 
with me. In terms of my career, it was over really before it had started; a 
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[degree] is obviously something you don’t fall into. I had been preparing for 
that for about eight or nine years.’ 
(Ollie, diagnosed aged 18 in 2009) 
For Ollie, his diagnosis had profound repercussions for his future plans, forcing him 
to reconsider not only what he was going to do with the rest of his life, but also how 
he was going to live it (Petersen 2006). Finding himself in a similar situation, George 
experienced sight loss in his teens whilst studying for his ‘A’ levels.20 When he was 
applying to join one of the Emergency Services. He spoke of his disappointment that 
he would no long be able to follow his chosen occupation:  
‘I couldn’t follow the career path that I always wanted to do. I wanted to 
become a [occupation]. People were saying, “You can still join and do 
admin”. I could do admin anywhere, it’s not the same. Although I wasn’t 
different, it was just that I had this eye condition where it was quite 
difficult for me―well, impossible―for me to do the things I have always 
done.’ 
 (George, diagnosed aged 16 in 2004) 
George, who was 26 at the time of interview, explained that following his sight loss, 
he did no go on to higher education nor has he secured employment since leaving 
school. He spoke of his frustration of applying for jobs but not being shortlisted for 
interview: ‘it’s just finding that employer who will employ you to give you a chance, 
give you an opportunity’. Later in his interview, George returned to the subject of 
being unemployed and how this impacted on his life: ‘even now 12 years down the 
line, I still don’t know what I would like to do with my life’. The RNIB (2017) report 
that those who are registered as severely sight impaired (previously blind) or sight 
impaired (previously partially sighted) are significantly less likely to be in paid 
employment than the general population or other disabled people.  
 For many of the participants, whether to disclose their sight loss to a prospective 
employer caused a dilemma and echoes the wider disability literature (Barlow et al. 
                                                          
20 The “A” level examinations are taken in the UK (excluding Scotland) in a specific subject. The “A” 
level is usually taken between the ages of 16 and 18 years old. 
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2007). Ross was diagnosed in 2003 aged seven. He was asked whether he discloses 
his sight loss to prospective employers, to which he replied: 
‘No, I don’t, I can use a computer okay I can get to and from work. I don’t think 
they would need to know, If they asked me, I would tell them. I think if I told 
them it would be a negative, I wouldn’t want to give them a chance to...I don’t 
think that most employers know enough about it really. They would just 
make assumptions on things like that’. 
 Similarly, Jason, who is currently in employment, also explained:  
‘At interviews, I have never quite worked out whether to hold it [sight 
loss] out upfront and say, “by the way, this is this” and then you can’t ask 
any questions from an HR perspective. Or do as somebody else told me 
which is completely hide it as much as possible to the latest point in the 
interview process; by then, they have fallen in love with you before they 
have seen the issue and therefore they are sold on you, they will see it as 
less significant.’  
 (Jason, diagnosed aged 15 in 2004)  
Douglas et al. (2009) in a review of the rates of employment among working age 
people who are registered as severely sight impaired or sight impaired found that 
only 33 per cent were in employment. This figure is significantly less than those 
people without a disability, or people with other disabilities. In contrast to George, 
Ollie returned to university to study a different discipline. He was awarded a First-
Class Honours Degree, after which he passed his Professional Examinations and is 
now employed in a large city firm. The factors that influence why some participants 
might be considered to be successful in a ‘mobilisation of resources’ (Bury 1982: 
170) to overcome adversity, while others do not, will be discussed later in the 
chapter.  
Unsurprisingly, sight loss has had a significant impact on all participants, making it 
more difficult for them to function and navigate in a world that, at times, is not 
compatible with sight loss. In the following extract, Ollie echoes the sentiments of 
many of the other participants:  
‘Visual impairment affects everyone who has it incredibly―socially, in the 
ability to independently plan and travel journeys, in the ability to see 
what people are saying, lip reading, and the ability to use technology, in 
the ability to communicate and make food and dress yourself in the 
morning. It affects every single aspect of one’s life.’  
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The considerable body of literature exploring the consequences of chronic illness 
(e.g. Charmaz 1983; Bury 1988, 1991; Sanders et al. 2002; Lowton and Gabe 2003), 
highlight the impact symptoms have on routine body maintenance activities which 
can only be accomplished with the assistance of others, such as bathing or going to 
the toilet (Barnes and Mercer 2010; Thomas and Sakellariou 2018). Ollie describes 
the daily frustrations and challenges of living with sight loss: ‘being able to put a 
piece of toothpaste on your toothbrush is difficult (laughs)’. He also explains how 
difficult it is to get dressed in the morning: ‘you try and put your socks on, you put one 
down, and then you can’t find it’. After his sight loss, Ollie claims that every aspect of 
his life has been affected and that dressing and getting ready for work now takes so 
much longer than before. In their research, Hansen and Philo (2007) also allude to 
this point, suggesting that taking longer than normal to complete tasks denotes, and 
reminds them of, their bodily difference.  
Ollie also highlights another issue identified by participants: sight loss makes it 
impossible for them to read facial expressions or recognise people. Baus (1999), 
who is a visually impaired therapist working with blind organisations, highlights the 
difficulties encountered in social interactions, including not being able to make eye 
contact or observe body language. One consequence of not recognising friends or 
indeed being aware of the presence of others in a social situation is a loss of social 
skills, a recurring theme in the interviews mirroring the wider sight loss literature 
(Owsley et al. 2006; Stanford et al. 2009; Bennion et al. 2012; Ferguson and de Abreu 
2016). As Paul put it: 
‘The most frustrating thing for me was struggling to recognise my friends. 
Not only is it embarrassing, it is also isolating.’  
(Paul, diagnosed aged 17 in 2011) 
 
Goffman (1956, 1959, 1963) has written extensively about how people can 
experience embarrassment in social interactions. He suggests that embarrassment 
arises when an individual in attempting to project a single integrated self is 
thwarted when ‘somehow confronted with another self which, although valid in 
other contexts, cannot be […] sustained in harmony with the first’ (1956: 269). For 
Paul, his embarrassment is heightened because his friends had previously known 
him as fully sighted and now he is visually impaired, changing the nature of his 
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relationship with them. Similarly, Declan, who was diagnosed with LHON when he 
was 12 also talks of his former friends who now pass him in the street and do not 
acknowledge him: ‘If I am walking down the street like they think I don’t see them, but 
I do. When people walk past me that I know I think, “Why have you done that?” They 
walked past me and not said nothing’. Paul also refers to the isolation he experiences 
since his sight loss. Living an isolated existence is often linked to spending 
protracted periods of time alone within the home; it can also be experienced in 
public spaces. One of the other participants, Andy, who described himself as an 
extrovert before his sight loss, explains his frustrations when in social situations: 
‘I would always be that kind of social person so if I went into a place, I 
would always say hello to everyone I knew and be the first to see 
someone I knew at the other end of the bar. Whereas I can’t do that now 
and so some people, even now, think I am not very sociable. They sort of 
think “He’s ignoring me”, whereas I would normally be that person that 
would be out there welcoming, seeing everyone, so that is probably the 
biggest frustration.’ 
(Andy, diagnosed aged 20 in 2008) 
Jake, who was diagnosed with LHON when he was 16, became very emotional 
when he confirmed that he had not seen the faces of his wife and children: 
‘Not being able to see peoples’ faces, that’s a massive frustration. Not 
being able to read body language that’s another big one.  I have two 
young children and a wife that I have never seen their faces. Certain 
things… like I didn’t see my wife in her wedding dress. Sometimes I think 
it’s horrible really, it’s torture.’ 
Later in the interview, Jake spoke of his anxiety that his sight loss has practical 
consequences for his children:  
 ‘I take my kids out on my own but it is proper nerve-racking sometimes. 
If one of them runs off, I am screwed really. I don’t really want to grab 
other people’s kids and things like that.’ 
  (Jake, diagnosed aged 16 in 2005) 
 
In his interview, Ollie refers to his eyes as ‘the main source of knowledge acquisition 
and without your eyes; you realise everything is just so much more difficult.’  A similar 
sentiment was expressed by Tim who was diagnosed in 2013 at the age of 23: 
‘obviously, vision is... it affects everything in life. We live in a visual world, so everything 
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suddenly became a struggle’. Here, Ollie and Tim tap in to cultural representations 
that privilege sight over the other senses (De Leo et al. 1999). The Global North is 
said to be dominated by ocularcentrism (Måseide and Grøttland 2015); the loss of 
sight can cause suffering far greater than that experienced from other forms of 
sensory impairment (Abolfotouh and Telmesani 1993; De Leo et al. 1999). In their 
study of retinitis pigmentosa (a condition that, similar to LHON, currently has no 
cure)21, Hayeems et al. (2005) define suffering in the context of sight loss as:  
‘A state of distress that occurs when person’s integrity or life plan is 
threatened disrupted or burdened; it lasts until integrity is restored 
either by eliminating the threat or adjusting to it’ (2005: 615).   
 
Within the sociological literature, the theme of suffering has been extensively 
considered by Charmaz (1983). Rejecting the narrow medicalised view of chronic 
illness which focuses on suffering caused by physical pain, Charmaz turns her 
attention to the destructive effect of chronic illness on the self and, in doing so, posits 
that the self is ‘fundamentally social in nature […] developed and maintained 
through social relations’ (1983: 170). Charmaz explains that individuals possess a 
‘self-concept’ grounded in the ‘organisation of attributes that have become 
consistent over time’ (1983: 170, original emphasis). Chronic illness is problematic, 
firstly, for the organisation of the self as the images the chronically ill present to 
others may be ‘inconsistent with their core self-concepts’ (1983: 170). Secondly, the 
ill person presents self-images that may be found to be ‘wholly incompatible with 
the individual’s criteria for possessing a valued self’ (1983: 170). Charmaz described 
the process as a ‘loss of self’ defined as ‘the crumbling away of former self-images 
without simultaneous development of equally valued new ones’ (1983: 168). The 
loss of self leads individuals to ‘question their own self-worth and view their 
developing limitations as losses’ (1983: 169).   
Four themes are identified by Charmaz as contributing to a loss of self. Firstly, living 
a ‘restricted life’ (1983: 172); individuals become aware that the symptoms of their 
illness impacts on their ability to undertake activities they previously valued and 
                                                          
21 Retinitis pigmentosa (RP) is an inherited eye condition that affects the retina at the back of the eye 
and, over time, stops it from working properly. RP is characterised by a gradual but permanent loss of 
sight by affecting the peripheral and central vision. The changes in vision occur slowly over a period of 
many years. There is currently no cure for the condition (RNIB 2017). 
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enjoyed. Withdrawing from society becomes preferable to allowing people to see 
them in their altered state (see also Locock et al. 2009). Secondly, leading a 
restricted lifestyle results in ‘social isolation’ (Charmaz 1983: 176). Charmaz 
suggests that the experience of being ‘discredited, embarrassed, ignored and 
otherwise devalued […] contributes to the growing isolation of ill individuals and to 
their subsequent reappraisals of self’ (1983: 177). Thirdly, experiencing a loss of self 
may result from ‘discrediting definitions of self’ (1983: 181), including ‘those arising 
in interaction with others’ and ‘those developing out of unmet expectations of the ill 
person’ (1983: 181). Finally, ‘becoming a burden’ (1983: 188) is associated with a 
loss of self as the chronically ill become more dependent and immobile, thus leading 
to a reliance on family, friends and work colleagues.  
The themes identified by Charmaz resonate with the interviews undertaken with 
participants in this thesis. Beth, who was diagnosed aged 51, represents a 
marginalised group in the LHON clinical literature (as being both a woman and 
older); she is also typical of the older participants who have struggled to come to 
terms with their sight loss. Beth has a more restricted lifestyle, since losing her sight, 
relying on her elderly parents to help her with daily tasks. Prior to her sight loss, 
Beth described herself as very independent with a wide social circle of friends. She 
also had a very successful career travelling the world. When I interviewed Beth 14 
months after her diagnosis, she talked about her life, using the metaphor of ‘living 
in a nightmare’ and spoke of her life being snatched away:  
‘It’s been an absolute nightmare. It still is. It’s been terrible. It’s like 
somebody has come and snatched away my life and I just want my life 
back, I want my independence back. I can’t just jump in the car and go to 
the shop. I can’t work, I can’t drive, I can’t read, I can’t write, I can’t watch 
the television.’ 
(Beth, diagnosed aged 51 in 2015) 
In her interview, Beth articulates her feelings that the life she once knew is no longer 
available to her. Beth is registered as severely sight impaired and is no longer able 
to drive,22 which she associates with a loss of independence. In the Global North, 
                                                          
22 In the UK, once registered as severely sight impaired, participants are prohibited by the Driver 
Vehicle Licensing Agency (DVLA) from driving. 
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independence and self-reliance are highly valued and therefore not being able to 
fulfil a socially expected role poses a threat to the individual’s self-esteem and sense 
of self (Nettleton 2013). Charmaz uses the example of driving as indicative of leading 
an independent life: 
‘knowing that one can no longer drive or function in other ways that 
symbolised independence prompts the realisation that life is becoming 
increasingly restricted as previously taken-for-granted activities become 
precluded’ (1983: 172).  
In the wider sight loss literature (Green et al. 2002; Horowitz 2003; Khadka et al. 
2012), the ability to drive is not only associated a sense of autonomy and 
independence but is also considered to be a ‘symbol of normality’ (Green et al. 2002: 
259). No longer being able to drive is one of the most feared losses associated with 
sight loss (Horwitz 2003). Beth is wistful when she reflects on her inability to drive 
and the impact on her participation in activities previously enjoyed: 
‘I would come home from a trip; I would have a couple of days off. I used 
to be able to get in the car—I would be meeting with friends. Those days 
off were quite full.’ 
Beth describes a very active life and one that revolved around her ability to drive 
and visit her friends. This life is no longer available to her as she is now reliant on 
her friends to visit her. The emotional effect of no longer being able to drive was 
present in a number of the other interviews irrespective of age, as the following 
extract illustrates:  
‘I remember at the time [of diagnosis] asking would I be able to drive. He 
[consultant] said “no”. I was fine while I was there [eye clinic] but I 
remember in the car journey home with my Dad, I just cried my eyes out 
for 10–15 minutes with the thought of not being able to drive. It gives you 
independence. It’s quite a big thing, driving.’ 
 (Andy, diagnosed aged 20 in 2008) 
Andy explained that he lives in a small rural community where public transport is 
unreliable and he learnt to drive as soon as he was able to apply for a provisional 
licence.  Kate, who had been driving for many years before her diagnosis, referred 
to not being able to drive as a ‘cross to ‘bear’:  
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‘The only thing that gets me down sometimes is not being able to drive. It 
is a life changing disease. That’s been my biggest cross to bear really… is 
not being able to drive because I would think nothing of jumping into the 
car and driving to the shops. Now I rely on public transport; I can’t see 
signs at the railway station or I can’t see bus numbers. Life is much 
harder.’ 
(Kate, diagnosed aged 48 in 2012) 
For one of the older males, Gerry, his refusal to acknowledge his failing eyesight 
caused arguments with his wife: 
‘I do remember some nasty arguments between my wife and I because 
she was trying to do the best for me, but you don’t, as the one with the 
problem, necessarily see that what someone is trying to do is the best for 
you. You see them as interfering and manipulating and things, 
particularly when it came to the point where she thought I wasn’t safe to 
drive, whereas I thought I could still see enough to drive at that time. But 
I did follow her guidance and did stop at that point.’ 
(Gerry, diagnosed aged 62 in 2014) 
Gerry’s reluctance to give up driving epitomises his desire to ‘hold on to normality’ 
(Locock et al. 2009: 1052).  The younger participants were also reluctant to give up 
driving. One of the mothers, Catrin, confirmed that, notwithstanding his 
deteriorating eyesight, her son (aged 20 when he started experiencing problems 
with his sight) refused to stop driving.  She explained: 
‘We had to stop him driving and I think we did have a bit of unhappiness 
when he realised he couldn’t drive anymore, I think there was a bit of 
anger and frustration. He was sulking around; he lashed out a few times. 
He was stomping around slamming doors and things like that. I think he 
punched the wall and put a hole in it at one point. Boys his age… they are 
all driving: it’s not the end of the world, but it’s the end of the world as 
you know it in your eyes.’ 
The point Catrin alludes to is that, for younger people affected by LHON, holding a 
driving licence is viewed as a ‘milestone, a symbol of independence’ (Rosenblum 
2000: 434) and an indication that adulthood is approaching. George’s comments are 
typical of the younger participants: ‘when you meet a woman, you think they want 
you to drive, especially when you are younger, because it’s cool to have a car when you 
are 19 or 20’. The reluctance to give up driving was linked for many of the 
participants with a desire to not only hold on to their independence, but also linked 
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to frustration at having to use a public transport system that is not designed for the 
visually impaired. Sarah, whose son had to sell his car after his sight loss, claimed: 
‘He can’t use a bus, it’s impossible—he can’t see the bus coming, he 
doesn’t know to put his hand out and he can’t see the number on the bus. 
That’s impossible for him.’ 
Andy travels extensively on both the underground and overland trains for his job, 
and says that this is one of the main causes of frustration for him:   
‘When I am travelling on a train and they don’t announce stops and things 
like that. They do have them all but its reliant on the drivers to switch 
them on or it might get out of sync, so it might be one station wrong. In 
terms of mainline trains as well, then sometimes they may announce it 
[train], sometimes they may not. The capability is there or if you get given 
information they say, “It’s Platform X or Y, it’s just over there”. Then you 
find you’re actually on a totally different platform. It can be really 
frustrating.’ 
In an attempt to minimise the impact of sight loss on their daily lives, participants 
like the young ex-service personnel in the work of Stevelink and colleagues (2015a: 
1), who experienced sudden sight loss whilst deployed in Iraq and Afghanistan, 
adopted a variety of “coping strategies” including learning new skills (touch typing), 
goal setting (finding employment) and utilising low vision aids. Andy, referred to 
above, overcomes the problem of getting off at the wrong tube station by: ‘double 
checking or counting [the stations] in my head or I will know the surroundings and 
know the door should be on the opposite side or whatever’. Whilst participants in this 
study adopted coping strategies to help with orientation and navigation, they also 
explained that getting around on foot in a built environment that is designed for 
those who do not have a disability could be problematic and, at times, precarious, 
particularly when using pedestrian crossings or avoiding inanimate objects 
including bollards, lampposts and, on occasions, badly parked vehicles. Charmaz 
(1983: 174) suggests that the lives of the chronically ill are more restrictive than 
they need to be as the ‘world is set up for the healthy and able’. This point is also 
alluded to by Green and colleagues (2002) in their study of glaucoma, highlighting 
that we live in a ‘social environment that systematically excludes those with 
impaired vision’ (2002: 259). The exclusion of the visually impaired from public 
spaces will be discussed in more detail later in this chapter. Beth described her 
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experience of being injured when she attempted to walk to her parents’ house, 
located in the next road. She tried to avoid a car parked on the pavement:  
‘I ended up in A&E… a car was on the pavement and I moved over, and I 
went over a neighbour’s wall.  My leg was cut open to the bone. For six 
weeks I had to go to the hospital three times a week to have it dressed.  
During that time, I couldn’t even get to my Mum’s on my own. I felt like a 
prisoner in my own house. I had to rely on someone to come for me.’ 
One repercussion of her accident is that Beth no longer has the confidence to go out 
on her own. Throughout her interview, she spoke of becoming a burden on her 
elderly parents who take her shopping, to social engagements, and to medical 
appointments. Beth spoke movingly of her parents, both of whom are in poor health:   
‘My Mum and Dad ... my Dad’s coming up to 86, my Mum’s is 82 and they 
have already gone through it [LHON diagnosis] once [with brother] and, 
for it to happen a second time, it’s unthinkable really. They are absolutely 
devastated (becoming emotional), and they have to do those things for 
me.’  
Beth is conscious that her parents have become her carers. Later in the interview, 
she reflected on what would happen to her if her parents were no longer able to help 
her: 
‘I try not to think about the future because if I do, I would go under. I try 
and get through each day as best I can. I can’t think about the future 
without my Mum and Dad. I honestly don’t know how I would cope. If I 
am perfectly honest with you, I would rather go before them. I have got 
to try and get through each day at a time. Sometimes, I get up in the 
morning and I can’t wait, I am counting the hours until I go to bed again. 
If my parents weren’t here, or something happened to them, I really don’t 
know what I would do.’ 
Beth talks of counting down the hours before she can go back to bed. She also stated 
that on occasions, she will not get out of bed: 
‘Some days, I don’t want to get out of bed. Some days, I can’t see a reason 
to get out of bed. The other week, I was in bed for 24 hours and it’s not 
good.’ 
 
A similar experience of staying in bed for prolonged periods was also described by 
one of the other older female participants, Sandra, who was diagnosed with LHON 
when she was 69:   
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‘If I feel like lying in bed all day which I quite frequently do… I can’t be 
bothered to do anything because I have a feeling there is nothing to do. 
Sometimes, it can go on for days and sometimes, it’s just the odd day.’  
 (Sandra, diagnosed aged 69 in 2015) 
Beth and Sandra describe living an isolated and, at times, lonely existence, with few 
friends calling in to see them. Social isolation has been linked to undermining self-
esteem (Whitehead 2006). Sandra commented: ‘there are people who you might have 
thought would have made a little bit of an effort and popped round’. She also went on 
to comment that ‘I am not imprisoned in the house but there is the feeling that a lot of 
the time I am’. Both participants also report being prescribed medication for 
depression. This is consistent with the wider sight loss literature that confirms 
experiencing sight loss later in life can result in feelings of anxiety, depression and 
isolation (Brody et al. 2001; Wong et al. 2004; Mogk 2008; Stanford et al. 2009; 
Hersh 2015). Beth describes a lifestyle that is dominated by her sight loss. She 
recognises that it is not healthy to stay in bed all day, but she struggles to find a way 
out of the downward spiral she finds herself in; she does not contemplate her life 
improving. Beth’s comments are mirrored in Frank’s (1995: 97) ‘chaos narrative’—
individuals are unable to interpret and make sense of their illness, and so there is no 
prospect of life getting better. In contrast, research undertaken by Moore (2000) 
with older women (63 to 85 years old) diagnosed with macular degeneration,23 
found that all their participants were able to maintain a positive outlook, 
notwithstanding the knowledge that their sight would not improve. In fact, the 
participants were able to ‘move beyond the difficulties of the visual loss experience 
to create new and unique ways for approaching life’ (2000: 578). One explanation 
for the difference in attitude may be attributed to the fact that Age Related Macular 
Degeneration (AMD), similar to rheumatoid arthritis, is considered to be an older 
person’s condition and, as such, is not totally unexpected. Therefore, the women in 
Moore’s study are likely to be able to adjust more easily to their sight loss.  
When I interviewed Beth and listened to her talk about her present and future life, I 
had a sense that she is experiencing emotions more acute than biographical 
                                                          
23 The participants had experienced visual loss in the first eye between 6 months and 20 years; and 
in the second eye 6 months and 12 years). 
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disruption—for her, life has ended. In their research with patients diagnosed with 
the terminal illness motor neurone disease, Locock and colleagues (2009: 1047) 
noted that whilst biographical disruption was present in their data, another strong 
theme emerged which they refer to as ‘biographical abruption’. Biographical 
abruption signals a sudden ending, a breaking off of life; the diagnosis was viewed 
as a death sentence—life was over, and participants were denied a future. Similarly, 
Beth describes her life as ending, as the following extract demonstrates: 
‘I have thought about suicide. I wish I was dead. Some days I have thought 
about it, I really have. I have thought “What have I got to live for?” It has 
been sprung on me and it’s like my life has been taken away.  I don’t feel 
any better now really than I did last year.’ 
In their research with elderly participants (aged 60‒85 years old) diagnosed with 
Age Related Macular Degeneration (AMD), Wong et al. (2004) also report that 
suicidal thoughts were voiced by women who had lived with the condition for 
several years. In the previous chapter, I discussed how a few participants expressed 
suicidal thoughts at the onset of sight loss. However, for most participants, such 
thoughts subsided as they began adjusting to their new circumstances.   
 Beth is not typical of other participants as she continues to suffer with her sight loss. 
In her research, Charmaz suggests that, for her participants, the ‘language of 
suffering’ is the ‘language of loss’ (1983: 191). They rarely talked of their suffering 
in positive terms or of ‘gaining heightened consciousness of the world’ (1983: 191) 
as a result of their chronic illness experience. Charmaz’s participants in their 
suffering experienced ‘heightened self-concern about the person they see 
themselves becoming and about valued self-images from the past which they have 
lost, sometimes irretrievably’ (1983: 190). Beth’s social life revolved around her 
work colleagues and she is still suffering as she struggles to reconcile her former life 
as a successful career woman with her present and (potentially) future life, which 
she sees as living an isolated and dependent existence. Her sudden sight loss in 
short, has deprived her life of ‘meaning, structure and purpose’ (Clarke and James 
2003: 1390).  
Participants referred to their dependency on family support to help them with 
everyday tasks. Providing care—whether that be cooking, helping someone to dress 
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or assisting in more intimate activities such as bathing—has the potential to alter 
the nature of family relationships, introducing new forms of engagement (Warren 
and Ayton 2015; Thomas and Sakellariou 2018). Ollie, (discussed earlier) explains 
that it can be the small tasks that prove the most frustrating and difficult for the 
visually impaired to accomplish: 
‘I rely on her [wife] for a lot of things in terms of being able to wash my 
own clothes and put the dishwasher on and things like that are quite 
difficult. Cooking is very difficult; ironing is impossible. There are things 
on a day to day basis.’ 
Similarly, George (discussed earlier) refers to the ordinary, mundane tasks that he 
finds difficult to accomplish and how reliant he is on his family and friends to help 
him:  
‘Like people don’t understand every day is a challenge, making a cup of 
tea is a challenge, having a shave is a challenge, getting dressed is a 
challenge, like colour co-ordinating and things like that, like you don’t 
realise half the time how much you do rely on your family and your 
friends and things like that.’ 
One of the other participants, Laura, indicated, that she relies, at times, on her fully 
sighted daughter aged 13. Laura describes herself as having Harding’s disease 
[diagnosed with LHON and multiple sclerosis]; she is unable to walk very far and 
experiences a tingling sensation in her legs and hands. Laura is severely visually 
impaired confirming that: ‘I can see objects, but I can’t read any writing unless it is 
very large but even then, not really’.  Laura is dependent on her daughter to help her 
with daily tasks and reflected on the reversal of their roles: 
‘I was her carer and, all of a sudden now, she is my carer. If there is 
something on the floor, I can clean it. But I just get her to check it. 
Sometimes serving dinner up… that’s an everyday thing… I can’t quite see 
what I have served up, if I have served it up equally or if it’s cooked.’ 
(Laura, diagnosed aged 48 in 2012) 
Laura spoke of her feelings that she is not fulfilling the role of a good mother. She 
spoke of feeling guilty that her daughter is having to take care of her and commented 
that she tries to ensure that her daughter leads a relatively normal life. In her 
research with mothers diagnosed with HIV, Wilson (2007) also highlighted that 
many of the mothers made strenuous efforts to ensure their children enjoyed a 
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normal childhood in spite of the symptoms of their illness and the dilemmas 
encountered in attempting to achieve this aim. Laura’s brother, who is single, 
following his LHON diagnosis has become an alcoholic and has repeatedly attempted 
to take his own life. Laura expressed her concerns, that without her daughter, she 
may also have descended into alcoholism: ‘I have had some very dark days, I won’t 
deny it. I have drunk a lot of wine’. Laura was asked whether there were days when 
she didn’t want to get up: 
‘No. I did get up with a hangover and just carried on. When you have got 
a child…my brother he just goes to the pub every day, but when you have 
got a child you can’t do that. I think my saviour has been my daughter, life 
would have been very different without her.’ 
Bury (1982: 169) suggests that chronic illness brings into sharp focus the nature of 
the relationship between individuals, their families and allies ‘disrupting normal 
rules of reciprocity and mutual support. Conrad (1987: 15) also makes the point that 
families are ‘pivotal actors’ in the world of chronic illness, and whilst providing 
valuable support systems, may also feel overburdened by the demands placed upon 
them (Charmaz 1983; Strauss et al. 1984; Conrad 1987). Catrin, one of the mothers, 
explained how her son’s loss of independence has impacted on her own life. The 
family live in a remote location with sporadic public transport which means she has 
to drive him everywhere:  
‘Today I had to pick him [name of son] up from someone’s house and take 
him to work. It’s not just a quick matter of just picking him up and 
dropping him off. He wants to go to the supermarket to get some lunch 
and then that turned into another half an hour of him wandering around 
saying “I will have this, I will have that”. It’s almost as if he is back to being 
a toddler again trailing around behind me at times. I have lost a part of 
my own life really. Everything that [name] arranges has an impact on me 
because he needs to be taken to and from places.’  
Catrin feels that she has lost a part of her own life and articulates her exasperation 
that her daily routine is now organised around her son. As Friedson has pointed out, 
the ‘chronically ill person who “expects too much” or “makes too many demands” is 
likely to be rejected by others’ (Friedson 1970: 235). Catrin faces a dilemma, in that 
she does not want to see her son struggle to undertake daily tasks. However, she 
also explained she is trying to encourage her son to be more independent as she is 
concerned for his future when she and her husband are no longer there to help him:  
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‘We still get very frustrated with each other because what he thinks of me 
as being awkward, I am trying to help him, like, instead of getting up and 
getting everything for him, I will say “right, it is on the shelf to the right.” 
Because I don’t want to be jumping up every time he wants something. 
He thinks I am being awkward by not getting it for him. But there is going 
to come a point in his life when he is going to have to live alone and he 
won’t have someone there doing everything for him.’  
Later in the interview, Catrin voiced her biggest fear that her younger son would 
also lose his sight. This was echoed in the interviews of the other mothers who also 
have children who are currently asymptomatic, for example Sally, who was 
diagnosed with LHON when she was 29 years old (having previously been 
misdiagnosed), explained that her younger son was diagnosed when he was seven 
years old. The older son started experiencing symptoms when he was studying for 
his ‘A’ levels. Sally reflected that as the years passed, the family thought the older 
son would not be affected: ‘we thought we had got away with it’. This family’s 
experience highlights the extremely unpredictable inheritance of LHON and this will 
be discussed in more detail in Chapter Seven. 
Having focused on the consequences of sight loss for my participants, the next 
section considers the biographical repair work undertaken by participants and 
whether they have come to terms with and ultimately accepted their sight loss. 
Triumph over adversity: reconstructing the self  
In this section, I turn attention to the biographical repair work undertaken by 
individuals in an attempt to come to terms with their chronic illness. In mobilising 
resources (Bury 1982), including rallying support from family and allies (Corbin and 
Strauss 1985), participants strive to reconstitute the self. Bury observed that 
chronic illness necessitates a fundamental rethinking of an individual’s biography 
and self-concepts if the chronically ill are to successfully adapt to their condition. In 
his research with patients diagnosed with rheumatoid arthritis, Williams (1984) 
also illustrates how his participants attempt to repair the threat to their biography 
by reconstructing accounts of the cause of their illness and, in so doing, make sense 
of why they had developed arthritis which was experienced as a profoundly 
disruptive event in their lives.  
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Similarly, participants in this thesis searching for meaning to their diagnosis 
reflected on their previous lifestyle. Declan explained: ‘I did play rugby for a local 
team; I think it was when I was playing rugby for the school when my head was 
stamped on. They think that’s what could have triggered it because it was around 
about the same week I can remember sort of noticing things’. Other participants 
referred to the levels of their smoking and alcohol consumption (both associated 
with the onset of LHON) in an attempt to rationalise their diagnosis. 
In her early research, Charmaz (1983) suggests that no positive benefit was derived 
by her participants from their chronic illness experience.  However, in her later 
work, Charmaz (1991: 4) posits that for her participants, the loss of self is not a 
permanent state and that the chronically ill learn to ‘live with their illnesses rather 
than for them […] often, they try to keep illness at the margins of their lives and 
outside the boundaries of their self-concepts’. Charmaz also suggests that for the 
chronically ill, adapting to chronic illness shades into acceptance (1995: 657). I will 
explore how (un)successful participants have been in adapting to sight loss and 
how, in the process, they are able to reconstruct a self. 
The narratives of Beth, and to a lesser extent, Sandra, suggest that their lives 
continue to be typified by Frank’s (1995) chaos narrative—life will not get better. 
This is because their lives are dominated by overwhelming despair, making it 
impossible for them to push their sight loss to the margins of their lives. However, 
Beth and Sandra are not typical of other participants, some of whom refer to 
experiencing “good days and bad days”. This is consistent with research by Charmaz 
(1991: 51) who claims that a good day is typified by ‘minimal intrusiveness’ of the 
illness and a bad day by ‘intensive intrusiveness’. One illustration is provided by 
Jake, who was interviewed when he was 27. Having lived with LHON for 11 years, 
he sums up the feelings expressed by other participants:  
‘I have good and bad days. It’s just like you can’t let it win but, deep down, 
I can’t let on to people that I am struggling. So, with my job, I travel quite 
often. I go to [city] probably once or twice a week and, if I get lost or 
someone is funny with me or I bump into someone or they are rude to me 
or whatever or I can’t do something, that’s when it sets it off. If I have a 
crap day… and then I go to bed that night feeling crap and then I wake up 
and it’s a new day.’ 
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Jake seeks to hide a bad day—which for him is characterised by bumping into 
inanimate objects or not being able to undertake simple tasks—from his family and 
friends. For Jake, the next may be a good day. With the possible exceptions of Beth 
and Sandra other participants, such as Jake, were not able to predict in advance the 
day they would have, but instead found that their day was shaped by their social and 
environmental interactions. What is also evident is that participants on occasions 
experience days that are neither good nor bad. Tina, who was diagnosed when she 
was 30, is in full-time employment and is typical of a few of the participants in that 
she explains: ‘I sometimes have my grumpy days’. Tina claimed that a grumpy day can 
occur even when nothing out of the ordinary has happened to trigger it. This is 
consistent with research undertaken by Warren and Ayton (2018) with participants 
diagnosed with Parkinson’s disease. The authors challenge the binary approach of 
the good and bad days scenario by highlighting that their participants experienced 
“Parkies” days, which are neither good nor bad, but are characterised by ‘a sense of 
ennui, in which they feel devoid of all emotion’ (2018: 152). For participants in this 
research, the level of residual vision may have an impact on whether they 
experience a good or bad day, and how successful they are in minimising the 
intrusiveness of sight loss in their daily lives. This point is illustrated by two 
brothers, Ross and Paul, whose mother, Sally (discussed earlier), is also visually 
impaired. Ross was diagnosed with sight loss when he was seven years old but 
experienced some visual recovery when he was 14 (although he remains eligible to 
be registered as severely sight impaired).24 His brother Paul experienced sight loss 
when he was 17 years old. The brothers have very different experiences of sight loss 
as Ross considers that the level of his residual vision allows him to lead a relatively 
normal life:  
‘My sight has improved.  I can do pretty much anything I want. It is only 
in tough light conditions or some days are worse than others. I am pretty 
good. I know my brother’s is a lot worse and my Mum’s is a lot worse. 
Mine is the best sight out of the three of us. It has never really stopped 
me from doing anything like it seems to stop my brother. I can always 
find a way around things.’ 
                                                          
24 Evidence suggests that there is more likelihood of spontaneous visual recovery if the onset of LHON 
occurs at a younger age (Riordan-Eva et al. 1995).   
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(Ross, diagnosed aged 7 in 2003)  
In contrast, Paul, whose peripheral and central vision are worse than his brother’s, 
indicated that following his sight loss, he dropped out of his ‘A’ levels, returning to 
school nine months later to take his exams. He is now in the final year of university, 
but says he is struggling to cope:  
‘Every day I am having to work twice as hard as everybody else. I still 
don’t know what I am going to do next year. I just don’t know what’s 
coming next. Almost as soon as I step out of the door to when I come back 
there is something that I can’t do. I feel like I have been in limbo for the 
last five years, or however long it’s been.’ 
(Paul, diagnosed aged 17 in 2011)  
The story Paul tells is consistent with Charmaz’s (1991) description of a ‘bad day’. 
For Paul, his sight loss is highly intrusive. When I interviewed him, he was due to 
sit his finals the following year, but he cast doubt on whether he would actually 
attend the exams: ‘I don’t really care either way. I almost think there is not much 
point’. The two brothers recount very different experiences of adjusting to their 
sight loss. Whilst the level of residual vision appears to be significant, other factors 
which also seem to be relevant are the age and the level of educational attainment 
at the time sight loss is experienced. Ollie believes that his educational background 
and work ethic were instrumental in helping him resume studying after his sight 
loss: 
‘I think educational background is definitely a factor, but then you have 
to see what really feeds into higher educational achievement. So what 
feeds into higher educational achievement is a good work ethic, probably 
a supportive family, probably a family with the resources financially and 
emotionally to help you through trauma. Then if you look at the aspects 
of someone who hasn’t achieved, this is a generalisation, but these are 
factors I suspect and someone who hasn’t achieved academically, and I 
suspect they haven’t got the network to support them, they may be from 
single parent families. They may be from a lower income band.’ 
My research also suggests that the assistance of a mentor can be a highly influential 
factor. As Jason commented: ‘in your life you meet unexpected angels, people who 
come in for a moment and do something significant to steer you in the right direction. 
I am privileged enough to have met a few’. Jason explained that from the age of 12, 
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he had wanted to work in a prestigious city firm, he recounted how his father 
arranged for him to speak to someone:  
‘My Dad arranged for me to go and see somebody [senior figure in the 
firm]. He was blind since he was eight, and he said to me “In the kingdom 
of the blind, the one-eyed man is King”. What he was saying to me was 
“you are the only person that can sort yourself out”.’  
Ollie also refers to an ‘angel’ who inspired him to change his degree course. He 
explained that, initially, it was his teacher who was inspirational in getting him to 
return to university:  
‘I just turned up [at school] one day―and I said this is what happening to 
me. He said, “Everything is fine apart from your eyes, let’s start running”. 
So we used to get a pair of women’s tights, we used to tie them in a band, 
and he basically used that as a guide rope and we used to run. I think that 
teacher was very instrumental in getting me back into education.’ 
Later in the interview, Ollie explained that after he completed his degree, he spoke 
to a number of charities to help find employment:  
‘I asked them “What can I do?” “You can do some piano tuning, or you can 
do some basket weaving.” I was not really interested in that. I had to take 
matters into my own hands and the only blind person I really knew in the 
public sphere doing a good job was David Blunkett, the Home Secretary 
at the time. I wrote to him and said “Dear David, I have recently lost my 
sight as of a year ago. I would like to see how a blind person operates in 
the work place”. He was like “Of course, come in”. I went to the House of 
Commons and followed him around for two days. I was absolutely in awe 
of this blind man who could rise to the top of the country and run it.’ 
Both Ollie and Jason successfully completed their degrees and professional 
examinations and now work in the city. In striving to return to employment, find 
employment, or continue with their education, participants spoke of wanting to 
maintain a ‘sense of ordinariness’ (McLaughlin and Coleman-Fountain 2018: 68) by 
undertaking the mundane taken-for-granted tasks that they had accomplished prior 
to their sight loss. LHON ruptures everyday life and participants sought to repair the 
rupture by resuming (subject to the limitations of sight loss) their previous lives and 
regain a ‘sense of normality’ in the face of that disruption (Gregory 2005; Buse and 
Twigg 2018; Coleman-Fountain 2018). One everyday taken-for-granted task that is 
said to typify the ordinary is that of dressing. In their research, Buse and Twigg 
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(2018) explore how people diagnosed with dementia and their carers are able to 
restore continuity or ‘ontological security’ (2018: 23) by focusing on dressing 
practices. The authors suggest that dress, and dressing, can support a sense of 
‘feeling normal through the maintenance of clothing and routines which sustain 
biographical continuity at an embodied and tactile level’ (2018: 33, original 
emphasis) and, so manage the disruption caused by the condition.  
Participants talked of wanting to ensure they were dressed appropriately. Mary 
(diagnosed with LHON and MS) explained that she cannot see colours and relies on 
her daughter to arrange her wardrobe:  
‘she puts the darker things on one side of the wardrobe and the lighter 
things on the other side. I have two wardrobes, one in my bedroom with 
my winter things in and the other one is in another bedroom with my 
summer things in.’  
By asking her daughter to arrange her wardrobe, Mary maintains a level of 
independence and ‘continuity of identity and self-expression’ (Buse and Twigg 
2018: 19) as she is able to ensure that her clothes are colour co-ordinated and that 
she is wearing the appropriate clothes for the seasons. The ordering of the wardrobe 
has also been considered to be a ‘strategy for the ordering and management of our 
everyday lives’ (Woodward 2007, cited in Buse and Twigg 2018: 23). For Mary, 
dressing appropriately allows her to manage the public perception of herself and 
‘pass’ (Goffman 1968: 92) as normal. 
For a number of participants, undertaking ordinary tasks required the use of 
assistive technologies. As observed in the previous chapter, participants recounted 
how they were not able to use their mobile phones or their computers. However, 
after undertaking extensive retraining, they were able to use their devices once 
again. This is consistent with the research undertaken by McLaughlin and Coleman-
Fountain (2018) with children diagnosed with cerebral palsy. The authors described 
how a lack of dexterity made it problematic for their participants to perform daily 
activities but, after undertaking training, they were able to complete difficult tasks. 
The authors identified that the impetus to undertake training was the need to feel 
independent rather than dependent on others. This again resonates with many of 
the participants in this thesis who underwent intensive rehabilitation, so they could 
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use magnifiers to read documents and use software packages on computers which 
enabled them to resume their degree courses or return to their previous 
employment. One of the activities that personified ordinariness for participants in 
this thesis was the ability to cook. Laura, who loves to cook, is able to continue to do 
so: ‘I do have a speaking thermometer—I haven’t poisoned anyone yet’. Catrin spoke 
of her son’s culinary expertise, explaining: ‘He enjoys cooking, we did buy him a 
couple of gadgets to help him, although I might have to go and check if his chicken is 
cooked (laughing)’. For other participants, being able to undertake sporting 
activities, including joining a visually impaired running club or playing visually 
impaired football, also helped them to feel a sense of normality. 
Striving to return to normality and resume their life much as it was before sight loss 
was evident in the interviews. This parallels Charmaz’s research where she suggests 
a hierarchy of identities, including the ‘restored self’ (1987: 301), which sees 
individuals strive for a self that is the same as before, picking up their previous life 
and re-establishing a sense of themselves. Ross and Ollie may be said to typify the 
restored self. A few of the participants spoke of the activities they had undertaken 
and goals they had accomplished after sight loss, which they would not have even 
considered before. By attempting to excel and compete and take on new challenges, 
they adopt what Charmaz refers to as a ‘supernormal self’’ (Charmaz 1987: 301). 
This supernormal self is alluded to by Jason:  
‘I have flown off the Orbit [large steel sculpture] in the Olympic Park. I 
have abseiled off Battersea Power Station before they started to renovate 
it. I have cliff jumped from Victoria Falls in Zambia, horse riding in 
Antigua, skiing in Canada and France, and quad biking.’  
(Jason, diagnosed aged 15 in 2004)  
Amy spoke of her passion for driving and, with the help of a local charity, was given 
the opportunity to drive fast cars notwithstanding her sight loss: 
‘I love cars, fast cars—Ferraris, Lamborghinis. I have with a couple of 
charities got to drive a Mini Cooper around a track, which was really 
fantastic and good fun. I have done quite a bit: I have walked on a fire, I 
have done abseiling. I have done loads.’  
(Amy, diagnosed aged 18 in 2011)  
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In adopting a “supernormal identity”, Charmaz (1987:298) suggests that individuals 
avoid interactions with others who have a similar illness or disability. Sandra 
illustrates this point when recounting that she had been invited to attend a meeting 
with a sight loss charity: ‘the thought of being at a gathering of people with varying 
degrees of sight loss did not appeal to me in the slightest. I felt that I didn’t belong 
there’. Later in the interview, she explained that she avoids the use of a white cane 
because she does not want to be identified as visually impaired: ‘I would prefer not 
to use a cane. I know everyone would prefer not to, but you know what I mean. I would 
find it ...I would have to put a paper bag over my head’. For participants, not 
associating with other visually impaired individuals resonates with the wider sight 
loss literature (Southwell 2012) and appears indicative of distancing themselves 
from the visually impaired community. The use of the white cane, for several of the 
participants, was identified as a contentious issue and associated with both “felt” 
and “enacted” stigma (Scambler and Hopkins 1986: 33). This will be discussed in 
more detail later in this chapter.  
Another contentious issue that divided opinion was the concept of “acceptance”.  A 
few of the participants in this thesis have attended counselling for their sight loss, 
including the use of cognitive-behavioural therapy (CBT). When participants 
described their feelings at the onset of their sight loss (Chapter Five), they referred 
to the Kübler-Ross’s (1963) five-stage grief model (discussed in Chapter Two), 
ultimately arriving at the final end stage of “acceptance”.  Both Beth and Sandra, who 
are in their fifties and seventies, respectively, referred to their inability to “accept” 
their sight loss. Beth indicated: 
 ‘I don’t think I will ever accept it. It’s like I can dream about the past and 
about my job and I know that I will never do it again’. 
 Sandra similarly expressed the view: ‘I think the problem with acceptance is that it 
can almost mean giving up hope. I know that they are not mutually compatible, but 
they do appear to be.’  
Similarly, Ollie, who is now in his twenties, also claimed that he did not envisage a 
point in the future where he would accept his sight loss:  
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‘I don’t think I will ever accept it. I will never be able to accept on paper 
an 18-year-old person in excellent physical condition losing their sight. I 
don’t think I will be able to accept that. I have come to terms with what 
my life is now, and I will appreciate all the benefits that have derived and 
all the things that I have done. I have come to terms with that and I 
appreciate that. But emotionally, I would never want to go through that 
or ever wish that on anyone because, if someone had told me how hard it 
was to recover from sight loss, I wouldn’t have done it. Because there is 
no manual that is written on how to deal with sight loss in an 18-year-old 
person.’  
A similar view was expressed by Adam:  
‘I will never accept it [sight loss]. How can you accept having something 
you were born with taken away from you? I would say I have got on with 
it, I am getting on with it, and I am putting up with it. There is always that 
day that I hope to God that somebody says to me “we can sort your eyes 
out”. I doubt it will happen in my lifetime.’  
In contrast, Jason viewed sight loss as a life—affirming event, suggesting that he put 
more effort into his academic studies. Jason adopts a different attitude to Ollie and 
Adam when discussing acceptance: ‘I have accepted it [sight loss]. I am so grateful for 
what it [sight loss] did for me. I don’t believe that lazy kid was capable of what I have 
achieved’. Jason’s comments are consistent with Petersen’s (2006) research with 
people diagnosed with diverse genetic conditions, highlighting how his participants 
spoke of the valuable lessons they had learnt and their positive experiences since 
being diagnosed. Andy’s comments that he has not only accepted his sight loss but 
is moving on with his life: ‘I have only just over the last three years accepted it and I 
not [only] accepted it but have moved on from it’. Other participants, whilst they did 
not feel that they have reached the point of “acceptance”, did consider they had 
reached an accommodation in that they occupy the middle ground, expressing their 
gratitude for the things they experienced before sight loss, and that life could be 
much worse. Adopting this attitude is consistent with the research undertaken by 
Moore (2000: 578), whose participants talked in terms of being ‘blessed’ with some 
residual vision.  George, who after his sight loss attended a residential sight loss 
college, reflected on his experience of meeting other visually impaired students:  
‘There were young girls and boys there [college] who had been born blind 
and deaf. At least I had 16 years where I have got memories—like how do 
you explain what the sky looks like to someone who has never seen it, or 
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a star? You can give someone an object to hold and they... it’s tactile but 
how do you explain what the sea is like or grass? You can’t, or colours. So, 
I have had that, and I am quite grateful for that.’ 
Expressing a similar view to George, Amy also voiced her gratitude that her life could 
have been much worse: ‘There are other people out there worse off than me. I could 
have cancer and die. I haven’t got that, I have got my life. I am a still out there.’  These 
two accounts echo previous research on the narratives of those living with chronic 
illness (Petersen 2006). One of the older female participants, Mary, who has been 
diagnosed with LHON and multiple sclerosis (MS), has a younger sister, Sian who 
had coped with symptoms of MS for many years.  In 2015 Sian began to experience 
problems with her eyes and was subsequently diagnosed with LHON at the age of 
48. Both sisters adopt a pragmatic view of their sight loss. Mary was particularly 
stoic:  
‘Everyone says how do you cope? I just get on with it. My motto is you 
can’t do nothing about it. There is no point sitting in the corner moaning, 
as no bugger listens. You know what I mean? Everyone sitting moaning 
“look at me, look at me”. There is no good sitting in the corner saying woe 
is me. It doesn’t do anything for you, does it?’  
(Mary, diagnosed aged 31 in 1992) 
In adopting the ‘mustn’t grumble’ (Barnes and Mercer 2010: 54) approach, Mary 
presents to the outside world an account of her sight loss which, at times, is 
inconsistent with her ‘private’ thoughts (2010: 54). As the interview progressed, 
Mary began to explain a little more about her symptoms:  
‘[T]he tips of my fingers are always numb. I can’t pick anything up… my 
extremities.... It is awkward to describe the numbness because it is 
always there. My arm is always numb. I have got a heavy leg on the right 
side.’ 
Later in the interview, Mary said that her sight loss did get her down: ‘I am a bit 
pissed off […], I think why me?’ In their research with participants diagnosed with 
osteoarthritis, Sanders et al. (2002) also claim that their participants presented a 
sense of resignation about their symptoms. However, participants also conceded 
that the consequences of their illness had a major impact on the way they lived their 
daily lives. Mary explained that, at times, her inability to do things for herself 
intrudes into her day: ‘I can’t drive; now I have to wait for someone to take me 
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shopping. I was going shopping for an outfit for a wedding: my daughter had to come 
with me. She had to go on the floor to put my foot into the shoe. I couldn’t feel where 
the shoe was.’ Before her sight loss, Mary was the ‘one taking care’ of her family, 
doing the shopping, cooking and cleaning, which typifies the traditional gendered 
roles within the family.  However, her husband now has to perform the household 
tasks which has disrupted both of their lives.  
I have discussed the longer-term consequences of living with sight loss experienced 
by participants. I have also described how the support of family, allies and mentors 
together, with use of assistive technologies helps participants in undertaking 
ordinary mundane everyday tasks. In accomplishing such tasks, the ordinary 
participants move towards reconstituting the self and regaining a sense of 
normality. In the next section, I will consider notions of stigma and disability within 
the context of sight loss. 
Sight loss, disability and stigma  
In the final part of this chapter, I consider conceptualisations of disability and stigma 
within the context of living with sight loss. Some of the participants claimed that 
they had experienced stigmatising attitudes since the loss of their sight. This was 
particularly evident when they were using the white cane—a powerful symbol of 
disability (Southwell 2010). I begin the discussion by considering the relationship 
between impairment and disability which remains contentious within the disability 
literature, with debates focusing on the dichotomy between the medical and social 
models of disability (Barnes 1990; Oliver 1990). Criticised for predominantly 
adopting the medical model (Oliver 1990; Pfeiffer 1998, 2000; Bickenbach et al. 
1999), the WHO (1980) International Classification of Impairments, Disability and 
Handicaps (ICIDH) defines impairment as ‘any loss or abnormality of psychological, 
physiological, or anatomical structure or function (Pfeiffer 1998: 504). Disability is 
defined as ‘any restriction or lack (resulting from an impairment) of ability to 
perform an activity in a manner or within the range considered normal for a human 
being (Pfeiffer 1998: 504). A handicap is defined as ‘a disadvantage for a given 
individual, resulting from an impairment or a disability, that limits or prevents the 
fulfilment of a role that is normal (depending on age, sex, and social and cultural 
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factors) (Pfeiffer 1998: 504). Hansen and Philo argue that the medical model of 
disability invites a ‘personal narrative of “tragedy” followed by “heroic” efforts at 
self-adjustment’ (2007: 494). Many participants in my study expressed their 
irritation when others treat them in such a way (see below). Within the context of 
the ICIDH, LHON is a condition that causes impairment (deterioration of the retinal 
ganglion cells), resulting in disability (severely sight impaired) and handicap 
(restrictions in full participation in social roles).  
Bury (2000: 1073), who was one of the three original authors of the ICIDH, asserts 
that the classification was an attempt to move away from a ‘narrow medical model 
of health and disease—one primarily concerned with body systems and 
aetiologies—to one which recognised the consequence (original emphasis) of 
health-related phenomena’. Amid criticisms of the ICIDH, including a suggestion that 
it advocates eugenics and euthanasia (Pfeiffer 1998), Bury contends that the ICIDH 
has made a ‘positive difference’ (2000: 1073) to people living with a disability. 
Notwithstanding his assertion, the ICIDH was subsequently revised and replaced by 
the ICIDH-2, The International Classification of Functioning, Disability and Health 
(WHO 2000). Although again not without its critics (Pfeiffer 2000; Imrie 2004), the 
rationale of the ICIDH-2 moves away from disability as a consequence of disease 
towards the social model, which distinguishes disability and impairment, 
acknowledging that ‘disability is located within oppressive and excluding 
environments’ (Ryan 2005: 292) or, as Oliver (1996: 35) has pointed out, ‘disability 
has nothing to do with the body but everything to do with society’.  
The extent to which the ICIDH-2 has integrated a social model of disability remains 
contentious, as critics suggest that the model medicalises disability and, so, allows 
medical professionals to make judgements on the quality of life of individuals with 
a disability who, apart from their disability, may be otherwise healthy (Pfeiffer 
2000; Green et al. 2002). This is particularly pertinent for LHON where many 
affected individuals are young, fit and healthy at the time of their diagnosis, and 
remain so after their sight loss. The disability movement have been instrumental in 
moving debates away from focusing on the medical model of disability towards an 
examination of a society that promotes disabling attitudes through social structures 
including cultural frameworks which privilege able-bodied normality. In her book 
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Songs at Twilight (2011), Susan Dale, a visually impaired sight loss counsellor, 
suggests:  
‘The attitudes society has towards blindness are socially constructed, 
thus within a world where the majority are sighted social interactions 
have developed to consider vision as “normal” and those of us who have 
different vision as “abnormal”’ (2011: 1).  
If Dale’s assertion is correct that people living with a disability are perceived as 
abnormal, and people who do not have a disability are normal, we can ask what does 
it mean to be ‘normal’? Who, or what, determines the parameters of normalcy? Davis 
(1995: 23) suggests that we live in a world of norms where we strive to be normal 
or, indeed, try to avoid being placed in the normal category. He further suggests that 
to understand disability, it is necessary to return to the concept of the ‘the norm, the 
normal body’. By focusing not on the construction of disability, but instead on the 
construction of normalcy, Davis argues that the ‘“problem” is not the person with 
disabilities; the problem is the way that normalcy is constructed to create the 
“problem” of the disabled person’ (1995: 24).  
Many participants in this thesis did not consider themselves to have a disability. 
Adam’s view is typical of other participants when he says: ‘I think of myself as 
completely normal apart from the fact I can’t see very well’.  Barnes and Mercer (2010: 
49) suggest that individuals who acquire a stigmatised condition in adulthood (as 
opposed to congenital impairment) are likely to be more resistant to identifying as 
a person with a disability because of ‘their prior assimilation of a personal tragedy 
perspective on impairment and disability’. Adam later explained that: ‘for a long time 
I was, like, I am not going to go out with a blind woman, never going to do that, it’s not 
going to happen. I am not going to have any blind friends, I am normal’. Although 
participants did not consider they had a disability, a recurring theme in the 
interviews was a desire, like Adam, to be perceived as normal. This was apparent in 
the interview with Declan, aged 22. During my interview with Declan, he 
unexpectedly jumped out of his chair and, standing in front of me, asked ‘Do I look 
right? Am I looking right? [pointing at his clothes.] Was I walking alright? [coming 
from the clinic waiting area.] Do I look normal to you?’ For Declan, the way in which 
he walks and being dressed appropriately is crucial in managing the ‘public 
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presentation’ (Entwistle 2000: 11) of himself as someone who is ‘normal’ resonating 
with the work of Buse and Twigg (2018) who highlight the importance of dress in 
managing the visibility of disability in the public realm.  
Declan raised the issue of ‘looking normal’ when we were discussing an unrelated 
topic. I asked Declan what had prompted his questions, to which he replied ‘I just 
want to be normal really. I just want to feel normal because I am still so young. I just 
know that I am not like everyone else’.  Davis (1995: 24) suggests that people have an 
‘inherent desire’ to compare themselves to others. In Declan’s case, he expressed 
feelings of inadequacy because he believed that when he compared himself to 
others, he did not meet their expectations.  Declan’s sight loss has had an impact on 
his sense of self as he considers that, notwithstanding his attempts to be perceived 
as normal, he does not actually believe that he is normal. As the interview 
progressed, it became much clearer why Declan felt he was not perceived as normal. 
He explained that after his sight loss, he initially stayed in mainstream education 
but, during this time, he was bullied by other children in the class: ‘they called me 
blind this and blind that. You can’t see this, and you can’t see that. I had a teaching 
assistant and they all said I was thick’. Declan’s comments are consistent with 
McLaughlin and Coleman-Fountain’s (2018: 68) research with children with 
cerebral palsy who, having been subjected to name calling, being the subject of jokes 
and physical bullying, realised at a young age that ‘others did not treat them as 
belonging in their social worlds’. Declan was later placed in a unit within the school 
with other children who had severe learning disabilities. He described how his 
teachers had low expectations of what he as a visually impaired student, could 
achieve:  
‘I noticed how they treated people with a VI, they were treating them as 
if they were babies. As if you had something…they would treat them like, 
I don’t like to say it, but like people treat Down syndrome people and 
people like that. Obviously, you can tell by me, the way I am speaking to 
you that I am not really slow […], they would drag you around by your 
arm, and if I wouldn’t go, like, they would grab me. They would try and 
guide me as well; I don’t need it. I was trying to be as normal as possible.’ 
(Declan, diagnosed aged 12 in 2006)  
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In his study of blindness in America, Scott (1969) identified that children and young 
people who attend specialised rehabilitation units are taught to adopt the 
stereotypical ‘blind’ role in everyday social interactions. This is not only contrary to 
the attitude and behaviour of the wider visually impaired community, but it also 
renders the severely sight impaired ‘seriously maladjusted to the outside world’ 
(1969: 199). Declan’s residual peripheral vision negates the use of a white cane. He 
felt it was unnecessary for the teachers to try to guide him, not only because he 
perceived this as a threat to his mobility and his independence, but also because it 
hindered his attempts to be considered normal. Two of the other participants in this 
study, Ollie and Jason, were particularly vociferous in sharing Declan’s view that the 
visually impaired can be held back by low expectation of their ability. Both 
participants considered that the visually impaired do not always reach their full 
potential because of society’s deeply embedded discriminatory beliefs. As Ollie 
explained:  
‘I think the greatest hindrance to a lot of VI people now is that they are 
really held back by the beliefs and the intrinsic and deep embedded 
discriminatory views that some people have. I am not really one to go and 
beat the left-wing disability drum which is disability rights. Of course, it’s 
incredibly important and we are not going to move on without that, but I 
also take the view that no one should view me any differently. I should be 
doing all the work that all the other employees do here, and I will tell 
someone if I can’t.’  
Jason also expressed his frustration that the expectations placed on the disabled are 
low:  
‘The thing I hate seeing is the carers, parents, do-gooders, and well-
wishers who restrict you because their expectations are defined by 
what’s in the ignorant social understanding of what it means to be VI. In 
other words, you don’t know anybody who is blind, you have no 
experience other than seeing somebody on the street with a dog or a cane, 
and your concept of blind is black, no vision whatsoever, can’t make a cup 
of tea without needing help and therefore how can they possibly have a 
career. So, if your expectations are down there, then this person you are 
their moral support and then their emotional net to catch them if that’s 
your expectations of them, that they won’t do much; you have written 
then off and I think out of the restrictions on us, the expectations are so 
light and that can ripple into the expectations of yourself.’  
The point made by Jason, that the visually impaired may have low expectations of 
their own ability has also been observed by Goffman, (1968: 18) who suggests that 
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stigmatised individuals are acutely aware of what others see as their failings and, on 
occasions, acknowledge (albeit briefly) that they do ‘indeed fall short of what they 
really ought to be’. A similar point is made by Scott (1969), who considers that the 
visually impaired are acutely aware that they possess a spoiling attribute, which 
comes to the fore when in the company of the sighted: 
 ‘The stigma of blindness makes problematic the integrity of the blind as 
acceptable human beings because those who see impute inferiority, the 
blind man [woman] cannot ignore this and is forced defend him [her] self. 
If as sometimes occurs, the blind man [woman] shares the values of the 
sighted, the process becomes even more insidious […] a man’s [woman’s] 
personal identity is under attack from within as well as from without’ 
(1969: 25).  
Here Scott is referring to the process of self-stigma which operates at an individual 
(micro) level and witnesses the stigmatised discredit themselves (Goffman 1968) by 
adopting society’s attitudes to disability, resulting in feelings of self-hatred and 
shame (Link et al. 2001) and having a negative impact on self-esteem (Green 2009). 
Goffman (1968: 11) posits that stigma sets people apart from “normals”; they are 
considered to be socially inferior, rejected as ‘a blemished person, ritually polluted 
to be avoided especially in public places’.  
Stigmatising attitudes of the sighted towards participants whilst using public spaces 
has, on occasions, proved problematic. A number of the participants referred to 
being subjected to comments made by complete strangers who cast them in the role 
of the tragic figure to be pitied and feared (McLaughlin and Coleman-Fountain 
2018). Garland-Thomas (2009: 19), suggests that in ‘[A]vowing disability as tragic 
and shameful’, we have concealed those living with a disability in secure institutions, 
special schools and hospitals. So, when we happen to gaze upon the sight of 
disability, ‘we stare in fascinated disbelief’ (2009: 20). A similar point is made by 
Carnevale (2007) who observes that, in public spaces, the stigmatised have their 
privacy invaded as they are stared at or randomly approached by strangers and, as 
a consequence, the stigmatised are not ‘afforded the social respect that is normally 
accorded to others’ (Carnevale 2007: 10).  Fourie (2007) also makes the point that 
people who have not been exposed to sight loss are embarrassed and not equipped 
to interact with visually impaired people.  
156 
 
All participants described unwanted public attention as irritating, annoying or 
patronising. Adam says: ‘Some people do have that automatic response of “how do you 
cope? How do you do this? How do you do that? You are disabled”. I know I am disabled, 
it doesn’t mean I am an idiot.’ Jake also voices his frustration at somehow being 
perceived as less able because of his sight loss:   
‘Personally, this really winds me up and I would say I probably get this 
once a week so it’s “How do you cope?”, “It’s amazing how you deal with 
this” or “I can’t believe how you do everything”, when really I am just 
getting on with things. It’s just normal really.’  
In his research with participants living with disability, Watson (2002) observes that 
a number of his participants described themselves as normal and refuted 
suggestions that their disability affected their view of themselves. For his 
participants, living with impairment was a fact of life and not considered to be 
important for their sense of self. This echoes Jake’s view of himself as he feels 
normal, considers himself to be normal, and wants to be thought of as just a ‘normal 
lad’ (McLaughlin and Coleman-Fountain 2018: 71) undertaking normal activities —
the same as everyone else. Watson makes the point that for his participants, it is not 
their disability that stops them from undertaking activities, but the presence of 
‘societal and environmental barriers’ (2002: 515). This resonates with the views 
expressed by participants with LHON who also referred to their experiences of being 
stigmatised and marginalised through the social organisation of public spaces 
which, at times, make it impossible to undertake normal everyday activities. As 
Schillmeier (2007a: 195) notes, it is these ordinary acts of everyday life that ‘make 
up the complex and contingent scenarios of disability that create enabling and 
disabling’ practices. The disability studies literature has also highlighted that 
disability is not a result of individual impairment, but the product of social 
structures and processes that are potentially disabling (Shakespeare and Watson 
1997; Barnes, Mercer and Shakespeare 1999; Green et al. 2002). This view is echoed 
by a few of the participants, including Ginny who strongly refutes the suggestion 
that she has a disability: ‘I am disabled by the way the world works sometimes, but I 
am not as a person. It is just my eyes don’t work too well.  Ginny claims that within her 
home, where she knows where everything is, she is completely independent. 
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However, it is in public spaces that she encounters problems. Imrie (2001: 232) has 
suggested that:  
‘For the disabled people, the physical construction of urban space often 
(re)produces distinctive specialities of demarcation and exclusion, from 
the lack of access to public transport systems to the absence of visual 
clues or guides in towns to enable the vision-impaired people to move 
with ease.’  
The impact of the lack of visual clues referred to by Imrie is demonstrated by Stuart 
who was diagnosed with LHON when he was 23 in 2013. He explains the problems 
he encounters when visiting somewhere new: ‘if I am in a new place or go to a new 
bar and try to find the toilets, I ask someone at the bar and they say they are over 
there… the problem is getting the right toilet; I have frequently gone to the wrong 
toilets’. Toilets are places that are usually identified by a symbol (male or female) on 
the door, but for the visually impaired, this is meaningless. Stuart explained that it 
is embarrassing as he only becomes aware of his mistake when the female occupants 
shout at him to leave. For Stuart and the other male participants in particular, once 
inside the toilet, they are faced with numerous challenges. For example, the location 
of urinal or cubical, washbasins, and hand dryers. There is a small body of 
sociological literature that has explored public toilets as places of exclusion for those 
living with a disability (Molotch 2010; Slater et al. 2017), with Molotch suggesting 
that toilets become a ‘zone of exclusion’ (2010: 16). Whilst disabled women may be 
more inclined to ask for help, men confronted with the gendered role of being strong 
and independent are less inclined to ask for information and help.  
One of the other participants, Tim, explained the problems he encountered the first 
time he attempted to use a cash machine after his sight loss:  
‘Accessing my own money is quite a big thing for me because I have been 
independent with money since I was probably about 10 and that was always 
a sense of independence. You know, how to control your money, how to have 
access to your money and not to have to rely on somebody else to put the PIN 
in and press the button. I just remember thinking “How am I ever going to be 
able to do anything of any use to anyone when I can’t even get a tenner out 
of the cash machine?”’  
In his research exploring how the visually impaired use money, Schillmeier (2007a, 
2007b) suggests that disability is the effect of complex sets of diverse social relations 
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that link bodies, material objects and technologies. He goes on to demonstrate that 
money—and indeed accessing money (via ATMs)—plays a pivotal role in being able 
to participate in daily life and how money technologies make up (dis)abling 
practices for the visually impaired.  For Tim, accessing his own money is associated 
with leading an independent life. Schillmeier makes the point that cash machines 
are ‘standardised materialities and technologies’ (2007a: 197) which for people, like 
Tim are highly problematic to access and use properly in everyday life. The effect of 
not being able to use money and money technologies, Schillmeier suggests, is that 
the visually impaired are ‘disabled’ in their social interactions, making them 
‘vulnerable, restricted in their mobility and dependent on others’ (2007a:197).  
Earlier, I referred to the use of assistive technologies and how they help participants 
regain a sense of normality by allowing them to undertake ordinary tasks. The use 
of one piece of equipment—the white cane—has proved to be a contentious issue 
for participants and will now be discussed in more detail.  
The white cane: a symbol of stigma 
  
In Chapter Two, I reviewed the stigma literature (Goffman 1968; Scambler and 
Hopkins 1986; Link and Phelan 1999, 2001; Scambler 2006, 2009, 2018;) before 
discussing the complex interconnections between sight loss and stigma. The 
majority of the participants in this study reported experiencing a degree of 
stigmatisation, both enacted (overtly discriminatory attitudes and behaviour used 
towards them) and felt (fear of shame and the fear of being confronted with enacted 
stigma) following their sight loss. Stigmatising attitudes were particularly evident 
when participants used a white cane. Notwithstanding advances in technology, the 
white cane remains the most popular low vision aid (Hersh 2015). It performs a dual 
function in that it aids mobility in helping people to avoid obstacles, and it is also a 
familiar symbolic indicator that the individual is visually impaired and may need 
assistance (Hersh 2015). Southwell (2012: 108) suggests that visually impaired 
people are reluctant to use the white cane because there is a ‘deep-rooted need to 
appear “normal”’, with Fourie (2007: 225) explaining that, for him, using the white 
cane represented a symbolic ‘throwing in the towel’, signalling a loss of ‘normality’, 
not just for him but to all of those in his world.  Avoiding the use of the white cane 
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allows individuals to participate in what Goffman (1968: 92) refers to as ‘passing’; 
presenting to others as not having a disability and, thus avoiding being stigmatised.  
Evident from the participant interviews is the divergence of opinion surrounding 
the use of the white cane. Some participants are reluctant to use it for fear of being 
perceived as vulnerable and stigmatised, and not being accepted as one of the 
“normals”. Tim’s view sums up the feelings of many participants:  
‘I carry a cane everywhere I go, but I choose not to use it all of the time. I 
am lucky to have the choice because that means people aren’t judging me 
before they get to know me. Whether you like it or not, if someone is 
walking along with a guide dog or cane, people automatically make 
assumptions about that person before they have even spoken to them. I 
am able to disclose my disability in certain situations and tell the person 
what I want them to know about it rather than them forming their own 
opinion.  
However, other participants such as Jason, have embraced its use as a means to 
achieving a more independent lifestyle: 
 ‘The stats around the percentage of blind people that will embrace the 
stick are so low. I find it liberating, it’s sort of a visual cue to sighted 
people who don’t have any training or knowledge or experience of the VI 
community that this person does have a visual impairment and might 
need help.’ 
Ginny, mirroring the wider sight loss literature (Hayeems et al. 2005), also explained 
that learning to use the white cane provided her with a level of independence.  Ginny 
also uses the cane as a ‘stigma symbol’ (Goffman 1968: 124), alerting others to her 
visual impairment and signifying that she may need assistance: 
‘I am so pleased that I learnt to use the cane, it is a great symbol. It 
explains to someone that I am partially sighted. If you have got the cane 
as a prop, they are more likely to help’ 
I interviewed Ginny at the Royal Albion Hospital; it was the first time she had 
travelled by train on her own. When we met, she was enormously proud of her 
achievement of arriving at the hospital on time and, as she put it, ‘in one piece’. Ginny 
explained that, had she not been using the white cane, she doubted whether she 
would have had the confidence to attempt the journey on her own. For her, the white 
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cane has made a positive contribution to her mobility and independence. Similarly, 
Ollie has also embraced the use of the white cane:  
‘What a cane does is symbolise the fact that you can’t see very well. It’s 
not so much a navigation device as a symbolic aid for people to see what 
you are and that is very useful. The cane is a good piece of technology, it 
has been used for 250 years now, it clearly works, and it clearly 
symbolises that you can’t see very well so you may need some assistance.’ 
The comments made by Jason, Ginny and Ollie demonstrate that, for them, using the 
white cane alerts others to the fact that they are visually impaired and, as such, may 
need assistance. However, not all the participants reported receiving positive 
responses from the use of the white cane. This is consistent with research 
undertaken by Ryan (2005: 298) with mothers of children with learning 
impairments. The research highlights how, in order to overcome negative attitudes, 
the mothers provide an account to others of their child’s impairment or give advance 
warning by the use of a ‘stigma symbol’, in this case, the use of ‘major buggies’ [large 
pushchairs]. As a result of these strategies, just under half of the mothers reported 
receiving positive responses to their accounts or explanations of their child’s 
learning impairment. Although there were positive accounts of using the white cane, 
the majority of my participants spoke of their reluctance to use the white cane 
because they had previously been subjected to unwanted attention in public spaces; 
this mirrors the experiences of participants in the research of Stevelink et al. (2015), 
who were subjected to verbal and physical abuse. Amy is a reluctant white cane user, 
as she explained: ‘people jump over mine like a skipping rope, they think I am a slow 
coach, they are like “move out of the way”.  Someone actually stepped on mine and bent 
it’. Adam gave up using the cane after initially using it:  
‘I think if you do use a stick, people think you are blinder than you are or 
even more disabled than what you are. I used the cane for a couple of 
weeks when I went to college. They all jumped round the cane. They were 
literally doing high jumps over it. I thought “stuff this”.’ 
By using the white cane, the visually impaired become what Goffman (1968: 14) 
refers to as ‘discredited’ (their sight loss is known about, or ‘evident on the spot’). 
Some participants believed that the use of the white cane marked them out as 
vulnerable or as less able than those who are fully sighted.  Jason explained that he 
161 
 
carries a white cane when using public transport and on those occasions strangers 
approach him: ‘some people will come up to you on the tube and say, “Do you need 
help?” mouthing it loudly and slowly, thinking “are you deaf”? Or am I foreign and thick 
(laughs)’. Adam also explained that he has been spoken to as if he has a hearing 
problem: ‘the odd person who has talked to me like I am deaf, or has talked down to 
me, I have said “No, no, you don’t do that anymore”’. Drawing upon the work of 
Gowman (1957), Goffman, refers to this attitude as a “gestalt of disability”, 
commenting that the blind are ‘frequently shouted at as if they are deaf’ (1968: 16).  
Although Ollie uses the white cane and extolled its virtues, later in his interview, he 
also conceded that his work colleagues are guilty of enacted stigma:  
‘I think that people think when you lose your sight and you carry a cane 
there is a clear deficiency in IQ, so they correlate your sight loss to not 
having any brains. Still today, people will come up to me and to my 
secretary and say, “Does Ollie want XYZ?” I will be like, “I am stood right 
behind her, you can address me”, but people will always think that you 
are inferior due to the fact you can’t see very well.’ 
For a few of the younger participants, the decision not use a white cane is associated 
with being conscious about their appearance. Catrin explained why her son refuses 
to use a white cane when potentially he should:  
‘Image. He is a 23. I suppose it is the image that people see of him. He 
doesn’t want to be known as blind because of the stigma I suppose. 
People with a disability are seen as not as able.’  
The desire to pass as normal raises conflict between the need to use a white cane for 
safety and the associated social stigma (Southwell 2012), resulting in shame (Fourie 
2007).  Jake is reluctant to use a white cane: ‘I don’t use a cane; it’s a personal choice 
really. I should potentially in some areas use one’. Later in his interview, he disclosed 
that he had been involved in a road traffic accident: 
‘I got run over. I was two paces behind my friend. Because I was taking 
too long, she [driver] tried to swerve round me. I didn’t see her coming 
and she clipped me and ran over my leg.’  
 
Jake’s experience is typical of other participants who valued being able to present to 
others as normal and avoid stigmatisation, (Green et al. 2002). However, in his 
desire to be perceived as sighted, Jake is unable to meet routine expectations of 
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ability (Green et al. 2003) and his refusal to use a white cane had serious 
repercussions for his personal safety.  Two participants, Laura and Jason, explained 
that they, on occasions, did not use a white cane because they were concerned their 
children, as opposed to themselves, would be stigmatised. This is described as 
courtesy or associated stigma (public disapproval as a consequence of associating 
with a stigmatised individual or group) (Goffman 1968: 43). Laura explained: ‘I think 
when they [children] go to High School, other kids can be very cruel, so I don’t use it 
[white cane] in my hometown’. Jason, who earlier described the cane as “liberating”, 
later in his interviewed conceded that he avoids using a cane when trying to protect 
his children: 
‘My biggest reason really is how people perceive me in terms of that 
vulnerability and also when I pick up my children from school. I don’t 
want them—and this is really sad when you quote this as an example—I 
don’t want my children to be picked on at school because their dad has 
got a disability or is blind. That sounds terrible when I say it but it’s the 
truth really. Children will pick up on anything.’ 
Southwell (2012) suggests that to overcome stigmatisation, there is a need to 
promote positive visually impaired role models and undertake a programme of 
public education. Jake, also referred to the lacuna in public understanding of sight 
loss:   
‘I don’t think there is enough education about different forms of 
disability. It is interesting now. So, my children are at nursery and they 
learn quite a lot around hearing impairment and sign language and 
things like that, but there is very little done around other disabilities 
really to make it normal. In school, I never learnt anything about 
disability. It should be part of science and biology.’   
One other problem identified by participants who did not use the cane was being 
challenged about their sight loss. LHON presents as a ‘paradoxical’ (Fourie 2007: 
222) eye condition as, in contrast to other eye conditions, the eyes look normal, and, 
although some individuals may be registered as severely sight impaired, the level of 
their residual peripheral vision allows them to navigate in public spaces without the 
assistance of a white cane or guide dog. In Goffman’s (1968) terms, they are 
‘discreditable’ (their sight loss is not known about). There is a misconception that 
sight loss means living in a world that is black with no light perception. Schillmeier 
(2008) suggests that when sight impaired people tell others that they have some 
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residual vision, these claims are dismissed as from the sighted perspective, they look 
‘blind’ to them, and categorise them accordingly. In contrast, participants who 
retained a good level of residual peripheral vision indicated that they are often 
challenged by others who do not believe they are visually impaired because they 
look normal. After losing his sight, David attended a college for the visually impaired 
to which he attributes his determination to be as independent as possible. He also 
explains: ‘I still have got quite a bit of peripheral vision, so I can still see quite a bit’. 
He went on to claim that: 
‘People have accused me of lying about my sight quite a few times 
because I am quite independent, and my eyes look normal and you know 
they see me about town avoiding bollards and avoiding bumping into 
people and things like that. I can fully understand why they accuse me 
because I didn’t understand sight loss until it happened to me.’ 
 (David, diagnosed in 2011 aged 24) 
As has been demonstrated by the narratives of participants in this thesis, the white 
cane continues to be a contentious issue. Whilst it has the advantage of aiding 
mobility and alerting others that the owner may need assistance, it also symbolises 
difference and thwarts attempts by those who wish to be perceived as ‘normal’. 
Summary  
In this chapter, I uncover the longer-term consequences of living with sudden sight 
loss. In observing the minutiae of everyday mundane micro encounters, including 
maintaining social relationships, continuing to undertake education and 
employment, I have highlighted the unique and   diverse experiences of participants. 
For a few participants, like Beth and Sandra, they have not adjusted to their sight 
loss and continue to experience anxiety, depression, and, on occasions, suicidal 
thoughts. However, the majority of the participants, consistent with Charmaz’s 
(1991) research, experience good and bad days and have been able to continue with 
their lives—regaining a sense of normality (Davis 1995). Some participants, in 
reconstructing their former lives, have adopted a ‘supernormal identity’ (Charmaz 
1987: 296) by undertaking high-risk activities, successfully returning to their 
studies, obtaining First Class Honours degrees, and securing senior management 
roles within their organisations.  
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However, I also acknowledge that some participants experience feelings of stigma, 
which is particularly evident when using the white cane. Nonetheless, other 
participants (including Ollie and Ginny) viewed its use as a valuable tool—a symbol 
of their sight loss, inviting others to help when assistance is required. Whilst others 
refused to consider using the white cane, either because they had direct experienced 
of ‘enacted stigma’ or ‘felt stigma’ (Scambler and Hopkins 1986: 33). On occasions, 
their refusal to use the white cane impacted on their safety, particularly when 
crossing busy roads. 
In conclusion, this chapter in focusing on participants lived experience of LHON, has 
tapped into the wider debates surrounding the medical and social models of 
disability and how the fear of stigma shapes their social interactions. It has also 
highlighted how participants strive to regain a sense of normalcy and, in so doing, 
live an ordinary life.  
In the following chapter, I consider participants anticipated futures by exploring 
narratives of hope within the context of the development of new treatments to 
restore sight or avoid the birth of children with LHON.  
 
 
 
 
 
 
 
 
 
 
 
165 
 
Chapter Seven: Finding a Cure: Narratives of Hope and 
Reproductive Responsibility 
 
Introduction 
 
In the previous chapter, I considered the longer-term consequences of living with 
Leber hereditary optic neuropathy (LHON). It was evident from the discussion that 
a small number of participants claimed to have accepted their sight loss and were 
not interested in finding a cure, in contrast to the majority of participants who spoke 
of their hope that new treatments would become available to restore their sight and 
return them to what they perceived as a ‘normal’ life. There are currently two 
clinical trials being undertaken in the UK (the GenSight Gene Therapy clinical trial25 
and the Santhera Pharmaceuticals LEROS Idebenone clinical trial),26 which are 
testing the effectiveness of treatments that potentially stabilise, and/or restore sight 
following, the onset of LHON. At the time of data collection, none of the participants 
had been enrolled into the GenSight clinical trial. However, a few were involved in 
the Santhera LEROS Idebenone clinical trial (hereafter referred to as the LEROS 
trial).  
Drawing predominantly on interview data and some observational data, I locate my 
claims within the sociology of hope (Petersen and Wilkinson 2014; Brown et al. 
2015; Petersen 2015). Within the field of health and healthcare, there is a 
considerable body of literature that has considered the concept of hope (Bernard 
1995; Simpson 2004; Wiles et al. 2008; Petersen 2015). Hope is said to have a 
powerful therapeutic effect, which is thought to be an important factor in shaping 
people’s experience of illness (Simpson 2004; Petersen 2015). Where there is no 
prospect of recovery, Petersen (2015) suggests that hope provides the ability to 
cope with suffering and the apparent hopelessness of the situation.  
                                                          
25 The GenSight (GS010 AAV2) Gene Therapy Trial is designed to evaluate the efficacy of using a 
Single Intravitreal Injection for participants who have been affected by the m.11778G>A LHON 
mutation for six months or less.  
26 The Santhera Idebenone trial is a Phase 4 trial evaluating the efficacy and safety of the long-term 
use of the drug Idebenone for participants affected for ≤5 years with the three primary LHON 
mutations. 
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The chapter will be presented in two sections. In the first, I introduce the concept of 
hope and explore how participants who are enrolled in the LEROS trial construct 
and negotiate hope to imagine their future biographies. Petersen (2015: 1) observes 
that the concept of hope ‘saturates both popular and political discourse and is seen 
to have some essential quality needed to unite communities and achieve change’. 
Within the LHON community, narratives of hope surrounding the potential benefits 
of Idebenone have been the subject of a sustained campaign by Santhera to have the 
drug routinely prescribed by ophthalmologist working in the NHS. By participating 
in what Novas (2006: 289) refers to as the ‘political economy of hope’, Santhera has 
been instrumental in mobilising stakeholders including research funders, research 
institutions, clinicians and patient advocacy organisations to move forward an 
agenda to establish research centres in the UK and encourage patients to participate 
in the LEROS trial. I consider how the ‘hype’ (Brown 2003: 3) surrounding the 
effectiveness of Idebenone has influenced participants’ actions and raised an 
expectation that Idebenone will restore their sight.  
The second section of this chapter explores narratives of hope associated with the 
use of mitochondrial replacement techniques (MRTs) to avoid the birth of a child 
with LHON, with the introduction of MRTs raising the expectation that women will 
be able to give birth to a healthy, genetically-related child. I will consider 
participants’ experiential knowledge of living with LHON and how their 
understanding of complex genetic inheritance shapes their decision-making when 
considering their reproductive options. The use of new genetic reproductive 
technologies, such as MRTs, is controversial as they are said to devalue the lives of 
those living with a disability (Shakespeare 1998, 1999, 2011; Edwards 2004; 
Boardman 2014). The extent to which women who are affected or are carriers of 
LHON are influenced by such discourses when exercising reproductive choice will 
also be discussed.  
The heartbreak clinic  
Hope has been identified as a ‘major motivator of action, as a source of resilience to 
overcome adversity—in times of […] limited options and despair’ (Petersen 2015: 
1). Within the field of health, hope is delineated as an important element in the 
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healing process (Wiles et al. 2008; Petersen and Wilkinson 2015), with the use of 
hope scales and indices (Brown 2014) measuring both the influence and the impact 
of hope (Petersen 2015). When hope is spoken of within the medical setting, 
Bernard (1995) notes that it is usually in extreme situations, such as when people 
are faced with a terminal illness or death. However, he suggests hope is equally 
relevant within the context of living with chronic illness and disability—arguing that 
such states ‘disclose the very aspect of human existence that gives birth to hope, 
namely, that human beings are poised on the boundary between finitude and 
transcendence’ (1995: 38). Bernard (1995: 40) refers to an ‘“existential paradox” of 
living with a chronic illness’. The chronically ill are said to ‘straddle a boundary 
between hope and despair’. For Bernard (1995: 48), to hope ‘means to project 
oneself beyond one’s present definition of reality, but with no guarantees against 
disappointment’.  
In the previous chapter, a minority of participants indicated that they had accepted 
their sight loss and were not interested in finding a cure. Gerry, who was in his early 
sixties when he was diagnosed with LHON, explained: ‘I am not a cure chaser. I have 
accepted the fact that I have lost my sight’. Gerry’s view is consistent with 
Schillmeier’s (2008) research with visually impaired people in which he observed 
that not all those who have experienced sight loss want to be cured. After receiving 
their LHON diagnosis, some participants were registered as severely sight impaired 
and discharged from the eye clinic without the prospect of any further treatment or 
a cure. The promises that heralded the arrival of the new genetics are rapidly coming 
to fruition within the ophthalmology clinic, with the discovery of the genetic basis 
of LHON and potential cures. However, there remains considerable uncertainty 
surrounding the prognosis of LHON and, consistent with Locock and colleagues’ 
(2009) research, this provided a source of hope for people with LHON. 
Notwithstanding the bleak future suggested by their ophthalmologists, participants 
continued to hope that their sight would not deteriorate any further or that they 
may have the mutation that is most likely to have spontaneous recovery. Other 
participants hoped that they would have the opportunity to be enrolled into clinical 
trials or that their family members would not be affected by LHON. As Petersen and 
Wilkinson (2014: 117) reflect, hope ‘has no single defining essence or significance, 
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but rather is ascribed multiple meanings, articulations, and implications’. For 
participants in this thesis, hope is multifaceted. Marion, whose son was diagnosed 
with LHON, explained that whilst waiting for her son’s blood test results, she started 
to consider which of the three LHON mutations would give her son the best chance 
of restoring his sight: 
‘I can remember sitting there hoping its 11778,27 that’s the most 
common, so if he has got that, it means he is up for all the research things 
that are coming along [gene therapy]. The 14484, that’s the one where 
there is the most chance of recovery. That will be good if he has got that.’   
Adam, who was diagnosed when he was 14 years old, speaks for the majority of 
participants who are seeking a cure (and are willing to travel to find it) when he 
says: ‘Hopefully my sight will be back. I am 26 and if I got my eyesight back when I was 
36 or 46, I am not bothered. I just want it back as soon as possible. I will go wherever I 
need to go to get the cure’. Similarly, Sandra, who was diagnosed in her late sixties, 
has struggled to cope with her sight loss:  
‘I would be prepared to go to anywhere if they could do something, you 
know, some intervention that would do something about this. I am in the 
fortunate position that I am not rich by any means, but I am not poor 
either. I have got the resources that I could pay if I needed to. If there 
were any intervention, I would be on the first plane or train or whatever 
it was. I would just do it.’ 
(Sandra, diagnosed aged 69 in 2015) 
Sandra is desperate to find a cure for LHON and is prepared to participate in what 
Petersen et al. (2013: 670) refer to as ‘medical tourism’, a burgeoning trend, one 
which “[exploits]” ‘the high optimism that surrounds new biomedical technologies’. 
After Amy was diagnosed with LHON, her family searched the internet to find a cure. 
Having read about stem cell treatment in China, they started fundraising to send her 
there: 
                                                          
27The m.11778G>A mutation has been identified as the most frequently occurring mutation, 
accounting for approximately 60‒90 per cent of cases, with m.14484T>C and m.3460G>A 
responsible for 25 per cent and 15 per cent respectively (Spruijt 2006; Martikainen and Chinnery 
2015). New LHON mutations continue to be identified and currently there are over 45 point 
mutations of mtDNA reported (Aune and Walters 2012). 
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‘The internet was saying about research in China, they even had film bits 
of people there saying they had used stem cells and that it had started to 
work, it was a miracle and all this. I remember coming to the hospital and 
having an appointment with [ophthalmologist]; he said, “whatever you 
do, don’t waste your money on any of it”. He said “it’s all a rip off; people 
are going over there paying thousands of pounds. People are being 
injected with stuff, they don’t know what they are being injected with, 
and actually, it does absolutely nothing”.’ 
(Amy, diagnosed aged 18 in 2011) 
The increasing popularity of medical tourism has prompted influential science 
bodies (including the International Society of Stem Cell Research) to raise concerns 
that private providers are profiting from clinically unproven and potentially harmful 
treatments (Petersen 2015). Petersen and Wilkinson (2014: 3), suggest that hope is 
increasingly being linked to the development of new technologies, particularly those 
that ‘promise to offer cures, [and] alleviate suffering’. For many participants the 
motivation for participating in clinical research was the hope that their contribution 
would lead to finding a cure not only for themselves, but also for their families and 
the wider LHON community, consistent with Herbrand and Dimond’s (2017) 
research with 21 women at risk of transmitting a mitochondrial condition to their 
children. The authors discovered that only a minority of the women who supported 
the introduction of MRTs were intending to use the techniques themselves. The 
majority of the women who were not intending to use the techniques nonetheless 
supported their introduction from a desire to provide hope for their families and 
hope for wider society.  
Tina was diagnosed with LHON when she was 30 years old and claims she has 
accepted her sight loss, but as she and her brother have one of the rarer LHON 
mutations, she agreed to participate in clinical research to find a cure, not for herself, 
but for others:  
‘It would be nice for other people to have a cure. I am not bothered for 
me. I am happy with the life I have got. I want to help other people 
understand it [LHON] because in my case, I do have a very rare mutation. 
My brother did get his eyesight back after 5 or 6 years. He is very unusual, 
being that we are related and we have the same mutation. If my eyesight 
did come back, then at least they have got the stuff from now, so it would 
be a good comparison for them. There is no guarantee that it will come 
back. I know that.’  
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(Tina, diagnosed aged 30 in 2013) 
Laura is also participating in clinical research and summed up the feelings of a 
number of the participants: 
‘I am hoping they are going to come up with a cure for Leber's, I really am. 
I think of all those young boys, I saw them at [name of research centre], 
it is heartbreak clinic. I have heard young boys telling them 
[ophthalmologists] where to go, swearing at them. I have seen them 
coming out slamming the door and then trying to find their way round 
the wall trying to get out, falling over chairs and they are upset, and they 
are crying, it’s heartbreak clinic. If they could just come up with a cure for 
these young boys.’ 
(Laura, diagnosed aged 48 in 2012) 
For other participants, although they were hoping for a cure, they adopted a 
pragmatic attitude, accepting that this may never happen. Jake, who lost his sight 
when he was 15, acknowledges: 
‘Hopefully they can find a cure for my eyesight. I am not going to bed 
every night praying for a cure. I am accepting that potentially, probably 
most likely, they will never... I will never see properly again for the rest 
of my life.’  
(Jake, diagnosed aged 15 in 2005) 
Two male participants, David and Declan, referred to winning the lottery when 
discussing the possibility of finding a cure. David, who was diagnosed when he was 
23 years old, says: 
‘I guess there is hope in the back of my mind. It’s more like thinking of it 
as winning the lottery. It’s what you would do if you won the lottery. You 
have that little hope in your mind where if I won the lottery I would do 
this but, at the same time, it’s also knowing that it might not happen.’ 
(David, diagnosed aged 23 in 2011) 
Similarly, Declan who experienced sight loss when he was 12, expresses how he 
would feel if his sight was restored: ‘It would be like winning the lottery. It would 
probably be better than winning the lottery, better than winning the Euro Millions’. 
Ollie, who experienced sight loss during his first year at university, indicated that as 
he has learnt more about LHON, he has become more realistic about the prospect of 
a cure: 
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‘I am actually very sceptical about finding a cure. I understand it is a 
whole body condition; it is a mitochondrial DNA condition. I understand 
the real limitations of finding a cure’.  
(Ollie, diagnosed aged 18 in 2009) 
One treatment potentially offering hope to participants that their sight will be 
restored is Idebenone, an antioxidant drug that, it is claimed, stabilises sight loss and 
may for some restore sight. Notwithstanding European Medicines Agency28 
approval under exceptional circumstances for the treatment of patients affected 
with LHON, Idebenone is not routinely prescribed for use in England and Wales.29 
A number of participants are currently enrolled into the LEROS trial which evaluates 
the efficacy and safety of Idebenone. The possibility of finding a cure is a powerful 
incentive to participate for those who are desperate to have their sight restored. I 
interviewed Dr Urquhart, a representative of the pharmaceutical company 
developing Idebenone. I asked him to explain what Idebenone actually does and, in 
response, he stated that: ‘We [pharmaceutical company] are going to argue that it 
actually can, in some patients, improve sight’.  He went on to explain how this was 
possible: 
‘Idebenone doesn’t correct the genetic problem, but it bypasses the 
problem. It takes electrons that normally get transferred from complex 1 
to complex 5 to make energy. Think of it as a factory: the factory has five 
steps and you need to go through five steps in order to produce energy. 
Step one is the one that doesn’t work—imagine all the electrons, all the 
parts that are supposed to go to step two, falling outside of the machine 
at step one. Idebenone soaks them up and takes them to step two or three, 
it is as simple as that. It is molecular in design; its chemical characteristics 
allow it to soak up the electrons that are escaping from complex 1 and 
transfer them to complex 2 and 3. Taking Idebenone allows the 
mitochondria to become functional again, but it is not a steroid, it doesn’t 
make them work better. We are not claiming that it works to 100 per cent. 
It just gets things moving again. By doing that, it restores energy to the 
RGCs [retinal ganglion cells] and, therefore, allows these electrical 
                                                          
28 The EMA produces evaluations of pharmaceutical products which are used by the European 
Commission to decide whether a medicine can be authorised for marketing in the European Union 
(EU). Without EMA approval Santhera are not able to market Idebenone until they receive a 
marketing authorisation from the European Commission. 
29 However, Idebenone was approved in May 2017 by the Scottish Medicines Consortium for use in 
Scotland. 
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impulses, the light that you see in your eye, to be converted to electricity 
to be transmitted to the brain.’ 
(Dr Urquhart, Pharmaceutical Company Representative) 
The claims made by Santhera Pharmaceuticals that Idebenone has the potential—in 
some patients—to improve sight have divided the scientific community (Carelli et 
al. 2011; Lyseng-Williams 2016; Yu-Wai-Man et al. 2017).30 In evaluating the 
veracity of the claims, participants are faced with traversing ‘regimes of truth and 
regimes of hope’ (Petersen et al. 2013: 671). A previous clinical trial evaluating the 
safety and efficacy of Idebenone, (RHODOS),31 failed to show a benefit for its pre-
specified primary end point,32 however it did show a benefit for three secondary end 
points. Dr Urquhart, without prompting, confronted the issue of the criticism 
levelled at Idebenone from the scientific community:  
‘The RHODOS study didn’t meet its primary aim, but it tended to be 
positive on a secondary main outcome. There were three secondary 
outcomes, and as you go down the secondary outcomes the P value got 
stronger and stronger but didn’t quite meet significance until the last one. 
The shortfall is when the RHODOS study was published the first 
perception that clinicians had was it [Idebenone] didn’t work. When we 
looked at the data we felt strongly that the trend was an indication that 
there was efficacy, and then what we did was we did some additional 
work to try to prove that.’33 
                                                          
30 Yu-Wai-Man et al. (2017: 42) reviewed of the use of Idebenone in the treatment of the m.11778G>A 
mutation. Their findings suggest that overall: ‘the current body of evidence does support a visual 
benefit with Idebenone in acute LHON, but only in a subgroup of treated patients and importantly, it 
is not possible to predict who will respond. Furthermore, it should be stressed that there is no solid 
evidence base to guide the optimal dose and duration of treatment, and it remains debatable whether 
Idebenone has any beneficial effect once optic atrophy has become established in the chronic phase 
of the disease’. 
31 RHODOS was a multicentre, 24 week double-blind, randomised placebo-controlled trial that 
enrolled 85 patients with a confirmed diagnosis of one of three primary mtDNA mutations (Yu-Wai-
Man et al. 2014). 
32 At the end of the 24 week trial, the primary end point (best recovery of visual acuity) in the group 
taking Idebenone was not statistically significant compared to the placebo group. However, 
Idebenone displayed an overall consistent trend (compared to the placebo group) with regard to 
providing protection against future vision loss.  
33In the follow-up RHODOS trial, the beneficial effect of 24 weeks of treatment with Idebenone 
persisted even after treatment was discontinued (Klopstock et al. 2013). Similarly, in a retrospective 
study of 103 patients with LHON, 44 patients with sight loss of one year’s duration or less were 
treated with Idebenone and followed for a period of at least five years. A higher proportion of those 
patients treated with Idebenone recovered vision. The contributing factors included the early 
initiation of treatment and prolonged treatment (Carelli et al. 2011; Yu-Wai-Man et al. 2014). 
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Using the ‘positive’ secondary outcome data from the RHODOS trial, and its follow-
up trial, Dr Urquhart suggested that there is evidence to support the expectation that 
Idebenone will provide a future benefit for the treatment of LHON. Relevant to the 
development of both Idebenone and MRTs, there is a small but influential body of 
literature that has explored the ‘sociology of technological expectations’ (Hedgecoe 
and Martin 2003; Brown 2005; Novas 2006). Borup et al. (2006: 286) suggest that 
technological expectations, or promises, visions and imaginaries can specifically be 
described as ‘real-time representations of future technological situations and 
capabilities’. Petersen (2015: 12) distinguishes the concept of hope from that of 
expectation, suggesting that: 
‘Expectations tend to involve implicit estimations of probabilities […] 
based on empirical research (e.g. lab-based experiments, double-blind 
trials). […] positive outcomes may provide sufficient empirical evidence 
to support the expectation of similar outcomes for other endeavours in 
the future. In this case, ‘expectation’ may equate with prediction’ 
(original emphasis). 
Whilst I was in Dr Penvenen’s clinic in the Royal Albion Hospital, I asked whether 
Idebenone was an effective treatment: 
‘My rule of thumb is that 1 in 3 people will benefit from taking Idebenone. 
I have a lot of difficulties with a lot of the claims that have been put 
forward which do not reflect my clinical experience. From my 
perspective some people believe its rubbish and it doesn’t work. My 
personal feeling is that the drug actually can have a modulatory effect. 
The bottom line is we need something better really. This is the only thing 
we have now and even though this is the only thing we have now, we can’t 
even prescribe it.’ 
(Dr Penvenen, Clinician Scientist and Neuro-ophthalmologist) 
 
Dr Penvenen suggests that some of the claims being made by Santhera are not 
consistent with the clinical experience of genetic ophthalmologists. As Idebenone is 
not routinely available on the NHS, participants who are not enrolled into the LEROS 
trial and wish to take Idebenone may buy it over the internet from the US. However, 
it is expensive, with participants explaining that it can cost up to £250 a month. 
Alternatively, participants can request that their ophthalmologist completes a 
named-patient request, thus authorising the drug to be prescribed by the NHS. 
When Marion’s son was diagnosed, she asked the ophthalmologist to prescribe 
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Idebenone: ‘He [ophthalmologist] laughed and said it’s no good. You can buy CoQ10 
[health supplement] over the counter in health stores, it will probably be as good’. Like 
many of the participants, Marion obtained Idebenone over the internet. Dr Urquhart 
spoke later in the interview of his concerns that people who order Idebenone over 
the internet may not be receiving Idebenone:  
‘Imagine you are a patient, you go to your physician and they say yes, I 
have heard about Idebenone, but I don’t think it works. The patient has 
to go away thinking what do I do now?  They go on to Facebook, Twitter, 
they hear about Idebenone being available in the US, they go to a website 
and they order it. What they don’t know is what they are getting. These 
are not pharmaceutical grade products—some claim to be, some not. 
These compounds have not been tested in a formal clinical trial, they are 
not compounds that go through GMP [Good Manufacturing Practice] 
which is a global standard for pharmaceutical companies and the Health 
Authorities. When they approve a drug, they approve a drug based on the 
data done in clinical trials, toxicology, safety and manufacturing, so we 
have very strict regulations about quality standards and manufacturing, 
which these internet suppliers don’t have to go through.’ 
 Two of the female participants, Sandra and Beth, also ordered Idebenone over the 
internet and asked their respective ophthalmologists to test the drug, confirming 
that they had indeed received a product of pharmaceutical quality. Sandra and Beth 
have invested both emotionally and financially in the treatment. For Sandra, having 
hope that her eye sight will improve is what keeps her going: 
‘Having heard about it [Idebenone], we went and ordered it [from the 
internet] straight away. I want to cling on to that one little hope that I am 
investing all this money in Idebenone. I have been taking it for quite a 
while. I think there has been a marginal improvement in colour 
perception and although the general fogginess is no better, but black and 
white seems to be a little better’.  
 
 Taking Idebenone gives Sandra agency to take control of her own destiny and 
imagine a future self—one with improved sight. Beth has been using Idebenone for 
11 months. In the previous chapter, Beth stated that she was not coping with her 
sight loss and, on occasions, spent days in bed. I interviewed her on two occasions. 
On the second occasion, she indicated that at her last sight test: 
‘There was a slight improvement and some of the central vision had come 
back in the right eye and just a slight improvement in the left. Today all 
these tests they have done show that there has been a bit of an 
improvement.  I had given up all hope’.  
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The slight improvement in her sight has given Beth some hope for the future, 
whereas previously, there was simply a sense of hopelessness, as she moved 
between feelings of hope that her eyesight would be restored, and despair that it 
may deteriorate further. However, it is increasingly being recognised that hope can 
be problematic. As Petersen and Wilkinson (2014: 116) suggest, hope can be 
‘“misguided” or “false”—based on faulty premises or no evidence’. Marion explained 
that, when her son David was diagnosed, she researched possible treatments for 
LHON: ‘I was in the position where I could drop everything and spend thousands of 
hours on this’. Marion, persuaded by the ‘hype’ (Brown 2003: 3) surrounding the 
effectiveness of Idebenone, was encouraged to buy the drug over the internet. Later 
in her interview, Marion reflected her current view of the drug: ‘We have lost faith 
in Idebenone. As far as we are concerned, my son took it religiously for three years and 
then stopped taking it because we believe it made no difference’. Marion was deeply 
disappointed that Idebenone did not live up to her expectation that it would improve 
her son’s eyesight. Notwithstanding Marion’s view of the effectiveness of Idebenone, 
based on the secondary outcomes of the RHODOS trial, Santhera have been 
successful in attracting research institutions, funders, clinicians and patient 
advocacy groups to form alliances or participate in what Novas (2006: 289) refers 
to as the ‘political economy of hope’. In interview Dr Urquhart explained in more 
detail how Santhera have sought to raise awareness of LHON amongst health 
professionals, many of whom (as observed in Chapter Four) do not include the 
condition in their differential diagnosis:  
‘For us, traditionally, as a pharmaceutical company we try to work with 
organisations and individuals so what we have is an opportunity at 
international congress to put on symposia. We are, of course publishing 
our data all the time. We have a highly specialised and very scientific sales 
force. We talk to a lot of doctors about disease. We also think about 
online; Medscape is quite popular. We are working with the Royal 
Colleges in individual countries to see what we can do from an 
educational point of view. We would love to work with the Royal College 
of Ophthalmology to put together an educational [service]. We work with 
a lot of patient advocacy groups because the problem isn’t just on the 
physician side. It is also making people aware who have Leber’s that they 
have Leber's… that they should talk to their doctor about treatment 
options. We are putting together a list of expert centres, we are putting 
them on websites, so we can share them with advocacy groups, we can 
share them with... You know, at the moment, there is no professional 
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organisation for LHON. There are small groups. What we are trying to do 
is, in some countries, we are helping to fund expert centres.’ 
 
In 2016, Santhera was instrumental in bringing together leading experts from 
Europe and North America to produce a consensus statement for the clinical and 
therapeutic management of LHON based on the current evidence available (Carelli 
et al. 2017). Dr Urquhart alluded to the targeting of patient advocacy groups, 
referring to the pivotal role they also play in raising the profile of LHON and, thereby, 
Idebenone as a treatment option.  Petersen (2015: 10) notes that the: 
‘Intermingling of the hopes of patients with the promises of new 
biomedical technologies […] contribute to the economy of hope for 
research through lobbying for research into a particular condition and 
working with policy makers and other influential actors to help bring 
about some hoped for clinically beneficial outcome.’ 
 
I interviewed Adrian, a representative of a patient advocacy charity based in the UK 
providing information and support to families coming to terms with a diagnosis of 
LHON. He described how his organisation had previously been actively involved 
with the European Medicines Agency. He explained that, although sceptical of many 
of the claims being made in relation to Idebenone, his organisation was now advising 
the pharmaceutical company which produced the drug. He explained his rationale 
for collaborating with them: 
  ‘I have actually taken the view now that it’s more important that I get 
involved with the pharmaceutical companies than it is with the 
regulators, because the EMA [European Medicines Agency] approved 
Idebenone but it is not available on prescription in the UK and it is going 
to be difficult to see how it will be available in the foreseeable future, 
notwithstanding the fact it is approved. I can probably be more effective 
trying to convince the pharmaceutical companies to do their jobs more 
diligently than I can with the regulators. They are concerned about delays 
in diagnosis; I think they feel the sooner the diagnoses are made, 
probably the more effective their treatment will be and, in fact, they were 
working with us to try and put together some materials that could be 
used to educate professionals. Now we are starting to get a little bit more 
involved as a society with them.’  
 (Adrian, Representative of Patient Organisation.) 
Evident from Adrian’s account of his organisation’s involvement with the 
pharmaceutical industry is the desire to speed up the process by which Idebenone 
is routinely prescribed in the UK. The organisation is also fulfilling a political role, as 
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Adrian explained that his organisation had recently successfully submitted written 
evidence to the Scottish Medicines Consortium on behalf of the organisation’s 
members.  
In the next chapter section, I explore the narratives of hope associated with 
mitochondrial replacement techniques to avoid the birth of a child with LHON.   
Reproductive technologies and reproductive risk 
In this section, predominantly drawing on interviews with women, I consider how 
hope is constructed and negotiated in the context of the development of new 
developing reproductive technologies to avoid the birth of a child with LHON. I 
interviewed 11 affected women, and six mothers (carriers). I also interviewed a 
woman (carrier) who, at the time of interview, was considering her reproductive 
options. Whilst a number of the women were no longer of child-bearing age, they 
expressed their concern for other relatives at risk of passing LHON onto their 
offspring. A few women raised the subject of what they refer to as ‘three-parent’ 
babies. In the following discussion, I use the term mitochondrial replacement 
techniques (MRTs) when discussing the techniques developed to avoid the birth of 
a child with LHON. 
Mitochondrial replacement techniques 
A woman at risk of passing LHON onto her offspring is presented with a number of 
difficult reproductive decisions due to the incomplete penetrance of the condition. 
Firstly, she may wish to avoid the risk by using a donated oocyte. The donated oocyte 
is fertilised with the partner’s sperm and the resulting embryo is transferred to the 
uterus of the mother who will give birth to the child. There is also the option of 
adopting a child. Neither of these options is appropriate for a woman who wishes to 
give birth to a genetically related child. Prenatal diagnosis for LHON after conception 
is a possibility where the pathogenic mutation has been identified. However, this 
technique is not appropriate for women who carry a homoplasmic mtDNA mutation 
as chronic villus sampling (CVS) or amniocentesis will not assist in assessing the risk 
of recurrence. Similarly, in heteroplasmic mtDNA mutations using, CVS and 
amniocentesis to test the foetus will not accurately predict the level of the mutation 
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in the tissues that are most susceptible (retinal ganglion cells) to LHON (Poulton et 
al. 2017).  
A possible solution for a woman who wishes to avoid passing LHON onto her 
offspring, but also wishes to give birth to a genetically related child, is to use 
mitochondrial replacement techniques (MRTs). There are two available techniques 
licensed (in 2015) for use in the UK, the first of which is maternal spindle transfer 
(MST). This is where the nucleus of the mother’s oocyte is transferred into a healthy 
enucleated donor egg which has healthy mitochondria. The reconstructed oocyte is 
fertilised and transferred into the mother’s uterus. The second technique—
pronuclear transfer (PNT)—takes place after fertilisation, following which the 
embryo is transferred into the mother’s uterus (Bredenoord and Braud 2011; HFEA 
2011, 2014). The techniques are controversial as they require germline 
modification, which means that the donor’s mitochondria will be passed down 
through future generations. In 2012, the UK Human Fertilisation and Embryology 
Authority (HFEA) convened a number of public consultation workshops on 
mitochondrial donation.34 Oral and written representations were received from a 
diverse group of stakeholders, including pro-life groups who tapped into analogies 
and metaphors from popular culture and science fiction (e.g. designer babies, ‘the 
slippery slope’, eugenic consumerism, and ‘Frankenstein’s monster’) to argue 
against the introduction of MRTs. In contrast, mothers who had experience of a child 
dying as result of mitochondrial disease actively sought to have the new techniques 
licensed for use (Herbrand and Dimond 2017). The social, legal and ethical 
repercussions of allowing germline modification have been extensively discussed by 
scholars (Bredenoord et al. 2011; Jones and Holme 2013; Dimond 2015; Wrigley et 
al. 2015; Newson and Wrigley 2017; Scully 2017). Later in the chapter, I consider 
whether women in this research were influenced by the ethical debates surrounding 
the use of MRTs when making reproductive decisions.  
                                                          
34 During July to December 2012 the HFEA conducted a comprehensive public dialogue and 
consultation exercise involving a survey, focus group, workshops, an open consultation 
questionnaire and open consultation meetings to consider the ethical and social issues surrounding 
the use of mitochondrial replacement therapies (Department of Health (DOH) 2014). 
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Reproductive responsibility 
The knowledge that LHON is passed on maternally provided certainty for the men 
in the study. During his interview, Gerry talked about his initial concerns for his 
daughter and grandchildren; his comments are typical of the other men:  
‘When we heard it was a genetic condition, obviously, the first concern 
was whether there was possibility it could have been passed to my 
daughter. So it was a relief to find out that I couldn’t pass it on, it was a 
purely a female mitochondrial condition.’  
One of the other participants, Jake, who experienced sight loss when he was 16 years 
old, was now aged 27, married, and keen to start a family: 
‘I have always really wanted children and they told me you can’t pass it 
on. That was important to me because if I could pass it on, I wouldn’t have 
children. That was something I needed to make sure of.’    
For women who were still of child-bearing age, the knowledge that they would pass 
LHON to their children led to a dilemma: should they conceive naturally and 
negotiate the uncertainty of whether their child would develop sight loss—or use 
MRTs to avoid passing LHON to their offspring? There is a body of sociological 
literature that has considered reproductive decision-making within the context of 
genetic inheritance (Kay and Kingston 2002; Etchegary et al. 2008; France et al. 
2011; Boardman 2014; Pond and Dimond 2018). In their research with women 
carriers of X-linked conditions, Kay and Kingston (2002: 170) identified a number 
of factors that influence reproductive decision-making, including ‘the actual risk of 
the condition being inherited […], perceptions of the consequences of raising an 
affected child and personal experience of the condition’. Similarly, Pond and 
Dimond’s (2018) research, with five mothers of children with undiagnosed 
developmental delay, identified five factors that influence reproductive decision-
making: (1) future uncertainty; (2) perceptions of risk; (3) the potential impact a 
child with LHON would have on their current children; (4) expectations of a family; 
and (5) the desire for another child. To what extent these factors are evident in the 
interviews with women in this study will be considered later in the chapter.  
One of the affected women, Tina, who experienced sight loss when she was 30 years 
old, has decided not to have children as she does not want to take the risk that her 
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child would develop sight loss: ‘When you are young, you think “I would like to have 
kids”. On the other hand, I know I can kill the gene by not having them’. Similarly, one 
of the other affected young women, Amy, who was diagnosed when she was 18 years 
old, faces a dilemma as she would like to have children but also wants to eradicate 
LHON: ‘I want to do everything to stop the gene. It’s an evil condition’. These views 
echo the sentiments expressed in Petersen’s (2006: 40) research with people living 
with diverse genetic conditions. He observed that concern for future generations, 
and taking responsibility for the health of others, precluded his participants from 
having children, presenting themselves as ‘moral, responsible citizens’ and, thus, 
placing the health and wellbeing of any future children above their own desires to 
be mothers. Arribas-Ayllon et al. (2008) suggest that the rise of genetic testing and 
genetic counselling has led to an increased awareness of the risks associated with 
passing on a genetic condition. However, one of the recurring themes in the 
interviews with the women was the lack of availability of genetic counselling 
following the LHON diagnosis.  
The aim of genetic counselling is to provide up-to-date and accurate information to 
people who are affected by, or are carriers of, a genetic disease, in respect of their 
prognosis, recurrence risk for the wider family and reproductive options (Poulton 
et al. 2017). Genetic counselling for women carrying mtDNA mutations is complex 
and influenced by a number of factors including the specific mutation, homoplasmy, 
heteroplasmy and disease penetrance (Thorburn and Dahl 2001; Poulton et al. 
2017). A number of the women explained that they had not been referred to genetic 
counselling following their child’s diagnosis, with the lack of information leading 
them to research LHON using the internet. However, mirroring research by 
Whitmarsh et al. (2007), they found the information was depressing and alarming. 
As Sara related: ‘I read the first two lines on Wikipedia, I was absolutely horrified, it 
was talking about the most sensational stories and worst case scenarios, I haven’t 
Googled since’. Notwithstanding the difficulties experienced by participants in 
obtaining accurate information, they all understood that, if they conceived naturally, 
they would pass LHON to their own children. There was, however, confusion 
surrounding the carrier status of other relatives.  This became evident during the 
interview with Gwyneth (carrier) whose son, Declan, has been diagnosed with 
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LHON; she understands that her younger son is also at risk. Gwyneth’s brother (now 
deceased) also experienced sight loss and Gwyneth suspects he had LHON, but it 
was never discussed within the family. Gwyneth also has a sister and a niece; the 
niece has two sons, both born after Declan’s diagnosis. I asked Gwyneth if, given the 
known family history, her niece had undertaken genetic testing and counselling 
before she decided to have her children. It was at this point that Gwyneth appeared 
to become confused35 in respect of her niece’s carrier status:  
‘No, she doesn’t need to. She wouldn’t have LHON because she is my 
sister’s daughter.  
If you and your sister have the same mum, it’s likely your sister also has 
LHON and she has passed it to your niece. 
Then it can be passed to her?  
You passed LHON to your sons, your sister is likely to have passed it to your 
niece.  
(sigh) It is so complicated. 
Was the inheritance of LHON explained to you?  
I think so, I had one genetic counselling session, but it is so difficult to 
keep it all in here (points at her head). My sister and niece have never 
been offered any blood test or counselling.’  
 
For Gwyneth, there is ambiguity surrounding the status of her sister and niece. She 
found that understanding complex genetic information following one genetic 
counselling session was challenging. Her sentiments resonated with Catrin (carrier), 
whose son was diagnosed with LHON; she also has a younger son who, again, she 
knows it is at risk. Catrin has a sister, and a niece. Catrin realises that her niece may 
pass LHON to her children, but explained that the family find it difficult to 
comprehend which family members may go on to experience sight loss:  
  ‘You know, for the lay person, all the genetics background is quite 
difficult to understand sometimes, you know when they go on about 
chromosomes. It is quite difficult. From my understanding, my niece, she 
is 20 at the moment, may be eligible for the three-way children.  
  You mentioned the three-parent baby? 
                                                          
35 During the interview with Gwyneth and a few of the other women, I found myself in the unusual 
position of having to explain the inheritance of LHON. This was an example of one of the ‘ethics in 
practice’ situations that I referred to in Chapter Three.     
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  Yes, it is taking an egg from a woman then replacing the bad cells with 
the good cells or something like that.  
  Would you have considered using it? 
  Possibly, yes.  
Would you have had children if you had known about LHON? 
  If I am being honest, no, I wouldn’t. I wouldn’t have had them because 
seeing what [son] is going though, that really upsets me (becoming 
emotional).’ 
Catrin is aware of MRT potentially being available for her niece; she also indicates 
that she may have used MRT had the techniques been available when she decided to 
have her children. One of the other issues present in the interviews was the most 
appropriate time to provide genetic counselling. Amy remembers being in the 
hospital and a genetic counsellor coming to see her to talk about LHON: ‘I was offered 
genetic counselling, but I didn’t accept it at the time. I wasn’t ready to talk about it’. At 
the time of her sight loss, Amy was not in a relationship and, so, felt it was pointless 
to have genetic counselling at that stage. Ginny recounts a similar experience when 
she and her boyfriend were offered genetic counselling:  
‘We had genetic counselling when we were 18 which was very....  I don’t 
think we were even thinking about getting married, so it seemed a bit of 
a ridiculous conversation. We hadn’t really found out that much about 
each other.’  
 
Echoing previous research (Parsons and Atkinson 1992; Cox and McKellin 1999; 
Petersen 2006), participants made the effort to become better informed in respect 
of the inheritance of LHON when they or their daughters reached a ‘critical juncture’ 
(Cox and McKellin 1999: 628) in life, for example, when they met a potential partner 
or were considering having children. Amy is now in a serious relationship:   
‘I have recently asked for genetic counselling; it is because of my partner. 
We are going to have children. I have asked for it now. But it needs to be 
talked about. It is very complicated, and I don’t want my children growing 
up with the same condition as me. I know that sounds terrible, but 
hopefully they can do something to not let it happen to them.’  
 
Amy faces a dilemma: she wants to eradicate LHON, but also would like to give birth 
to a child that is genetically related to her. She has recently asked to be referred to a 
genetic counsellor to find out her reproductive options. There was considerable UK 
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media coverage of the mitochondrial debate in the lead up to the Parliamentary vote 
in 2015, though Amy claimed not to be aware of the techniques. Similarly, other 
women also stated that they had not heard of MRTs. Consistent with Herbrand and 
Dimond’s (2017) research, this may be attributed to the fact that a number of 
women were no longer of child-bearing age, not intending to have further children, 
or did not want to have children. Of the remaining women only four (Marion, Naomi, 
Ginny and Sally) felt confident in discussing MRTs in any detail. Drawing on the 
interviews with these four women, I explore how reproductive responsibility is 
negotiated within families at risk of passing a genetic condition to their offspring. 
Focusing on reproductive decision-making, I discuss whether the four women are 
influenced by the ongoing ethical debates surrounding the use of MRTs and whether 
in imaging their child’s future (France et al. 2011) their experiential knowledge of 
either living with sight loss, or living with an affected relative, influences their 
decision to conceive naturally or use the techniques.  
Firstly, I talk about Marion, now in her mid-fifties, and who was unaware of her 
carrier status until her son David was diagnosed. In her interview, she spoke of her 
concern for her daughter, Naomi (carrier), who is in a long-term relationship, and 
although she has often spoken of having children, has yet to do so. Secondly, I discuss 
Naomi, who is well informed in respect of the ethical debates surrounding the use 
of MRTs. Naomi, together with other family members, attended a genetic counselling 
appointment after her brother was diagnosed. At the time of interview, Naomi and 
her partner had asked to be referred to a genetic counsellor to discuss their 
reproductive options. I then consider Ginny who experienced sight loss when she 
was 18. Knowing that she would pass LHON to her children, Ginny and her husband 
decided to conceive naturally. Finally, I discuss Sally, who experienced sight loss 
when she was seven. Sally was initially misdiagnosed and only became aware of 
LHON after her youngest son was affected when he was also seven. 
Marion 
 
I begin the discussion with Marion who, in addition to David and Naomi, has two 
other children. During my interview, she raised the subject of Naomi not having had 
children yet, which had clearly been troubling her for some time. Marion explained 
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that Naomi had been in a stable relationship for some years and worries that her 
carrier status is deterring her from having children. She explained:  
‘My daughter spoke to her partner and he said it [LHON] didn’t matter. 
Now we are three years down the line and she still hasn’t had children 
and I know it’s something she worries about. I said to her before “why 
don’t you just go ahead and have children? The only difference between 
you and me is that you know about it and I didn’t know about it”.  
 Would knowing about LHON have made a difference to you? 
(long pause) That’s an interesting question. I... (sigh) I feel desperately 
sorry for my daughter because I know it makes a difference to her. As to 
whether it would have made a difference to me, I would like to say no but 
I don’t know. I certainly wouldn’t wish any of them [children] away. 
Do you think the diagnosis is stopping your daughter having children? 
 (sigh) I don’t know. I keep saying to her [daughter] other people are 
having children, they don’t know what the odds are for them, the child 
could be born with hereditary cancer or hereditary you name it… just 
because we happen to know what the odds are for us.’  
 
Before her son received his formal diagnosis, the family had been given an indication 
that it could be LHON. Marion had researched the condition on the internet and 
realised that the condition was maternally inherited. She explained that Naomi 
attended the appointment with the genetic neuro-ophthalmologist to receive 
confirmation of her son’s blood test. The family also attended a genetic counselling 
appointment. Given that Naomi has not yet started a family, she reflected on 
whether it was the right decision to take her daughter to the appointments:  
‘I know she was going to have to hear it sometime.  How can you sweeten 
the pill? Should I have shielded her at the time do you think? It’s a 
complex one. She has been with her partner for a long time. Bearing in 
mind she is [age] now, I know she has thought about it [having children] 
and we have talked about it. Knowing her as I do, I feel that it’s stopping 
her from getting on and she has talked about adopting a child.’ 
Marion spoke of the turmoil she experienced at the time of her son’s diagnosis. 
Mirroring Hallowell and colleagues’ (2003) research, Marion wanted to protect her 
daughter from unnecessary distress, but by the same token, she believes that her 
daughter had the right to know the inheritance of LHON to make an informed 
reproductive choice. Six years after her son’s diagnosis, echoing previous research 
(Arribas-Ayllon et al. 2008; Chapple et al. 1995), Marion, still experiences feelings of 
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guilt and self-blame that she had passed LHON to him. She also feels guilty that her 
daughter has not yet had children, and she believes it is because of her carrier status. 
Later in the interview, Marion acknowledged that her daughter would have 
discovered that she has inherited LHON and would pass it to her children. However, 
she still experiences conflicting emotions as to whether it was the right decision to 
take her to the appointments: 
‘I am asking for the impossible, aren’t I? Because she is an intelligent 
woman, she would have realised she will pass it [LHON] to her children.  
We are very interested in the three-person IVF. We went to all the 
consultation workshops which were very interesting, especially hearing 
the religious side of it. I thought “where is your human compassion in all 
this?”  On one platform, you have a woman talking about her child dying 
in front of her and a slight alteration in her mitochondria making a change 
to this. The attitude [of others] is unbelievable.’  
Hallowell et al. (2003: 77) suggest women, in delivering bad news, to family 
members draw on different rhetorical strategies to balance responsibility and 
autonomy. One strategy is to draw on ‘discourses of hope’ associated with new 
technology breakthroughs such as MRTs that promise to eradicate disease. Marion 
who continues to feel guilty that she has passed LHON on to Naomi encouraged 
Naomi to attend the HFEA public consultations workshops, in the hope that she 
would become better informed about the possibility of the use of MRTs. Towards 
the end of the interview, Marion again returned to the subject of Naomi not having 
children and suggests that it may have been better for Naomi not to know of her 
carrier status and to have been in the same position as she was when she had her 
children: 
‘I keep saying to my husband I wish she didn’t know. I wish she didn’t 
know that she is a carrier for LHON and that she will definitely pass it on 
to all of her children. I just wish she was in the same situation that I was 
when I had my four children in that we didn’t know anything about it.’ 
Given Marion’s comments, I asked her if she would have preferred her daughter to 
have had children before her son David’s diagnosis: 
‘Yes, that would be it... we all had genetic counselling following my son’s 
diagnosis. My daughter was told by the genetic counsellor that she could 
be eligible for sex selection. What is the point of that? So, you can have a 
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girl who will pass it on to all subsequent generations or you have a boy 
who is more likely to get it, so it’s Hobson’s choice really.’ 
Evident from Marion’s interview is that she continues to try and reconcile her 
feelings of guilt that she has passed LHON to her children—even though she was not 
aware of her carrier status when she conceived her children. She also continues to 
be conflicted as to whether it was the right decision to take Naomi to the 
appointments. 
Naomi 
 
I later spoke to Naomi who, together with her family, attended an appointment with 
a genetic counsellor where her reproductive options were explained to her:  
‘The genetic counsellor said I would pass it [LHON] on but there are some 
options.  Some people might go for sex selection to have a female [child] 
with less chance. She mentioned at that point about the three-person IVF. 
I have kept an eye on what’s been going on in the media.  Also thinking 
about children, I am going to have to think about it. I am not getting any 
younger and I do want to have children. It is a bit of a dark cloud I feel like 
I have to think about but don’t really want to. My partner says why not 
just get IVF? It’s not as simple as that. It can be painful and traumatic on 
couples if it doesn’t work. I am not sure that I want it, even if it is available 
right now, I don’t know if I would want to be a guinea pig. I think that 
having children is a bit of a lottery anyway.’ 
At the time of the interview, Naomi, was waiting for an appointment with a genetic 
counsellor to discuss the possibility of being eligible for MRTs. She has spent 
considerable time reading the scientific literature following the media debates at the 
time of the Parliamentary vote to legalise MRTs in the UK.  Naomi suggests that 
having children is a lottery and I asked her, given this view, if she would consider 
having a child naturally: 
 ‘That’s kind of what I am thinking, but I don’t know. It is something my 
partner and I are not talking about very often. But are thinking about it 
and trying to figure it out. I think going to genetic counselling will give us 
something to chew on. So we can weigh it up. I am not a fan of the slippery 
slope argument. As humans, we are sensible enough to not go down the 
slippery slope. I feel quite angry that people’s religious views play a 
bigger part than they should in issues like this. I think for me when I was 
reading about it at the time, there are lots of mito [mitochondrial] 
conditions that are far worse, for want of a better word, where women 
just can’t have babies or they do, and the baby dies before it is a year old. 
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If that is what I had then it would be a much simpler choice to have the 
three-person IVF. I think the media are making the mistake that it’s three-
parent IVF that annoys me. It’s clumsy and it’s stupid and I think it is 
nobody’s business stopping people’s access to these things.'  
Whilst Naomi refers to the ethical debates surrounding the use of MRTs, she was 
firm in her view that she was not influenced by such rhetoric. Naomi suggested that 
she and her partner have a tendency to avoid making decisions. Pond and Dimond 
(2018) suggest that, for some couples, they never reach a consensus, or if they do, 
this may change over time. The authors suggest that the decision to have a child is 
influenced by perceptions of risk and personal experience of the genetic condition. 
As the interview progressed, it became apparent that Naomi’s decision to conceive 
naturally was being influenced not by the ethical debates, but instead based on how 
well she perceived her brother had coped with his sight loss. I asked her if this was 
the case: 
  ‘There is an element of that. My brother has dealt with it very differently 
to the way I would deal with it. I would hate that if I couldn’t see. I think 
having a child and the child knowing that we had chosen to have a baby 
knowing that they may go blind, I wonder what the child would think of 
that.’ 
Naomi reflects on how her child would react to losing their sight knowing that their 
mother was aware that she would pass LHON to them. In the case of Adam, one of 
the participants, discussed in Chapter Five, his parents were aware of his mother’s 
carrier status and chose to have a child naturally. Adam lost his sight when he was 
14 years old, and now 26 years old he and remains extremely angry that his parents 
chose to have him:  
‘Since what’s happened to me, I am a big believer now that if you have got 
a genetic condition and there is no way you can pass it on, fine, have a 
child. If you are going to pass it on, don’t do it, there is no point. I still get 
moments now when I am thinking I am blind, and I shouldn’t be because 
that’s what I went through: “I shouldn’t be like this”.’  
Adam’s relationship with his parents remains uncomfortable; he is unable to forgive 
them since he believes that they were selfish and had a child despite knowing that 
he would lose his sight. 
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Ginny 
Ginny experienced sight loss when she was 18 years old. Knowing that her children 
may also lose their eye sight, she decided to conceive naturally. Ginny’s decision is 
influenced in part by her brother, who is now in his early thirties and has not 
experienced problems with his sight. Ginny has two sons, and at the time of 
interview, was considering having another child. Although MRTs were not available 
when Ginny decided to have her first two children, there were other options 
(adoption and oocyte donation) which Ginny and her husband chose not to use. I 
asked Ginny if she had genetic counselling before having her children: 
‘We had genetic counselling—they gave us the 50% chance that a boy 
would be affected and 10% that a girl would be affected. You just think 
it’s 10% and I have still done it [lived life], so anything is possible. We 
were of the opinion, yes, it could happen, but it’s not the end of the world. 
We feel very much that there is a genetic load that you bring into this 
world that gets passed down from generations of your family. There are 
plenty of other things in our family, like cancer and heart disease, that I 
would want them to have less [than LHON] in some respects.’  
Ginny expressed thoughts that were present in a number of the other participant 
interviews that LHON is not a life-threatening condition, which is consistent with 
Petersen’s research (2006). Ginny plays down the significance of LHON on her life, 
indicating that she has still managed to live her life the way she wants to. At the time 
of interview, Ginny was in the process of returning to further education, having given 
up her studies because of a lack of support from her teachers when she was first 
diagnosed. Ginny has recently celebrated her 15-year anniversary of sight loss: 
‘We had a ‘balls to blindness’ dinner with all my family. We had meat 
balls, then we had melon balls and grapes, and then profiteroles in the 
shape of eye balls. It was an “up yours”, you know “look at me now, you 
might have thought you beat me 15 years ago”. I would love to go back 
and see the teacher who said I couldn’t do it and say “remember me?”’ 
Ginny has taken what was evidently a traumatic experience in her life and reframed 
it in a positive light. I asked Ginny if, when she made the decision to conceive 
naturally, she had discussed her options with other family members.  
 ‘No. It was our decision to make; she [mother-in-law] didn’t like it though. 
I have as little to do with her as possible (laughing). We don’t get on, shall 
we say. She has lots of opinions about me.’  
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Ginny believes that her mother-in-law would have preferred her son to be married 
to someone who did not have sight loss. She also explained that her mother-in-law 
is aware that Ginny has transmitted LHON to her children and was disapproving of 
her decision to conceive naturally, consistent with Parsons and Atkinson’s (1992) 
insight that women at risk of transmitting Duchenne Muscular Dystrophy faced 
hostility from their future mothers-in-law who considered it inappropriate to take 
the risk of transmitting the condition to offspring.  I asked Ginny, given her mother-
in-law’s concerns, if she had considered any other reproductive options: 
‘It didn’t even cross my mind at that point. If my Mum could have had that 
information that long ago and decided to have me, and not my brother, 
and then I would still have a problem. There is no guarantee if I had girls, 
they would pass it on.’ 
The point Ginny makes is that there is no guarantee that a female child will not 
experience sight loss or that a male will become affected. Although the scientific 
literature suggests that affected females are more likely to give birth to children who 
will also be affected (Van Senus 1963; Harding et al. 1995; Newman and Biousse 
2004). Ginny reiterated that she has coped very well with her sight loss: ‘It doesn’t 
affect my daily life, I know my way around and I also have somebody to help me’.  I 
asked Ginny how she would feel if her sons developed sight loss: 
‘I would try to do my best to make sure they have positive role models 
around them and hope that I am one of their positive role models, that 
Mummy did it, she still does everything else, and go from there’.   
As the interview progressed, the subject of Ginny having another child was raised. 
Given that MRTs are now licensed for use in the UK, I asked her if she would consider 
using the techniques:  
‘It’s a personal preference thing. If people want to do that and make sure 
their children are without this, that’s their opinion, their choice. To me, 
where do you draw the line? What else do you take away, where are we 
going with this? It will be almost like a form, there will be a tick box: you 
can get rid of Leber’s and maybe diabetes and cancer, what would you 
like us to get rid of in your child?  That’s not nature because that’s not the 
way it works. We are going to end up with people who are never poorly 
or then maybe they will live for an awfully long time. To me, where does 
the line stop?’ 
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Ginny did not indicate that her decision to conceive naturally was being made on 
religious grounds. However, her decision is influenced by the ethical arguments 
surrounding the use of MRTs. Ginny refers to having a tick box where genetic 
conditions can be removed, or characteristics altered. One of the enduring 
arguments associated with the use of MRTs is that they will result in a ‘slippery 
slope’ to the modification of the nuclear DNA and the birth of ‘designer babies’ 
(NCOB 2012: 52). Ginny also refers to what Buchanan (1996: 28) describes as the 
‘expressivist objection’, which suggests that using reproductive technologies to 
‘correct, ameliorate, or prevent genetic defects expresses (and presupposes) 
negative, extremely damaging judgments about the value of disabled persons’. 
Whilst Ginny is influenced by this argument, it is also evident that her view of 
reproductive technologies is grounded in her own ‘embedded experiential 
knowledge’ (Abel and Browner 1998, cited in Boardman 2014: 137) of living with 
sight loss. Boardman (2014) argues that experiential knowledge in the context of 
reproductive decision-making is increasingly being recognised as an important 
source of knowledge utilised by prospective parents when evaluating reproductive 
risks and exercising informed choice. Whilst Ginny uses her own experience to 
inform her thinking, Naomi uses her ‘empathetic knowledge’ (Abel and Browner 
1998, cited in Boardman 2014: 137) of the way her brother has coped with his sight 
loss. For Ginny and Naomi, their experiential knowledge is highly influential in their 
decision-making around reproductive options. Ginny, later in the interview, talked 
of her experience of joining a Facebook support group for LHON and how she had 
frequently contributed to the threads. However, following a number of adverse 
comments, prompted by her decision to conceive naturally, she now describes 
herself as an observer.  I asked Ginny to expand on the comments that had been 
posted: 
‘That they would never give this to their child. It is the worst thing in their 
life. They would never accept it, would never move on and they feel guilty 
now because they have got children and if they knew about the condition, 
they would not have had them. I have now become this quiet observer, I 
don’t often offer up my opinion. In no way do I think they are wrong, but 
it’s not quite the way I see the world.’ 
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Sally 
One of the other affected mothers, Sally, experienced sight loss when she was seven 
years old and did not receive her LHON diagnosis until after she had her two sons, 
both of whom have experienced sight loss. When talking about her decision to have 
children, Sally was very emotional that she was deprived of the opportunity to make 
an informed choice. I asked her whether, if she had been aware of LHON, she would 
still have conceived naturally: 
 ‘Yes (long pause), I don’t know. It’s really hard because they are here. You 
are talking about two individuals. You are talking about the possibility of 
having a child with a condition. I feel quite resentful about it all really, the 
lack of being told anything.’ 
 
As the interview continued, it became apparent that Sally’s embodied knowledge of 
growing up with sight loss has been influential in the way she has lived her life.  Sally 
explained that she attended a special school: 
‘All my mates went to the school down the road.  I was different; I went 
to this special school. I refused to go on the school bus because it was 
what everybody called the brown bus, the special bus. It’s horrific really 
but you know it was the special needs bus. People had tokens for bus fare. 
You were just made to be very, very different.’  
Sally suggests that if she had known of her diagnosis, she would have been in the 
position to imagine what kind of future her two sons would have. Given her own 
experience of growing up with sight loss, she may have decided not to have children. 
She feels angry and frustrated that the choice whether or not to have children was 
taken away from her. 
The affected women who were also mothers expressed strong views that they 
wanted their daughters to receive genetic counselling before they themselves 
decided to have children. Downing (2005) suggests that people who share a genetic 
risk with other relatives feel an obligation to help them in making reproductive 
choices by encouraging them to participate in genetic testing. Moira, who has MS-
like symptoms and LHON, and experienced sight loss when she was 26 years old, is 
typical of these participants. She has four daughters (one of whom has also lost her 
sight) and 10 grandchildren. In her interview, Moira expressed her regret that, 
knowing that she had lost her sight, her daughters did not have genetic counselling: 
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‘None of them had any counselling.  They all knew [about LHON] and they 
said to me “Mum, we made our decision, it was our choice to have our 
children”. Now with the three-parent baby… it’s too late for them because 
they have children… but their children, if they want to get rid of LHON, 
they can.’ 
Moira believes that her daughters chose not to undertake genetic testing because 
their perception is that she has coped with her sight loss. However, it seems that 
Moira would dispute this view, and refers to her grandchildren having the 
opportunity to use MRTs to avoid passing on LHON. One of the other affected 
women, Mary, recounted a similar experience with her children who were also 
reluctant to consider genetic testing and counselling. Mary and her sister, Sian, also 
have MS-like symptoms associated with the LHON m.11778G>A mutation. For this 
family, there is heightened uncertainty as to whether it is MS or LHON that is 
responsible for their sight loss. Mary developed sight loss in the early 1990s after 
the birth of her youngest daughter and, because of her symptoms (including lack of 
sensation in her fingers and numbness in her feet), she was given a diagnosis of MS. 
Mary also experienced seizures for which she was given medication. However, 
Mary’s eyesight continued to deteriorate and, in 2010, she was diagnosed with 
LHON. Sian, following the sudden onset of pins and needles and numbness in her 
feet, was diagnosed with MS after an MRI scan and lumbar puncture. The two sisters 
are concerned that their children and grandchild may also lose their sight. Mary has 
two daughters, who thus far have refused to participate in genetic testing and 
counselling.  Mary’s youngest daughter is now thinking of having children: 
‘I think I might push it now. Get the two of them to go and have it [genetic 
testing]. To actually sit down with a geneticist and to go through it with 
them. It’s not sinking in with them. I can tell my children until I am blue 
in the face. But for their peace of mind, it would be nice to know. They 
might get problems in the future.  
 Why don’t they want to be tested? 
  I think it is because we said they have got it. We have said this gene is in 
your body as well. Gran has passed it down to me and I have passed it 
down to you.  They didn’t go [for blood test] because they don’t like 
needles (laughs). My older daughter has got two boys, one is six and the 
other one is 18 months. 
Your daughter knew she was a carrier when she had the youngest child?  
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Yes, but then again, I don’t think anything would have stopped her. If she 
wanted to have a kid, she would have had one. We said “you could end up 
like me or it could bypass you lot altogether. You could be like Gran 
because my mother has got nothing wrong with her apart from old age”’. 
 
Moira, Mary and Sian’s experience of their children refusing to participate in genetic 
testing is mirrored in Dimond’s (2013) research with adult patients living with 
mitochondrial disease. Dimond claims that the participants attributed their 
children’s reluctance to be tested to not wanting to assume an ‘illness identity’. 
Instead, they made the decision to ‘get on with life’ (2013: 6). Moira also has a 
diagnosis of LHON and MS-like symptoms; during her interview she expressed her 
confusion as to whether she has MS with sight problems or LHON with MS-like 
symptoms. Moira when attending appointments, makes a point of asking for 
clarification of her symptoms: 
‘I always ask [clinicians] “have I got LHON with MS symptoms, or have I 
got MS?” They [clinicians] say I will never have full blown MS. My 
daughter is crippled with it. What is that? Definitely MS? And yet they say 
MS isn’t hereditary. I don’t understand it. MS is not hereditary but LHON 
is, so what is the connection between the two?’ 
Moira expresses her frustration that she cannot be given a definitive answer to her 
questions. Stivers and Timmermans (2016: 202) note that genetic testing does not 
‘always produce causal variants but often reveals ambiguous findings that have the 
potential to exacerbate rather than ease the patient’s diagnostic uncertainty’. Mary 
and Sian had been referred from their local hospitals to attend an appointment with 
Dr Morgan in St Tristan’s Hospital. I spoke with the sisters prior to the appointment, 
and they explained that they were hoping Dr Morgan would be able to provide some 
certainty in respect of the prognosis of their condition. During the appointment, 
Mary raised her concerns that her daughters and grandchildren may also lose their 
sight. Dr Morgan explained the uncertainty for patients diagnosed with LHON and 
who also experience the MS-like symptoms: 
Dr:  There is not much you can do other than reassure them 
[daughters] and hope for the best. But you know they could all be 
lucky. They, in fact, have got to a stage where they are in their mid-
20s to early 30s, they seem okay. So maybe things will be okay. 
Mary: But the thing is we are looking at my mother, she is 83.  There is 
nothing wrong with her.  
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Dr:  This is where the uncertainty comes in. They all carry the 
mutation in the mitochondrial DNA, but only some people develop 
the condition. That’s partly bad luck. You have been unlucky, both 
of you. In some respects, you are more closely related to each 
other than say your grandchildren are to you, obviously you are 
sisters. There is something that has clearly triggered the MS-like 
illness in yourselves that may not carry through to the other 
people in your family.  
Mary: It [sight loss] could have been something specific just to us with 
the MS? 
Dr:  If you look at the MS and the causation of MS, of course we don’t 
know... but there could be environmental triggers, there could be 
things in your childhood, there could be... something that may 
have affected you together. It could be lots of things; no one has 
actually found a trigger. It could be even past infections. The one 
certainty is you have the visual problem and obviously you also 
have the other MS symptoms. It’s a really difficult conundrum. 
Obviously, something in females, whether it is hormones, whether 
there are other aetiological factors which might cause it and pre-
dispose women to be more likely to get it. But again you are 
dealing with risks, you are not dealing with certainties.’ 
Mary and Sian have a degree of certainty as they know they have the m.11778G>A 
mutation and they also know that they experience MS-like symptoms. However, the 
cause of their symptoms remains unidentified which leaves them living with 
uncertainty. After their appointment with Dr Morgan I interviewed the sisters, who 
expressed their disappointment that they had not received the answers they were 
looking for. Sian captured the thoughts of the sisters:  
‘Whenever I go anywhere, its well it’s probably to do with the MS. 
Nobody seems to want to commit themselves. Like this morning the 
consultant hasn’t told me anything that I didn’t already know. I saw the 
pictures [OCT and retinal imaging] which were nice because I haven’t 
seen any pictures before.’ 
Stivers and Timmermans (2016: 201) suggest that diagnostic uncertainty ‘occurs 
when available information is limited or characterised by probability, ambiguity, or 
complexity and may lead to confusion, anxiety, and indecision’. Dr Morgan attempts 
to provide some certainty for the sisters, by suggesting that they may have 
experienced an event in childhood, which is unlikely to be replicated for their 
children and grandchildren. Dr Morgan aware that the two sisters were 
disappointed,  that they had not been given more certainty in respect of whether 
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their children and grandchild would be affected suggested to me: ‘uncertainty is not 
a concept that patients very easily accept. The fact is people expect there to be 
certainty, they expect there to be certainty around treatments, and what is going to 
happen in future, and that isn’t always so.  During the appointment, the sisters 
continue to experience anxiety because they do not know whether their extra-ocular 
symptoms will deteriorate over the course of their lives. However, consistent with 
the findings of Latimer et al.’s (2006) research in the dysmorphology clinic, Dr 
Morgan asked the sisters if they would like to continue to attend the genetic 
ophthalmology clinic, so that their condition would continue to be monitored.  
Summary  
I began this chapter by locating participants’ claims within the sociology of hope. 
Participants spoke passionately of their hope that new treatments would be 
available to restore their sight or avoid the birth of children with LHON. A number 
of participants have invested emotionally and, in some cases, financially in the 
potential for one treatment—Idebenone—to improve their sight. It is evident that 
the pharmaceutical company developing Idebenone have participated in the 
‘political economy of hope’ (Novas 2006: 289) and strategically brought together 
key actors (including research funders, clinicians and patient advocacy groups) to 
raise awareness of LHON and in so doing to accomplish their agenda of recouping 
their investment in the development of the drug by having it approved for use by 
the NHS in the UK. I discussed how the ‘hype’ (Brown 2003: 3) surrounding the claim 
that Idebenone has the potential to restore sight has divided the scientific 
community (Carelli et al. 2011; Lyseng-Williams 2016; Yu-Wai-Man et al. 2017). 
Similarly, participants were also divided on the effectiveness of the drug. Beth and 
Sandra felt it had helped improve their eye sight. In contrast, Marion spoke of her 
disappointment that her son had used Idebenone for several years without an 
improvement in his visual acuity.  
In the second part of the chapter, drawing predominantly upon the experiences of 
four women (Marion, Naomi, Ginny and Sally), I discussed narratives of hope 
surrounding the introduction of mitochondrial replacement techniques (MRTs) to 
avoid the birth of a child with LHON. I explored to what extent the women were 
influenced in their reproductive decisions by the ethical arguments that the 
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techniques would create a ‘slippery slope’ to ‘designer babies’ (NCON 2012: 52). 
Naomi, who is a carrier, supported the use of MRTs. In contrast, Ginny, who was 
affected when she was 18 years old, raised her concerns that in choosing to use 
MRTs, this devalues the lives of those who live with a disability. Sally suggests that 
she may have considered the use of MRTs had the techniques been available when 
she conceived her two sons. I would suggest that these women were more 
influenced by their experiential knowledge of either being affected (Ginny and Sally) 
or, in the case of Naomi, living with a relative who has been affected. Sally describes 
her experience of growing up with sight loss as traumatic. In contrast Ginny views 
her sight loss in a positive light, claiming that it has not stopped her from doing the 
things that she wants to do.  Similarly, Naomi considers that her brother has coped 
extremely well with sight loss.  
I also considered the extent to which women affected by LHON were keen to 
persuade their children, particularly their daughters, to undertake genetic testing 
and genetic counselling before having children of their own. Consistent with 
Dimond’s (2013) research, there was a great deal of reluctance by women who are 
carriers of LHON to be tested, which in part, is attributable to adopting a 
philosophical attitude that if their children are affected, they will deal with it. It was 
evident that the children of affected women, using their experiential knowledge, 
decided that their mothers had coped well with sight loss and so they did not 
perceive having children who may develop sight loss as an issue.  
In Chapter Eight, I provide an overview of the thesis and bring together the themes 
that have been identified in the empirical chapters. I will also consider how the 
experience of living with sudden sight loss can contribute to wider debates around 
living with chronic illness.    
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Chapter Eight: Discussion 
 
In the preceding chapters, I identified Leber hereditary optic neuropathy (LHON) as 
an under-researched mitochondrial condition, suggesting that people living with 
LHON constitute ‘missing voices’ (Lawton 2003: 36) within the sociological 
scholarship. To address the gap in the literature, I have drawn heavily on interview 
data and some observations to explicate the lived experiences of men and women 
affected by LHON, their mothers who carry the LHON mutation, and the health care 
professionals who diagnose, treat and seek to find a cure for the condition. I have 
discussed, within the four empirical chapters, participants’ chronic illness trajectory 
(Glaser and Strauss 1964), looking at their past, their present and their imagined 
futures, with trajectory seen in terms of  Conrad’s (1987: 10) comments that 
trajectory ‘encompasses process and change but does not assume linearity or 
orderliness’. On the contrary, mirroring Yoshida’s (1993: 222) research with people 
who experienced traumatic spinal cord injury, participants in this thesis, over a 
period of years, move back and forth between experiencing ‘nondisabled and 
disabled aspects of self’. 
This chapter will begin by unpacking three of the major themes emerging from the 
research: (1) professional knowledge, uncertainty and contestation: (2) normalcy, 
stigma and the everyday experience of illness: (3) imagined futures. These themes 
evolved from exploring key sociological and disability studies scholarship, and the 
formulation of an over-arching research question outlined in Chapter One:  
What are the subjective experiences and perceptions of people affected by 
LHON, and how are relationships within the family renegotiated following 
the diagnosis?  
 
Moreover, the themes were informed by four subsidiary research questions:  
 
1. What are the challenges presented to genetic ophthalmologists in the 
diagnosis and treatment of LHON? 
 
2. To what extent does LHON disrupt an individual’s biography and what are 
the implications for their identity and sense of self?  
 
3. How do people with LHON imagine their future? 
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4. Are women influenced by their experiential knowledge of LHON when 
making reproductive decisions?  
In discussing the three themes, I suggest how the experiences of participants both 
coalesce and on occasions diverge from classic and contemporary social scientific 
accounts of chronic illness and disability. From here I am able to justify why I have 
both adopted and extended the work of leading scholars, including Bury (1982) and 
Charmaz (1983, 1991). In the final part of this chapter, I will ponder what the future 
holds for people with LHON. Specifically, I consider the challenges and hardships 
likely to be encountered by visually impaired people (and disabled people more 
generally) going forward, including navigating the context of austerity politics 
which has provoked drastic cuts to the Health and Social Care budget,  
Professional knowledge, uncertainty and contestation 
Drawing on interview data and several observations, I capture how LHON is 
characterised by uncertainty and contestation surrounding the diagnosis and 
prognosis of the condition. Consistent with other rare conditions (Rare Disease UK 
2016), participants often experienced a protracted and contested quest to find a 
diagnosis. In Chapter Four, I suggested that diagnosis is an interpretive process of 
identifying and classifying disease which takes place within the doctor/patient 
consultation—in which the doctor calls upon an agreed stock of knowledge to label 
a condition and provide treatment (Jutel and Dew 2014). However, I also argued 
that diagnosing LHON is not confined to such an interaction. Indeed, I suggest that 
the identification and categorisation of LHON parallels previous research in the 
dysmorphology clinic, for example where accomplishing a genetic diagnosis is 
located at the intersection of the clinic and the laboratory (Featherstone et al. 2005; 
Latimer et al. 2006; Latimer 2013). The clinician’s expert gaze is utilised to identify 
the characteristic symptoms of the condition, by calling upon not only repertoires of 
evidence (slit-lamp examination, OCT, MRI) but also their clinical judgment. The use 
of innovative molecular genetic technologies, (including next-generation 
sequencing) provides confirmation of the LHON mutation. However, it is the 
clinician’s expertise that remains central to the diagnostic process. I have 
highlighted how LHON is an elusive condition and symptoms are, occasionally 
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misinterpreted and—it is in these moments —where clinicians cannot ‘transform 
patient problems into solvable problems’ (Berg 1992: 172) that people with LHON 
are reconfigured as ‘bad’ patients (Jeffrey 1979). Care is downgraded with patients 
categorised as time wasters, who are denied access to medical treatment and 
‘disposed’ of by being discharged from the clinic (Latimer 1997, 1999). The 
repercussions of not receiving a timely diagnosis are significant as participants are 
denied access to additional resources to support their return to employment and 
education, obtain welfare benefits and secure referrals to specialist services 
(including genetic counselling).  
When I interviewed people with LHON, I did not anticipate that the process of 
diagnosis would dominate their narratives. In unpacking their accounts, I identified 
three areas of concern in the diagnosis and treatment of LHON. Firstly, LHON is 
rarely observed in clinical practice, and therefore specialist registrars (and 
sometimes consultants) do not include it in the differential diagnosis. When women, 
young children and older people present in the eye casualty clinic with bi-lateral 
sight loss, ophthalmologists discount LHON as a possibility as they believe the 
condition is the preserve of men in their early teens and twenties. I subsequently 
argue that the ophthalmic training curriculum is inadequate in training 
ophthalmologists to recognise rare inherited conditions in clinical practice.  
Secondly, it is suggested that in the UK doctors are trained to use diagnostic tests in 
a linear way; only after a test has proved negative is the next test ordered.  This is 
problematic for LHON, as the clinical evidence (see Chapter Four) suggests that new 
treatments such as Idebenone and gene therapy are likely to be most effective when 
administered at the onset of LHON. Therefore, speed of diagnosis is of the essence.  
Thirdly, delays in diagnosis occur when blood samples are sent to the gene panel for 
analysis. The clinicians interviewed in my thesis all agreed that the lengthy delays 
in obtaining test results were in part due to the cuts to the NHS budget. In an age of 
austerity, the NHS is challenged by increased patient demand for healthcare with 
finite resources. A clinician in this study, Dr Penvenen suggested that budgetary 
controls within the NHS have resulted in genetic testing taking up to four months in 
some parts of the UK. Newdick (2005: 1) argues that the demand for health care 
continues to exceed the supply of resources made available by the NHS, with the 
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spending on healthcare ‘outpacing economic growth […] forcing governments to 
find new funds or pass a larger share of costs onto individuals’. The age of austerity 
has thereby restricted the availability of specialist services including genetic 
counselling. A number of participants in this research explained that they did not 
receive a referral, experienced inordinate delays before receiving their 
appointment, or were only offered one genetic counselling appointment. As a 
consequence, some of them paid privately to see a genetic counsellor. Participants 
such as Beth who are well educated and, so equipped to negotiate the healthcare 
system, hold the appropriate capital for both articulating their views in interactions 
with doctors and paying privately for treatment. Not all people with LHON, however, 
will be so fortunate.  
Normalcy, stigma and the everyday experience of illness 
Throughout this thesis I borrow Bury’s (1982) concept of biographical disruption to 
explore the consequences of sight loss. Irrespective of age or gender, every person 
with LHON who participated in this study described experiencing disruption in the 
weeks and months following their diagnosis. Whilst acknowledging that Bury’s 
(1982, 1991) framework has been the subject of continuous debate (Lawton 2003; 
Pierret 2003; Williams 2000), I suggest that it has stood the test of time, especially 
in terms of making sense of the participants’ claims in this research. A number of 
participants expressed their frustration and at times irritation that they were no 
longer able to perform daily activities including ‘routine body maintenance’ (Barnes 
and Mercer 2010: 52), and required assistance from their family to accomplish these 
taken-for-granted tasks. It is in these moments that family relationships are re-
negotiated, a key focus for the likes of Bury (1982) and Charmaz (1983). Whilst I 
have adopted Bury’s (1982) concept, I have also extended its application. Bury’s 
participants were relatively young when they experienced rheumatoid arthritis. 
Answering Williams’ (2000: 61) call for the extension of the ‘biographical focus’ of 
studies in the sociology of chronic illness ‘to both ends of the life course’ (original 
emphasis), I interviewed individuals, who were children, and individuals who were 
in their sixties, when they experienced sight loss.  
Whilst Bury outlines how his young participants experienced biographical 
disruption at the onset of their illness. I argue that Bury’s concept is pertinent in 
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understanding how people with LHON negotiate the longer-term consequences of 
illness.  
In locating this research within the wider scholarship, I acknowledge that different 
chronic conditions give rise to a range of varying experiences.  However, as Kelly 
(1992: 48) puts it, ‘in many ways the problems posed by such illnesses share a 
quality which cuts across particular medical diagnoses and is common to them all’. 
In reviewing the classic chronic illness scholarship I have highlighted two points of 
departure. Firstly, there is an assumption that chronic illness is to be expected in 
older age (Pound 1998; Williams 2000; Sanders et al. 2002; Faircloth et al. 2004), 
and therefore, is not considered to be disruptive since it is a normal component of 
the life-course. Williams (2000: 51) suggests that in older age chronic illness may be 
perceived as a ‘biographically anticipated event’. Similarly, Faircloth et al. (2004: 
245), also argue the onset of sudden illness such as stroke is not always perceived 
as a disruptive event, but instead may be viewed in terms of a ‘biographical flow’. 
This is not the case for older participants in this thesis, some of whom allude to being 
‘healthy and feeling cheated (Sandra) by the loss of their sight.  I argue, then, that 
rather than focus on the age of onset of sight loss we should instead adopt Lawton’s 
(2003: 29) suggestion that it is more appropriate to consider an ‘individual’s whole 
biography, not just the age at which they first contract a particular disease’.  
Secondly, there is an assumption, predominantly within the psychological sight loss 
literature, that following sight loss people move in a unidirectional way through the 
five stages of grief, ultimately arriving at acceptance (Kübler-Ross 1963). Mirroring 
more recent research (Murray et al. 2010), the narratives of participants in this 
thesis suggest that the traditional grief model is too simplistic and fails to account 
for the diverse and highly individualised experiences of sudden sight loss. Many 
participants in this thesis continue to experience episodes of grief many years after 
the onset of sight loss—and thus, never reach acceptance. I have also captured the 
initial reactions of mothers to their child’s diagnosis. LHON is a sporadic condition, 
as in the majority of cases there is no family history. Mothers who were unaware of 
their carrier status experienced feelings not only of guilt and self-blame, but also 
shock and devastation after their child was diagnosed (Clarke 2016). Mirroring 
Thomas’ (2014) study with mothers of children diagnosed with Down’s syndrome, 
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they mourn the loss of the perfect idealised child. In the months following their 
child’s diagnosis, mothers expressed the view that their children would never lead 
an independent life or get married and have children of their own. However, again 
mirroring Thomas’s research, mothers later spoke of their pride in their children’s 
achievements.  
Following the early weeks and months, participants start to re-position themselves 
by recognising that LHON is a long-term condition. I have explored how participants 
negotiate the longer-term everyday realities of living with sudden sight loss by 
considering the significance (Bury 1991) for them of living with LHON. I again draw 
on Bury’s (1982) conceptual framework of biographical disruption. Whilst 
acknowledging that Bury’s framework refers to a single event occurring at the onset 
of illness, this is a point of departure for this thesis. Participants, some of whom had 
lived with sight loss for nearly 20 years, referred to experiencing repeated events of 
disruption throughout their lives—a kind of ‘recurrent biographical disruption 
(Saunders 2017: 726). As a chronic illness, LHON occupies an unusual space within 
the chronic illness literature. Many participants were in good health before the onset 
of LHON and (with the exception of the four women diagnosed with MS-like 
symptoms), remain so after their sight loss. However, although not terminal, LHON 
is a chronic condition as it is long-term and currently has there no cure.  
I identified that irrespective of age, a number of participants considered that after 
receiving their diagnosis a life was over. I have captured how some of the younger 
participants, have not yet come to terms with their sight loss. Charmaz (1983) has 
characterised living with long-term illness as leading a restricted life, experiencing 
social isolation, and negotiating discredited definitions of self, forcing individuals to 
reconceptualise their self-identity. The narratives of participants in my thesis 
resonates with Frank’s (1995: 97) ‘chaos narrative’. However, I also claim that 
participants experience emotions more severe than biographical disruption aligning 
more with  Locock et al.’s (2009: 1043) concept of ‘biographical abruption’, that is 
when people consider a diagnosis to be a ‘death sentence’. 
I explored how participants overcome the challenges presented to them by sudden 
bi-lateral sight loss. One of the dominant themes that emerged from participant 
narratives was the desire to return to a ‘normal’ life. Normality was interpreted as 
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once again undertaking tasks that had previously been taken-for-granted or doing 
the same things as everyone else. My findings parallel current research that has 
considered how normalcy is negotiated in everyday life (Gregory 2005; Hanson and 
Philo 2007; Seidman 2013; Coleman-Fountain 2017; Buse and Twigg 2018; 
McLaughlin and Coleman-Fountain 2018). Green (2009: 4) argues that by 
promoting positive images of illness and disability, those who have previously been 
categorised as ‘not normal’ are challenging what it is to be ‘normal’. There has also 
been a wealth of anti-discrimination legislation such as the Equality Act 2010, 
designed to protect the right of those living with a disability. 
Such legislation is an example of how attitudes to those living with a disability are 
being challenged; (although the relative successes of such legislation in achieving 
this lofty aim has been debated, (Thomas 2012)). Disability activists continue to 
contest perceptions that disability is a personal tragedy and those living with 
disability are to be pitied. The old order, that positioned disability within a medical 
model preoccupied with the symptoms of disease, is being usurped by the 
introduction of a social model of disability, which acknowledges that it is not a 
problem located within the impaired body but is a consequence of an oppressive 
social environment (Oliver 1990, 1996; Barnes et al. 2002; Thomas 2007). As Green 
(2009: 9) comments: 
‘the social model shifts the problem away from people with disabilities 
and focuses upon society and societal attitudes that create a physical and 
social environment that socially excludes and oppresses disabled 
people.’ 
Notwithstanding these welcome changes in attitude, for many participants the 
social model of disability has failed to bring about changes to the physical 
environment which continues to exclude them and poses a threat to their desire to 
be perceived as normal. Whilst the built environment has proved challenging, the 
most pervasive challenge to normality identified by participants was that of 
experiencing stigma, both felt and enacted (Scambler and Hopkins 1986), which at 
times sabotaged their attempts to be perceived by others as normal. Participants did 
not believe they were stigmatised by their diagnosis of a genetic condition, but 
rather by the reaction of others to the physical manifestations of their sight loss.  
Echoing Watson’s (2002) research, many of the participants in this thesis, felt that 
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they were ‘normal’. Scambler and Hopkins (1986) claim that, for their participants 
felt stigma was more apparent than enacted stigma. However, although participants 
in my thesis referred to experiencing both felt and enacted stigma, it was enacted 
stigma that dominated their social interactions. Participants’ narratives recounted 
numerous instances of (overt) stigma whilst using public transport, or whilst in the 
workplace, or out shopping. Scambler and Paoli (2008: 1851) have added a further 
dimension to understanding felt and enacted stigma by introducing the concept 
which they refer to as ‘project’, suggesting that people respond to discreditable or 
discredited illnesses, ‘without either internalising cultural norms of shame and 
blame or becoming fearful, defensive or subdued by prospects of discrimination’. 
The authors argue that people living with disabling conditions ‘formulate positive 
strategies and tactics that acknowledge the risks of enacted stigma and deviance 
whilst trying to avoid the pitfalls of felt stigma and deviance’. There was no evidence 
to suggest that participants in my thesis had formulated positive strategies when 
confronted with stigma (felt or enacted). For instance, whist some participants 
identified the ‘secondary gains’ (Goffman 1968) of a white cane, they also conceded 
that they would avoid using it in certain situations. 
Imagined futures 
Over time, the majority of participants were able to adopt coping strategies to 
successfully live with their changed circumstances and imagine a future where they 
realise their aspirations, including finding a good job and buying their own home- 
where they could in short, live a ‘good life’ (Sakellariou 2015; Errington et al. 2018). 
In Chapter Seven I looked to the future and located my discussion in the sociology 
of hope (Petersen and Wilkinson 2014). Whilst a few participants claimed that they 
had accepted their sight loss and were not interested in finding a cure, the vast 
majority of participants invested emotionally and financially in the introduction of 
one new treatment—Idebenone—to restore their sight. I have alluded to how the 
effectiveness of Idebenone has divided the scientific community. I have also argued 
and that Santhera Pharmaceuticals provides an example of how a multinational 
company, seeking to recoup the costs of developing Idebenone, has attempted to 
mobilise stakeholders to have Idebenone routinely prescribed in the UK and in so 
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doing have participated in what Novas (2006: 289) refers to as the ‘political 
economy of hope’.  
I also explored the hope felt women who were interested in the development of 
mitochondrial replacement techniques (MRTs) which potentially will provide them 
with the opportunity to give birth to a genetically-related healthy child. I focused on 
the narratives of four women, in particular, two of whom at the time of interview 
were considering their reproductive options. Notwithstanding the extensive media 
debates surrounding the ethical, social and legal implications of allowing MRTs, the 
women were influenced not by the extensive media rhetoric but by their own 
experiential knowledge of being affected by LHON or living with a relative who is 
affected. 
Chronic illness and disability 
These three key themes, I argue, combine to suggest two key, unique contributions 
to the wider literature. First, the thesis extends Bury’s (1982) conceptual framework 
of biographical disruption through exploring the lived experiences not only of men 
and women affected by LHON, but of their mothers who carry the mutation, a group 
of people rarely the focus of sociological interest. Using interview data and some 
observations, I also unpacked the work of the genetic ophthalmologists in 
diagnosing and treating LHON. In so doing, I would argue that this research 
contributes to the sociology of diagnosis scholarship (Blaxter 1978, 2009; Brown 
1990, 1995; Jutel 2009; Jutel and Nettleton 2011).  
I acknowledge throughout the thesis that Bury’s conceptual framework has been the 
subject of much debate (Lawton 2003; Pierret 2003; Williams 2000); indeed Bury 
(2001) has revisited and extended his original work. I have also acknowledged that 
more recent research (for example, Locock et al. 2009; Saunders 2017) has provided 
a new perspective on Bury’s concept. Nonetheless, the narratives of participants in 
this thesis chimes incredibly accurately with Bury’s own insight – as well as those of 
scholars like Charmaz (1983) and Williams (1984). Such classical works, when used 
to frame the experiences of people with LHON in this research, show remarkable 
durability.  
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Finally, I suggest that by unpacking the complex interconnections between sight 
loss, disability, normalcy, and stigma, my thesis is located at the intersection of 
disability studies and medical sociology, thereby contributing to the ongoing debate 
surrounding disability and impairment. As Watson (2013: 78) has commented, the 
social model of disability was developed by disability activists and promoted by 
disabled scholars, who were ‘disillusioned with the way that sociology in general, 
and medical sociology in particular, defined and researched disability’. In turn, 
Thomas (2007: 570) suggests that disability studies are informed by the idea that 
disability is ‘culturally structured by social oppression, inequality and exclusion’.  In 
contrast, medical sociology delineates disability as a consequence of illness and 
impairment and entails suffering and some social disadvantage.  
The future  
So what now for people with LHON? Against the background of austerity politics, 
people living with sight loss in the UK may be said to be facing a precarious future 
as financial cuts to the Health and Social Care budget impact on the provision of eye 
clinic services, the recruitment and training of ophthalmologists (Royal College of 
Ophthalmologists 2018), and support services provided by local authorities. The 
RNIB recently published a series of reports and consultation papers (2016) focusing 
on how cuts to the social care budget impact on the quality of life of the visually 
impaired. There are almost three quarters of a million blind or sight impaired people 
living in the UK and this number is predicted to increase by 12 per cent in the next 
five years (RNIB 2016). The RNIB claim that of the severely sight impaired and sight 
impaired people who are known to their local authority in England, 49 per cent do 
not receive assessment for vision rehabilitation support. Similarly, research 
undertaken by the Thomas Pocklington Trust (2018) suggests that reductions in the 
availability and amount of welfare benefits have caused exceptional financial 
hardship to those living with visual impairment. 
There has been a lack of sociological scholarship exploring the lived experience of 
sudden sight loss.  In what follows, I suggest some avenues for further exploration. 
For instance, whilst I have focused on affected men and women and their mothers, I 
believe there are a number of areas of further research including, firstly, collecting 
the narratives of unaffected siblings, who have to cope with ‘survivor guilt’ (Arribas-
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Ayllon 2008: 1522) and who may themselves develop sight loss at some point in the 
future. Moreover, I did not have the opportunity to interview fathers to discuss their 
experience of living with a partner who carries or is affected by LHON and one or 
more children who are affected, this indicates a possible point of departure for 
future researchers.  Finally, undertaking research with people currently enrolled 
into the gene therapy trial would provide the opportunity to consider in more depth 
the motivation for participating in an experimental treatment that may potentially 
restore sight but also may result in loss of visual acuity.  
Conclusion 
In drawing my thesis to a conclusion, I have alluded to the lack of sociological 
scholarship exploring LHON. Although this could be considered a disadvantage, I 
suggest that it has given me the opportunity to locate my thesis within the chronic 
illness literature whilst also providing the opportunity to unpack wider sociological 
debates exploring the complex interconnections between sight loss, disability and 
normalcy. From here, I have been able to both engage with and extend key themes 
(including biographical disruption (Bury 1982), loss of self (Charmaz 1983), 
uncertainty (Fox 1957; Atkinson 1984; Davis 1960), regaining a sense of normalcy 
(Davis 1995) and stigma (Goffman 1968; Scambler and Hopkins 1986, Scambler 
1989, 2006, 2009, 2018)), and discuss their relevance to people living with LHON. I 
have suggested that LHON is a condition that is poorly understood, a condition that 
does not sit easily within the chronic illness literature with the majority of 
participants remaining fit and healthy after their sight loss—and yet having a long-
term inherited condition for which there is currently no cure.  In addressing the 
existing gaps in the literature, I argue that my thesis is located at the intersection of 
the chronic illness and disability studies. 
I finish by reminding myself of Southwell’s (2012: 109) comments that ‘fear, pity 
and stigmatisation of visual impairment are not just somewhere out in the 
atmosphere, they are within all of us to a degree, until we take the trouble to learn 
that they are subconsciously assumed stereotypes that we can correct’.  
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Appendices 
 
Appendix 1: Anatomy of the Eye  
 
 
 
Source: The Royal College of Ophthalmologists (2018). 
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Appendix 2: Invitation letter adult participant interview and observation 
(example) 
 
Study Title: Living with Leber hereditary optic neuropathy: 
exploring the experiences and perceptions of children, young 
adults and their families. 
 
Date: 
 
Dear           
My name is Lydia Harper and I am a PhD researcher at Cardiff 
University. I am conducting a research study and would like to invite 
you to participate. My research is interested in finding out what it is 
like to have a genetic eye condition known as Leber hereditary optic 
neuropathy (LHON). I would like to be present when you attend the 
hospital for your eye clinic appointment and after the appointment, I 
would like to interview you. 
I have included in this letter an information sheet and consent form. 
If you would like to take part in my research, please email me at 
HarperL@cardiff.ac.uk. I will then arrange to discuss my research in 
more detail with you and answer any questions you may have 
before you make a final decision. 
Thank you for your help. 
Yours Sincerely 
Lydia Harper 
PhD Researcher 
Cardiff University School of Social Sciences 
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Appendix 3: Invitation letter child participant interview and observation 
(example) 
 
Study Title: Living with Leber hereditary optic neuropathy: 
exploring the experiences and perceptions of children, young 
adults and their families. 
Date: 
 
Dear [Insert Parent/ Guardian Name] 
My name is Lydia Harper and I am a PhD researcher at Cardiff 
University. I am conducting a research study and would like to invite 
your child to participate. My research is interested in finding out what 
it is like to have a genetic eye condition known as Leber hereditary 
optic neuropathy (LHON). I would like to be present when your child 
attends the hospital for their eye clinic appointment and after the 
appointment, I would like to interview you your child. 
I have included in this letter an information sheet and parental 
consent form. If you are interested in my research, please contact 
me on the telephone number or email above. I will make arrange to 
discuss the information sheet with you in more detail and answer 
any questions you may have before you make a final decision. 
Thank you for your help. 
Yours Sincerely 
 
Lydia Harper 
PhD Researcher 
Cardiff University School of Social Sciences 
 
 
 
248 
 
Appendix 4:  Information sheet and consent form adult participant 
(example) 
 
Participant Information Sheet and Consent Form for Adults attending the 
Eye Clinic 
 
This Information Sheet and Consent Form is for research participants who are 
being invited to participate in a study that will explore what it is like to live with 
the genetic eye condition known as Leber hereditary optic neuropathy (LHON). 
This form has two parts: 
 Information Sheet (gives you information about the study) 
 Consent Form (this is where you sign if you agree to participate). 
You will be given a copy of this form. 
Part 1: Information Sheet 
Introduction 
My name is Lydia Harper and I am a PhD Researcher at Cardiff University. As 
part of my degree I am inviting you to take part in my research project which 
aims to discover what it is like to live with the genetic eye condition known as 
Leber hereditary optic neuropathy (LHON). Your involvement in the research 
will be voluntary, your medical treatment will not change, and I will not have 
access to your medical records. Before deciding whether you would like to 
participate, I would like you to understand the reasons for my research and 
what it may involve for you.  Reading the information sheet will take around 10-
20 minutes. Part 1 of this formation sheet tells you the purpose of the study and 
provides more detailed information. Part 2 is the consent form which you sign if 
you are happy to participate. If you would like to participate, please contact me 
by telephone or email. 
What is the purpose of the study? 
Developments in genetic technologies to identify and treat rare genetic eye 
conditions are advancing at a rapid pace. This means that there is now far more 
information available than ever before. Some of the information may be very 
complex and difficult to understand. My research is concerned with the 
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experiences and perceptions of adults who have been diagnosed with LHON. If 
you previously attended the genetic eye clinic or genetic counselling clinic, I 
would like you to tell me about your experience. My research is also considering 
how adults and their families come to terms with a sudden loss of sight caused 
by a genetic eye condition. 
Who has reviewed the study? 
All research in the NHS is reviewed by an independent group of people, called a 
Research Ethics Committee, which is there to protect your safety, rights, 
wellbeing and dignity. This project has been approved by the Wales REC 1. 
Why have I been invited to participate? 
You have been invited to participate in the research because you have been 
identified by your ophthalmologist as having LHON.  
What will happen if I take part? 
If you agree to take part, I would like to be present during your eye clinic 
appointment. During the appointment I will be taking notes and may use a 
digital recorder to record the conversation between you and the 
ophthalmologist; this is to ensure that I type up accurately what is said during 
the appointment. I will only record the appointment if you agree to this. If you do 
not want me to record the appointment, then I will not do so. I will not be 
requesting any extra time on top of what is already allocated for the 
appointment. 
  
After the appointment I would like to interview you about your experiences and 
perceptions of living with a genetic eye condition and if you have developed 
problems with your eyesight how this affects your ability to undertake daily 
activities. If you agree to the interview, this would take place immediately after 
your appointment or (if you prefer) at a later date. I will be taking notes during 
the interview and may also use a digital recording device to record the 
interview. This is to ensure I accurately record what you say during the 
interview.  However, if you do not want me to record the interview then I will not 
do so. You can choose when and where you want the interview to take place. 
The interview will last approximately 1–1½ hours.  
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Is participation in the study voluntary? 
Yes. You do not have to agree to take part in the research.  If you do agree to 
participate, you will need to sign a consent form. If at a later date you change 
your mind, you can withdraw your consent to participate in the research. In the 
event that you do decide to withdraw consent, any information collected during 
the research will be destroyed securely. 
What are the potential benefits of taking part? 
The study will not help you directly, but the information you provide may help 
other people to understand what it is like to have a sudden loss of sight caused 
by a genetic eye condition. 
What are the risks of taking part? 
You will be asked sensitive questions about your eyesight and how it impacts 
on your ability to take part in daily activities and how your eyesight will 
potentially affect your prospects of continuing your education and obtaining 
employment. You may find talking about these things upsetting; however, this 
research has been designed to ensure that your welfare is the most important 
consideration. If at any time you find talking about your eyesight distressing, the 
interview will be stopped. You can also decide not to participate in the research 
if it is too upsetting for you to carry on. If you do decide to withdraw from the 
research any information I have collected will be destroyed securely. 
What if I do not want to carry on with the study? 
If you decide you want to withdraw from the study, please contact me 
immediately. Any information that has been collected up to this point will be 
deleted. However, if at a later date you change your mind and want to 
participate once again you can re-register an interest at any time during the 
study. 
Will I find out anything about the outcome of the study? 
Yes. At the end of the research, I will send you a summary of the results.  I am 
also intending to use the results of the study as the basis for articles that may 
be printed in research journals, and for presentations at academic conferences. 
The data will be anonymised so that you cannot be identified.  
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Who is organising and funding the study? 
This study is sponsored by Cardiff University and is funded by the Economic 
and Social Research Council (ESRC). 
What consequences will this have for the data collected? 
The ESRC requires that researchers send data to the UK Data Archive (UKDA). 
The data will include typed-up transcripts from the clinical appointments and the 
interview transcripts. The transcripts will be heavily edited to ensure that there 
are no identifiable individuals or locations. The data stored at the UKDA will be 
anonymised and made available to third parties. However, your data will only be 
sent to the UKDA and made available to third parties if you agree to this.  The 
typed-up interview notes will be kept for a minimum period of five years from the 
end of the research. This is in accordance with Cardiff University’s data 
retention period. After five years, the data will be destroyed consistent with 
Cardiff University’s ‘Complying with Data Protection and Freedom of 
Information’ policy. 
Will my participation in the study be kept confidential? 
Yes. All the information about your involvement in this study will be confidential. 
This means that you will not be identified in any report or publication. The 
identities of everyone taking part in the study will be protected by being given 
false names or numerical codes. The data collected from you (audio-recordings 
and typed-up interview notes) will be stored securely either in a locked filing 
cabinet (which only I can access) on security-controlled Cardiff University 
premises or on a password-protected Cardiff University computer and a 
password-protected USB computer device. The data will have your name 
removed and replaced by a numerical code. The sheet containing these codes 
and your contact details will be kept as manual records in a locked filing cabinet 
on security-controlled Cardiff University premises. After the PhD thesis is 
completed, your data and details will be deleted and/or shredded in accordance 
with Cardiff University regulations. Please note you have the right to check the 
accuracy of the data that I hold. 
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What if I have a complaint about my participation in the study? 
If you have concerns about the study, please do not hesitate to contact me, 
Lydia Harper at HarperL@cardiff.ac.uk. You may also contact my academic 
supervisors, Professor Adam Hedgecoe (02920 870027, 
HedgecoeAM@cardiff.ac.uk) or Professor Joanna Latimer (02920 876908, 
LatimerJE@cardiff.ac.uk). You may also wish to contact the Clinical Supervisor 
for this research: Dr Morgan, consultant ophthalmologist, St Tristan’s Hospital. If 
you remain unhappy and wish to complain formally, you should contact the 
Complaints Department by email: Concerns@wales.nhs.uk. 
What happens if I am harmed while participating in the study? 
In the unlikely event that something goes wrong and you are harmed during the 
research, and this is due to someone else’s negligence, then you may have 
grounds for a legal action for compensation against Cardiff University.  
Further information and contact details 
Thank you for taking time to read this Information Sheet and Consent Form. If 
you require further information about the study or wish to register an interest in 
participating, please contact me using the details below: 
Lydia Harper 
Cardiff University School of Social Sciences 
PhD Office 
1‒3 Museum Place  
Cardiff CF10 3BD 
HarperL@cardiff.ac.uk 
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Part 2: Consent Form 
 
Participant ID: 
 
  Please Initial Box 
 
I have read and understood the information leaflet (version 2.0 dated 09/10/15). 
I have had the opportunity to consider the information and ask questions and 
have had these answered satisfactorily. 
 
I understand that my participation is voluntary and that I am free to withdraw at 
any time without giving any reason.  
I agree/do not agree* to take part in an interview with the researcher which will 
be anonymised. (*Delete as appropriate)  
 
I agree/do not agree* to the interview being tape-recorded by the 
Interviewer.(*Delete as appropriate)  
 
I agree/ do not agree* to my data being sent to the UK Data Archaive 
and made available to third parties. (*Delete as appropriate)  
 
I acknowledge that my data may be used in the PhD thesis and academic or 
other publications. 
I acknowledge that I can request a summary of the study findings.   
 
I agree to take part in the above study.  
__________________  _________  ____________________ 
Research Participant     Date   Signature 
 
__________________  _________  ____________________ 
Name of Person taking  Date   Signature 
Consent 
 
When completed: 1 for participant; 1 (original) to be kept by researcher. 
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Appendix 5: Parental Information sheet and consent form (example) 
 
Parental Information Sheet and Parental Consent Form for Young People 
aged 13‒15 with LHON attending the eye clinic 
 
This Information Sheet and Consent Form is for the parents/guardians of young 
people who are being invited to participate in a study that will explore what it is 
like to live with the genetic eye condition known as Leber hereditary optic 
neuropathy (LHON). 
This form has two parts: 
 
 Information Sheet (gives you information about the study) 
 
 Parental Consent Form (this is where you sign if you agree that your child 
can participate). 
 
You will be given a copy of this form. 
 
Part 1: Information Sheet 
 
Introduction 
 
My name is Lydia Harper and I am a PhD Researcher at Cardiff University. As 
part of my degree I am inviting your child to take part in my research project 
which aims to discover what it is like to live with the genetic eye condition 
known as Leber hereditary optic neuropathy (LHON). My research is also 
concerned with how doctors give complex information to patients about their 
eye condition and the questions patients ask during their appointment. I would 
like to be present during your child’s appointment in the eye clinic. To do this 
this, I will require your permission. After you have heard more about the study, 
and if you agree, the next thing I will do is ask your child for their agreement as 
well. After the appointment in the eye clinic I would like to interview your child. 
Both of you have to agree independently before I can do this. You do not need 
to decide today whether or not you agree that your child can participate in this 
research. Before you decide, you can talk to anyone you feel comfortable with. 
If there is anything you do not understand, please ask me to stop as we go 
through the information and I will take time to explain. If you have any questions 
later, you can contact me by telephone, email or letter. 
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Your child’s involvement in the research will be voluntary, their medical 
treatment will not change, and I will not have access to their medical records. 
Before deciding whether you would like to participate, I would like you to 
understand the reasons for my research and what it may involve for you.  
Reading the information sheet will take around 10-20 minutes. Part 1 of this 
formation sheet tells you the purpose of the study and provides more detailed 
information. Part 2 is the consent form which you sign if you are happy for your 
child to participate.  If you would like your child to participate, please contact me 
by telephone or email. 
 
What is the purpose of the study? 
 
In recent years doctors have been able to find out much more about how to 
recognise and treat sight loss caused by genetic eye conditions. This means 
that there is now far more information available than ever before.   Some of the 
information is very complex and may be difficult to understand. My research is 
concerned with finding out how doctors diagnose genetic eye conditions, how 
doctors explain complex information to young people and how young people 
make sense of the information they are given.  
 
Who has reviewed the study? 
 
All research in the NHS is reviewed by an independent group of people, called a 
Research Ethics Committee, which is there to protect your child’s safety, rights, 
wellbeing and dignity. This project has been approved by the Wales REC 1. 
 
Why has my child been invited to participate? 
 
Your child has been invited to participate in the research because they have 
been referred to the genetic eye clinic. 
 
What will happen if my child takes part? 
 
If you agree to your child taking part, I will be in attendance during the 
appointment in the clinic.  During the appointment I will be taking notes and may 
also use a digital recording device to tape the conversation between your child 
and the ophthalmologist; this is to ensure that I accurately type up what was 
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said during the appointment. However, if you do not want me to record the 
appointment then I will not do so.  
 
Is participation in the study voluntary? 
 
Yes. You do not have to agree to your child taking part in the research. You can 
choose to say no and any services that you and your family receive at the 
hospital will not change. If you do agree to allow your child to participate, your 
child will also have to confirm that they would like to take part. If you change 
your mind later, you can withdraw your consent to your child’s participation in 
the research. Your child may also decide to withdraw from the research at any 
time. In the event that either you or your child decides to withdraw 
consent/assent, any information collected during the research will be destroyed 
securely. 
 
What are the potential benefits of my child taking part? 
The study will not help your child directly, but the information your child provides 
may help to improve the way in which children are dealt with in the eye clinic 
and how complex information is given to them.  The information obtained from 
your child may also help other people to understand what it is like at a young 
age to have a sudden loss of sight caused by LHON. 
 
What are the risks to my child in taking part? 
 
I will be present during your child’s appointment with the doctor. The doctor may 
ask your child sensitive questions about their eyesight and how it impacts on 
their ability to take part in daily activities. Your child may find talking about these 
things in front of me upsetting. However, this research has been designed to 
ensure that your child’s welfare is the most important consideration. If at any 
time your child finds talking about their eyesight in front of me distressing, the 
interview will be stopped. Your child can also decide not to participate in the 
research if it is too upsetting for them to carry on. If your child does decide to 
withdraw from the research any information I have collected will be destroyed. 
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What if I do not want my child to carry on with the study? 
 
If you decide you want your child to withdraw from the study, please contact me 
immediately. Any information that has been collected up to this point will be 
deleted. However, if at a later date you change your mind and want your child to 
participate then you can re-register an interest at any time during the study. If 
this happens, your child will also be asked to confirm that they wish to be 
involved in the research. 
 
Will I find out anything about the outcome of the study? 
 
Yes. At the end of the research, I will send you and your child a summary of the 
results.  I am also intending to use the results of the study as the basis for 
articles that may be printed in research journals, and for presentations at 
academic conferences. The data will be anonymised so that your child cannot 
be identified.  
 
What if I have a complaint about my child’s participation in the study? 
 
If you have concerns about the study, please do not hesitate to contact me, 
Lydia Harper, on 07715254962 or HarperL@cardiff.ac.uk. You may also contact 
my academic supervisors, Professor Adam Hedgecoe (02920 870027, 
HedgecoeAM@cardiff.ac.uk) or Professor Joanna Latimer (02920 876908, 
LatimerJE@cardiff.ac.uk). You may also wish to contact the Clinical Supervisor 
for this research: Dr Morgan, consultant ophthalmologist, St Tristan’s Hospital. If 
you remain unhappy and wish to complain formally, you should contact the 
Complaints Department by email: Concerns@wales.nhs.uk. 
 
What happens if my child is harmed while participating in the study? 
 
In the unlikely event that something goes wrong and your child is harmed during 
the research, and this is due to someone else’s negligence, then you may have 
grounds for a legal action for compensation against Cardiff University. The 
normal NHS complaints mechanism will still be available to you (if appropriate). 
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Will my child’s participation in the study be kept confidential? 
 
Yes. All the information about your child’s involvement in this study will be 
confidential. This means that neither you nor your child will be identified in any 
report or publication. The location of Dr Morgan’s clinic and the identities of 
everyone taking part in the study will be protected by being given false names 
or numerical codes. The data collected from your child (audio-recordings, typed-
up notes from your appointment and typed-up interview notes) will be stored 
securely either in a locked filing cabinet (which only I can access) on security-
controlled Cardiff University premises or on a password-protected Cardiff 
University computer and a password-protected USB computer device. The data 
will have your child’s name removed and replaced by a numerical code. The 
sheet containing these codes and your child’s contact details will be kept as 
manual records in a locked filing cabinet on security-controlled Cardiff 
University premises. After the PhD thesis is completed, your child’s data and 
details will be deleted and/or shredded in accordance with Cardiff University 
regulations. Please note you have the right to check the accuracy of the data 
that I hold. 
Who is organising and funding the study? 
 
This study is sponsored by Cardiff University and is funded by the Economic and 
Social Research Council (ESRC). 
 
What consequences will this have for the data collected? 
 
The ESRC requires that researchers send data to the UK Data Archive (UKDA). 
The data will include typed-up transcripts from the eye clinic appointment and 
the interview transcripts. The transcripts will be heavily edited to ensure that 
there are no identifiable individuals or locations. The data stored at the UKDA 
will be anonymised and made available to third parties. However, the data will 
only be sent to the UKDA and made available to third parties if both you and 
your child agree. The notes taken during the eye clinic appointment and the 
typed-up interview notes will be kept for a minimum period of five years from the 
end of the research. This is in accordance with Cardiff University’s data 
retention period. After five years, the data will be destroyed consistent with 
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Cardiff University’s ‘Complying with Data Protection and Freedom of 
Information’ policy. 
Further information and contact details 
 
Thank you for taking time to read this parental consent form. If you require 
further information about the study or wish to register an interest in participating, 
please contact me using the details below: 
Lydia Harper 
Cardiff University School of Social Sciences 
PhD Office 
1‒3 Museum Place,  
Cardiff CF10 3BD 
HarperL@cardiff.ac.uk 
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Participant ID: 
Part 2:  Parental Consent Form 
I have been asked to give consent for my child to participate in the above research 
study.  
Please Initial Box 
I confirm that I have read and understood the information        
sheet (version 2.0. 09/10/15). 
  
I have had the opportunity to consider the information and ask questions.  
I know I can ask further questions later if I want to.     
I understand my child’s participation is voluntary and my child     
may withdraw at any time without giving a reason and this will 
not affect my child’s medical treatment. 
 
I agree/do not agree* to the researcher being present during my  
child’s appointment in the eye clinic. (*Delete 
as appropriate) 
 
I agree/do not agree* to the appointment being tape-recorded. 
(*Delete as appropriate)  
 
I agree/do not agree* to my child taking part in an interview with 
the researcher. (*Delete as appropriate)  
 
 
I agree/do not agree* to my child’s data being sent to the  
UK Data Archive and made available to third parties.  
(*Delete as appropriate)  
 
I acknowledge that data collected during the study may be used   
 in the PhD thesis and academic publications. 
 
I acknowledge that I can request a summary of the study 
 and findings. 
 
I consent voluntarily for my child to participate in this research study. 
 
____________________      _________     _________________ 
Name of parent         Date   Signature 
/guardian 
 
 
___________________           _________    ___________________ 
Name of researcher                   Date               Signature  
When completed: 1 for participant; 1 (original) to be kept by researcher. 
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Appendix 6: Child participant information sheet and assent form (example) 
 
 Participant Information Sheet and Assent Form for Young People aged 13‒
15 with LHON attending the eye clinic 
 
This Information Sheet and Assent Form is for young people who have been 
referred to the genetic eye clinic, and who are being invited to participate in a 
study that will explore what it is like to live with the genetic eye condition known 
as Leber hereditary optic neuropathy. 
This Information Sheet and Assent Form has two parts: 
 Information Sheet (gives you information about the study) 
 Assent Form (this is where you sign if you agree to participate). 
You will be given a copy of this form. 
 
Part 1: Information Sheet 
Introduction 
My name is Lydia Harper and I am a PhD Researcher at Cardiff University. As 
part of my degree I am inviting you to take part in my research project which 
aims to discover what it is like to live with the genetic eye condition known as 
Leber hereditary optic neuropathy (LHON). My research is also concerned with 
how doctors give complex information to patients about their eye condition and 
the questions patients ask during their appointment. I would like to be present 
during your appointment in the eye clinic. To do this, you will have to agree. 
This study only talks about your experience of going to the clinics—you do not 
need to attend any extra appointments in the clinics.  I am going to give you 
information and invite you to take part in my research study. Your involvement 
will be voluntary, and your medical treatment will not change. I have discussed 
this research with your Mum, Dad or carer and they know that I am asking for 
your agreement. If you are going to participate in the research, they will also 
have to agree. If you do not wish to take part in the research, you do not have 
to. 
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You may discuss anything in this form with anyone you feel comfortable talking 
to. You can decide whether or not to take part after you have talked it over; you 
do not have to decide immediately. If there are words you do not understand or 
things you want me to tell you more about, please ask me to stop and I will take 
time to explain. 
Before deciding whether you wish to take part, I would like you to understand 
why this research is being done and what it involves for you. Reading this form 
will take about 20 minutes. Part 1 tells you all about the study and why it is 
being done. Part 2 is the assent form that you sign if you agree to being 
involved in the study. 
After you have heard more about the study, and if you agree, after your 
appointment in the eye clinic I would like to interview you. You do not need to 
decide today whether or not to participate in this research. Before you decide, 
you can talk to anyone you feel comfortable with. If there is anything you do not 
understand, please ask me to stop as we go through the information and I will 
take time to explain. If you have any questions later, you can contact me by 
telephone, email or letter. 
What is the purpose of the study? 
In recent years doctors have been able to find out much more about how to 
recognise and treat sight loss caused by genetic eye conditions. This means 
that there is now far more information available than ever before.  Some of the 
information may be very complex and difficult to understand. My research is 
interested in how the work of the genetic eye clinic is undertaken. My research 
is also concerned with how doctors explain complex information to young 
people and the questions young people ask during their appointment to make 
sense of the information they are given.  
Who has reviewed the study? 
Before my research can go ahead it has to be considered by a Research Ethics 
Committee. The committee makes sure that your interests are protected and 
that the research is carried out fairly. This project has been approved by the 
Wales REC 1.  
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Why are you inviting me to participate in the study? 
You have been invited to take part in the study because you attend the eye 
clinic. 
Do I have to do this? 
No. You do not have to be in this research if you do not want to. It is up to you. 
If you decide that you do not want to be involved in the research, that’s okay, it 
will not affect your medical treatment. If you decide to say “yes” now, you can 
change your mind later and that’s okay as well. 
What is going to happen to me? 
Firstly, I have already spoken to your parents or carer and discussed my 
research in more detail with them. Your parents or carer have indicated they are 
happy for me to speak to you. I will answer any questions you would like to ask 
me. If you agree to take part, I will be present when you have your appointment 
in the eye clinic. I will be taking notes and I may also use a digital recorder to 
record your conversation. However, if you do not want me to record the 
appointment then I will not do so. I am interested in how information is given to 
you about your eye condition and the questions you ask during the 
appointment. I will not be getting involved in your treatment. Your appointment 
will not take any longer than normal. I would also like to interview you after your 
appointment. Again, you do not have to agree to be interviewed. The choice is 
yours. 
What are the benefits of taking part? 
The study will not help you directly, but the information you provide may help to 
improve the way in which young people are dealt with in the eye clinic and how 
complex information is given to them. 
 
Are there any disadvantages or risks of taking part? 
I will be present during your appointment with the doctor. You may find it 
distressing to have me present when you are being asked sensitive questions 
about your eyesight. However, this research has been designed to ensure that 
your welfare is the most important consideration. If you do find talking about 
your eyesight in front of the researcher upsetting, then I will leave the 
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appointment. You can also decide not to be involved in the research anymore. If 
you do withdraw from the research any information collected about you will be 
destroyed. 
What if I do not want to carry on with the study? 
If you decide you do not want to carry on with the study, just tell your Mum, Dad 
or carer at any time. They will not be cross with you. Information that has 
already been collected up to this point will be deleted. However, if you later 
change your mind and wish to take part in the study you may re-register an 
interest. Should this happen, I will need to speak to your Mum, Dad or carer to 
confirm that they are still happy for you to participate. 
Will I find out anything about the outcome of the study? 
At the end of the research, I will send you and your Mum, Dad or carer a 
summary of the results. After this I will be telling more people about the 
research. I will be doing this by writing research articles that may be printed in 
educational journals, and by speaking at academic meetings. 
Who is organising and funding the study? 
The study is sponsored by Cardiff University and is funded by the Economic 
and Social Research Council (ESRC).  
What consequences will this have for the data collected? 
The ESRC requires that researchers send data to the UK Data Archive (UKDA). 
The data will include typed-up transcripts from the clinical appointments. The 
transcripts will be heavily edited to ensure that there are no identifiable 
individuals or locations. The data stored at the UKDA will be anonymised and 
made available to third parties. However, your data will only be sent to the 
UKDA or disclosed to third parties if you agree. The notes taken during the eye 
clinic appointment and will be kept for a minimum period of five years from the 
end of the research. This is in accordance with Cardiff University’s data 
retention period. After five years, the data will be destroyed consistent with 
Cardiff University’s ‘Complying with Data Protection and Freedom of 
Information’ policy. 
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What can I do if I have complaint? 
If you have concerns about the study, you should firstly tell your Mum, Dad or 
carer. You can also contact me, Lydia Harper (07715254962, 
HarperL@cardiff.ac.uk). You may also contact my supervisors, Adam 
Hedgecoe (02920 870027, HedgecoeAM@cardiff.ac.uk) or Joanna Latimer 
(02920 876908, LatimerJE@cardiff.ac.uk). You may also wish to contact Dr 
Morgan who is the doctor seeing you at in the eye clinic. 
What happens if I am harmed while participating in the study? 
In the unlikely event that something goes wrong and you are harmed during the 
research and this is due to someone else’s fault, you and your parents/guardian 
may have grounds to take legal action against Cardiff University. 
Will my participation in the study be kept confidential? 
Yes. All the information about your involvement in this study will be confidential. 
This means you will not be identified in any report or publication. Fake names or 
numerical codes will be given to the location of Dr Morgan’s clinic and the 
identities of everyone taking part in the study. The data collected from you 
(audio-recordings, typed-up notes from your appointment) will be stored 
securely either in a locked filing cabinet (which only I can access) on security-
controlled Cardiff University premises, or on a password-protected Cardiff 
University computer and a password-protected USB computer device. 
Further information and contact details 
Thank you for taking time to read this Information Sheet and Assent Form. If 
you require further information about the study or wish to register an interest in 
participating, please contact me using the details below: 
Lydia Harper 
Cardiff University School of Social Sciences 
PhD Office 
1‒3 Museum Place,  
Cardiff CF10 3BD 
HarperL@cardiff.ac.uk 
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Part 2:  Assent Form 
Young person (or, if unable, parent/guardian on their behalf) to circle all they 
agree with: 
Has somebody explained the research to you?    Yes/No 
Do you understand what the project is about?    Yes/No 
Have you asked all the questions you want?    Yes/No 
Have you had your questions answered in a way you    
understand ?        Yes/No 
Do you understand it’s OK to stop taking part at any time?  Yes/No 
 
Do you agree to the researcher being present during your  Yes/No 
appointment in the eye clinic? 
 
Do you agree to the researcher using a digital recorder  Yes/No 
during your appointment at the eye clinic? 
 
    
Do you agree to being interviewed by the researcher?   Yes/No 
 
Do you agree to your data being deposited at the UK Data  Yes/No 
Archive and made available to third parties? 
 
If you do want to take part, you can write your name below 
 
Your name     __________________    Date ____________ 
 
The person who explained this project to you needs to sign too: 
 
Print Name  ____________________________  
 
Signature ____________________________           
Date   ____________________________ 
Thank you for your help. 
When completed: 1 for participant; 1 (original) to be kept by researcher. 
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Appendix 7: Participant interview questions (example) 
 
Introductory question 
Tell me about your experience of living with LHON, starting with when you first 
noticed problems with your eyes. 
Conversational prompts 
What information were you given by the doctors about your eye condition? 
Do you think the doctors could have done more to help you with the emotional 
aspects of sight loss? 
Tell me a little more about your feelings when you were given your diagnosis. 
Did the relationship with your mother change after your diagnosis? If so, how did it 
change? 
Did the relationship with your siblings’ change? If so, how did it change? 
Do you feel your friends and work colleagues treated you differently after you lost 
your sight?  If so, give me some examples of how they treated you differently. 
Were you offered sight loss/genetic counselling after you lost your sight? 
When do you think the most appropriate time to have counselling would be?  
What was your lifestyle like before your diagnosis? 
Are there things you can no longer do? If so, what things do you miss doing? 
Do you use low vision aids? 
Has your attitude towards disability altered? 
Concluding question 
Is there anything else you would like to tell me about your experience of living with 
LHON? 
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